
<html lang="en"     class="pb-page"  data-request-id="55627877-bacd-42c3-8b32-3d0848ecf17c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2013.56.issue-14;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm400402q"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials" /></meta><meta name="dc.Creator" content="Thomas H.  Marsilje" /></meta><meta name="dc.Creator" content="Wei  Pei" /></meta><meta name="dc.Creator" content="Bei  Chen" /></meta><meta name="dc.Creator" content="Wenshuo  Lu" /></meta><meta name="dc.Creator" content="Tetsuo  Uno" /></meta><meta name="dc.Creator" content="Yunho  Jin" /></meta><meta name="dc.Creator" content="Tao  Jiang" /></meta><meta name="dc.Creator" content="Sungjoon  Kim" /></meta><meta name="dc.Creator" content="Nanxin  Li" /></meta><meta name="dc.Creator" content="Markus  Warmuth" /></meta><meta name="dc.Creator" content="Yelena  Sarkisova" /></meta><meta name="dc.Creator" content="Frank  Sun" /></meta><meta name="dc.Creator" content="Auzon  Steffy" /></meta><meta name="dc.Creator" content="AnneMarie C.  Pferdekamper" /></meta><meta name="dc.Creator" content="Allen G.  Li" /></meta><meta name="dc.Creator" content="Sean B.  Joseph" /></meta><meta name="dc.Creator" content="Young  Kim" /></meta><meta name="dc.Creator" content="Bo  Liu" /></meta><meta name="dc.Creator" content="Tove  Tuntland" /></meta><meta name="dc.Creator" content="Xiaoming  Cui" /></meta><meta name="dc.Creator" content="Nathanael S.  Gray" /></meta><meta name="dc.Creator" content="Ruo  Steensma" /></meta><meta name="dc.Creator" content="Yongqin  Wan" /></meta><meta name="dc.Creator" content="Jiqing  Jiang" /></meta><meta name="dc.Creator" content="Greg  Chopiuk" /></meta><meta name="dc.Creator" content="Jie  Li" /></meta><meta name="dc.Creator" content="W. Perry  Gordon" /></meta><meta name="dc.Creator" content="Wendy  Richmond" /></meta><meta name="dc.Creator" content="Kevin  Johnson" /></meta><meta name="dc.Creator" content="Jonathan  Chang" /></meta><meta name="dc.Creator" content="Todd  Groessl" /></meta><meta name="dc.Creator" content="You-Qun  He" /></meta><meta name="dc.Creator" content="Andrew  Phimister" /></meta><meta name="dc.Creator" content="Alex  Aycinena" /></meta><meta name="dc.Creator" content="Christian C.  Lee" /></meta><meta name="dc.Creator" content="Badry  Bursulaya" /></meta><meta name="dc.Creator" content="Donald S.  Karanewsky" /></meta><meta name="dc.Creator" content="H. Martin  Seidel" /></meta><meta name="dc.Creator" content="Jennifer L.  Harris" /></meta><meta name="dc.Creator" content="Pierre-Yves  Michellys" /></meta><meta name="dc.Description" content="The synthesis, preclinical profile, and in vivo efficacy in rat xenograft models of the novel and selective anaplastic lymphoma kinase inhibitor 15b (LDK378) are described. In this initial report, ..." /></meta><meta name="Description" content="The synthesis, preclinical profile, and in vivo efficacy in rat xenograft models of the novel and selective anaplastic lymphoma kinase inhibitor 15b (LDK378) are described. In this initial report, ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 26, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400402q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400402q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400402q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400402q" /></link>
        
    
    

<title>Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400402q" /></meta><meta property="og:title" content="Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0010.jpeg" /></meta><meta property="og:description" content="The synthesis, preclinical profile, and in vivo efficacy in rat xenograft models of the novel and selective anaplastic lymphoma kinase inhibitor 15b (LDK378) are described. In this initial report, preliminary structure–activity relationships (SARs) are described as well as the rational design strategy employed to overcome the development deficiencies of the first generation ALK inhibitor 4 (TAE684). Compound 15b is currently in phase 1 and phase 2 clinical trials with substantial antitumor activity being observed in ALK-positive cancer patients." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400402q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400402q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400402q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400402q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400402q&amp;href=/doi/10.1021/jm400402q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 5675-5690</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401005u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Featured Article</span><a href="/doi/10.1021/jm400328s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+H.++Marsilje">Thomas H. Marsilje</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Pei">Wei Pei</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bei++Chen">Bei Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenshuo++Lu">Wenshuo Lu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tetsuo++Uno">Tetsuo Uno</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yunho++Jin">Yunho Jin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Jiang">Tao Jiang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sungjoon++Kim">Sungjoon Kim</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nanxin++Li">Nanxin Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Warmuth">Markus Warmuth</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yelena++Sarkisova">Yelena Sarkisova</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Sun">Frank Sun</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Auzon++Steffy">Auzon Steffy</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=AnneMarie+C.++Pferdekamper">AnneMarie C. Pferdekamper</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allen+G.++Li">Allen G. Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sean+B.++Joseph">Sean B. Joseph</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Young++Kim">Young Kim</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bo++Liu">Bo Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tove++Tuntland">Tove Tuntland</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoming++Cui">Xiaoming Cui</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nathanael+S.++Gray">Nathanael S. Gray</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruo++Steensma">Ruo Steensma</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongqin++Wan">Yongqin Wan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiqing++Jiang">Jiqing Jiang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Greg++Chopiuk">Greg Chopiuk</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jie++Li">Jie Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=W.+Perry++Gordon">W. Perry Gordon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wendy++Richmond">Wendy Richmond</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Johnson">Kevin Johnson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Chang">Jonathan Chang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Todd++Groessl">Todd Groessl</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=You-Qun++He">You-Qun He</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Phimister">Andrew Phimister</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alex++Aycinena">Alex Aycinena</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian+C.++Lee">Christian C. Lee</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Badry++Bursulaya">Badry Bursulaya</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+S.++Karanewsky">Donald S. Karanewsky</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=H.+Martin++Seidel">H. Martin Seidel</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+L.++Harris">Jennifer L. Harris</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pierre-Yves++Michellys">Pierre-Yves Michellys</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="AFF-d240e277-autogenerated"><span class="aff-text">Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#e89885818b808d8484919ba88f868ec6879a8f"><span class="__cf_email__" data-cfemail="a0d0cdc9c3c8c5ccccd9d3e0c7cec68ecfd2c7">[email protected]</span></a>. Phone: (858) 332-4781.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400402q&amp;href=/doi/10.1021%2Fjm400402q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 5675–5690</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 6, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 March 2013</li><li><span class="item_label"><b>Published</b> online</span>26 June 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 July 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400402q" title="DOI URL">https://doi.org/10.1021/jm400402q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5675%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DThomas%2BH.%2BMarsilje%252C%2BWei%2BPei%252C%2BBei%2BChen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D14%26contentID%3Djm400402q%26title%3DSynthesis%252C%2BStructure%25E2%2580%2593Activity%2BRelationships%252C%2Band%2Bin%2BVivo%2BEfficacy%2Bof%2Bthe%2BNovel%2BPotent%2Band%2BSelective%2BAnaplastic%2BLymphoma%2BKinase%2B%2528ALK%2529%2BInhibitor%2B5-Chloro-N2-%25282-isopropoxy-5-methyl-4-%2528piperidin-4-yl%2529phenyl%2529-N4-%25282-%2528isopropylsulfonyl%2529phenyl%2529pyrimidine-2%252C4-diamine%2B%2528LDK378%2529%2BCurrently%2Bin%2BPhase%2B1%2Band%2BPhase%2B2%2BClinical%2BTrials%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5690%26publicationDate%3DJuly%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400402q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">11156</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">249</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400402q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;H. Marsilje&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Pei&quot;},{&quot;first_name&quot;:&quot;Bei&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Wenshuo&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Tetsuo&quot;,&quot;last_name&quot;:&quot;Uno&quot;},{&quot;first_name&quot;:&quot;Yunho&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Sungjoon&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Nanxin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Warmuth&quot;},{&quot;first_name&quot;:&quot;Yelena&quot;,&quot;last_name&quot;:&quot;Sarkisova&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Auzon&quot;,&quot;last_name&quot;:&quot;Steffy&quot;},{&quot;first_name&quot;:&quot;AnneMarie&quot;,&quot;last_name&quot;:&quot;C. Pferdekamper&quot;},{&quot;first_name&quot;:&quot;Allen&quot;,&quot;last_name&quot;:&quot;G. Li&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;B. Joseph&quot;},{&quot;first_name&quot;:&quot;Young&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Bo&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Tove&quot;,&quot;last_name&quot;:&quot;Tuntland&quot;},{&quot;first_name&quot;:&quot;Xiaoming&quot;,&quot;last_name&quot;:&quot;Cui&quot;},{&quot;first_name&quot;:&quot;Nathanael&quot;,&quot;last_name&quot;:&quot;S. Gray&quot;},{&quot;first_name&quot;:&quot;Ruo&quot;,&quot;last_name&quot;:&quot;Steensma&quot;},{&quot;first_name&quot;:&quot;Yongqin&quot;,&quot;last_name&quot;:&quot;Wan&quot;},{&quot;first_name&quot;:&quot;Jiqing&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Greg&quot;,&quot;last_name&quot;:&quot;Chopiuk&quot;},{&quot;first_name&quot;:&quot;Jie&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;W.&quot;,&quot;last_name&quot;:&quot;Perry Gordon&quot;},{&quot;first_name&quot;:&quot;Wendy&quot;,&quot;last_name&quot;:&quot;Richmond&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Johnson&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Todd&quot;,&quot;last_name&quot;:&quot;Groessl&quot;},{&quot;first_name&quot;:&quot;You-Qun&quot;,&quot;last_name&quot;:&quot;He&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Phimister&quot;},{&quot;first_name&quot;:&quot;Alex&quot;,&quot;last_name&quot;:&quot;Aycinena&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;C. Lee&quot;},{&quot;first_name&quot;:&quot;Badry&quot;,&quot;last_name&quot;:&quot;Bursulaya&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;S. Karanewsky&quot;},{&quot;first_name&quot;:&quot;H.&quot;,&quot;last_name&quot;:&quot;Martin Seidel&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;L. Harris&quot;},{&quot;first_name&quot;:&quot;Pierre-Yves&quot;,&quot;last_name&quot;:&quot;Michellys&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;5675-5690&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400402q&quot;},&quot;abstract&quot;:&quot;The synthesis, preclinical profile, and in vivo efficacy in rat xenograft models of the novel and selective anaplastic lymphoma kinase inhibitor 15b (LDK378) are described. In this initial report, preliminary structure–activity relationships (SARs) are described as well as the rational design strategy employed to overcome the development deficiencies of the first generation ALK inhibitor 4 (TAE684). Compound 15b is currently in phase 1 and phase 2 clinical trials with substantial antitumor activity being observed in ALK-positive cancer patients.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400402q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400402q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400402q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400402q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400402q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400402q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400402q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400402q&amp;href=/doi/10.1021/jm400402q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400402q" /></input><a href="/doi/pdf/10.1021/jm400402q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400402q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400402q%26sid%3Dliteratum%253Aachs%26pmid%3D23742252%26genre%3Darticle%26aulast%3DMarsilje%26date%3D2013%26atitle%3DSynthesis%252C%2BStructure%25E2%2580%2593Activity%2BRelationships%252C%2Band%2Bin%2BVivo%2BEfficacy%2Bof%2Bthe%2BNovel%2BPotent%2Band%2BSelective%2BAnaplastic%2BLymphoma%2BKinase%2B%2528ALK%2529%2BInhibitor%2B5-Chloro-N2-%25282-isopropoxy-5-methyl-4-%2528piperidin-4-yl%2529phenyl%2529-N4-%25282-%2528isopropylsulfonyl%2529phenyl%2529pyrimidine-2%252C4-diamine%2B%2528LDK378%2529%2BCurrently%2Bin%2BPhase%2B1%2Band%2BPhase%2B2%2BClinical%2BTrials%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D14%26spage%3D5675%26epage%3D5690%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jmcmar.2013.56.issue-14/production/jmcmar.2013.56.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The synthesis, preclinical profile, and in vivo efficacy in rat xenograft models of the novel and selective anaplastic lymphoma kinase inhibitor <b>15b</b> (LDK378) are described. In this initial report, preliminary structure–activity relationships (SARs) are described as well as the rational design strategy employed to overcome the development deficiencies of the first generation ALK inhibitor <b>4</b> (TAE684). Compound <b>15b</b> is currently in phase 1 and phase 2 clinical trials with substantial antitumor activity being observed in ALK-positive cancer patients.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18487" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18487" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase of the insulin receptor superfamily. Expression of ALK in normal human tissues is only found in a subset of neural cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> However, altered expression and hyperactivation of ALK as a consequence of translocations or point mutations have been demonstrated to be an essential oncogenic lesion in a number of cancers.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> To date, no essential role has been found for ALK in mammals. Mice deficient in ALK have normal development and display an antidepressive phenotype with enhanced performance in hippocampus-dependent tasks, potentially due to increased hippocampal progenitor cells.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Deregulation of ALK was first identified in anaplastic large cell lymphoma (ALCL), where the tyrosine kinase domain is fused to nucleophosmin (NPM), a product of recurrent t(2;5)(p23;q35) chromosomal translocation.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Subsequently, chromosomal rearrangements resulting in ALK fused to various partner genes have been found in nearly 70% of ALCL, 40–60% of inflammatory myofibroblastic tumors (IMT),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> a few dozen cases of diffuse large B-cell lymphoma (DLBCL), and most recently in 2–7% of non-small-cell lung cancer (NSCLC).<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> Among fusion partner genes identified to date, NPM is the most common partner in ALCL and echinoderm microtubule-associated protein-like 4 (EML4) is the main partner in NSCLC. In addition to the chromosomal rearrangements that result in ALK fusion genes, amplification of ALK gene and activating point mutations in the full length ALK gene have recently been reported in neuroblastoma,<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> inflammatory breast cancer,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and ovarian cancer.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">Multiple pharmaceutical companies have described ALK inhibitors (ALKi) at various stages of development.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24">(16-24)</a> Structures of ALKi in clinical development are depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. Compound <b>1</b> (PF-02341066, crizotinib)<a onclick="showRef(event, 'ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28">(25-28)</a> was approved in 2011 by the FDA to treat ALK-positive NSCLC patients. Other ALK inhibitors, including <b>3</b> (CH5424802, Roche/Chugai),<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a><b>5</b> (ASP3026, Astellas),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a><b>2</b> (X-396, X-Covery),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> AP26113 (Ariad Pharmaceuticals. structure undisclosed, series exemplified as compound <b>6</b>),<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> Tesaro (structure undisclosed), and <b>15b</b> (LDK378, Novartis),<a onclick="showRef(event, 'cit35a'); return false;" href="javascript:void(0);" class="ref cit35a">(35a)</a> are currently in phase 1/2 clinical trials.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected ALK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In this report, we describe the work we performed around the previously disclosed ALKi <b>4</b> (TAE684).<a onclick="showRef(event, 'cit35b'); return false;" href="javascript:void(0);" class="ref cit35b">(35b)</a> This research allowed us to find novel and selective ALK inhibitors with potent in vivo efficacy in ALCL and NSCLC rat xenograft models as well as improved development characteristics, leading to the discovery of compound <b>15b</b>.</div><div class="NLM_p">Compound <b>4</b> is a potent ALK inhibitor; however, it was found to form an extensive number of reactive adducts upon metabolic oxidation, which creates the potential for significant toxicological liabilities. Semiquantitative LC–MS analysis indicated that approximately 20% of <b>4</b> is converted into reactive species when incubated in liver microsomes (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), and these reactive species can be trapped using glutathione (GSH).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Although no correlation was found between hepatotoxic drugs and the formation of GSH adducts,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> it has been postulated that reactive metabolites may have a role in idiosyncratic<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and/or other toxicities.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">A systematic evaluation of various compounds from the historical SAR data set revealed that the reactive metabolite formation was primarily correlated with the presence of a solubilizing group connected by a nitrogen atom onto the central aniline moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). It is hypothesized that metabolic oxidation of the electron-rich aromatic ring undergoes the formation of a 1,4-diiminoquinone moiety (A), which is highly reactive and forms adducts in the presence GSH (B).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hypothesized mechanism of reactive adduct formation from <b>4</b> or <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Analogue Design and Chemistry</h3><div class="NLM_p">On the basis of modeling information,<a onclick="showRef(event, 'cit35b'); return false;" href="javascript:void(0);" class="ref cit35b">(35b)</a> previous work in our laboratories has focused on increasing the kinase selectivity of <b>4</b> by modifying the methoxy moiety. This work resulted in finding that other alkoxy groups, such as an isopropoxy moiety (<b>7</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), were also well tolerated for ALK (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) while having a positive effect on improved overall kinase selectivity (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>, Figure S9) and reducing the potential metabolic liability associated with methoxy moieties.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> However, it was also found that the formation of reactive adducts observed with <b>7</b> and closely related analogues (unpublished results) was independent of the nature of alkoxy moiety present on the molecules (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), confirming our hypothesis stated in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. With this information in hand, we took the decision to re-evaluate the SAR around this scaffold and focus our efforts toward eradicating the reactive adducts that prevented <b>4</b> and some close analogues like <b>7</b> to enter into development. In order to reach this goal, we chose to retain the isopropylsulfoneaniline as well as the isopropoxy moieties, since these were shown to be important for potent and selective ALK inhibition. Variations on this theme were synthesized and profiled (e.g., cyclobutylsulfoneaniline, <i>N</i>,<i>N</i>-dimethylsulfonamide) to determine the moiety with the best overall development profile. We also replaced the isopropoxy with a cyclobutyloxy moiety, which is well-tolerated by ALK. For the compounds described in this report, we also kept the pyrimidine hinge-binding core constant, changing only the 5-chloro substituent to a 5-methyl in the case of compounds <b>18a</b>–<b>d</b>. As an additional point of comparison, <b>23</b>, which replaces the pyrimidine core with a pyridine, was synthesized. The focus of this report is on the SAR of the 4-position aniline “tail” containing the solubilizing moiety. The SAR changes are highlighted in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. Additional, broader SAR explorations will be discussed in future publications.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure–activity relationship overview.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With the aim of designing novel derivatives that would not form reactive adducts, we made the rational design decision to reverse the piperidine at the para position of the aniline moiety present in the series of compounds represented by <b>4</b> in order to remove the possibility of a 1,4-diiminoquinone formation. We also designed the inclusion of a methyl group para to the isopropoxy moiety in order to further reduce metabolism on the interior phenyl ring, thereby further reducing the possibility of forming reactive metabolites.</div><div class="NLM_p">The syntheses of the compounds <b>15a</b>–<b>e</b>, <b>16a</b>,<b>b</b>, <b>17a</b>–<b>i</b>, <b>18a</b>–<b>d</b>, <b>19</b>, <b>20</b>, and <b>23</b> are shown in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The aniline moieties <b>8a</b>,<b>b</b> were synthesized in two steps from 2-fluoronitrobenzene according to a known procedure.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a><b>8c</b> was synthesized in a very straightforward way from 2-nitrobenzenesulfonyl chloride.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a><b>8a</b>–<b>c</b> were then coupled to 2,3,5-trichloropyrimidine or 2,4-dichloro-5-methylpyrimidine to afford compounds <b>9a</b>–<b>d</b> in acceptable overall yield (40–61%). The anilines <b>13a</b>–<b>e</b> were synthesized in five to six synthetic steps from 2-chloro-4-fluorotoluene or 3-chlorofluorobenzene, while <b>13f</b> was synthesized from 2,4-dichloro-5-nitropyrimidine using an identical synthetic route. Nitration<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> of 2-chloro-4-fluorotoluene or 3-chlorofluorobenzene using KNO<sub>3</sub> in H<sub>2</sub>SO<sub>4</sub> yielded the corresponding nitro derivatives <b>10a</b>,<b>b</b>. Condensation of <b>10a</b>,<b>b</b> with isopropanol or cyclobutanol (60 °C in the presence of K<sub>2</sub>CO<sub>3</sub> in DMF/DMSO) afforded <b>11a</b>–<b>c</b> in excellent yield (>80%). Suzuki coupling of <b>11a</b>–<b>c</b> with 4-pyridineboronic acid afforded <b>12a</b>–<b>c</b> in >70% yield. N-Methylation of <b>12b</b> followed by global reduction (NaBH<sub>4</sub> followed by PtO<sub>2</sub>/H<sub>2</sub>) generated <b>13d</b>. Alternatively, concomitant reduction of the pyridine and the nitro group present in <b>12a</b>–<b>c</b> using PtO<sub>2</sub>/H<sub>2</sub> afforded the piperidine–aniline intermediates, which were subsequently protected, generating the Boc derivatives <b>13a</b>–<b>c</b> in good yields (>60%). Compound <b>13e</b> was synthesized by condensation of 2-methoxy-4-pyridylboronic acid onto <b>11b</b>, followed by demethylation of the methoxy group (refluxing concentrated HCl in dioxane) and reduction of the pyridine ring (PtO<sub>2</sub>/H<sub>2</sub>). For the syntheses of <b>15a</b>–<b>e</b>, <b>16a</b>,<b>b</b>, <b>17a</b>–<b>i</b>, <b>18a</b>–<b>d</b>, <b>19</b>, <b>20</b>, <b>9a</b>–<b>d</b> were typically coupled to the aniline <b>13a</b>–<b>f</b> using a modified Buchwald coupling (Xantphos (10%), Pd(OAc)<sub>2</sub> (5%), Cs<sub>2</sub>CO<sub>3</sub> (3 equiv), THF, MW, 150 °C). Aside from <b>16a</b>,<b>b</b> and <b>19</b>, this was followed by Boc deprotection (TFA, CH<sub>2</sub>Cl<sub>2</sub>). Finally, subsequent piperidine alkylation or acylation afforded <b>17a</b>–<b>i</b> and <b>18a</b>–<b>d</b> in good overall yields. Compounds <b>19</b> and <b>20</b> followed a similar synthetic route except <b>9a</b> was coupled to 2-isopropoxy-5-methyl-4-(2-oxopiperidin-4-yl)benzenaminium 2,2,2-trifluoroacetate for <b>19</b> and <b>13f</b> in the case of <b>20</b>. In order to synthesize compound <b>23</b>, we had to reverse the synthetic sequence. Amination of 4-bromo-2,5-dichloropyridine with <b>13d</b> (Xantphos, Pd(OAc)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, THF, MW, 150 °C) afforded <b>22</b> in 41% yield. <b>22</b> was subsequently aminated with <b>8a (</b>Pd<sub>2</sub>(dba)<sub>3</sub>, dicyclohexyl(2,4,6- triisopropylphenyl)phosphine, NaO<i><sup>t</sup></i>Bu THF, MW, 150 °C) to afford <b>23</b> in 11% yield.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, DMF/DMSO, 0–20 °C ; (b) KNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 0–20 °C; (c) alcohol, Cs<sub>2</sub>CO<sub>3</sub>, 60 °C; (d) 4-pyridineboronic acid, dioxane/H<sub>2</sub>O or 1-BuOH (Pd<sub>2</sub>(dba)<sub>3</sub>, 2-dicyclohexylphosphine-2′,6′-dimethoxy biphenyl, MW, 150 °C.; (e) AcOH/TFA, PtO<sub>2</sub>, H<sub>2</sub>; (f) anhydrous CH<sub>2</sub>Cl<sub>2</sub>, TEA, Boc<sub>2</sub>O, 20 °C; (g) CH<sub>3</sub>I, THF, 40 °C, sealed tube; (h) NaBH<sub>4</sub>, CH<sub>3</sub>OH, 0–20 °C; (i) (2-methoxypyridin-4-yl)boronic acid, Pd<sub>2</sub>dba<sub>3</sub>, 2-dicyclohexylphosphine-2′,6′-dimethoxybiphenyl, K<sub>3</sub>PO<sub>4</sub>, 1-BuOH, 150 °C; (j) concentrated HCl, dioxane, reflux.</p></p></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Xantphos, Pd(OAc)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, THF, MW, 150 °C; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (c) RBr (or RI), Et<sub>3</sub>N, DMF, 20 °C or <i>N</i>-methyl-4-piperidone, 1,2-dichloroethane, NaBH(OAc)<sub>3</sub>, AcOH, RT in the case of <b>17e</b>; (d) ClC(O)CH<sub>2</sub>N(Me)<sub>2</sub>·HCl, Et<sub>3</sub>N, 20 °C; (e) Pd<sub>2</sub>(dba)<sub>3</sub>, dicyclohexyl(2,4,6-triisopropylphenyl)phosphine, NaO<sup><i>t</i></sup>Bu THF, MW, 150 °C.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> In Vitro SAR</h3><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> shows the in vitro cellular activity of compounds <b>1</b>, <b>4</b>, <b>7</b>, <b>15a</b>–<b>e</b>, <b>16a</b>,<b>b</b>, <b>17a</b>–<b>i</b>, <b>18a</b>–<b>d</b>, <b>19</b>, <b>20</b>, and <b>23</b> against Ba/F3-NPM-ALK, Ba/F3-Tel-InsR, and in Karpas299 cells. Since we had very potent starting points (compounds <b>4</b> and <b>7</b>) for this second-generation ALK inhibitor project, we decided to evaluate ALK inhibition directly in a cellular context by measuring the proliferation of Ba/F3 cells expressing the NPM-ALK or Tel-InsR fusion protein. Wild-type (WT) Ba/F3 cells were used as counterscreen in order to check for nonspecific cytotoxicity or interference with coexpressed luciferase which was used to monitor cell proliferation. Antiproliferative activity was monitored using the Karpas299 cell line which is a well-established line isolated from ALK-positive ALCL tumors possessing the NPM-ALK fusion. The data for the compounds described in this report are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Activity Profile of Compounds <b>1</b>, <b>4</b>, <b>7</b>, <b>15a</b>–<b>e</b>, <b>16a</b>,<b>b</b>, <b>17a</b>–<b>i</b>, <b>18a</b>–<b>d</b>, <b>19</b>, <b>20</b>, and <b>23</b><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">Ba/F3-NPM-ALK</th><th class="colsep0 rowsep0" align="center">Ba/F3-Tel-InsR</th><th class="colsep0 rowsep0" align="center">Ba/F3-WT</th><th class="colsep0 rowsep0" align="center">Karpas299</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">150.8 ± 17.8</td><td class="colsep0 rowsep0" align="left">1643 ± 272.0</td><td class="colsep0 rowsep0" align="left">3479 ± 180.0</td><td class="colsep0 rowsep0" align="left">64.2 ± 6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">3.7 ± 0.5</td><td class="colsep0 rowsep0" align="left">43.7 ± 7.3</td><td class="colsep0 rowsep0" align="left">1336 ± 279.1</td><td class="colsep0 rowsep0" align="left">2.4 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">24.8 ± 7.9</td><td class="colsep0 rowsep0" align="left">414.0 ± 81.0</td><td class="colsep0 rowsep0" align="left">3395 ± 600</td><td class="colsep0 rowsep0" align="left">25.5 ± 7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="left">10.6 ± 1.7</td><td class="colsep0 rowsep0" align="left">281.8 ± 28.2</td><td class="colsep0 rowsep0" align="left">3013 ± 154.0</td><td class="colsep0 rowsep0" align="left">7.8 ± 2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left">26.0 ± 0.3</td><td class="colsep0 rowsep0" align="left">319.5 ± 23.5</td><td class="colsep0 rowsep0" align="left">2477 ± 448.0</td><td class="colsep0 rowsep0" align="left">22.8 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15c</b></td><td class="colsep0 rowsep0" align="left">40.6 ± 5.5</td><td class="colsep0 rowsep0" align="left">541.5 ± 54.0</td><td class="colsep0 rowsep0" align="left">2884 ± 194.0</td><td class="colsep0 rowsep0" align="left">13.1 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15d</b></td><td class="colsep0 rowsep0" align="left">38.1 ± 2.2</td><td class="colsep0 rowsep0" align="left">197.2 ± 26.2</td><td class="colsep0 rowsep0" align="left">2460 ± 260.0</td><td class="colsep0 rowsep0" align="left">13.5 ± 2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15e</b></td><td class="colsep0 rowsep0" align="left">17.3 ± 5.9</td><td class="colsep0 rowsep0" align="left">510.0 ± 50.0</td><td class="colsep0 rowsep0" align="left">2517 ± 406.0</td><td class="colsep0 rowsep0" align="left">13.1 ± 9.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">11.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">464 ± 42.0</td><td class="colsep0 rowsep0" align="left">3997 ± 24.6</td><td class="colsep0 rowsep0" align="left">11.2 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="left">25.0 ± 5.3</td><td class="colsep0 rowsep0" align="left">339.0 ± 33.0</td><td class="colsep0 rowsep0" align="left">1190 ± 110.0</td><td class="colsep0 rowsep0" align="left">14.3 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="left">32.1 ± 3.8</td><td class="colsep0 rowsep0" align="left">344.5 ± 40.0</td><td class="colsep0 rowsep0" align="left">4120 ± 475.0</td><td class="colsep0 rowsep0" align="left">11.1 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="left">29.9 ± 4.4</td><td class="colsep0 rowsep0" align="left">240.1 ± 53.6</td><td class="colsep0 rowsep0" align="left">3855 ± 215.0</td><td class="colsep0 rowsep0" align="left">14.5 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17c</b></td><td class="colsep0 rowsep0" align="left">8.1 ± 2.3</td><td class="colsep0 rowsep0" align="left">326.5 ± 58.5</td><td class="colsep0 rowsep0" align="left">4336 ± 285.0</td><td class="colsep0 rowsep0" align="left">8.1 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17d</b></td><td class="colsep0 rowsep0" align="left">43.5 ± 6.0</td><td class="colsep0 rowsep0" align="left">349.0 ± 38.5</td><td class="colsep0 rowsep0" align="left">4973 ± 310.0</td><td class="colsep0 rowsep0" align="left">16.1 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17e</b></td><td class="colsep0 rowsep0" align="left">258.4 ± 49.7</td><td class="colsep0 rowsep0" align="left">1186 ± 92.5</td><td class="colsep0 rowsep0" align="left">1420 ± 107.5</td><td class="colsep0 rowsep0" align="left">100.3 ± 19.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17f</b></td><td class="colsep0 rowsep0" align="left">305.7 ± 105.2</td><td class="colsep0 rowsep0" align="left">4874 ± 290.0</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">293.5 ± 81.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17g</b></td><td class="colsep0 rowsep0" align="left">88.9 ± 20.9</td><td class="colsep0 rowsep0" align="left">891.5 ± 106.0</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">15.3 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17h</b></td><td class="colsep0 rowsep0" align="left">16.5 ± 3.2</td><td class="colsep0 rowsep0" align="left">361.1 ± 42.3</td><td class="colsep0 rowsep0" align="left">7543 ± 1050</td><td class="colsep0 rowsep0" align="left">7.9 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17i</b></td><td class="colsep0 rowsep0" align="left">25.8 ± 3.4</td><td class="colsep0 rowsep0" align="left">416.0 ± 49.0</td><td class="colsep0 rowsep0" align="left">2737 ± 113.0</td><td class="colsep0 rowsep0" align="left">21.7 ± 5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18a</b></td><td class="colsep0 rowsep0" align="left">14.6 ± 2.6</td><td class="colsep0 rowsep0" align="left">375.3 ± 24.6</td><td class="colsep0 rowsep0" align="left">4077 ± 173.3</td><td class="colsep0 rowsep0" align="left">15.6 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18b</b></td><td class="colsep0 rowsep0" align="left">29.4 ± 3.6</td><td class="colsep0 rowsep0" align="left">401.0 ± 32.0</td><td class="colsep0 rowsep0" align="left">4005 ± 480.0</td><td class="colsep0 rowsep0" align="left">10.5 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18c</b></td><td class="colsep0 rowsep0" align="left">63.6 ± 6.9</td><td class="colsep0 rowsep0" align="left">1643 ± 126.0</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">23.8 ± 2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18d</b></td><td class="colsep0 rowsep0" align="left">44.0 ± 5.0</td><td class="colsep0 rowsep0" align="left">418.0 ± 31.0</td><td class="colsep0 rowsep0" align="left">4407 ± 290.0</td><td class="colsep0 rowsep0" align="left">22.4 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">48.3 ± 7.8</td><td class="colsep0 rowsep0" align="left">784.0 ± 112.0</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">38.4 ± 4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">36.4 ± 4.6</td><td class="colsep0 rowsep0" align="left">564.0 ± 74.0</td><td class="colsep0 rowsep0" align="left">3800 ± 200.0</td><td class="colsep0 rowsep0" align="left">33.3 ± 4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">4240 ± 1360</td><td class="colsep0 rowsep0" align="left">1920 ± 890.0</td><td class="colsep0 rowsep0" align="left">5412 ± 330.0</td><td class="colsep0 rowsep0" align="left">5510 ± 2190</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">All data given in nM and are an average of at least duplicate measurements.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. GSH-Trapping Results of Derivatives <b>4</b>, <b>7</b>, <b>15b</b>, <b>15e</b>, <b>17a</b>, <b>17e</b>, and <b>18a</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">GSH-trapping result (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">∼20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">∼19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15e</b></td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17e</b></td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18a</b></td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr></tbody></table></div></div><div class="NLM_p">Overall, most substitutions on the nitrogen of the piperidine were fairly well-tolerated (most cellular IC<sub>50</sub> values against ALK ranged from 10 to 50 nM). Among the compounds tested, derivatives such as <b>15a</b>, <b>16a</b>, and <b>17c</b> approached the potency of compound <b>4</b> and were more potent than <b>7</b>. They were only approximately 2- to 3-fold less potent in the Ba/F3-NPM-ALK assay, and they possessed a better selectivity window versus the insulin receptor compared to <b>4</b> (InsR, 25- to 40-fold versus 11- and 15-fold for <b>4</b> and <b>7</b>, respectively). Most compounds tested had an IC<sub>50</sub> for NPM-ALK below 50 nM. However, it is interesting to note that addition of p<i>K</i><sub>a</sub> modulating moieties [such as a 2,2-trifluoroethyl group (<b>17f</b>) or an acetic acid (<b>17g</b>)] decreased ALK inhibition activity. In contrast, addition of an acetamide (<b>17h</b>) or a <i>N</i>,<i>N</i>-dimethylaminoacetate (<b>17i</b>) or conversion to a cyclic lactam (<b>19</b>) was well-tolerated for ALK inhibition and retained selectivity versus InsR. A similar trend was observed in the Karpas299 cell line. <b>23</b>, in which we replaced the pyrimidine core with a pyridine, resulted in a large loss of potency. This observation is likely the result of a conformational difference due to the lack of the N<sup>3</sup> in compound <b>23</b> preventing it to adopt the correct conformation needed for potent activity. We synthesized and profiled a number of minor variations of <b>15b</b> to identify the best development candidate. Substitutions in <b>15d</b>, <b>15e</b>, <b>16b</b>, and <b>20</b> were tolerated but did not show any significant development advantages over <b>15b</b>. A selected set of the compounds from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> was tested in the GSH-trapping assay to evaluate their potential to form reactive adducts. The data are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. All the derivatives tested were found to have close to undetectable levels of GSH adducts (<1%) when submitted to the same assay conditions as <b>4</b> and <b>7</b> (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>, Figures S1–S4), experimentally confirming the validity of our rational designs.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking of <b>15b</b> in the ALK kinase domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Modeling and Docking</h3><div class="NLM_p">We performed molecular modeling of <b>15b</b> based upon the reported crystal structure of TAE684 with the kinase domain of ALK.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> As expected, the ligand makes hydrogen bonds at the hinge area via the pyrimidine and amino nitrogen atoms onto the backbone nitrogen and oxygen of Met<sub>1199</sub> respectively. Our model, shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, does not show the hydrogen bond between the carbonyl oxygen of Met<sub>1199</sub> and the amino nitrogen of the inhibitor, even though they are within the range of a typical hydrogen bond, both distance- and angle-wise. The reason is that these two atoms occupy different planes, probably because of constraints of the crystal structure. We expect that they form a hydrogen bond in the context of a conformationally flexible protein in solution. The central pyrimidine ring of the inhibitor is sandwiched between Ala<sub>1148</sub> and Leu<sub>1256</sub> and its chlorine substituent is directed toward the back of the pocket, making hydrophobic contact with gatekeeper Leu<sub>1196</sub>. The piperidine ring extends to the solvent and is engaged in a salt bridge with Glu<sub>1210</sub>. The sulfonyl makes an intramolecular H-bond with the amine and is directed at Lys<sub>1150</sub>. The isopropyl substituent bends down into the cavity formed by amino acids Arg<sub>1253</sub>, Asn<sub>1254</sub>, Cys<sub>1255</sub>, Leu<sub>1256</sub>, Gly<sub>1260</sub>, and Asp<sub>1270</sub>. The isopropoxy group fits into a pocket formed by side chains of Arg<sub>1120</sub> and Glu<sub>1132</sub> and the Leu<sub>1198</sub>-Ala<sub>1200</sub>-Gly<sub>1201</sub>-Gly<sub>1202</sub> hinge segment.</div><div class="NLM_p last">While this model was not primarily used for compound optimization, it does correlate well with some of the SAR observations. For example, the lower potency of <b>17e</b> compared to <b>15b</b> may be explained by a greater number of rotatable bonds (entropic effect) present in <b>17e</b> as well as its greater mobility in the bound state. The latter follows from a difference in docking poses. In <b>15b</b>, the terminal piperidine fits closely to the protein surface and makes a salt bridge with E1210. In <b>17e</b>, by contrast, the corresponding central piperidine ring is pushed up into the solvent. This allows the formation of a salt bridge between its terminal piperidine and E1210 of the enzyme. The fact that <b>17e</b> has reduced surface contact with protein (see Figure S7 in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>) leads to its greater mobility. This can be demonstrated by conducting mixed Monte Carlo multiple minimum (MCMM)/LLMOD (large scale low mode) conformational search available in MacroModel 9.9 (Schrodinger, Inc., Portland, OR, 2012). The MCMM/LLMOD simulations revealed much greater mobility in the <b>17e</b> complex, especially in its terminal piperidine and the side chain of E1210 (see Figure S8 in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). We hypothesize that this greater mobility of <b>17e</b> translates into its weaker binding potency.</div></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> ADME SAR</h3><div class="NLM_p">A selected set of these derivatives were evaluated for their ADME properties. Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> shows a summary of liver microsome intrinsic clearance, CYP3A4 inhibition, high throughput (HT) solubility, and hERG inhibition (dofetilide binding assay) for <b>15a</b>,<b>b</b>, <b>15e</b>, <b>16a</b>, <b>17c</b>, <b>17i</b>, <b>18a</b>, and <b>20</b>. The selected compounds have relatively good metabolic stability when tested in liver microsomes.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Moderate CYP3A4 (midazolam substrate) inhibition was observed for these derivatives without a clear SAR trend. A wide range of solubility values was observed, which was largely dependent on the p<i>K</i><sub>a</sub> of the amine appended to the molecule. As expected, some hERG inhibition was also seen (again correlating well with the p<i>K</i><sub>a</sub> of the amine moiety). hERG patch clamp experiments showed IC<sub>50</sub> of 46 and 20 μM, respectively, for <b>15b</b> and <b>18a</b>. Compound <b>15b</b> was further evaluated in vivo in both dog and monkey telemetry studies, and no evidence of QTc prolongation was observed (data not shown).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. ADME Profile of Selected Derivatives</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">CL<sub>int</sub> (m, r, h)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">CYP3A4<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">HTsol<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">hERG<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="left">15, 15, 15</td><td class="colsep0 rowsep0" align="left">1.4 ± 0.2</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">5.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left">15, 10, 19</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.3</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">1.25<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15e</b></td><td class="colsep0 rowsep0" align="left">15, 15, 15</td><td class="colsep0 rowsep0" align="left">7.3 ± 0.8</td><td class="colsep0 rowsep0" align="left"><2</td><td class="colsep0 rowsep0" align="left">3.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">15, 4, 17</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.4</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">3.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17c</b></td><td class="colsep0 rowsep0" align="left">15, 14, 15</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">2.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17i</b></td><td class="colsep0 rowsep0" align="left">45, 21, 46</td><td class="colsep0 rowsep0" align="left">0.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">24.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18a</b></td><td class="colsep0 rowsep0" align="left">15, 14, 8</td><td class="colsep0 rowsep0" align="left">9.8 ± 1.2</td><td class="colsep0 rowsep0" align="left">144</td><td class="colsep0 rowsep0" align="left">1.1<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">21, 18, 16</td><td class="colsep0 rowsep0" align="left">9.3 ± 0.8</td><td class="colsep0 rowsep0" align="left">138</td><td class="colsep0 rowsep0" align="left">0.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Clearance (CL<sub>int</sub>) is in μL min<sup>–1</sup> mg<sup>–1</sup> in liver microsomes.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Data in μM. Inhibition measured using midazolam as substrate.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Data in μM measured from DMSO solution in buffer adjusted to pH 6.8.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Data in μM in hERG dofetilide binding assay.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">Follow-up hERG patch clamp data are shown in the body of paper.</p></div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Full in Vitro and in Vivo Profiling of <b>15b</b></h3><div class="NLM_p">Additional profiling of compound <b>15b</b> for its kinase selectivity and pharmacokinetic profile was performed. Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> display a selected enzymatic and cellular kinase profile of <b>15b</b>, and Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> displays its PK profile in mouse, rat, dog, and monkey. Compound <b>15b</b> displays a remarkable selectivity profile when tested against an enzyme panel of 30 kinases, showing biochemical inhibition below 100 nM for only three kinases: IGF-1R, InsR, and STK22D with IC<sub>50</sub> values of 8, 7, and 23 nM, respectively. Compound <b>15b</b> is very potent against ALK at the enzymatic level (IC<sub>50</sub> of 200 pM); thus, its selectivity against these off-targets is 80-, 70-, and 230-fold, respectively. When tested in a cellular proliferation panel of 18 kinases, <b>15b</b> proved to be very selective. Aside from ALK, no inhibition below 100 nM was observed for all kinases tested and the potent inhibitions observed for IGF-1R and FLT3 at the enzymatic level proved to be nonreproducible in a cellular context (IC<sub>50</sub> of 410 and 3143 nM, respectively). Likewise, cellular inhibition of FGFR2 and FGFR4 was found to be >2 μM. We could not establish a cellular assay for STK22D, but its inhibition was deemed not to be prohibitive for clinical development.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Enzymatic Kinase Profile of <b>15b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ABL</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">FGFR4</td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="left">LYN</td><td class="colsep0 rowsep0" align="left">0.84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKT</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">FLT3</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">cMET</td><td class="colsep0 rowsep0" align="left">3.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALK</td><td class="colsep0 rowsep0" align="left">0.0002</td><td class="colsep0 rowsep0" align="left">GSK3β</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">MKNK2</td><td class="colsep0 rowsep0" align="left">2.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aurora</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">IGF-1R</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">PAK2</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BTK</td><td class="colsep0 rowsep0" align="left">3.36</td><td class="colsep0 rowsep0" align="left">InsR</td><td class="colsep0 rowsep0" align="left">0.007</td><td class="colsep0 rowsep0" align="left">PDGFRα</td><td class="colsep0 rowsep0" align="left">1.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK2</td><td class="colsep0 rowsep0" align="left">3.97</td><td class="colsep0 rowsep0" align="left">JAK1</td><td class="colsep0 rowsep0" align="left">3.73</td><td class="colsep0 rowsep0" align="left">RET</td><td class="colsep0 rowsep0" align="left">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK4</td><td class="colsep0 rowsep0" align="left">4.72</td><td class="colsep0 rowsep0" align="left">JAK2</td><td class="colsep0 rowsep0" align="left">0.61</td><td class="colsep0 rowsep0" align="left">ROCK2</td><td class="colsep0 rowsep0" align="left">1.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">JAK3</td><td class="colsep0 rowsep0" align="left">7.92</td><td class="colsep0 rowsep0" align="left">SYK</td><td class="colsep0 rowsep0" align="left">3.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR2</td><td class="colsep0 rowsep0" align="left">0.26</td><td class="colsep0 rowsep0" align="left">cKit</td><td class="colsep0 rowsep0" align="left">1.28</td><td class="colsep0 rowsep0" align="left">STK22D</td><td class="colsep0 rowsep0" align="left">0.023</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR3</td><td class="colsep0 rowsep0" align="left">0.43</td><td class="colsep0 rowsep0" align="left">LCK</td><td class="colsep0 rowsep0" align="left">0.56</td><td class="colsep0 rowsep0" align="left">ZAP70</td><td class="colsep0 rowsep0" align="left">9.7</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Cellular Kinase Profile of <b>15b</b> in Ba/F3 Cells</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-ALK</td><td class="colsep0 rowsep0" align="left">40.7 ± 5.3</td><td class="colsep0 rowsep0" align="left">Tel-JAK2</td><td class="colsep0 rowsep0" align="left">2160 ± 320</td><td class="colsep0 rowsep0" align="left">Tel-RET</td><td class="colsep0 rowsep0" align="left">2304 ± 459</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EML4-ALK</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.5</td><td class="colsep0 rowsep0" align="left">Tel-KDR</td><td class="colsep0 rowsep0" align="left">4210 ± 170</td><td class="colsep0 rowsep0" align="left">Tel-Ros</td><td class="colsep0 rowsep0" align="left">141.8 ± 22.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-FGFR3</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">Tel-ckit</td><td class="colsep0 rowsep0" align="left">2855 ± 215</td><td class="colsep0 rowsep0" align="left">Tel-Src</td><td class="colsep0 rowsep0" align="left">1694 ± 276</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-FGR</td><td class="colsep0 rowsep0" align="left">1947 ± 433</td><td class="colsep0 rowsep0" align="left">Tel-Lck</td><td class="colsep0 rowsep0" align="left">672 ± 264</td><td class="colsep0 rowsep0" align="left">Tel-TRKA</td><td class="colsep0 rowsep0" align="left">2727 ± 222</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-FLT3</td><td class="colsep0 rowsep0" align="left">3143 ± 933</td><td class="colsep0 rowsep0" align="left">Tel-LYN</td><td class="colsep0 rowsep0" align="left">2306 ± 552</td><td class="colsep0 rowsep0" align="left">Tel-TRKB</td><td class="colsep0 rowsep0" align="left">1829 ± 80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-IGF-1R</td><td class="colsep0 rowsep0" align="left">410 ± 10</td><td class="colsep0 rowsep0" align="left">Tel-Met</td><td class="colsep0 rowsep0" align="left">1339 ± 74</td><td class="colsep0 rowsep0" align="left">Tel-WT</td><td class="colsep0 rowsep0" align="left">3250 ± 710</td></tr></tbody></table></div></div><div class="NLM_p">Compound <b>15b</b> was tested in mouse, rat, dog, and monkey for its PK profile (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The compound exhibited low plasma clearance in animals (mouse, rat, dog, and monkey) compared to liver blood flow. The volume of distribution at steady state (<i>V</i><sub>ss</sub>) was high and approximately 10-fold greater than total body water. Half-life (<i>T</i><sub>1/2</sub>) ranged from moderate to long (6.2–26 h). Following a single oral administration of <b>15b</b> as a solution or suspension, the oral bioavailability was good (≥55%) in mouse, rat, dog, and monkey. Time of maximal concentration (<i>T</i><sub>max</sub>) occurred consistently late in animal species tested, indicating slow oral absorption. Overall, <b>15b</b> displays a consistent PK profile across all species tested. Although compound <b>15a</b>, which deletes the methyl para to the alkoxy group in <b>15b</b>, was fully tolerated by ALK, <b>15a</b> displayed significantly worse oral bioavailability in rat compared to <b>15b</b> (<i>F</i> = 12% vs <i>F</i> = 66%).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Mouse, Rat, Dog, and Monkey PK Parameters of <b>15b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">mouse</th><th class="rowsep1 colsep0" colspan="2" align="center">rat</th><th class="rowsep1 colsep0" colspan="2" align="center">dog</th><th class="rowsep1 colsep0" colspan="2" align="center">monkey</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">iv<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">po<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">iv<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">po<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">iv<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">po<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">iv<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">po<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (h·nM)</td><td class="colsep0 rowsep0" align="left">5634</td><td class="colsep0 rowsep0" align="left">12296</td><td class="colsep0 rowsep0" align="left">2779</td><td class="colsep0 rowsep0" align="left">6092</td><td class="colsep0 rowsep0" align="left">18096</td><td class="colsep0 rowsep0" align="left">67904</td><td class="colsep0 rowsep0" align="left">11305</td><td class="colsep0 rowsep0" align="left">76325</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">26.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">36.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">12.8</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">9.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">21.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">13.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (nM)</td><td class="colsep0 rowsep0" align="left">1756</td><td class="colsep0 rowsep0" align="left">696</td><td class="colsep0 rowsep0" align="left">770</td><td class="colsep0 rowsep0" align="left">259</td><td class="colsep0 rowsep0" align="left">2329</td><td class="colsep0 rowsep0" align="left">1899</td><td class="colsep0 rowsep0" align="left">2526</td><td class="colsep0 rowsep0" align="left">1697</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">7.0</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">7.0</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">9.1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">119</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">56</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Formulated in a solution of 75% polyethylene 300 and 25% dextrose (5%) in water.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Formulated in a solution of 30% propylene glycol and 5% Solutol in phosphate-buffered saline.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Formulated in a suspension of 0.5% (w/v) aqueous methylcellulose and 0.5% Tween 80.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">Formulated in a suspension of 0.5% (w/v) aqueous methylcellulose.</p></div></div></div><div class="NLM_p">Compound <b>15b</b> was tested for in vivo efficacy in 2-week Karpas299 (sc injection of Karpas299 cells possessing the NPM-ALK fusion) and H2228 (sc injection of H2228 cells possessing the EML4-ALK fusion) rat xenograft models. Doses were chosen to be 6.25, 12.5, 25, and 50 mg/kg daily dosing for the Karpas299 study and 5, 10, and 25 mg/kg daily dosing for the H2228 study. The efficacy of <b>15b</b> in these two models is summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a and Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b. In the Karpas299 study, <b>15b</b> induced a dose-dependent growth inhibition (tumor growth inhibition factor <i>T</i>/<i>C</i> = 74% at 6.25 mg/kg; <i>T</i>/<i>C</i> = 30% at 12.5 mg/kg) and tumor regression (<i>T</i>/<i>C</i> = −33% at 25 mg/kg and <i>T</i>/<i>C</i> = −66% at 50 mg/kg). In the H2228 study, <b>15b</b> induced a dose-dependent growth inhibition (<i>T</i>/<i>C</i> = 67% at 5 mg/kg; <i>T</i>/<i>C</i> = 2% at 10 mg/kg) and complete tumor regression at 25 mg/kg (<i>T</i>/<i>C</i> = −100% at 25 mg/kg). In both models, <b>15b</b> was well tolerated and no body-weight loss was observed at all doses tested (Figures S5 and S6, <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). These results are consistent with our previous observations (Karpas299 is a much more aggressive in vivo model than H2228) and with the relative potency of <b>15b</b> against the NPM-ALK and EML4-ALK fusions (26.0 and 2.2 nM, respectively)</div><div class="NLM_p">A single-dose PK/PD experiment was performed in the rat Karpas299 model at 50 mg/kg, and the biomarker pSTAT3 response correlated well with the tumor regression observed in the xenograft study. Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> shows the plot of plasma and tumor drug concentrations (left-hand side of the graph) versus pSTAT3 inhibition (right-hand side of the graph). Upon single-dose oral administration at 50 mg/kg, sustained pSTAT3 inhibition (about 80%) was observed through 72 h, which paralleled the sustained tumor concentrations of <b>15b</b>.</div><div class="NLM_p">In contrast to the first-generation ALK inhibitor <b>4</b>, compound <b>15b</b> showed no impact on insulin levels or plasma glucose utilization (tested via an oral glucose tolerance test) in the mouse upon chronic dosing up to 100 mg/kg (data not shown). This lack of in vivo effect on insulin receptor was confirmed using a homeostasis model assessment of insulin resistance (HOMA-IR; OGTT/ITT ratio) in the same animals (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). This in vivo selectivity is not fully understood at this time (the in vitro selectivity versus the InsR is comparable between <b>4</b> and <b>15b</b>) but indicates an additional advantage of <b>15b</b> over <b>4</b>.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Efficacy of <b>15b</b> in a 14-day rat xenograft Karpas299 model. (b) Efficacy of <b>15b</b> in a 14-day rat xenograft H2228 model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Single-dose PK/PD relationship of <b>15b</b> (50 mg/kg) in the rat Karpas299 model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. HOMA-IR results of <b>15b</b> and <b>4</b> after 7 days of dosing in mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have described the synthesis of novel, selective, and potent ALK inhibitors. Medicinal chemistry intuition and rational design were used to specifically and successfully address the extensive reactive adduct formation liability present in the first-generation clinical candidate <b>4</b>. Compound <b>15b</b> proved to have an acceptable overall profile (selectivity, ADME) and a consistent PK profile across species (mouse, rat, dog, and monkey) and displayed strong in vivo efficacy in ALCL and NSCLC cancer xenograft models at well-tolerated doses. Compound <b>15b</b> also showed an improved profile in terms of in vivo glucose homeostasis over <b>4</b> when examined in mouse OGTT experiments. For these reasons, compound <b>15b</b> was chosen to move into development and is currently being evaluated in ALK-positive patients<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> where it has displayed substantial preliminary antitumor clinical activity.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38432" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38432" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless otherwise noted, materials were obtained from commercial suppliers and were used without further purification. Removal of solvent under reduced pressure or concentration refers to distillation using Büchi rotary evaporator attached to a vacuum pump (3 mmHg). Products obtained as solids or high boiling oils were dried under vacuum (1 mmHg).</div><div class="NLM_p">Purification of compounds by preparative RP-HPLC was achieved using a Waters autopurification system consisting of a 2767 autosampler/fraction collector, a 2525 binary gradient module, a 2487 UV detector, and a ZQ mass spectrometer. Compounds were purified using a flow rate of 30 mL/min with a 50 mm × 20 mm i.d. Ultra 120, 5 μm C18Q column (Peeke Scientific, Novato, CA). A 7.5 min linear gradient from 10% solvent A (acetonitrile with 0.035% trifluoroacetic acid) in solvent B (water with 0.05% trifluoroacetic acid) to 30–90% A was used, followed by a 2.5 min hold at 90% A. Silica gel chromatography was performed either by CombiFlash (separation system Sg. 100c, ISCO) or using silica gel (Merck Kieselgel 60, 230–400 mesh). Elemental analyses were carried out by Midwest Microlabs LLC, Indianapolis, IN. <sup>1</sup>H NMR spectra were recorded on a Bruker XWIN-NMR (400 MHz) spectrometer. Proton resonances are reported in parts per million (ppm) downfield from tetramethylsilane (TMS). <sup>1</sup>H NMR data are reported as multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; quint, quintuplet; sept septuplet; dd, doublet of doublets; dt, doublet of triplets; bs, broad singlet). For spectra obtained in CDCl<sub>3</sub>, DMSO-<i>d</i><sub>6</sub>, and CD<sub>3</sub>OD, the residual protons (7.27, 2.50, and 3.31 ppm, respectively) were used as the internal reference.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Purity of Compounds</h3><div class="NLM_p last">All compounds were analyzed with a Waters ZQ 2000 LC/MS system, which used an Agilent binary pump and photodiode array detector (PDA) along with a Sedere 75 evaporative light scattering detector (ELSD). Samples were injected from 96-well or 384-well plates with a Leap Technologies HTS Pal autosampler. The mobile phases used were (A) H<sub>2</sub>O + 0.05% TFA and (B) acetonitrile + 0.035% TFA. A gradient HPLC method with flow of 1.0 mL/min started at 5% B, with a hold of 0.1 min before a linear increase to 95% B at 2.70 min. At 2.71 min the B mobile phase was increased to 100% and held until 2.98 min. Total run time was 3.0 min. The column used was a Waters Atlantis dC18 2.1 mm × 30 mm, 3 μm. The mass spectrometer was operated in positive mode, with a spray voltage of 3.2 kV and cone voltage of 30 V. The source and desolvation temperatures were 130 and 400 °C, respectively, with 600 L/h of nitrogen desolvation flow. The progress of reactions and the purity of products were measured using 254 and 220 nm wavelengths and electrospray ionization (ESI) positive mode. Mass spectra were obtained in ESI positive mode. All the reported compounds were found to be >95% when analyzed at the 254 nm wavelength.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Synthesis of 2-Chloro-<i>N</i>-(2-(isopropylsulfonyl)phenyl)-5-methylpyrimidin-4-amine <b>9b</b></h3><div class="NLM_p last">To a suspension of 730 mg of NaH in a mixture of DMF/DMSO (25/2.5 mL) was added dropwise at 0 °C 2.53 g (12.69 mmol) of 2-(isopropylsulfonyl)benzenamine <b>8a</b> in DMF/DMSO (10 mL, ratio 9/1). The solution was stirred for 30 min at 0 °C, and then 4.11 g (25.3 mmol, 2 equiv) of 2,4-dichloro-5-methylpyrimidine diluted in 10 mL of DMF/DMSO (ratio: 9/1) was added slowly. The solution was warmed to room temperature and stirred overnight. After aqueous workup, the crude product was directly crystallized from cold CH<sub>3</sub>CN in several batches to afford 2.53 g (7.75 mmol, 61%) of 2-chloro-<i>N</i>-(2-(isopropylsulfonyl)phenyl)-5-methylpyrimidin-4-amine <b>9b</b> as pale creamy colored crystals: ESMS <i>m</i>/<i>z</i> 326.1 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.29 (s, 1H), 8.41 (dd, <i>J</i> = 0.9, 8.3 Hz, 1H), 8.23 (d, <i>J</i> = 0.8 Hz, 1H), 7.93–7.78 (m, 2H), 7.48–7.37 (m, 1H), 3.58–3.43 (m, 1H), 2.18 (s, 3H), 1.16 (d, <i>J</i> = 6.8 Hz, 6H).</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis of 2,5-Dichloro-<i>N</i>-(2-(isopropylsulfonyl)phenyl)pyrimidin-4-amine <b>9a</b></h3><div class="NLM_p last">By use of the same procedure described for the synthesis of 2-chloro-<i>N</i>-(2-(isopropylsulfonyl)phenyl)-5-methylpyrimidin-4-amine <b>9b</b>, 2,5-dichloro-<i>N</i>-(2-(isopropylsulfonyl)phenyl)pyrimidin-4-amine <b>9a</b> was isolated in 60% yield as a creamy colored solid from <b>8a</b> and 2,4,5-trichloropyrimidine: ESMS <i>m</i>/<i>z</i> 346.0 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.81 (s, 1H), 8.57 (s, 1H), 8.32 (d, <i>J</i> = 8.3 Hz, 1H), 7.96–7.82 (m, 2H), 7.56–7.42 (m, 1H), 3.61–3.46 (m, 1H), 1.16 (d, <i>J</i> = 6.8 Hz, 6H).</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis of 2-Chloro-4-fluoro-5-nitrotoluene <b>10b</b></h3><div class="NLM_p last">To a solution of 100 g (0.7 mol) of 2-chloro-4-fluorotoluene in 250 mL of concentrated H<sub>2</sub>SO<sub>4</sub> was added portionwise 85 g (0.875 mol) of KNO<sub>3</sub> at 0 °C (addition of the total amount of KNO<sub>3</sub> was complete in about 1 h). The reddish mixture was slowly warmed to room temperature, stirred overnight, then poured over crushed ice and extracted with EtOAc. The organic layers were combined, dried over MgSO<sub>4</sub>, and concentrated. The crude oil was purified over a large silica plug (eluent, 97/3 hexanes/EtOAc) to afford 94.7 g (0.5 mol, yield 71%) of 2-chloro-4-fluoro-5-nitrotoluene <b>10b</b> as a pale yellow oil that solidifies upon standing. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 Mz): δ 7.97 (d, <i>J</i> = 8.0 Hz, 1H), 7.32 (d, <i>J</i> = 10.4 Hz, 1H), 2.43 (s, 3H).</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis of 2-Chloro-4-isopropoxy-5-nitrotoluene <b>11b</b></h3><div class="NLM_p last">To a solution of 25 g (0.131 mol) of 2-chloro-4-fluoro-5-nitrotoluene <b>10b</b> in 250 mL of 2-propanol was added 208 g (0.659 mol, 5 equiv) of Cs<sub>2</sub>CO<sub>3</sub>. The mixture was stirred at 60 °C overnight, and after cooling to room temperature, most of the 2-propanol was evaporated under reduced pressure. Water was added, and the solution was extracted with EtOAc. The organic layers were combined, dried over MgSO<sub>4</sub>, concentrated, and the crude product was filtered through a silica plug (eluent, 95/5 hexanes/EtOAc) to afford 28.7 g (0.125 mol, 95%) of 2-chloro-4-isopropoxy-5-nitrotoluene <b>11b</b> as a pale yellow fluffy solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.90 (d, <i>J</i> = 0.6 Hz, 1H), 7.52 (s, 1H), 4.92–4.76 (m, 1H), 2.30 (s, 3H), 1.27 (d, <i>J</i> = 6.0 Hz, 6H).</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthesis of 4-(5-Isopropoxy-2-methyl-4-nitrophenyl)pyridine <b>12b</b></h3><div class="NLM_p last">4-Pyridineboronic acid (147 mg, 1.20 mmol, 1.1 equiv) was dissolved in a 2:1 v/v mixture of dioxane and H<sub>2</sub>O (15 mL), and N<sub>2</sub> was bubbled through for 5 min. Pd<sub>2</sub>dba<sub>3</sub> (100 mg, 0.109 mmol, 0.1 equiv), 2-dicyclohexylphosphine-2′-6′-dimethoxybiphenyl (112 mg, 0.272 mmol, 0.25 equiv), 1-chloro-5-isopropoxy-2-methyl-4-nitrobenzene (<b>11b</b>, 250 mg, 1.09 mmol, 1.0 equiv), and K<sub>3</sub>PO<sub>4</sub> (462 mg, 2.18 mmol, 2.0 equiv) were added under a N<sub>2</sub> blanket. The reaction vessel was sealed and heated with microwave irradiation to 150 °C for 20 min. After cooling to room temperature, the reaction was diluted with ethyl acetate and washed twice with 1 N aqueous NaOH. The organic layer was then dried over Na<sub>2</sub>SO<sub>4</sub> and filtered. After concentration, the crude product was purified by silica gel chromatography (gradient from hexanes to 30% ethyl acetate in hexanes) to give 217 mg (0.798 mmol, 73%) of 4-(5-isopropoxy-2-methyl-4-nitrophenyl)pyridine (<b>12b</b>) as a brown solid. ESMS <i>m</i>/<i>z</i> 273.1 (M + H<sup>+</sup>).</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis of 2-Isopropoxy-5-methyl-4-(1-methyl-piperidin-4-yl)phenylamine (<b>13d</b>)</h3><div class="NLM_p">4-(5-Isopropoxy-2-methyl-4-nitrophenyl)pyridine (<b>12b</b>, 217 mg, 0.798 mmol) was dissolved in anhydrous THF (9 mL). Iodomethane (0.10 mL, 1.61 mmol, 2 equiv) was added and the mixture was stirred at 40 °C in a sealed tube for 2 days. The volatiles were removed under vacuum, generating 4-(5-isopropoxy-2-methyl-4-nitrophenyl)-1-methylpyridinium iodide as a brown solid directly used in the next step: ESMS <i>m</i>/<i>z</i> 287.1 (M<sup>+</sup>).</div><div class="NLM_p last">4-(5-Isopropoxy-2-methyl-4-nitrophenyl)-1-methylpyridinium iodide (0.80 mmol) was dissolved in CH<sub>3</sub>OH (20 mL) and cooled to 0 °C. NaBH<sub>4</sub> (302 mg, 8.0 mmol, 10 equiv) was slowly added. After this addition was complete, the cooling bath was removed and the mixture was stirred at room temperature for 2.5 h. The reaction was quenched by the slow addition of 1 N aqueous HCl (14 mL). The CH<sub>3</sub>OH was partially removed by vacuum, and the resulting residue was partitioned between EtOAc and 1 N aqueous NaOH. Additional 50% aqueous NaOH was added until the aqueous layer pH was >12. The EtOAc layer was washed twice with 1 N aqueous NaOH. The organic layer was then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. After concentration, the crude product (175 mg) was dissolved in acetic acid (10 mL). TFA (0.15 mL, 3 equiv) and PtO<sub>2</sub> (53 mg, 30% w/w) were added, and the mixture was placed under 50 psi of H<sub>2</sub> gas in a Parr shaker for 14 h. The reaction mixture was filtered and the filtrate concentrated under vacuum. The resulting residue was partitioned between EtOAc and 1 N aqueous NaOH. Additional 50% aqueous NaOH was added until the aqueous layer pH was >12. The EtOAc layer was washed with 1 N aqueous NaOH (2×), and then the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum to give 2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenylamine <b>13b</b> (161 mg, 77%): ESMS <i>m</i>/<i>z</i> 263.2 (M + H<sup>+</sup>).</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthesis of 4-(4-Amino-5-isopropoxy-2-methylphenyl)piperidin-2-one <b>13e</b></h3><div class="NLM_p">1-Chloro-5-isopropoxy-2-methyl-4-nitrobenzene <b>11b</b> (275 mg, 1.20 mmol, 1.0 equiv) was dissolved in 1-butanol (6 mL), and N<sub>2</sub> is bubbled through for 5 min. Pd<sub>2</sub>dba<sub>3</sub> (55 mg, 0.06 mmol, 0.05 equiv), 2-dicyclohexylphosphine-2′-6′-dimethoxybiphenyl (50 mg, 0.12 mmol, 0.1 equiv), (2-methoxypyridin-4-yl)boronic acid (239 mg, 1.56 mmol, 1.3 equiv), and K<sub>3</sub>PO<sub>4</sub> (497 mg, 2.4 mmol, 2.0 equiv) were added under a N<sub>2</sub> blanket. The reaction vessel was sealed and heated at 150 °C overnight. After the mixture was cooled to room temperature, the solvent was removed under reduced pressure and the residue was purified by silica gel chromatography (gradient from 0% to 20% ethyl acetate in hexanes) to give 130 mg of 4-(5-isopropoxy-2-methyl-4-nitrophenyl)-2-methoxypyridine as a yellow oil. ESMS <i>m</i>/<i>z</i> 303.1 (M + H<sup>+</sup>). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 Mz): δ 8.21 (d, <i>J</i> = 5.6 Hz, 1H), 7.70 (s, 1H), 7.08 (s, 1H), 6.96 (dd, <i>J</i> = 5.6, 1.6 Hz, 1H), 6.79 (s, 1H), 4.75 (m, 1H), 3.97 (s, 3H), 2.22 (s, 3H), 1.34 (d, <i>J</i> = 6.0 Hz, 6H).</div><div class="NLM_p">4-(5-Isopropoxy-2-methyl-4-nitrophenyl)-2-methoxypyridine (130 mg, 0.43 mmol) was dissolved in 1,4-dioxane (8.0 mL), and concentrated HCl (1.0 mL) was added. The resulting mixture was refluxed overnight. After the mixture was cooled to room temperature, the solvent was removed under reduced pressure and the crude product, 4-(5-isopropoxy-2-methyl-4-nitrophenyl)pyridin-2-ol, was used directly for the next step without further purification. ESMS <i>m</i>/<i>z</i> 289.1 (M + H<sup>+</sup>). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 Mz): δ 8.00 (d, <i>J</i> = 6.4 Hz, 1H), 7.65 (s, 1H), 7.12 (s, 1H), 7.05 (dd, <i>J</i> = 6.4, 1.6 Hz, 1H), 6.92 (d, <i>J</i> = 1.6 Hz, 1H), 4.70 (m, 1H), 2.19 (s, 3H), 1.26 (d, <i>J</i> = 6.0 Hz, 6H).</div><div class="NLM_p last">To the above product, 4-(5-isopropoxy-2-methyl-4-nitrophenyl)pyridin-2-ol, in TFA (8.0 mL) was added PtO<sub>2</sub> (9.8 mg). The mixture was purged with H<sub>2</sub> and stirred at room temperature overnight under 1 atm of H<sub>2</sub> (g). After filtration through Celite, the filtrate was concentrated to yield the crude product 4-(4-amino-5-isopropoxy-2-methylphenyl)piperidine-2-one <b>13e</b>, which was used directly for the next step without further purification. ESMS <i>m</i>/<i>z</i> 263.1 (M + H<sup>+</sup>).</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Synthesis of <i>tert</i>-Butyl 4-(5-Amino-4-isopropoxypyrimidin-2-yl)piperidine-1-carboxylate <b>13f</b></h3><div class="NLM_p last">A mixture of 194.0 mg (1.0 mmol) of 2,4-dichloro-5-nitropyrimidine, 138 mg of K<sub>2</sub>CO<sub>3</sub> (1.0 mmol) and 5 mL of IPA was heated at 40 °C for 16 h. After cooling to RT, workup and concentration, the residue was purified over silica gel column chromatography to afford 115.0 mg (0.53 mmol, yield: 53%) of 2-chloro-4-isopropoxy-5-nitropyrimidine <b>14</b>. ESMS <i>m</i>/<i>z</i> = 217.0 (M + H). A degassed mixture of 109 mg (0.5 mmol) of 2-chloro-4-isopropoxypyrimidin-5-amine, 230 mg (0.75 mmol) of <i>tert</i>-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2<i>H</i>)-carboxylate, Pd(OAc)<sub>2</sub> (10 mg, 0.044 mmol), Xantphos (20 mg, 0.034 mmol), K<sub>3</sub>PO<sub>4</sub> (350 mg, 1.5 mmol) in 1.5 mL of THF was heated to 85 °C for 24 h. After cooling at room temperature, the mixture was filtered, concentrated, and dissolved in 5 mL of dry MeOH, and 5 mg of Pd/C was added. The resulting mixture was flushed with N<sub>2</sub> and placed under H<sub>2</sub> atmosphere (balloon) ON. After filtration and concentration, the residue was purified over SiO<sub>2</sub> column to afford 20 mg (0.059 mmol, yield 12%) of <i>tert</i>-butyl 4-(5-amino-4-isopropoxypyrimidin-2-yl)piperidine-1-carboxylate <b>13f</b> as an oil. ESMS <i>m</i>/<i>z</i> 337.2 (M + H<sup>+</sup>).</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of 4-(4-Amino-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester <b>13b</b></h3><div class="NLM_p last">4-(5-Isopropoxy-2-methyl-4-nitrophenyl)pyridine <b>12b</b> (438 mg, 1.61 mmol) dissolved in acetic acid (30 mL) was treated with TFA (0.24 mL, 3.22 mmol) and PtO<sub>2</sub> (176 mg, 40% w/w). The reaction mixture was vigorously stirred under 1 atm of H<sub>2</sub> for 36 h. The reaction mixture was filtered, and the filtrate was concentrated under vacuum. The resulting residue was diluted with ethyl acetate and washed twice with 1 N aqueous NaOH. The organic layer was then dried over Na<sub>2</sub>SO<sub>4</sub> and filtered. After concentration, the crude product (391 mg) was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (30 mL). TEA was added (0.44 mL, 3.15, 2 equiv) followed by Boc<sub>2</sub>O (344 mg, 1.6 equiv). The mixture was stirred at room temperature for 30 min and then concentrated under vacuum. The resulting residue was purified by silica gel chromatography (gradient from hexanes to 30% ethyl acetate in hexanes) to give 4-(4-amino-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylic acid <i>tert</i>-butyl ester <b>13b</b> (340 mg, 0.976 mmol, yield 60% over two steps) as a sticky foam: ESMS <i>m</i>/<i>z</i> 293.1 (M – <i><sup>t</sup></i>Bu + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.61 (s, 1H), 6.76 (s, 1H), 4.64–4.45 (m, 1H), 4.22 (d, <i>J</i> = 13.2, 2H), 2.90 (m, 3H), 2.28 (s, 3H), 1.73 (d, <i>J</i> = 12.2, 2H), 1.54 (d, <i>J</i> = 11.4, 2H), 1.52 (s, 9H), 1.31 (d, <i>J</i> = 6.0, 6H).</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Synthesis of 4-(4-Amino-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester <b>13a</b></h3><div class="NLM_p last"><b>13a</b> was synthesized according to the same procedure described for <b>13b</b> from 660 mg (3.40 mmol) of 2-isopropoxy-4-(pyridin-4-yl)aniline <b>12a</b> in 58% overall yield (660 mg isolated, 1.97 mmol). ESMS <i>m</i>/<i>z</i> 335.2 (M + H<sup>+</sup>).</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Synthesis of <i>tert</i>-Butyl 4-(4-Amino-5-cyclobutoxy-2-methylphenyl)piperidine-1-carboxylate <b>13c</b></h3><div class="NLM_p last"><b>13c</b> was synthesized according to the same procedure described for <b>13b</b> from 270 mg (0.95 mmol) of 2-cyclobutoxy-5-methyl-4-(pyridin-4-yl)aniline <b>12c</b> in 80% overall yield (300 mg isolated, 0.84 mmol). ESMS <i>m</i>/<i>z</i> 361.2 (M + H<sup>+</sup>).</div></div><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Final Molecules. Synthesis of 5-Chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-piperidin-4-ylphenyl)-<i>N</i>4-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine <b>15b</b></h3><div class="NLM_p last">4-(4-Amino-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylic acid <i>tert</i>-butyl ester (<b>13b</b>, 170 mg, 0.488 mmol), (2,5-dichloropyrimidin-4-yl)-[2-(propane-2-sulfonyl)phenyl]amine (<b>9a</b>, 169 mg, 0.488 mmol, 1 equiv), Xantphos (28 mg, 0.049 mmol, 0.1 equiv), Pd(OAc)<sub>2</sub> (5.5 mg, 0.024 mmol, 0.05 equiv), and Cs<sub>2</sub>CO<sub>3</sub> (477 mg, 1.46 mmol, 3 equiv) were dissolved in anhydrous THF (6 mL). N<sub>2</sub> was bubbled through the reaction mixture for 5 min, and then the reaction vessel was sealed and heated under microwave irradiation to 150 °C for 20 min. The mixture was filtered and the filtrate concentrated under vacuum. After concentration, the crude product was purified by silica gel chromatography (gradient from hexanes to 30% ethyl acetate in hexanes) to give 4-(4-{5-chloro-4-[2-(propane-2-sulfonyl)phenylamino]pyrimidin-2-ylamino}-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylic acid <i>tert</i>-butyl ester as a yellow film (105 mg) which was directly used in the next step: ESMS <i>m</i>/<i>z</i> 658.3 (M + H<sup>+</sup>). This product (105 mg, 0.160 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) and treated with TFA (3 mL). After 45 min, the mixture was concentrated under vacuum. Then 1 N HCl in Et<sub>2</sub>O (5 mL × 2) was added causing the product HCl salt to precipitate. The solvent was removed by decantation. The resulting 5-chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-piperidin-4-ylphenyl)-<i>N</i>4-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine (<b>15b</b>) was dried under high vacuum, generating an off-white powder (101 mg, 35% yield): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> + trace D<sub>2</sub>O) δ 8.32 (s, 1H), 8.27 (d, 1H), 7.88 (d, 1H), 7.67 (dd, 1H), 7.45 (dd, 1H), 7.42 (s, 1H), 6.79 (s, 1H), 4.56–4.48 (m, 1H), 3.49–3.32 (m, 3H), 3.10–2.91 (m, 3H), 2.09 (s, 3H), 1.89–1.77 (m, 4H), 1.22 (d, 6H), 1.13 (d, 6H); ESMS <i>m</i>/<i>z</i> 558.1 (M + H<sup>+</sup>). Anal. Calcd for C<sub>28</sub>H<sub>36</sub>ClN<sub>5</sub>O<sub>3</sub>S: C, 60.25; H, 6.50; Cl, 6.35; N, 12.55; O, 8.60; S, 5.75. Found: C, 60.29; H, 6.45; N, 12.55 (analytical sample of free base).</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Synthesis of 5-Chloro-<i>N</i>2-(2-isopropoxy-4-(piperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (<b>15a</b>)</h3><div class="NLM_p last">5-Chloro-<i>N</i>2-(2-isopropoxy-4-(piperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (<b>15a</b>) was synthesized in 29% overall yield (89 mg, 0.164 mmol) according to the same procedure described for <b>15b</b> from 199 mg (0.576 mmol) of <b>9a</b> and 214 mg (0.63 mmol) of <b>13a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> + trace D<sub>2</sub>O) δ 8.33–8.26 (m, 2H), 7.85 (d, 1H), 7.66 (dd, 1H), 7.52 (d, 1H), 7.44 (dd, 1H), 6.90 (s, 1H), 6.68 (d, 1H), 4.63–4.53 (m, 1H), 3.45–3.30 (m, 3H), 3.04–2.93 (m, 2H), 2.86–2.76 (m, 1H), 1.99–1.87 (m, 2H), 1.82–1.68 (m, 2H), 1.21 (d, 6H), 1.12 (d, 6H); ESMS <i>m</i>/<i>z</i> 544.2 (M + H<sup>+</sup>). HRMS for C<sub>27</sub>H<sub>34</sub>ClN<sub>5</sub>O<sub>3</sub>S calcd, 544.2144; found, 544.2142.</div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Synthesis of <i>N</i>2-(2-Isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)-5-methylpyrimidine-2,4-diamine (<b>15c</b>)</h3><div class="NLM_p last"><i>N</i>2-(2-Isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)-5-methylpyrimidine-2,4-diamine (<b>15c</b>) was synthesized in 56% overall yield (127 mg, 0.237 mmol) according to the same procedure described for <b>15b</b> from 138 mg (0.424 mmol) of <b>9b</b> and 123 mg (0.353 mmol) of <b>13b</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.79 (bs, 0.5H), 9.15 (bs, 0.5H), 8.75 (bs, 1H), 8.56 (bs, 1H), 8.02–7.87 (m, 3H), 7.73 (dd, 1H), 7.55 (dd, 1H), 7.23 (s, 1H), 6.75 (s, 1H), 4.56–4.44 (m, 1H), 3.04–2.84 (m, 3H), 2.48–2.44 (m, 3H), 2.12 (s, 3H), 1.95 (s, 3H), 1.85–1.69 (m, 4H), 1.19 (d, 6H) 1.05 (d, 6H); ESMS <i>m</i>/<i>z</i> 538.3 (M + H<sup>+</sup>). HRMS for C<sub>29</sub>H<sub>39</sub>N<sub>5</sub>O<sub>3</sub>S calcd, 538.2847; found, 538.2853.</div></div><div id="sec7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Synthesis of 5-Chloro-<i>N</i>4-(2-(cyclobutylsulfonyl)phenyl)-<i>N</i>2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)pyrimidine-2,4-diamine (<b>15d</b>)</h3><div class="NLM_p last">5-Chloro-<i>N</i>4-(2-(cyclobutylsulfonyl)phenyl)-<i>N</i>2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)pyrimidine-2,4-diamine (<b>15d</b>) was synthesized according to the same procedure described for <b>15b</b> from 36 mg (0.10 mmol) of 2,5-dichloro-<i>N</i>-(2-(cyclobutylsulfonyl)phenyl)pyrimidin-4-amine and 32.3 mg (0.10 mmol) of 2-isopropoxy-5-methyl-4-(piperidin-4-yl)aniline in 35% overall yield (20 mg isolated, 0.035 mmol). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.43 (d, <i>J</i> = 8.0 Hz, 1H), 8.14 (s, 1H), 7.93 (dd, <i>J</i> = 1.5, 8.0 Hz, 1H), 7.73 (s, 1H), 7.68–7.61 (m, 1H), 7.38–7.30 (m, 1H), 6.85 (s, 1H), 4.65–4.53 (m, 1H), 4.07–3.96 (m, 1H), 3.20–3.12 (m, 2H), 2.91–2.81 (m, 1H), 2.81–2.71 (m, 2H), 2.52–2.39 (m, 2H), 2.19 −2.08 (m, 5H), 2.03–1.85 (m, 2H), 1.78–1.70 (m, 2H), 1.70–1.57 (m, 2H), 1.32 (d, <i>J</i> = 6.1 Hz, 6H). ESMS <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 570.2. HRMS for C<sub>29</sub>H<sub>36</sub>ClN<sub>5</sub>O<sub>3</sub>S calcd, 570.2300; found, 570.2304.</div></div><div id="sec7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Synthesis of 5-Chloro-<i>N</i>2-(2-cyclobutoxy-5-methyl-4-(piperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (<b>15e</b>)</h3><div class="NLM_p last">5-Chloro-<i>N</i>2-(2-cyclobutoxy-5-methyl-4-(piperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (<b>15e</b>) was synthesized according to the same procedure described for <b>15b</b> from 145 mg (0.42 mmol) of <b>9a</b> and 151 mg (0.42 mmol) of <b>13c</b> in 6% overall yield (15 mg, 0.059 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.74 (bs, 1H), 8.94–8.76 (m, 2H), 8.39–8.31 (m, 2H), 7.87 (d, 1H), 7.65 (dd, 1H), 7.47–7.38 (m, 2H), 6.63 (s, 1H), 4.69–4.59 (m, 1H), 3.09–2.92 (m, 3H), 2.44–2.32 (m, 3H), 2.11 (s, 3H), 2.16–1.98 (m, 3H), 1.96–1.69 (m, 6H), 1.66–155 (m, 1h), 1.15 (d, 6H); ESMS <i>m</i>/<i>z</i> 570.2 (M + H<sup>+</sup>). HRMS for C<sub>29</sub>H<sub>36</sub>ClN<sub>5</sub>O<sub>3</sub>S calcd, 570.2300; found, 570.2308.</div></div><div id="sec7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Synthesis of 4-Bromo-5-chloro-<i>N</i>-(2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)pyridin-2-amine (<b>22</b>) and 5-Chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyridine-2,4-diamine (<b>23</b>)</h3><div class="NLM_p">A mixture of 52.4 mg (0.2 mmol) of 2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)aniline <b>13d</b>, 59.1 mg (0.22 mmol) of 4-bromo-2,5-dichloropyridine, 8.8 mg (5 mol %) of Pd(OAc)<sub>2</sub>, 28.8 mg (10 mol %) of Xantphos, and 130.4 mg of Cs<sub>2</sub>CO<sub>3</sub> in 4.0 mL of anhydrous THF was heated at 150 °C for 40 min under microwave irradiation. After the mixture was cooled to room temperature and concentrated, the residue was purified with silica gel column chromatography (eluent, 0–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford 38.0 mg (0.084 mmol, yield 42%) of 4-bromo-5-chloro-<i>N</i>-(2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)pyridin-2-amine <b>22</b> as a yellow oil. MS (ES+): 454.0 (M + 1)<sup>+</sup>.</div><div class="NLM_p last">A mixture of 38.0 mg (0.084 mmol) of <b>22</b>, 20 mg (0.10 mmol) of 2-(isopropylsulfonyl)aniline, 3.9 mg (5 mol %) of Pd<sub>2</sub>dba<sub>3</sub>, 4.0 mg (10 mol %) of dicyclohexyl(2,4,6-triisopropylphenyl)phosphine, and 12 mg (0.168 mmol) of NaO<sup><i>t</i></sup>Bu in 1.0 mL of dry THF was heated to 150 °C under microwave irradiation. After concentration the residue was purified by preparative RP-HPLC to afford 5.5 mg (0.0096 mmol, yield 11%) of 5-chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyridine-2,4-diamine <b>23</b> as an oil.<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (broad s, 1H), 8.47 (broad s, 1H), 7.94 (m, 2H), 7.67 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.57 (m, 1H), 7.10 (m, 2H), 6.75 (s, 1H), 6.09 (s, 1H), 4.43 (m, 1H), 3.05 (m, 3H), 2.93 (m, 1H), 2.76 (m, 3H), 2.21 (s, 3H), 1.80 (m, 4H), 1.13 (d, <i>J</i> = 6.0 Hz, 6H), 1.04 (d, <i>J</i> = 6.8 Hz, 6H). ESMS <i>m</i>/<i>z</i> 571.2 (M + H<sup>+</sup>). HRMS for C<sub>30</sub>H<sub>39</sub>ClN<sub>4</sub>O<sub>3</sub>S calcd, 571.2504; found, 571.2502.</div></div><div id="sec7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Synthesis of 5-Chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (<b>16a</b>)</h3><div class="NLM_p last">5-Chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (<b>16a</b>) was synthesized according to the same procedure described for <b>15b</b> from 71.4 mg (0.2 mmol) of <b>9a</b> and 160.9 mg (0.614 mmol) of <b>13d</b> in 93% overall yield (106.6 mg, 0.187 mmol). <sup>1</sup>H NMR (HCl salt, DMSO-<i>d</i><sub>6</sub> + trace D<sub>2</sub>O): δ 8.28 (s, 1H), 8.19 (d, 1H), 7.86 (d, 1H), 7.66 (dd, 1H), 7.45 (dd, 1H), 7.37 (s, 1H), 6.77 (s, 1H), 4.56–4.49 (m, 1H), 3.51–3.37 (m, 3H), 3.16–3.08 (m, 2H), 2.98–2.88 (m, 1H), 2.77 (s, 3H), 2.05 (s, 3H), 1.90–1.81 (m, 4H), 1.19 (d, 6H), 1.11 (d, 6H). ESMS <i>m</i>/<i>z</i>: 572.24 (M + 1)<sup>+</sup>. HRMS for C<sub>29</sub>H<sub>38</sub>ClN<sub>5</sub>O<sub>3</sub>S calcd, 572.2457; found, 572.2462.</div></div><div id="sec7_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Synthesis of 5-Chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-(1-ethylpiperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (<b>17a</b>)</h3><div class="NLM_p last">To a solution of <b>15b</b> (56 mg, 0.1 mmol) and DIEA (35 uL, 0.2 mmol, 2 equiv) in 3.0 mL of EtOH was added 1-iodoethane (20 mg, 0.13 mmol, 1.3 equiv). The resulting mixture was heated at 50 °C overnight. After cooling to room temperature, the reaction mixture was concentrated and the residue was purified by silica column chromatography (eluted with 0–5% MeOH in DCM) to afford 30 mg (0.051 mmol, 51% yield) of <b>17a</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 9.51 (s, 1H), 8.58–8.60 (d, <i>J</i> = 8.0 Hz, 1H), 8.18 (s, 1H), 8.06 (s, 1H), 7.94–7.96 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.62–7.67 (m, 1H), 7.61 (s, 1H), 7.25–7.29 (m, 1H), 7.02 (s, 1H), 4.73–4.76 (m, 1H), 3.60–3.80 (m, 2H), 3.23–3.30 (m, 1H), 3.08–3.18 (m, 2H), 2.98–3.08 (m, 1H), 2.72–2.92 (m, 4H), 2.15 (s, 3H), 1.90–2.05 (m, 2H), 1.57–1.61 (t, <i>J</i> = 8.0 Hz, 3H), 1.38–1.40 (d, <i>J</i> = 8.0 Hz, 6H), 1.31–1.33 (d, <i>J</i> = 8.0 Hz, 6H). MS (ES+): 586.26 (M + 1)<sup>+</sup>. HRMS for C<sub>30</sub>H<sub>40</sub>ClN<sub>5</sub>O<sub>3</sub>S calcd, 586.2613; found, 586.2620.</div></div><div id="sec7_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Synthesis of 5-Chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-(1-isopropylpiperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (<b>17b</b>)</h3><div class="NLM_p last"><b>17b</b> was synthesized according to the procedure described for <b>17a</b> using 56.0 mg (0.1 mmol) of <b>15b</b> and 2-iodopropane (22.0 mg, 0.13 mmol) as alkylating agent in overall 37% yield (22.0 mg, 0.0367 mmol). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 9.49 (s, 1H), 8.57–8.59 (d, <i>J</i> = 8.0 Hz, 1H), 8.16 (s, 1H), 8.06 (s, 1H), 7.91–7.94 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.59–7.65 (m, 3H), 7.23–7.28 (m, 1H), 7.11 (s, 1H), 4.78–4.81 (m, 1H), 3.58–3.60 (m, 3H), 3.23–3.28 (m, 1H), 2.90–3.10 (m, 5H), 2.15 (s, 3H), 1.90–2.00 (m, 2H), 1.53–1.54 (d, <i>J</i> = 4.0 Hz, 6H), 1.39–1.40 (d, <i>J</i> = 4.0 Hz, 6H), 1.31–1.32 (d, <i>J</i> = 4.0 Hz, 6H). MS (ES+): 600.2 (M + 1)<sup>+</sup>. HRMS for C<sub>31</sub>H<sub>42</sub>ClN<sub>5</sub>O<sub>3</sub>S calcd, 600.2770; found, 600.2777.</div></div><div id="sec7_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Synthesis of 2-[4-(4-{5-Chloro-4-[2-(propane-2-sulfonyl)phenylamino]pyrimidin-2-ylamino}-5-isopropoxy-2-methylphenyl)-piperidin-1-yl]ethanol (<b>17c</b>)</h3><div class="NLM_p last"><b>17c</b> was synthesized in overall 31% yield (22.2 mg, 0.037 mmol) according to the procedure described for <b>17a</b> using 75 mg (0.119 mmol) of <b>15b</b> and 149 mg (84 μL, 1.19 mmol) of 1-chloro-2-hydroxyethane as alkylating agent. <sup>1</sup>H NMR (HCl salt, DMSO-<i>d</i><sub>6</sub> + trace D<sub>2</sub>O): δ 8.34–8.23 (m, 2H), 7.85 (d, 1H), 7.64 (dd, 1H), 7.47–7.38 (m, 2H), 6.78 (s, 1H), 4.55–4.46 (m, 1H), 3.79–3.72 (m, 2H), 3.63–3.53 (m, 2H), 3.47–3.34 (m, 1H), 3.21–3.03 (m, 4H), 3.02–2.91 (m, 1H), 2.09 (s, 3H), 2.01–1.79 (m, 4H), 1.21 (d, 6H), 1.13 (d, 6H). MS (ES+): 602.3 (M + 1)<sup>+</sup>. HRMS for C<sub>30</sub>H<sub>40</sub>ClN<sub>5</sub>O<sub>4</sub>S calcd, 602.2563; found, 602.2559.</div></div><div id="sec7_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Synthesis of 5-Chloro-<i>N</i>2-(2-isopropoxy-4-(1-(2-methoxyethyl)piperidin-4-yl)-5-methylphenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (<b>17d</b>)</h3><div class="NLM_p last"><b>17d</b> was synthesized according to the procedure described for <b>17a</b> using 37 mg (0.0586 mmol) of <b>15b</b> and 8.1 mg (5.5 mL, 0.059 mmol) of 1-chloro-2-methoxyethane as alkylating agent in overall 32% yield (12.0 mg, 0.019 mmol). <sup>1</sup>H NMR (HCl salt, DMSO-<i>d</i><sub>6</sub> + trace D<sub>2</sub>O): δ 8.34–8.28 (m, 1H), 8.25 (s, 1H), 7.85 (d, 1H), 7.63 (dd, 1H), 7.46–7.38 (m, 2H), 6.77 (s, 1H), 4.50 (hept, 1H), 3.70–3.63 (m, 2H), 3.60–3.51 (m, 2H), 3.45–3.23 (m, 2H), 3.32 (s, 3H), 3.14–2.90 (m, 4H), 2.09 (s, 3H), 1.97–1.81 (m, 4H), 1.21 (d, 6H), 1.12 (d, 6H). MS (ES+): 616.3 (M + 1)<sup>+</sup>. HRMS for C<sub>31</sub>H<sub>42</sub>ClN<sub>5</sub>O<sub>4</sub>S calcd, 616.2719; found, 616.2716.</div></div><div id="sec7_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Synthesis of 5-Chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-(1-(1-methylpiperidin-4-yl)piperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (<b>17e</b>)</h3><div class="NLM_p last">5-Chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-<i>N</i>4-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine <b>15b</b> (20 mg, 0.036 mmol) and <i>N</i>-methyl-4-piperidone (40 mg, 0.36 mmol, 10 equiv) were dissolved in 1,2-dichloroethane (0.3 mL). NaBH(OAc)<sub>3</sub> (110 mg, 0.53 mmol, 15 equiv) was added followed by AcOH (4 μL, 0.072 mmol, 2 equiv). This reaction mixture was stirred at room temperature for 3 days. The crude product mixture was diluted with EtOAc and washed with aqueous 1 N NaOH. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification with preparative RP-HPLC generated <b>17e</b> in 19% yield, which was then converted to its HCl salt with 1 N HCl in Et<sub>2</sub>O. <sup>1</sup>H NMR (HCl salt, DMSO-<i>d</i><sub>6</sub> + trace D<sub>2</sub>O): δ 8.31–8.23 (m, 2H), 7.86 (d, 1H), 7.72–7.62 (m, 2H), 7.47–7.40 (m, 1H), 6.80 (s, 1H), 4.51 (hept, 1H), 3.62–3.37 (m, 6H), 3.22–3.11 (m, 2H), 3.09–2.96 (m, 3H), 2.77 (s, 3H), 2.37–2.28 (m, 2H), 2.09 (s, 3H), 2.09–1.87 (m, 6H), 1.21 (d, 6H), 1.12 (d, 6H). MS (ES+): 655.3 (M + 1)<sup>+</sup>.</div></div><div id="sec7_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Synthesis of 5-Chloro-<i>N</i>2-(4-(1-(2,2-difluoroethyl)piperidin-4-yl)-2-isopropoxy-5-methylphenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (<b>17f</b>)</h3><div class="NLM_p last"><b>17f</b> was synthesized in 5% yield (3 mg isolated, 0.048 mmol) according to the procedure described for <b>17a</b> using <b>15b</b> (56 mg, 0.1 mmol) and 2-bromo-1,1-difluoroethane (15 mg, 0.1 mmol) as alkylating agent. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.20 (dd, <i>J</i> = 8.4, 1.2, 1H), 7.95 (s, 1H), 7.84 (dd, <i>J</i> = 7.6, 2, 1H), 7.24–7.31 (m, 3H), 6.78 (s, 1H), 6.61 (tt, <i>J</i> =53, 3.6, 1H), 4.45 (m, 1H), 3.82 (d, <i>J</i> = 11.6, 2H), 3.40–3.48 (m, 2H), 2.88–3.13 (m, 4H), 2.15–2.25 (m, 2H), 2.14 (s, 3H), 1.90 (d, <i>J</i> = 12.7, 2H), 1.27 (d, <i>J</i> = 6.0, 6H), 1.18 (d, <i>J</i> = 6.8, 6H). MS (ES+): 622.10 (M + 1)<sup>+</sup>. HRMS for C<sub>30</sub>H<sub>38</sub>ClF<sub>2</sub>N<sub>5</sub>O<sub>3</sub>S calcd, 622.2425; found, 622.2438.</div></div><div id="sec7_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Synthesis of 2-(4-(4-((5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-5-isopropoxy-2-methylphenyl)piperidin-1-yl)acetic Acid (<b>17g</b>)</h3><div class="NLM_p last"><b>17g</b> was synthesized in overall 53% yield (29.5 mg, 0.0479 mmol) according to the procedure described for <b>17a</b> using 63 mg (0.09 mmol) of <b>15b</b> di-HCl salt and 19 mg (15 μL) of <i>tert</i>-butyl 2-chloroacetate as alkylating agent and <i>tert</i>-butyl ester deprotection (TFA/DCM). <sup>1</sup>H NMR (HCl salt, DMSO-<i>d</i><sub>6</sub> + trace D<sub>2</sub>O): δ 8.29–8.22 (m, 2H), 7.85 (d, 1H), 7.65 (dd, 1H), 7.45–7.38 (m, 2H), 6.79 (s, 1H), 4.57–4.45 (m, 1H), 4.10 (s, 2H), 3.65–3.53 (m, 2H), 3.45–3.33 (m, 1H), 3.22–3.08 (m, 2H), 3.01–2.89 (m, 1H), 2.08 (s, 3H), 2.03–1.80 (m, 4H), 1.21 (d, 6H), 1.12 (d, 6H). MS (ES+): 616.2 (M + 1)<sup>+</sup>. HRMS for C<sub>30</sub>H<sub>38</sub>ClN<sub>5</sub>O<sub>5</sub>S calcd, 616.2355; found, 616.2353.</div></div><div id="sec7_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Synthesis of 2-(4-(4-((5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-5-isopropoxy-2-methylphenyl)piperidin-1-yl)acetamide (<b>17h</b>)</h3><div class="NLM_p last"><b>17h</b> was synthesized in overall 67% yield (41.2 mg, 0.67 mmol) according to the procedure described for <b>17a</b> using the HCl salt of <b>15b</b> (63 mg, 0.1 mmol) and 18 mg (0.13 mL) of 2-bromoacetamide as alkylating agent. <sup>1</sup>H NMR (HCl salt, DMSO-<i>d</i><sub>6</sub> + trace D<sub>2</sub>O): δ 8.26 (s, 1H), 8.24–8.17 (m, 1H), 7.85 (d, 1H), 7.64 (dd, 1H), 7.43 (dd, 1H), 7.38 (s, 1H), 6.79 (s, 1H), 4.50 (hept, 1H), 3.86 (s, 2H), 3.56–3.48 (m, 2H), 3.43–3.31 (m, 1H), 3.19–3.06 (m, 2H), 2.99–2.88 (m, 1H), 2.05 (s, 3H), 2.05–1.90 (m, 2H), 1.88–1.78 (m, 2H), 1.20 (d, 6H), 1.10 (d, 6H). MS (ES+): 615.2 (M + 1)<sup>+</sup>. HRMS for C<sub>30</sub>H<sub>39</sub>ClN<sub>6</sub>O<sub>4</sub>S calcd, 615.2515; found, 615.2514.</div></div><div id="sec7_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Synthesis of 1-(4-(4-((5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-5-isopropoxy-2-methylphenyl)piperidin-1-yl)-2-(dimethylamino)ethanone (<b>17i</b>)</h3><div class="NLM_p last">5-Chloro-<i>N</i>2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-<i>N</i>4-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine (<b>15b</b>, 0.1 mmol) was dissolved in anhydrous DMF (5 mL). Dimethylaminoacetyl chloride hydrochloride (0.15 mmol, 1.5 equiv) was added followed by Et<sub>3</sub>N (0.3 mmol, 3 equiv). The reaction mixture was stirred at 25 °C for 12 h. After concentration, the crude product was purified using preparative RP-HPLC to give 1-(4-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-5-isopropoxy-2-methylphenyl)piperidin-1-yl)-2-(dimethylamino)ethanone <b>17i</b> as an oil in 70% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.46 (d, <i>J</i> = 8.4, 1H), 8.13 (d, <i>J</i> = 2.0, 1H), 7.92 (d, <i>J</i> = 8.0, 1H), 7.77 (s, 1H), 7.66 (t, <i>J</i> = 7.9, 1H), 7.36 (t, <i>J</i> = 7.7, 1H), 6.79 (s, 1H), 4.67 (d, <i>J</i> = 13.1, 1H), 4.57 (dt, <i>J</i> = 6.0, 12.1, 1H), 4.16 (d, <i>J</i> = 13.3, 1H), 3.32 (dt, <i>J</i> = 10.2, 14.1, 3H), 3.20 (dd, <i>J</i> = 10.7, 23.2, 1H), 3.00 (t, <i>J</i> = 11.9, 1H), 2.75 (t, <i>J</i> = 12.3, 1H), 2.35 (s, 6H), 2.16 (s, 3H), 1.80 (d, <i>J</i> = 12.7, 2H), 1.75–1.47 (m, 2H), 1.31 (d, <i>J</i> = 6.0, 6H), 1.25 (d, <i>J</i> = 6.8, 6H). MS (ES+): 643.2 (M + 1)<sup>+</sup>. HRMS for C<sub>32</sub>H<sub>43</sub>ClN<sub>6</sub>O<sub>3</sub>S calcd, 643.2828; found, 643.2823.</div></div><div id="sec7_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Synthesis of <i>N</i>2-(2-Isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)-5-methylpyrimidine-2,4-diamine (<b>18a</b>)</h3><div class="NLM_p last"><b>18a</b> was synthesized in overall 19% yield (168 mg, 0.058 mmol) according to the procedure described for <b>16a</b> using intermediates <b>9b</b> (99.0 mg, 0.305 mmol) and <b>13d</b> (80.0 mg, 0.305 mmol). <sup>1</sup>H NMR (HCl salt, DMSO-<i>d</i><sub>6</sub> + trace D<sub>2</sub>O, 400 MHz) δ 8.04 (s, 1H), 7.96 (dd, <i>J</i> = 8.0, 1.6 Hz, 2H), 7.79 (m, 1H), 7.61 (m, 1H), 7.27 (s, 1H), 6.81 (s, 1H), 4.55 (m, 1H), 3.43 (m, 3H), 3.08 (m, 2H), 2.91 (m, 1H), 2.77 (s, 3H), 2.17 (s, 3H), 1.98 (s, 3H), 1.91 (m, 2H), 1.80 (m, 2H), 1.24 (d, <i>J</i> = 6.0 Hz, 6H), 1.10 (d, <i>J</i> = 6.8 Hz, 6H). HRMS for C<sub>30</sub>H<sub>41</sub>N<sub>5</sub>O<sub>3</sub>S calcd, 552.3003; found, 552.3009.</div></div><div id="sec7_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Synthesis of <i>N</i>2-(2-Isopropoxy-5-methyl-4-(1-ethylpiperidin-4-yl)phenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)-5-methylpyrimidine-2,4-diamine (<b>18b</b>)</h3><div class="NLM_p last"><b>18b</b> was synthesized in overall 28% yield (10.0 mg isolated, 0.014 mmol) according to the procedure described for <b>17a</b> using 26.9 mg (0.05 mmol) of intermediate <b>15c</b> and 31.2 mg (16.0 μL, 0.2 mmol) of 1-iodoethane as alkylating agent. <sup>1</sup>H NMR (TFA salt, 400 MHz, CD<sub>3</sub>OD) δ 8.28 (s, 1H), 8.01 (dd, <i>J</i> = 1.4, 8.0 Hz, 1H), 7.82 (s, 1H), 7.74 (t, <i>J</i> = 7.5 Hz, 1H), 7.54 (t, <i>J</i> = 7.7 Hz, 1H), 7.35 (s, 1H), 6.89 (s,1H), 4.69–4.58 (m, 1H), 3.75–3.66 (m, 2H), 3.40–3.33 (m, 2H), 3.25 (q, <i>J</i> = 7.3 Hz, 2H), 3.20–3.09 (m, 3H), 2.26 (s, 3H), 2.20 (s, 3H), 2.13 −1.91 (m, 4H), 1.41 (t, <i>J</i> = 7.3 Hz, 3H), 1.29 (d, <i>J</i> = 6.0 Hz, 6H), 1.23 (d, <i>J</i> = 6.8 Hz, 6H). MS (ES+): 566.3.</div></div><div id="sec7_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Synthesis of 2-(4-(5-Isopropoxy-4-((4-((2-(isopropylsulfonyl)phenyl)amino)-5-methylpyrimidin-2-yl)amino)-2-methylphenyl)piperidin-1-yl)ethanol (<b>18c</b>)</h3><div class="NLM_p last"><b>18c</b> was synthesized in overall 36% yield (21 mg isolated, 0.036 mmol) according to the procedure described for <b>17a</b> using 54 mg (0.10 mmol) of intermediate <b>15c</b> and 62 mg (0.50 mmol) of 1-bromo-2-hydroxyethane as alkylating agent. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.50 (d, <i>J</i> = 8.0, 1H), 7.93 (s, 1H), 7.89 (d, <i>J</i> = 8.0, 1H), 7.84 (s, 1H), 7.66 (t, <i>J</i> = 7.1, 1H), 7.31 (t, <i>J</i> = 7.2, 1H), 6.85 (s, 1H), 4.66–4.54 (m, 1H), 3.74 (t, <i>J</i> = 6.2, 2H), 3.12 (d, <i>J</i> = 11.6, 2H), 2.73 (m, 1H), 2.60 (t, <i>J</i> = 6.1, 2H), 2.23 (m, 3H), 2.17 (d, <i>J</i> = 7.6, 3H), 2.11 (s, 3H), 1.76 (m, 4H), 1.33 (dd, <i>J</i> = 6.0, 11.1, 6H), 1.24 (d, <i>J</i> = 6.8, 6H). MS (ES+): 582.2. HRMS for C<sub>31</sub>H<sub>43</sub>N<sub>5</sub>O<sub>4</sub>S calcd, 582.3109; found, 582.3104.</div></div><div id="sec7_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Synthesis of <i>N</i>2-(2-Isopropoxy-4-(1-(2-methoxyethyl)piperidin-4-yl)-5-methylphenyl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)-5-methylpyrimidine-2,4-diamine (<b>18d</b>)</h3><div class="NLM_p last"><b>18d</b> was synthesized in 36% yield (21 mg isolated, 0.036 mmol) according to the procedure described for <b>17a</b> using intermediate <b>15c</b> (54 mg, 0.1 mmol) and 1-chloro-2-methoxyethane (62 mg, 0.5 mmol) as alkylating agent. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.29 (s, 1H), 8.01 (d, <i>J</i> = 8.0, 1H), 7.82 (s, 1H), 7.73 (t, <i>J</i> = 7.8, 1H), 7.54 (t, <i>J</i> = 7.7, 1H), 7.32 (s, 1H), 6.91 (s, 1H), 4.64 (dt, <i>J</i> = 6.0, 12.1, 1H), 3.79–3.74 (m, 3H), 3.73 (s, 1H), 3.44 (m, 3H), 3.40 (m, 2H), 3.16 (m, 4H), 2.25 (s, 3H), 2.20 (s, 3H), 2.03 (m, 4H), 1.29 (d, <i>J</i> = 6.0, 6H), 1.23 (d, <i>J</i> = 6.8, 6H). MS (ES+): 596.3. HRMS for C<sub>32</sub>H<sub>45</sub>N<sub>5</sub>O<sub>4</sub>S calcd, 596.3265; found, 596.3273.</div></div><div id="sec7_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Synthesis of Synthesis of 2-((5-Chloro-2-((2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)amino)pyrimidin-4-yl)amino)-<i>N</i>,<i>N</i>-dimethylbenzenesulfonamide (<b>16b</b>)</h3><div class="NLM_p last"><b>16b</b> was synthesized according to the same procedure described for <b>15a</b> from 34.4 mg (0.1 mmol) of <b>9d</b> and 26.2 mg (0.1 mmol) of <b>13d</b> in overall 25% yield (14.5 mg, 0.025 mmol). <sup>1</sup>H NMR δ (HCl salt, CD<sub>3</sub>OD, 400 MHz) 8.14 (s, 1H), 8.09 (broad s, 1H), 7.87 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.60 (m, 1H), 7.44 (m, 1H), 7.25 (s, 1H), 6.84 (s, 1H), 4.59 (m, 1H), 3.53 (m, 2H), 3.14 (m, 2H), 3.03 (m, 1H), 2.83 (s, 3H), 2.62 (s, 6H), 1.92 (m, 4H), 1.20 (d, <i>J</i> = 6.0 Hz, 6H). MS (ES+): 573.3. HRMS for C<sub>28</sub>H<sub>37</sub>ClN<sub>6</sub>O<sub>3</sub>S calcd, 573.2409; found, 573.2426.</div></div><div id="sec7_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Synthesis of 4-(4-((5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-5-isopropoxy-2-methylphenyl)piperidin-2-one (<b>19</b>)</h3><div class="NLM_p last">To a mixture of 2,5-dichloro-<i>N</i>-(2-(isopropylsulfonyl)phenyl)pyrimidin-4-amine <b>9a</b> (34.5 mg, 0.10 mmol, 1 equiv) and 2-isopropoxy-5-methyl-4-(2-oxopiperidin-4-yl)benzenaminium 2,2,2-trifluoroacetate <b>13e</b> (37.6 mg, 0.10 mmol, 1 equiv) in 2-propanol (1.0 mL) was added concentrated HCl (40 μL, 5 equiv). The 5 mL microwave reaction vessel was then sealed and heated under microwave irradiation to 150 °C for 30 min followed by purification with preparative RP-HPLC to give 2.0 mg (0.0035 mmol, 3.5%) of 4-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-5-isopropoxy-2-methylphenyl)piperidin-2-one (<b>19</b>). <sup>1</sup>H NMR δ (TFA salt, DMSO-<i>d</i><sub>6</sub>, 400 MHz) 9.50 (s, 1H), 8.44 (d, <i>J</i> = 8.4 Hz, 1H), 8.27 (s, 1H), 8.15 (s, 1H), 7.84 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.65 (m, 1H), 7.60 (m, 1H), 7.52 (s, 1H), 7.38 (m, 1H), 6.91 (s, 1H), 4.59 (m, 1H), 3.45 (m, 1H), 3.22 (m, 3H), 2.31 (m, 2H), 2.13 (s, 3H), 1.82 (m, 2H), 1.22 (d, <i>J</i> = 6.0 Hz, 6H), 1.16 (d, <i>J</i> = 6.0 Hz, 6H). MS (ES+): 572.1. HRMS for C<sub>28</sub>H<sub>34</sub>ClN<sub>5</sub>O<sub>4</sub>S calcd, 572.2093; found, 572.2106.</div></div><div id="sec7_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Synthesis of 5-Chloro-<i>N</i>2-(4-isopropoxy-2-(piperidin-4-yl)pyrimidin-5-yl)-<i>N</i>4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (<b>20</b>)</h3><div class="NLM_p last"><b>20</b> was synthesized in overall 27% yield (6.6 mg isolated, 0.012 mmol) according to the procedure described for <b>15b</b> using <b>9a</b> (17.0 mg, 0.05 mmol) and 4-(5-amino-4-isopropoxypyrimidin-2-yl)piperidine-1-carboxylic acid <i>tert</i>-butyl ester (10 mg, 0.0.297 mmol) <b>13f</b> as reagents. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 9.04 (s, 1H), 8.45–8.47 (d, <i>J</i> = 8.0 Hz, 1H), 8.25 (s, 1H), 7.92–7.95 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.71–7.75 (m, 1H), 7.38–7.42 (m, 1H), 5.52–5.55 (m, 1H), 3.50–3.53 (m, 3H), 3.10–3.18 (m, 3H), 2.24–2.26 (m, 2H), 2.02–2.16 (m, 2H), 1.41–1.43 (d, <i>J</i> = 6 Hz, 6H), 1.25–1.27 (d, <i>J</i> =6.8 Hz, 6H). MS (ES+): 546.20.</div></div><div id="sec7_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Cell Lines</h3><div class="NLM_p last">The murine pro-B cell line Ba/F3 and human cell line Karpas-299 were maintained in RPMI medium 1640 supplemented with 10% FBS. Ba/F3 cells were grown in the presence of IL-3 (10 ng/mL). Ba/F3 cells were used to generate a panel of sublines whose proliferation and survival were rendered IL-3-independent by stable transduction with individual tyrosine kinases activated by fusion with the amino-terminal portion of TEL (amino acid 1–375) or with BCR-Abl, NPM-ALK, or EML4-ALK. Cell lines expressing luciferase alone or in combination with fusion constructs were generated by retroviral transduction of cells with pMSCV IRES puro/Luc vector.</div></div><div id="sec7_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Cell Proliferation Assays</h3><div class="NLM_p last">Luciferase-expressing cells were incubated with serial dilutions of compounds or DMSO for 2–3 days. Luciferase expression was used as a measure of cell proliferation/survival and was evaluated with the Bright-Glo luciferase assay system (Promega, Madison, WI). IC<sub>50</sub> values were generated by using XLFit software.</div></div><div id="sec7_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Enzymatic Kinase Profiling Description</h3><div class="NLM_p">All kinases were expressed as either histidine- or GST-tagged fusion proteins using the baculovirus expression technology except for the untagged ERK2 which was produced in <i>E. coli</i>. AURORA-A, JAK2, MK2, SYK, and PKA were purchased from Invitrogen. ERK2 was from ProQinase, and all other kinases were supplied in-house. The kinase activity was measured in the LabChip mobility-shift assay (PerkinElmer). The assay was performed at 30 °C for 60 min.</div><div class="NLM_p last">The effect of compound on the enzymatic activity was obtained from the linear progress curves in the absence and presence of compound and routinely determined from one reading (end point measurement).</div></div><div id="sec7_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> GSH-Trapping Assay</h3><div class="NLM_p last">For the characterization of the metabolic activation, 10 mmol/L DMSO stock solutions of the compounds were incubated at 37 °C for up to 60 min with human liver microsomes (50 μL), containing 1 mg protein/mL with phosphate buffer. Four microliters of 0.5 mM of 20 μL of DMSO stock solution of compound in 180 μL of a mixture of acetonitrile/water (ratio 1:1) was added to 50 μL of 1 mg/mL liver microsomes in phosphate buffer and preincubated for 3 min at 37 °C. After preincubation, the reaction was started by addition of 50 μL of the NADPH (1 mmol/L), UDPGA (1 mmol/L), MgCl (2 mmol/L), and ethyl ester GSH reduced (2 mmol/L). After 60 min, the reaction was stopped with 200 μL of ice-cold acetonitrile. The reaction mixture was stored at −20 °C. The mixture was centrifuged (10000<i>g</i>, 5 min), and 250 μL of 300 μL supernatant was transferred. From this solution, 20 μL aliquots were used for analysis. The liquid chromatographic separation was performed using an Agilent HP1100 pump (Agilent Technologies, Wilmington, DE) and a Phenyl HexylRP column, 150 mm × 2.0 mm, particle size 4.6 μm. Gradient mobile phase programming was used with a flow rate of 350 μL/min. Eluent A was Milli-Q water with 0.1% formic acid. Eluent B was acetonitrile with 0.1% formic acid. The mobile phase was a linear gradient from 5% B to 95% B over 6 min and held for 2 min at 95% B for a total run time of 10 min. The column effluent was introduced directly into the ion source of a triple quadrupole MS instrument (TS-Quantum, Finnigan, San Jose, CA) or ion trap MS instrument (DecaXP, Finnigan, San Jose, CA). The ionization technique employed was positive electrospray (ES). The TS-Quantum was used in a product ion scan mode, utilizing collision induced dissociation in Q2 (collision chamber). Collision gas was argon. The collision energy was set at 30 eV.</div></div><div id="sec7_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Solubility Assays</h3><div class="NLM_p last">One-hundred microliter aliquots of 1 mM DMSO solutions were added to each of three glass vials and evaporated to dryness prior to addition of 500 μL of pH 6.8 buffer. Following 24 h of shaking, the solutions were vacuum filtered through MultiScreen Solubility 96-well plates with 0.4 μm modified PCTE membrane (Millipore, MSSLBPC10), and an aliquot of each filtrate is transferred to a UV plate for quantification as described in Uvarova et al.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div></div><div id="sec7_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Metabolic Clearance Assays</h3><div class="NLM_p last">The metabolic clearance assays were conducted using the method described in Richmond et al.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div><div id="sec7_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> CYP Inhibition Assays</h3><div class="NLM_p last">The samples were prepared as 10 mM solutions in DMSO, then assayed and analyzed using the general LC–MS/MS method described by Bell et al.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div></div><div id="sec7_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> PK Studies</h3><div class="NLM_p">In vivo PK studies were conducted in mice, rats, dogs, and cynomolgus monkeys. <b>15b</b> (HCl salt) was formulated as a solution in 75% PEG300/25% D5W and administered to male Balb/c mice intravenously via tail vein at 5 mg/kg (<i>n</i> = 3) and orally via gavage at 20 mg/kg (<i>n</i> = 3). By use of the same formulation, <b>15b</b> (HCl salt) was dosed to Sprague–Dawley rats intravenously via the tail vein at 3 mg/kg (<i>n</i> = 3) and orally via gavage at 10 mg/kg (<i>n</i> = 3). Blood samples were collected serially at scheduled times over 24 h after dosing.</div><div class="NLM_p">Male beagle dogs received a single intravenous (<i>n</i> = 2) or oral (<i>n</i> = 3) dose of <b>15b</b> (phosphate salt) as an intravenous solution in 30% propylene glycol/5% Solutol buffer at 5 mg/kg and an oral suspension in suspension in 0.5% (w/v) aqueous methylcellulose/0.5% Tween 80 at 20 mg/kg, respectively.</div><div class="NLM_p last">Male cynomologus monkeys received single intravenous (<i>n</i> = 2) or oral (<i>n</i> = 3) dose of <b>15b</b> (free base) as an intravenous solution in 30% propylene glycol/5% solutol at 5 mg/kg and an oral suspension in 0.5% (w/v) methylcellulose at 60 mg/kg, respectively. Blood samples for plasma were collected at prescheduled times over 144 h after dosing.</div></div><div id="sec7_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> In Vivo Experiments</h3><div class="NLM_p">RNU nude rats bearing the Karpas299 tumors were randomized into five groups (<i>n</i> = 6 rats per group) with an average tumor size of 326 ± 128 mm<sup>3</sup>. <b>15b</b> (phosphate salt) was formulated in 0.5% MC/0.5% Tween 80 and administered by oral gavage at a dosing volume of 10 μL/g of an animal body weight. Animals in each group received vehicle or 6.25, 12.5, 25, 50 mg/kg <b>15b</b> every day for 14 consecutive days.</div><div class="NLM_p">RNU nude rats bearing the H2228 tumors were randomized into four groups (<i>n</i> = 4 rats per group) with an average tumor volume of 371 ± 139 mm<sup>3</sup>. <b>15b</b> (phosphate salt) was formulated in 0.5% MC/0.5% Tween 80 and administered by oral gavage at a dosing volume of 10 μL/g of an animal body weight. Animals in each group received vehicle or 5, 10, 25 mg/kg <b>15b</b> (phosphate salt) every day for 14 consecutive days.</div><div class="NLM_p last">RNU nude rats bearing the Karpas299 tumors were dosed with <b>15b</b> (phosphate salt) at 50 mg/kg. Tumor and plasma samples were collected 7, 24, 48, and 72 h after dosing. Two tumor pieces were collected from each animal, one piece for protein extraction and the other for PK analysis. Proteins were extracted from tumor samples and then subjected to SDS–PAGE followed by Western blot with phospho-STAT3 antibody (pSTAT3, Tyr705) (Cell Signaling, no. 9131, Danvers, MA).</div></div><div id="sec7_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> HOMA-IR</h3><div class="NLM_p">Homeostatic model assessment (HOMA) of insulin resistance (IR) is a technical method for assessing IR from basal (fasting) glucose and insulin or C-peptide concentrations. The model is widely used to estimate insulin resistance.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p last">Groups of wild-type mice (<i>n</i> = 8 mice per group) were randomized into treatment groups based on their initial body weight. Mice were housed four per cage and dosed with vehicle orally, or ALK inhibitor (<b>15b</b> or <b>4</b>), orally once per day for 7 days. On day 7, compound was administered 180 min prior to a 3 g/kg glucose bolus. OGTT evaluations were performed in conscious mice that were 11 weeks of age. The mice were fasted by removing food at 6 p.m. the day before. A baseline blood sample was taken at <i>t</i> = −180 min, and the mice were then dosed orally with the compounds. A baseline blood sample was taken at <i>t</i> = 0 min, and the animals were then administered an oral glucose bolus (3 g/kg) immediately. Blood was obtained (via tail bleeding) to measure blood glucose (using glucometer). A single drop of blood from the tail was measured for glucose using a glucometer at <i>t</i> = −180, 0, 20, 40, 60, 120 min. Approximately 40 μL samples of blood were collected separately for insulin analysis 3 h prior to dosing (on day 0 and day 7) into chilled collection tubes containing EDTA. Plasma was isolated and stored at −70 °C until further analysis. The homeostatic model assessment-insulin resistance index (HOMA-IR) was used as a measure of insulin resistance and was calculated using the formula HOMA-IR = (FPG × FPI)/22.5 where FPG (mM) is the fasting plasma glucose concentration and FPI (μU/mL) is the fasting plasma insulin concentration. Insulin levels were determined using a detection assay kit from Mesoscale Discovery (MSD): catalog no. K112BZC-2. Higher values indicate insulin resistance.</div></div><div id="sec7_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Modeling and Docking</h3><div class="NLM_p">Flexible docking was performed using Glide 5.8 (Schrodinger, Inc., Portland, OR, 2012). The protein coordinates were taken from the Protein Data Bank (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xb7">2xb7</a>.pdb). The grid box was centered on the cocrystallized ligand <b>15b</b> and extended 10 Å from the center, with the outer box extending an additional 20 Å. The ligand was docked using the standard precision (SP) algorithm and scored using GlideScore.</div><div class="NLM_p last">In the MCMM/LLMOD method the structural perturbation via LLMOD method is alternated with the random changes in torsion angles and/or molecular position from the MCMM method. During the LLMOD structural perturbation and subsequent minimization, protein residues within 4 Å from the bound ligand were allowed to move freely. The remaining residues were not allowed to move; however, their electrostatic and van der Waals interactions with moving atoms were included in the calculation. The inhibitor was subjected to perturbations via TORS command available in MacroModel. The LLMOD step was applied using leap vectors comprising different random mixtures of the first 10 nontrivial low modes, and the fastest-moving atom with respect to the particular leap vector was displaced by a randomly selected distance between 3 and 6 Å. During the TORS move randomly selected torsion angle was perturbed by a random value between 0° and 180°. A conjugate gradient minimization was employed during the conformational search with convergence criterion set at 0.5 kJ mol<sup>–1</sup> Å<sup>–1</sup>. Minimum energy conformations were saved within an energy window of 40 kJ/mol above the global minimum. The employed force field was OPLS-AA 2005 with distance dependent dielectric constant 4<i>r</i> and no explicit solvation.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62"><a href="/doi/suppl/10.1021/jm400402q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">GSH-trapping results (LC–UV) for <b>4</b> and <b>15b</b>, body weight of animals from Karpas299 and H2228 xenograft studies, superposition of compounds <b>15b</b> and <b>16e</b> in ALK kinase domain, and kinase selectivity comparison between <b>4</b> and <b>7</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400402q/suppl_file/jm400402q_si_001.pdf">jm400402q_si_001.pdf (913.86 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400402q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre-Yves Michellys</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4b3b262228232e272732380b2c252d6524392c"><span class="__cf_email__" data-cfemail="0b7b666268636e676772784b6c656d2564796c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas H. Marsilje</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Pei</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bei Chen</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenshuo Lu</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tetsuo Uno</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yunho Jin</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Jiang</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sungjoon Kim</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nanxin Li</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Warmuth</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yelena Sarkisova</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Sun</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Auzon Steffy</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">AnneMarie C. Pferdekamper</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allen G. Li</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean B. Joseph</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Young Kim</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bo Liu</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tove Tuntland</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoming Cui</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathanael S. Gray</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruo Steensma</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongqin Wan</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiqing Jiang</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Greg Chopiuk</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jie Li</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">W. Perry Gordon</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wendy Richmond</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Johnson</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Chang</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Todd Groessl</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">You-Qun He</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Phimister</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alex Aycinena</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian C. Lee</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Badry Bursulaya</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald S. Karanewsky</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">H. Martin Seidel</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer L. Harris</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675
John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d240e5311-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05651" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05651" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge Daniel Mason for providing HRMS data on the compounds described in this manuscript, John Isbell (analytical group from GNF), and Paul Calvin and his group (compound management)</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i64" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i64"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i65" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i65"> Abbreviations Used</h2><tr><td class="NLM_term">ALK</td><td class="NLM_def"><p class="first last">anaplastic lymphoma kinase</p></td></tr><tr><td class="NLM_term">ALKi</td><td class="NLM_def"><p class="first last">anaplastic lymphoma kinase inhibitor</p></td></tr><tr><td class="NLM_term">NPM</td><td class="NLM_def"><p class="first last">nucleophosmin</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">ALCL</td><td class="NLM_def"><p class="first last">anaplastic large cell lymphoma</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung cancer</p></td></tr><tr><td class="NLM_term">DLBCL</td><td class="NLM_def"><p class="first last">diffuse large B-cell lymphoma</p></td></tr><tr><td class="NLM_term">IMT</td><td class="NLM_def"><p class="first last">myofibroblastic tumor</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">microwave irradiation</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">HOMA-IR</td><td class="NLM_def"><p class="first last">homeostatic model assessment of insulin resistance</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52007" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52007" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naeve, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, D. P.</span><span> </span><span class="NLM_article-title">ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin’s lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2175</span><span class="NLM_x">–</span> <span class="NLM_lpage">2188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=2175-2188&author=S.+W.+Morrisauthor=C.+Naeveauthor=P.+Mathewauthor=P.+L.+Jamesauthor=M.+N.+Kirsteinauthor=X.+Cuiauthor=D.+P.+Witte&title=ALK%2C+the+chromosome+2+gene+locus+altered+by+the+t%282%3B5%29+in+non-Hodgkin%E2%80%99s+lymphoma%2C+encodes+a+novel+neural+receptor+tyrosine+kinase+that+is+highly+related+to+leukocyte+tyrosine+kinase+%28LTK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DNaeve%26aufirst%3DC.%26aulast%3DMathew%26aufirst%3DP.%26aulast%3DJames%26aufirst%3DP.%2BL.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DWitte%26aufirst%3DD.%2BP.%26atitle%3DALK%252C%2520the%2520chromosome%25202%2520gene%2520locus%2520altered%2520by%2520the%2520t%25282%253B5%2529%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%252C%2520encodes%2520a%2520novel%2520neural%2520receptor%2520tyrosine%2520kinase%2520that%2520is%2520highly%2520related%2520to%2520leukocyte%2520tyrosine%2520kinase%2520%2528LTK%2529%26jtitle%3DOncogene%26date%3D1997%26volume%3D14%26spage%3D2175%26epage%3D2188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Chiarle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrogio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inghirami, G.</span><span> </span><span class="NLM_article-title">The anaplastic lymphoma kinase in the pathogenesis of cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1038%2Fnrc2291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=18097461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKku73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=11-23&issue=1&author=R.+Chiarleauthor=C.+Voenaauthor=C.+Ambrogioauthor=R.+Pivaauthor=G.+Inghirami&title=The+anaplastic+lymphoma+kinase+in+the+pathogenesis+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The anaplastic lymphoma kinase in the pathogenesis of cancer</span></div><div class="casAuthors">Chiarle, Roberto; Voena, Claudia; Ambrogio, Chiara; Piva, Roberto; Inghirami, Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-23</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The receptor tyrosine kinase anaplastic lymphoma kinase (ALK) was first identified as part of a chromosomal translocation assocd. with some anaplastic large cell lymphomas (ALCLs).  Now data are emerging that indicate that ALK might be a valid therapeutic target in ALCL and that it could also be involved in other cancers.  Tyrosine kinases are involved in the pathogenesis of most cancers.  However, few tyrosine kinases have been shown to have a well-defined pathogenetic role in lymphomas.  The anaplastic lymphoma kinase (ALK) is the oncogene of most anaplastic large cell lymphomas (ALCL), driving transformation through many mol. mechanisms.  In this review, we will analyze how translocations or deregulated expression of ALK contribute to oncogenesis and how recent genetic or pharmacol. tools, aimed at neutralizing its activity, can represent the basis for the design of powerful combination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5HoaZPQUiUrVg90H21EOLACvtfcHk0liawdIV9uuWng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKku73P&md5=a57d7ab61be51664ca9f5b804c3e2910</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc2291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2291%26sid%3Dliteratum%253Aachs%26aulast%3DChiarle%26aufirst%3DR.%26aulast%3DVoena%26aufirst%3DC.%26aulast%3DAmbrogio%26aufirst%3DC.%26aulast%3DPiva%26aufirst%3DR.%26aulast%3DInghirami%26aufirst%3DG.%26atitle%3DThe%2520anaplastic%2520lymphoma%2520kinase%2520in%2520the%2520pathogenesis%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer.%26date%3D2008%26volume%3D8%26issue%3D1%26spage%3D11%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Webb, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slavish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rentrop, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span> </span><span class="NLM_article-title">Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1586%2F14737140.9.3.331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=19275511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtFaltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=331-356&issue=3&author=T.+R.+Webbauthor=J.+Slavishauthor=R.+E.+Georgeauthor=A.+T.+Lookauthor=L.+Xueauthor=Q.+Jiangauthor=X.+Cuiauthor=W.+B.+Rentropauthor=S.+W.+Morris&title=Anaplastic+lymphoma+kinase%3A+role+in+cancer+pathogenesis+and+small-molecule+inhibitor+development+for+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy</span></div><div class="casAuthors">Webb, Thomas R.; Slavish, Jake; George, Rani E.; Look, A. Thomas; Xue, Liquan; Jiang, Qin; Cui, Xiaoli; Rentrop, Walter B.; Morris, Stephan W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-356</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase in the insulin receptor superfamily, was initially identified in constitutively activated oncogenic fusion forms - the most common being nucleophosmin-ALK - in anaplastic large-cell lymphomas, and subsequent studies have identified ALK fusions in diffuse large B-cell lymphomas, systemic histiocytosis, inflammatory myofibroblastic tumors, esophageal squamous cell carcinomas and non-small-cell lung carcinomas.  More recently, genomic DNA amplification and protein overexpression, as well as activating point mutations, of ALK have been described in neuroblastomas.  In addn. to those cancers for which a causative role for aberrant ALK activity is well validated, more circumstantial links implicate the full-length, normal ALK receptor in the genesis of other malignancies - including glioblastoma and breast cancer - via a mechanism of receptor activation involving autocrine and/or paracrine growth loops with the reported ALK ligands, pleiotrophin and midkine.  This review summarizes normal ALK biol., the confirmed and putative roles of ALK in the development of human cancers and efforts to target ALK using small-mol. kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoERzbvlik_c7Vg90H21EOLACvtfcHk0lhI65YDaXIOIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtFaltrc%253D&md5=a980ef18ac316bd3894b72ddd2748c17</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1586%2F14737140.9.3.331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.9.3.331%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DT.%2BR.%26aulast%3DSlavish%26aufirst%3DJ.%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26aulast%3DLook%26aufirst%3DA.%2BT.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DRentrop%26aufirst%3DW.%2BB.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26atitle%3DAnaplastic%2520lymphoma%2520kinase%253A%2520role%2520in%2520cancer%2520pathogenesis%2520and%2520small-molecule%2520inhibitor%2520development%2520for%2520therapy%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2009%26volume%3D9%26issue%3D3%26spage%3D331%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Iwahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupples, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratzkin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span> </span><span class="NLM_article-title">Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=439-449&author=T.+Iwaharaauthor=J.+Fujimotoauthor=D.+Wenauthor=R.+Cupplesauthor=N.+Bucayauthor=T.+Arakawaauthor=S.+Moriauthor=B.+Ratzkinauthor=T.+Yamamoto&title=Molecular+characterization+of+ALK%2C+a+receptor+tyrosine+kinase+expressed+specifically+in+the+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIwahara%26aufirst%3DT.%26aulast%3DFujimoto%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DCupples%26aufirst%3DR.%26aulast%3DBucay%26aufirst%3DN.%26aulast%3DArakawa%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DRatzkin%26aufirst%3DB.%26aulast%3DYamamoto%26aufirst%3DT.%26atitle%3DMolecular%2520characterization%2520of%2520ALK%252C%2520a%2520receptor%2520tyrosine%2520kinase%2520expressed%2520specifically%2520in%2520the%2520nervous%2520system%26jtitle%3DOncogene%26date%3D1997%26volume%3D14%26spage%3D439%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bilsland, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeldon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Znamenskiy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnert, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heavens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiting, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Sanjuan, I.</span><span> </span><span class="NLM_article-title">Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=685-700&author=J.+G.+Bilslandauthor=A.+Wheeldonauthor=A.+Meadauthor=P.+Znamenskiyauthor=S.+Almondauthor=K.+A.+Watersauthor=M.+Thakurauthor=V.+Beaumontauthor=T.+P.+Bonnertauthor=R.+Heavensauthor=P.+Whitingauthor=G.+McAllisterauthor=I.+Munoz-Sanjuan&title=Behavioral+and+neurochemical+alterations+in+mice+deficient+in+anaplastic+lymphoma+kinase+suggest+therapeutic+potential+for+psychiatric+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilsland%26aufirst%3DJ.%2BG.%26aulast%3DWheeldon%26aufirst%3DA.%26aulast%3DMead%26aufirst%3DA.%26aulast%3DZnamenskiy%26aufirst%3DP.%26aulast%3DAlmond%26aufirst%3DS.%26aulast%3DWaters%26aufirst%3DK.%2BA.%26aulast%3DThakur%26aufirst%3DM.%26aulast%3DBeaumont%26aufirst%3DV.%26aulast%3DBonnert%26aufirst%3DT.%2BP.%26aulast%3DHeavens%26aufirst%3DR.%26aulast%3DWhiting%26aufirst%3DP.%26aulast%3DMcAllister%26aufirst%3DG.%26aulast%3DMunoz-Sanjuan%26aufirst%3DI.%26atitle%3DBehavioral%2520and%2520neurochemical%2520alterations%2520in%2520mice%2520deficient%2520in%2520anaplastic%2520lymphoma%2520kinase%2520suggest%2520therapeutic%2520potential%2520for%2520psychiatric%2520indications%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D685%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmer, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span> </span><span class="NLM_article-title">Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=1281-1284&author=S.+W.+Morrisauthor=M.+N.+Kirsteinauthor=M.+B.+Valentineauthor=K.+G.+Dittmerauthor=D.+N.+Shapiroauthor=D.+L.+Saltmanauthor=A.+T.+Look&title=Fusion+of+a+kinase+gene%2C+ALK%2C+to+a+nucleolar+protein+gene%2C+NPM%2C+in+non-Hodgkin%E2%80%99s+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DValentine%26aufirst%3DM.%2BB.%26aulast%3DDittmer%26aufirst%3DK.%2BG.%26aulast%3DShapiro%26aufirst%3DD.%2BN.%26aulast%3DSaltman%26aufirst%3DD.%2BL.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DFusion%2520of%2520a%2520kinase%2520gene%252C%2520ALK%252C%2520to%2520a%2520nucleolar%2520protein%2520gene%252C%2520NPM%252C%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DScience%26date%3D1994%26volume%3D263%26spage%3D1281%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Griffin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlman, E. J.</span><span> </span><span class="NLM_article-title">Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2776</span><span class="NLM_x">–</span> <span class="NLM_lpage">2780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=10383129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADyaK1MXktVOktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2776-2780&author=C.+A.+Griffinauthor=A.+L.+Hawkinsauthor=C.+Dvorakauthor=C.+Henkleauthor=T.+Ellinghamauthor=E.+J.+Perlman&title=Recurrent+involvement+of+2p23+in+inflammatory+myofibroblastic+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors</span></div><div class="casAuthors">Griffin, Constance A.; Hawkins, Anita L.; Dvorak, Cecily; Henkle, Carol; Ellingham, Tara; Perlman, Elizabeth J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2776-2780</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">Inflammatory myofibroblastic tumor (IMT) is a relatively rare soft tissue tumor.  The reactive vs. neoplastic pathogenesis of this tumor is unresolved.  We found clonal chromosome aberrations involving 2p23 upon metaphase anal. of two IMTs.  Fluorescence in situ hybridization with a probe flanking the ALK gene at 2p23 demonstrated rearrangement of the probe in both of these cases and in a third case, and immunohistochem. revealed ALK expression in all three cases.  A 2p22-24 involvement has been reported previously in four addnl. cases of IMT.  We suggest that chromosomal rearrangements involving 2p23 near or within ALK are recurrent alterations in IMT and that ALK may have a novel role outside its previously recognized realm of lymphoid neoplasms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocvXV2ukz3crVg90H21EOLACvtfcHk0lgnUfG3UAdpCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVOktbk%253D&md5=8054eeaaf0cb85ee85afff461797c84c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DC.%2BA.%26aulast%3DHawkins%26aufirst%3DA.%2BL.%26aulast%3DDvorak%26aufirst%3DC.%26aulast%3DHenkle%26aufirst%3DC.%26aulast%3DEllingham%26aufirst%3DT.%26aulast%3DPerlman%26aufirst%3DE.%2BJ.%26atitle%3DRecurrent%2520involvement%2520of%25202p23%2520in%2520inflammatory%2520myofibroblastic%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D2776%26epage%3D2780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurashina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=561-566&author=M.+Sodaauthor=Y.+L.+Choiauthor=M.+Enomotoauthor=S.+Takadaauthor=Y.+Yamashitaauthor=S.+Ishikawaauthor=S.+Fujiwaraauthor=H.+Watanabeauthor=K.+Kurashinaauthor=H.+Hatanakaauthor=M.+Bandoauthor=S.+Ohnoauthor=Y.+Ishikawaauthor=H.+Aburataniauthor=T.+Nikiauthor=Y.+Soharaauthor=Y.+Sugiyamaauthor=H.+Mano&title=Identification+of+the+transforming+EML4%E2%80%93ALK+fusion+gene+in+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DEnomoto%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DKurashina%26aufirst%3DK.%26aulast%3DHatanaka%26aufirst%3DH.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DNiki%26aufirst%3DT.%26aulast%3DSohara%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520the%2520transforming%2520EML4%25E2%2580%2593ALK%2520fusion%2520gene%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DNature%26date%3D2007%26volume%3D448%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Non-solid oncogenes in solid tumors: EML4–ALK fusion genes in lung cancer</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2349</span><span class="NLM_x">–</span> <span class="NLM_lpage">2355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1111%2Fj.1349-7006.2008.00972.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=19032370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisF2gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=2349-2355&author=H.+Mano&title=Non-solid+oncogenes+in+solid+tumors%3A+EML4%E2%80%93ALK+fusion+genes+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer</span></div><div class="casAuthors">Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2349-2355</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  It is generally accepted that recurrent chromosome translocations play a major role in the mol. pathogenesis of hematol. malignancies but not of solid tumors.  However, chromosome translocations involving the e26 transformation-specific sequence transcription factor loci have been demonstrated recently in many prostate cancer cases.  Furthermore, through a functional screening with retroviral cDNA expression libraries, we have discovered the fusion-type protein tyrosine kinase echinoderm microtubule-assocd. protein like-4 (EML4)-anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC) specimens.  A recurrent chromosome translocation, inv(2)(p21p23), in NSCLC generates fused mRNA encoding the amino-terminal half of EML4 ligated to the intracellular region of the receptor-type protein tyrosine kinase ALK.  EML4-ALK oligomerizes constitutively in cells through the coiled coil domain within the EML4 region, and becomes activated to exert a marked oncogenicity both in vitro and in vivo.  Break and fusion points within the EML4 locus may diverge in NSCLC cells to generate various isoforms of EML4-ALK, which may constitute -5% of NSCLC cases, at least in the Asian ethnic group.  In the present review I summarize how detection of EML4-ALK cDNA may become a sensitive diagnostic means for NSCLC cases that are pos. for the fusion gene, and discuss whether suppression of ALK enzymic activity could be an effective treatment strategy against this intractable disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbxSS7U51wKbVg90H21EOLACvtfcHk0likm-kaOhhfEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisF2gsw%253D%253D&md5=84386550daedbd29b3a34b11a4774684</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.00972.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.00972.x%26sid%3Dliteratum%253Aachs%26aulast%3DMano%26aufirst%3DH.%26atitle%3DNon-solid%2520oncogenes%2520in%2520solid%2520tumors%253A%2520EML4%25E2%2580%2593ALK%2520fusion%2520genes%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D2349%26epage%3D2355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B.</span><span> </span><span class="NLM_article-title">Targeting anaplastic lymphoma kinase in lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2081</span><span class="NLM_x">–</span> <span class="NLM_lpage">2086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1158%2F1078-0432.CCR-10-1591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=21288922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslCgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=2081-2086&issue=8&author=A.+T.+Shawauthor=B.+Solomon&title=Targeting+anaplastic+lymphoma+kinase+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Anaplastic Lymphoma Kinase in Lung Cancer</span></div><div class="casAuthors">Shaw, Alice T.; Solomon, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2081-2086</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Several decades of cancer research have revealed a pivotal role for tyrosine kinases as key regulators of signaling pathways, controlling cell growth and differentiation.  Deregulation of tyrosine kinase-mediated signaling occurs frequently in cancer and is believed to drive the initiation and progression of disease.  Chromosomal rearrangements involving the tyrosine kinase anaplastic lymphoma kinase (ALK) occur in a variety of human malignancies including non-small cell lung cancer (NSCLC), anaplastic large cell lymphomas, and inflammatory myofibroblastic tumors.  The aberrant activation of ALK signaling leads to "oncogene addiction" and marked sensitivity to ALK inhibitors such as crizotinib (PF-02341066).  This review focuses on ALK rearrangements in NSCLC, starting with the discovery of the EML4-ALK fusion oncogene, and culminating in the recent validation of ALK as a therapeutic target in patients with ALK-rearranged NSCLC.  Current efforts seek to expand the role of ALK kinase inhibition in lung and other cancers and to address the mol. basis for the development of resistance.  Clin Cancer Res; 17(8); 2081-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCqEzvXv0qJrVg90H21EOLACvtfcHk0likm-kaOhhfEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslCgs7k%253D&md5=6d0f5e1174ba934f00c10a877a3b17e1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-1591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-1591%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DSolomon%26aufirst%3DB.%26atitle%3DTargeting%2520anaplastic%2520lymphoma%2520kinase%2520in%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26issue%3D8%26spage%3D2081%26epage%3D2086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Osajima-Hakomori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, R.</span><span> </span><span class="NLM_article-title">Biological role of anaplastic lymphoma kinase in neuroblastoma</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1016%2FS0002-9440%2810%2962966-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=15972965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXms1eitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2005&pages=213-222&author=Y.+Osajima-Hakomoriauthor=I.+Miyakeauthor=M.+Ohiraauthor=A.+Nakagawaraauthor=A.+Nakagawaauthor=R.+Sakai&title=Biological+role+of+anaplastic+lymphoma+kinase+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Biological role of anaplastic lymphoma kinase in neuroblastoma</span></div><div class="casAuthors">Osajima-Hakomori, Yuko; Miyake, Izumi; Ohira, Miki; Nakagawara, Akira; Nakagawa, Atsuko; Sakai, Ryuichi</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">213-222</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor originally identified as part of the chimeric nucleophosmin-ALK protein in the t(2;5) chromosomal rearrangement assocd. with anaplastic large cell lymphoma.  We recently demonstrated that the ALK kinase is constitutively activated by gene amplification at the ALK locus in several neuroblastoma cell lines.  Forming a stable complex with hyperphosphorylated ShcC, activated ALK modifies the responsiveness of the mitogen-activated protein kinase pathway to growth factors.  In the present study, the biol. role of activated ALK was examd. by suppressing the expression of ALK kinase in neuroblastoma cell lines using an RNA interference technique.  The suppression of activated ALK in neuroblastoma cells by RNA interference significantly reduced the phosphorylation of ShcC, mitogen-activated protein kinases, and Akt, inducing rapid apoptosis in the cells.  By immunohistochem. anal., the cytoplasmic expression of ALK was detected in most of the samples of neuroblastoma tissues regardless of the stage of the tumor, whereas significant amplification of ALK was obsd. in only 1 of 85 cases of human neuroblastoma samples.  These data demonstrate the limited frequency of ALK activation in the real progression of neuroblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3yzyhgfKX4rVg90H21EOLACvtfcHk0likm-kaOhhfEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXms1eitrc%253D&md5=591aceb254b3e707d315b6309ec5fba0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2962966-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252962966-5%26sid%3Dliteratum%253Aachs%26aulast%3DOsajima-Hakomori%26aufirst%3DY.%26aulast%3DMiyake%26aufirst%3DI.%26aulast%3DOhira%26aufirst%3DM.%26aulast%3DNakagawara%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DA.%26aulast%3DSakai%26aufirst%3DR.%26atitle%3DBiological%2520role%2520of%2520anaplastic%2520lymphoma%2520kinase%2520in%2520neuroblastoma%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2005%26volume%3D167%26spage%3D213%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Mosse, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laudenslager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attiyeh, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquaglia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laureys, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speleman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakonarson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torkamani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schork, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonini, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappaport, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span> </span><span class="NLM_article-title">Identification of ALK as a major familial neuroblastoma predisposition gene</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1038%2Fnature07261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=18724359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Ggur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=930-935&author=Y.+P.+Mosseauthor=M.+Laudenslagerauthor=L.+Longoauthor=K.+A.+Coleauthor=A.+Woodauthor=E.+F.+Attiyehauthor=M.+J.+Laquagliaauthor=R.+Sennettauthor=J.+E.+Lynchauthor=P.+Perriauthor=G.+Laureysauthor=F.+Spelemanauthor=C.+Kimauthor=C.+Houauthor=H.+Hakonarsonauthor=A.+Torkamaniauthor=N.+J.+Schorkauthor=G.+M.+Brodeurauthor=G.+P.+Toniniauthor=E.+Rappaportauthor=M.+Devotoauthor=J.+M.+Maris&title=Identification+of+ALK+as+a+major+familial+neuroblastoma+predisposition+gene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of ALK as a major familial neuroblastoma predisposition gene</span></div><div class="casAuthors">Mosse, Yael P.; Laudenslager, Marci; Longo, Luca; Cole, Kristina A.; Wood, Andrew; Attiyeh, Edward F.; Laquaglia, Michael J.; Sennett, Rachel; Lynch, Jill E.; Perri, Patrizia; Laureys, Genevieve; Speleman, Frank; Kim, Cecilia; Hou, Cuiping; Hakonarson, Hakon; Torkamani, Ali; Schork, Nicholas J.; Brodeur, Garrett M.; Tonini, Gian P.; Rappaport, Eric; Devoto, Marcella; Maris, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7215</span>),
    <span class="NLM_cas:pages">930-935</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuroblastoma is a childhood cancer that can be inherited, but the genetic etiol. is largely unknown.  Here we show that germline mutations in the anaplastic lymphoma kinase (ALK) gene explain most hereditary neuroblastomas, and that activating mutations can also be somatically acquired.  We first identified a significant linkage signal at chromosome bands 2p23-24 using a whole-genome scan in neuroblastoma pedigrees.  Re-sequencing of regional candidate genes identified three sep. germline missense mutations in the tyrosine kinase domain of ALK that segregated with the disease in eight sep. families.  Re-sequencing in 194 high-risk neuroblastoma samples showed somatically acquired mutations in the tyrosine kinase domain in 12.4% of samples.  Nine of the ten mutations map to crit. regions of the kinase domain and were predicted, with high probability, to be oncogenic drivers.  Mutations resulted in constitutive phosphorylation, and targeted knockdown of ALK mRNA resulted in profound inhibition of growth in all cell lines harboring mutant or amplified ALK, as well as in two out of six wild-type cell lines for ALK.  Our results demonstrate that heritable mutations of ALK are the main cause of familial neuroblastoma, and that germline or acquired activation of this cell-surface kinase is a tractable therapeutic target for this lethal pediatric malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMNOcIFf5xjbVg90H21EOLACvtfcHk0lhO47vaKjthOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Ggur%252FP&md5=bb998ef8f6bfbd85f928263e13954ce4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature07261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07261%26sid%3Dliteratum%253Aachs%26aulast%3DMosse%26aufirst%3DY.%2BP.%26aulast%3DLaudenslager%26aufirst%3DM.%26aulast%3DLongo%26aufirst%3DL.%26aulast%3DCole%26aufirst%3DK.%2BA.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DAttiyeh%26aufirst%3DE.%2BF.%26aulast%3DLaquaglia%26aufirst%3DM.%2BJ.%26aulast%3DSennett%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DJ.%2BE.%26aulast%3DPerri%26aufirst%3DP.%26aulast%3DLaureys%26aufirst%3DG.%26aulast%3DSpeleman%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DHakonarson%26aufirst%3DH.%26aulast%3DTorkamani%26aufirst%3DA.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26aulast%3DTonini%26aufirst%3DG.%2BP.%26aulast%3DRappaport%26aufirst%3DE.%26aulast%3DDevoto%26aufirst%3DM.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520of%2520ALK%2520as%2520a%2520major%2520familial%2520neuroblastoma%2520predisposition%2520gene%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D930%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Azarova, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, R. E.</span><span> </span><span class="NLM_article-title">Emerging importance of ALK in neuroblastoma</span> <span class="citation_source-journal">Semin. Cancer Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1016%2Fj.semcancer.2011.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=21945349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSktLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=267-275&author=A.+M.+Azarovaauthor=G.+Gautamauthor=R.+E.+George&title=Emerging+importance+of+ALK+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging importance of ALK in neuroblastoma</span></div><div class="casAuthors">Azarova, Anna M.; Gautam, Gargi; George, Rani E.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">267-275</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Since the original descriptions of gain-of function mutations in anaplastic lymphoma kinase (ALK), interest in the role of this receptor tyrosine kinase in neuroblastoma development and as a potential therapeutic target has escalated.  As a group, the activating point mutations in full-length ALK, found in approx. 8% of all neuroblastoma tumors, are distributed evenly across different clin. stages.  However, the most frequent somatic mutation, F1174L, is assocd. with amplification of the MYCN oncogene.  This combination of features appears to confer a worse prognosis than MYCN amplification alone, suggesting a cooperative effect on neuroblastoma formation by these two proteins.  Indeed, F1174L has shown more potent transforming activity in vivo than the second most common activating mutation, R1275Q, and is responsible for innate and acquired resistance to crizotinib, a clin. relevant ALK inhibitor that will soon be com. available.  These advances cast ALK as a bona fide oncoprotein in neuroblastoma and emphasize the need to understand ALK-mediated signaling in this tumor.  This review addresses many of the current issues surrounding the role of ALK in normal development and neuroblastoma pathogenesis, and discusses the prospects for clin. effective targeted treatments based on ALK inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpqmFzh9Q3frVg90H21EOLACvtfcHk0lhO47vaKjthOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSktLzN&md5=e07445aecd9829c465f1f4023124521f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2011.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2011.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DAzarova%26aufirst%3DA.%2BM.%26aulast%3DGautam%26aufirst%3DG.%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26atitle%3DEmerging%2520importance%2520of%2520ALK%2520in%2520neuroblastoma%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D267%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Tuma, R. S.</span><span> </span><span class="NLM_article-title">ALK gene amplified in most inflammatory breast cancers</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1093%2Fjnci%2Fdjr553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=22215853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2012&pages=87-88&issue=2&author=R.+S.+Tuma&title=ALK+gene+amplified+in+most+inflammatory+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">ALK Gene Amplified in Most Inflammatory Breast Cancers</span></div><div class="casAuthors">Tuma, Rabiya S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-88</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Inflammatory breast cancer (IBC) is a rare form of the disease that differs substantially from non-inflammatory breast cancer in presentation and response to therapy. Despite those differences, researchers have uncovered few mol. characteristics that distinguish IBC from non-inflammatory breast cancer, and IBC treatment generally relies on std. breast cancer regimens.  Recently, it has been reported that ALK gene amplification is a common feature of IBC tumors and that small-mol. ALK inhibitors are effective in mouse xenograft models.  Current developments on this recent report are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB9yX6fegRi7Vg90H21EOLACvtfcHk0lhO47vaKjthOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWhsb0%253D&md5=46e7633055aadc3aacfc6bac9b4cb591</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjr553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjr553%26sid%3Dliteratum%253Aachs%26aulast%3DTuma%26aufirst%3DR.%2BS.%26atitle%3DALK%2520gene%2520amplified%2520in%2520most%2520inflammatory%2520breast%2520cancers%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2012%26volume%3D104%26issue%3D2%26spage%3D87%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beausoleil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innocenti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, T.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ynag, Y.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comb, M. J.</span><span> </span><span class="NLM_article-title">Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">3312</span><span class="NLM_x">–</span> <span class="NLM_lpage">3323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=3312-3323&author=H.+Renauthor=X.+Z.+Tanauthor=C.+Crosbyauthor=H.+Haackauthor=J.-M.+Renauthor=S.+Beausoleilauthor=A.+Moritzauthor=G.+Innocentiauthor=J.+Rushauthor=Y.+Zhangauthor=X.-M.+Zhouauthor=T.-L.+Guauthor=Y.-F.+Ynagauthor=M.+J.+Comb&title=Identification+of+anaplastic+lymphoma+kinase+as+a+potential+therapeutic+target+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DX.%2BZ.%26aulast%3DCrosby%26aufirst%3DC.%26aulast%3DHaack%26aufirst%3DH.%26aulast%3DRen%26aufirst%3DJ.-M.%26aulast%3DBeausoleil%26aufirst%3DS.%26aulast%3DMoritz%26aufirst%3DA.%26aulast%3DInnocenti%26aufirst%3DG.%26aulast%3DRush%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.-M.%26aulast%3DGu%26aufirst%3DT.-L.%26aulast%3DYnag%26aufirst%3DY.-F.%26aulast%3DComb%26aufirst%3DM.%2BJ.%26atitle%3DIdentification%2520of%2520anaplastic%2520lymphoma%2520kinase%2520as%2520a%2520potential%2520therapeutic%2520target%2520in%2520ovarian%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D3312%26epage%3D3323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ott, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzalone, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underiner, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quail, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100158s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=493-498&author=G.+R.+Ottauthor=R.+Tripathyauthor=M.+Chengauthor=R.+McHughauthor=A.+V.+Anzaloneauthor=T.+L.+Underinerauthor=M.+A.+Curryauthor=M.+R.+Quailauthor=L.+Luauthor=W.+Wanauthor=T.+S.+Angelesauthor=M.+S.+Albomauthor=L.+D.+Aimoneauthor=M.+A.+Atorauthor=B.+A.+Ruggeriauthor=B.+D.+Dorsey&title=Discovery+of+a+potent+inhibitor+of+anaplastic+lymphoma+kinase+with+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity</span></div><div class="casAuthors">Ott, Gregory R.; Tripathy, Rabindranath; Cheng, Mangeng; McHugh, Robert; Anzalone, Andrew V.; Underiner, Ted L.; Curry, Matthew A.; Quail, Matthew R.; Lu, Lihui; Wan, Weihua; Angeles, Thelma S.; Albom, Mark S.; Aimone, Lisa D.; Ator, Mark A.; Ruggeri, Bruce A.; Dorsey, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">493-498</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel 7-amino-1,3,4,5-tetrahydrobenzo[b]azepin-2-one derivs. within the diaminopyrimidine class of kinase inhibitors were identified that target anaplastic lymphoma kinase (ALK).  These inhibitors are potent against ALK in an isolated enzyme assay and inhibit autophosphorylation of the oncogenic fusion protein NPM-ALK in anaplastic large cell lymphoma (ALCL) cell lines.  The lead inhibitor 15 (I), which incorporates a bicyclo[2.2.1]hept-5-ene ring system in place of an aryl moiety, activates the pro-apoptotic caspases (3 and 7) and displays selective cytotoxicity against ALK-pos. ALCL cells.  Furthermore, 15 provides more than 40-fold selectivity against the structurally related insulin receptor, is orally bioavailable in multiple species, and displays in vivo antitumor efficacy when dosed orally in ALK-pos. ALCL tumor xenografts in Scid mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof0qilbcAbZ7Vg90H21EOLACvtfcHk0lj6T3GHjt2VJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtrrJ&md5=15d4f7aea64f212338d8c9cd88a36c64</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml100158s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100158s%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DTripathy%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DMcHugh%26aufirst%3DR.%26aulast%3DAnzalone%26aufirst%3DA.%2BV.%26aulast%3DUnderiner%26aufirst%3DT.%2BL.%26aulast%3DCurry%26aufirst%3DM.%2BA.%26aulast%3DQuail%26aufirst%3DM.%2BR.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520with%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D493%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Mesaros, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugan, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzalone, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quail, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B, D.</span><span> </span><span class="NLM_article-title">Novel 2,3,4,5-tetrahydro-benzo[<i>d</i>]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=463-466&author=E.+F.+Mesarosauthor=J.+P.+Burkeauthor=J.+D.+Parrishauthor=B.+J.+Duganauthor=A.+V.+Anzaloneauthor=T.+S.+Angelesauthor=M.+S.+Albomauthor=L.+D.+Aimoneauthor=M.+R.+Quailauthor=W.+Wanauthor=L.+Luauthor=Z.+Huangauthor=M.+A.+Atorauthor=B.+A.+Ruggeriauthor=M.+Chengauthor=G.+R.+Ottauthor=B%2C+D.+Dorsey&title=Novel+2%2C3%2C4%2C5-tetrahydro-benzo%5Bd%5Dazepine+derivatives+of+2%2C4-diaminopyrimidine%2C+selective+and+orally+bioavailable+ALK+inhibitors+with+antitumor+efficacy+in+ALCL+mouse+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMesaros%26aufirst%3DE.%2BF.%26aulast%3DBurke%26aufirst%3DJ.%2BP.%26aulast%3DParrish%26aufirst%3DJ.%2BD.%26aulast%3DDugan%26aufirst%3DB.%2BJ.%26aulast%3DAnzalone%26aufirst%3DA.%2BV.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DQuail%26aufirst%3DM.%2BR.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DDorsey%26aufirst%3DB%252C%2BD.%26atitle%3DNovel%25202%252C3%252C4%252C5-tetrahydro-benzo%255Bd%255Dazepine%2520derivatives%2520of%25202%252C4-diaminopyrimidine%252C%2520selective%2520and%2520orally%2520bioavailable%2520ALK%2520inhibitors%2520with%2520antitumor%2520efficacy%2520in%2520ALCL%2520mouse%2520models%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D463%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Milkiewicz, K. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of 1,2,3,4-tetrahydropyrido[2,3-<i>b</i>]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4351</span><span class="NLM_x">–</span> <span class="NLM_lpage">4362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4351-4362&author=K.+L+Milkiewiczauthor=L.+R.+Weinbergauthor=M.+S.+Albomauthor=T.+S.+Angelesauthor=M.+Cheng&title=Synthesis+and+structure%E2%80%93activity+relationships+of+1%2C2%2C3%2C4-tetrahydropyrido%5B2%2C3-b%5Dpyrazines+as+potent+and+selective+inhibitors+of+the+anaplastic+lymphoma+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL%26aulast%3DWeinberg%26aufirst%3DL.%2BR.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DCheng%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%25201%252C2%252C3%252C4-tetrahydropyrido%255B2%252C3-b%255Dpyrazines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520anaplastic%2520lymphoma%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4351%26epage%3D4362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ott, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieu, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quail, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisko, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesaros, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span> </span><span class="NLM_article-title">2,7-Disubstituted-pyrrolo[2,1-<i>f</i>][1,2,4]triazines: new variant of an old template and application to the discovery of anaplastic lymphoma kinase (ALK) inhibitors with in vivo antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6328</span><span class="NLM_x">–</span> <span class="NLM_lpage">6341</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200758k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6328-6341&issue=18&author=G.+R.+Ottauthor=G.+J.+Wellsauthor=T.+V.+Thieuauthor=M.+R.+Quailauthor=G.+J.+Liskoauthor=E.+F.+Mesarosauthor=D.+E.+Gingrichauthor=A.+K.+Ghoseauthor=W.+Wanauthor=L.+Luauthor=M.+Chengauthor=M.+S.+Albomauthor=T.+S.+Angelesauthor=Z.+Huangauthor=L.+D.+Aimoneauthor=M.+A.+Atorauthor=B.+A.+Ruggeriauthor=B.+D.+Dorsey&title=2%2C7-Disubstituted-pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazines%3A+new+variant+of+an+old+template+and+application+to+the+discovery+of+anaplastic+lymphoma+kinase+%28ALK%29+inhibitors+with+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm200758k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200758k%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DWells%26aufirst%3DG.%2BJ.%26aulast%3DThieu%26aufirst%3DT.%2BV.%26aulast%3DQuail%26aufirst%3DM.%2BR.%26aulast%3DLisko%26aufirst%3DG.%2BJ.%26aulast%3DMesaros%26aufirst%3DE.%2BF.%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3D2%252C7-Disubstituted-pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%253A%2520new%2520variant%2520of%2520an%2520old%2520template%2520and%2520application%2520to%2520the%2520discovery%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520inhibitors%2520with%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D18%26spage%3D6328%26epage%3D6341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantla, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickens, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chucholowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, T. R.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1006</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050824x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1006-1015&author=R.+Liauthor=L.+Xueauthor=T.+Zhuauthor=Q.+Jiangauthor=X.+Cuiauthor=Z.+Yanauthor=D.+McGeeauthor=J.+Wangauthor=V.+R.+Gantlaauthor=J.+C.+Pickensauthor=D.+McGrathauthor=A.+Chucholowskiauthor=S.+W.+Morrisauthor=T.+R.+Webb&title=Design+and+synthesis+of+5-aryl-pyridone-carboxamides+as+inhibitors+of+anaplastic+lymphoma+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm050824x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050824x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DMcGee%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGantla%26aufirst%3DV.%2BR.%26aulast%3DPickens%26aufirst%3DJ.%2BC.%26aulast%3DMcGrath%26aufirst%3DD.%26aulast%3DChucholowski%26aufirst%3DA.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DWebb%26aufirst%3DT.%2BR.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205-aryl-pyridone-carboxamides%2520as%2520inhibitors%2520of%2520anaplastic%2520lymphoma%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1006%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ardini, E.; Menichincheri, M.; De Ponti, C.; Amboldi, N.; Ballinari, D.; Saccardo, M. B.; Croci, V.; Stellari, F.; Texido, G.; Orsini, P.; Perrone, E.; Bandiera, T.; Borgia, A. L; Lansen, J.; Isacchi, A.; Colotta, F.; Pesenti, E.; Magnaghi, P.; Galvani, A.</span><span> </span><span class="NLM_article-title">A Highly Potent, Selective and Orally Available ALK Inhibitor with Demonstrated Antitumor Efficacy in ALK Dependent Lymphoma and Non-Small Cell Lung Cancer Models</span>. Presented at the Annual Meeting of the American Association for Cancer Research (AACR), San Diego, CA,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Abstract 3737.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=E.+Ardini&author=M.+Menichincheri&author=C.+De+Ponti&author=N.+Amboldi&author=D.+Ballinari&author=M.+B.+Saccardo&author=V.+Croci&author=F.+Stellari&author=G.+Texido&author=P.+Orsini&author=E.+Perrone&author=T.+Bandiera&author=A.+L+Borgia&author=J.+Lansen&author=A.+Isacchi&author=F.+Colotta&author=E.+Pesenti&author=P.+Magnaghi&author=A.+Galvani&title=A+Highly+Potent%2C+Selective+and+Orally+Available+ALK+Inhibitor+with+Demonstrated+Antitumor+Efficacy+in+ALK+Dependent+Lymphoma+and+Non-Small+Cell+Lung+Cancer+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DArdini%26aufirst%3DE.%26atitle%3DA%2520Highly%2520Potent%252C%2520Selective%2520and%2520Orally%2520Available%2520ALK%2520Inhibitor%2520with%2520Demonstrated%2520Antitumor%2520Efficacy%2520in%2520ALK%2520Dependent%2520Lymphoma%2520and%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Models%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sabbatini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korenchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowand, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leperi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumble, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gontarek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maksimchuk, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suravajjala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapierre, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shotwell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2811</span><span class="NLM_x">–</span> <span class="NLM_lpage">2820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1158%2F1535-7163.MCT-09-0423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=19825801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2811-2820&issue=10&author=P.+Sabbatiniauthor=S.+Korenchukauthor=J.+L.+Rowandauthor=A.+Groyauthor=Q.+Liuauthor=D.+Leperiauthor=C.+Atkinsauthor=M.+Dumbleauthor=J.+Yangauthor=K.+Andersonauthor=R.+G.+Krugerauthor=R.+R.+Gontarekauthor=K.+R.+Maksimchukauthor=S.+Suravajjalaauthor=R.+R.+Lapierreauthor=J.+B.+Shotwellauthor=J.+W.+Wilsonauthor=S.+D.+Chamberlainauthor=S.+K.+Rabindranauthor=R.+Kumar&title=GSK1838705A+inhibits+the+insulin-like+growth+factor-1+receptor+and+anaplastic+lymphoma+kinase+and+shows+antitumor+activity+in+experimental+models+of+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers</span></div><div class="casAuthors">Sabbatini, Peter; Korenchuk, Susan; Rowand, Jason L.; Groy, Arthur; Liu, Qi; Leperi, Dominic; Atkins, Charity; Dumble, Melissa; Yang, Jingsong; Anderson, Kelly; Kruger, Ryan G.; Gontarek, Richard R.; Maksimchuk, Kenneth R.; Suravajjala, Sapna; Lapierre, Russell R.; Shotwell, J. Brad; Wilson, Joseph W.; Chamberlain, Stanley D.; Rabindran, Sridhar K.; Kumar, Rakesh</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2811-2820</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The insulin-like growth factor-I receptor (IGF-IR) signaling pathway is activated in various tumors, and inhibition of IGF-IR kinase provides a therapeutic opportunity in these patients.  GSK1838705A is a small-mol. kinase inhibitor that inhibits IGF-IR and the insulin receptor with IC50s of 2.0 and 1.6 nmol/L, resp.  GSK1838705A blocks the in vitro proliferation of cell lines derived from solid and hematol. malignancies, including multiple myeloma and Ewing's sarcoma, and retards the growth of human tumor xenografts in vivo.  Despite the inhibitory effect of GSK1838705A on insulin receptor, minimal effects on glucose homeostasis were obsd. at efficacious doses.  GSK1838705A also inhibits the anaplastic lymphoma kinase (ALK), which drives the aberrant growth of anaplastic large-cell lymphomas, some neuroblastomas, and a subset of non-small cell lung cancers.  GSK1838705A inhibits ALK, with an IC50 of 0.5 nmol/L, and causes complete regression of ALK-dependent tumors in vivo at well-tolerated doses.  GSK1838705A is therefore a promising antitumor agent for therapeutic use in human cancers. [Mol Cancer Ther 2009;8(10):2811-20].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyQ0LEFOBer7Vg90H21EOLACvtfcHk0ligwCE2_ZszEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7N&md5=42e56e8dd4920322b82bedd13721be5b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0423%26sid%3Dliteratum%253Aachs%26aulast%3DSabbatini%26aufirst%3DP.%26aulast%3DKorenchuk%26aufirst%3DS.%26aulast%3DRowand%26aufirst%3DJ.%2BL.%26aulast%3DGroy%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLeperi%26aufirst%3DD.%26aulast%3DAtkins%26aufirst%3DC.%26aulast%3DDumble%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26aulast%3DMaksimchuk%26aufirst%3DK.%2BR.%26aulast%3DSuravajjala%26aufirst%3DS.%26aulast%3DLapierre%26aufirst%3DR.%2BR.%26aulast%3DShotwell%26aufirst%3DJ.%2BB.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26aulast%3DChamberlain%26aufirst%3DS.%2BD.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DGSK1838705A%2520inhibits%2520the%2520insulin-like%2520growth%2520factor-1%2520receptor%2520and%2520anaplastic%2520lymphoma%2520kinase%2520and%2520shows%2520antitumor%2520activity%2520in%2520experimental%2520models%2520of%2520human%2520cancers%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D10%26spage%3D2811%26epage%3D2820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lewis, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellwagen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saffran, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szilvassy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brake, R. L.</span><span> </span><span class="NLM_article-title">The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6540</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3005866" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6523-6540&author=R.+T.+Lewisauthor=C.+M.+Bodeauthor=D.+M.+Choquetteauthor=M.+Potashmanauthor=K.+Romeroauthor=J.+C.+Stellwagenauthor=Y.+Tefferaauthor=E.+Mooreauthor=D.+A.+Whittingtonauthor=H.+Chenauthor=L.+F.+Epsteinauthor=R.+Emkeyauthor=P.+S.+Andrewsauthor=V.+L.+Yuauthor=D.+C.+Saffranauthor=M.+Xuauthor=A.+Drewauthor=P.+Merkelauthor=S.+Szilvassyauthor=R.+L.+Brake&title=The+discovery+and+optimization+of+a+novel+class+of+potent%2C+selective%2C+and+orally+bioavailable+anaplastic+lymphoma+kinase+%28ALK%29+inhibitors+with+potential+utility+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm3005866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3005866%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DR.%2BT.%26aulast%3DBode%26aufirst%3DC.%2BM.%26aulast%3DChoquette%26aufirst%3DD.%2BM.%26aulast%3DPotashman%26aufirst%3DM.%26aulast%3DRomero%26aufirst%3DK.%26aulast%3DStellwagen%26aufirst%3DJ.%2BC.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DMoore%26aufirst%3DE.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DYu%26aufirst%3DV.%2BL.%26aulast%3DSaffran%26aufirst%3DD.%2BC.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DDrew%26aufirst%3DA.%26aulast%3DMerkel%26aufirst%3DP.%26aulast%3DSzilvassy%26aufirst%3DS.%26aulast%3DBrake%26aufirst%3DR.%2BL.%26atitle%3DThe%2520discovery%2520and%2520optimization%2520of%2520a%2520novel%2520class%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520inhibitors%2520with%2520potential%2520utility%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6523%26epage%3D6540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, W. II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jänne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of 3,5-diamino-1,2,4-triazole ureas as potent anaplastic lymphoma kinase inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200002a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=379-384&author=X.+Dengauthor=J.+Wangauthor=J.+Zhangauthor=T.+Simauthor=N.+D.+Kimauthor=T.+Sasakiauthor=W.+II+Lutherauthor=R.+E.+Georgeauthor=P.+A.+J%C3%A4nneauthor=N.+S.+Gray&title=Discovery+of+3%2C5-diamino-1%2C2%2C4-triazole+ureas+as+potent+anaplastic+lymphoma+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml200002a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200002a%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DLuther%26aufirst%3DW.%2BII%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%25203%252C5-diamino-1%252C2%252C4-triazole%2520ureas%2520as%2520potent%2520anaplastic%2520lymphoma%2520kinase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D379%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span> </span><span class="NLM_article-title">Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3314</span><span class="NLM_x">–</span> <span class="NLM_lpage">3322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1158%2F1535-7163.MCT-07-0365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=18089725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=3314-3322&issue=12&author=J.+G.+Christensenauthor=H.+Y.+Zouauthor=M.+E.+Arangoauthor=Q.+Liauthor=J.+H.+Leeauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=G.+R.+Altonauthor=B.+Mroczkowskiauthor=G.+Los&title=Cytoreductive+antitumor+activity+of+PF-2341066%2C+a+novel+inhibitor+of+anaplastic+lymphoma+kinase+and+c-Met%2C+in+experimental+models+of+anaplastic+large-cell+lymphoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma</span></div><div class="casAuthors">Christensen, James G.; Zou, Helen Y.; Arango, Maria E.; Li, Qiuhua; Lee, Joseph H.; McDonnell, Scott R.; Yamazaki, Shinji; Alton, Gordon R.; Mroczkowski, Barbara; Los, Gerrit</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">3314-3322</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A t(2;5) chromosomal translocation resulting in expression of an oncogenic kinase fusion protein known as nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) has been implicated in the pathogenesis of anaplastic large-cell lymphoma (ALCL).  PF-2341066 was recently identified as a p.o. bioavailable, small-mol. inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK fusion protein.  PF-2341066 also potently inhibited NPM-ALK phosphorylation in Karpas299 or SU-DHL-1 ALCL cells (mean IC50 value, 24 nmol/L).  In biochem. and cellular screens, PF-2341066 was shown to be selective for c-Met and ALK at pharmacol. relevant concns. across a panel of >120 diverse kinases.  PF-2341066 potently inhibited cell proliferation, which was assocd. with G1-S-phase cell cycle arrest and induction of apoptosis in ALK-pos. ALCL cells (IC50 values, ∼30 nmol/L) but not ALK-neg. lymphoma cells.  The induction of apoptosis was confirmed using terminal deoxyribonucleotide transferase-mediated nick-end labeling and Annexin V staining (IC50 values, 25-50 nmol/L).  P.o. administration of PF-2341066 to severe combined immunodeficient-Beige mice bearing Karpas299 ALCL tumor xenografts resulted in dose-dependent antitumor efficacy with complete regression of all tumors at the 100 mg/kg/d dose within 15 days of initial compd. administration.  A strong correlation was obsd. between antitumor response and inhibition of NPM-ALK phosphorylation and induction of apoptosis in tumor tissue.  In addn., inhibition of key NPM-ALK signaling mediators, including phospholipase C-γ, signal transducers and activators of transcription 3, extracellular signal-regulated kinases, and Akt by PF-2341066 were obsd. at concns. or dose levels, which correlated with inhibition of NPM-ALK phosphorylation and function.  Collectively, these data illustrate the potential clin. utility of inhibitors of NPM-ALK in treatment of patients with ALK-pos. ALCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptqY0tUwGnurVg90H21EOLACvtfcHk0lg3tWGGeo3VOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrrL&md5=04fbbaf43ca527408bde8cabcd38e1fd</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0365%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DAlton%26aufirst%3DG.%2BR.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DLos%26aufirst%3DG.%26atitle%3DCytoreductive%2520antitumor%2520activity%2520of%2520PF-2341066%252C%2520a%2520novel%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520and%2520c-Met%252C%2520in%2520experimental%2520models%2520of%2520anaplastic%2520large-cell%2520lymphoma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26issue%3D12%26spage%3D3314%26epage%3D3322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I..</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crizotinib, A.</span><span> </span><span class="NLM_article-title">Small-molecule dual inhibitor of the c-Met and ALK receptor tyrosine kinases</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1477</span><span class="NLM_x">–</span> <span class="NLM_lpage">1490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1477-1490&author=S.+J.+Rodigauthor=G.+I..+Shapiroauthor=A.+Crizotinib&title=Small-molecule+dual+inhibitor+of+the+c-Met+and+ALK+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DShapiro%26aufirst%3DG.%2BI..%26aulast%3DCrizotinib%26aufirst%3DA.%26atitle%3DSmall-molecule%2520dual%2520inhibitor%2520of%2520the%2520c-Met%2520and%2520ALK%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D11%26spage%3D1477%26epage%3D1490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Dube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrous, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal–epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6342</span><span class="NLM_x">–</span> <span class="NLM_lpage">6363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2007613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6342-6363&issue=18&author=J.+J.+Cuiauthor=M.+Tran-Dubeauthor=H.+Shenauthor=M.+Nambuauthor=P.-P.+Kungauthor=M.+Pairishauthor=L.+Jiaauthor=J.+Mengauthor=L.+Funkauthor=I.+Botrousauthor=M.+McTigueauthor=N.+Grodskyauthor=K.+Ryanauthor=E.+Padriqueauthor=G.+Altonauthor=S.+Timofeevskiauthor=S.+Yamazakiauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensenauthor=B.+Mroczkowskiauthor=S.+Benderauthor=R.+S.+Kaniaauthor=M.+P.+Edwards&title=Structure+based+drug+design+of+crizotinib+%28PF-02341066%29%2C+a+potent+and+selective+dual+inhibitor+of+mesenchymal%E2%80%93epithelial+transition+factor+%28c-MET%29+kinase+and+anaplastic+lymphoma+kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm2007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007613%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DStructure%2520based%2520drug%2520design%2520of%2520crizotinib%2520%2528PF-02341066%2529%252C%2520a%2520potent%2520and%2520selective%2520dual%2520inhibitor%2520of%2520mesenchymal%25E2%2580%2593epithelial%2520transition%2520factor%2520%2528c-MET%2529%2520kinase%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D18%26spage%3D6342%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kwak, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camidge, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maki, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dezube, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jänne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varella-Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidias, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbs, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sequist, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino-Kenudson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shreeve, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratain, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span> </span><span class="NLM_article-title">Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1703</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1056%2FNEJMoa1006448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=20979469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKitL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1693-1703&issue=18&author=E.+L.+Kwakauthor=Y.+J.+Bangauthor=D.+R.+Camidgeauthor=A.+T.+Shawauthor=B.+Solomonauthor=R.+G.+Makiauthor=S.+H.+Ouauthor=B.+J.+Dezubeauthor=P.+A.+J%C3%A4nneauthor=D.+B.+Costaauthor=M.+Varella-Garciaauthor=W.+H.+Kimauthor=T.+J.+Lynchauthor=P.+Fidiasauthor=H.+Stubbsauthor=J.+A.+Engelmanauthor=L.+V.+Sequistauthor=W.+Tanauthor=L.+Gandhiauthor=M.+Mino-Kenudsonauthor=G.+C.+Weiauthor=S.+M.+Shreeveauthor=M.+J.+Ratainauthor=J.+Settlemanauthor=J.+G.+Christensenauthor=D.+A.+Haberauthor=K.+Wilnerauthor=R.+Salgiaauthor=G.+I.+Shapiroauthor=J.+W.+Clarkauthor=A.+J.+Iafrate&title=Anaplastic+lymphoma+kinase+inhibition+in+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer</span></div><div class="casAuthors">Kwak, Eunice L.; Bang, Yung-Jue; Camidge, Ross; Shaw, Alice T.; Solomon, Benjamin; Maki, Robert G.; Ou, Sai-Hong I.; Dezube, Bruce J.; Janne, Pasi A.; Costa, Daniel B.; Varella-Garcia, Marileila; Kim, Woo-Ho; Lynch, Thomas J.; Fidias, Panos; Stubbs, Hannah; Engelman, Jeffrey A.; Sequist, Lecia V.; Tan, WeiWei; Gandhi, Leena; Mino-Kenudson, Mari; Wei, Greg C.; Shreeve, Martin; Ratain, Mark J.; Settleman, Jeffrey; Christensen, James G.; Haber, Daniel A.; Wilner, Keith; Salgia, Ravi; Shapiro, Geoffrey I.; Clark, Jeffrey W.; Iafrate, A. John</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1693-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma kinase (ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7% of such tumors.  The authors explored the therapeutic efficacy of inhibiting ALK in such tumors in an early-phase clin. trial of crizotinib (PF-02341066), an orally available small-mol. inhibitor of the ALK tyrosine kinase.  METHODS: After screening tumor samples from approx. 1500 patients with non-small-cell lung cancer for the presence of ALK rearrangements, the authors identified 82 patients with advanced ALK-pos. disease who were eligible for the clin. trial.  Most of the patients had received previous treatment.  These patients were enrolled in an expanded cohort study instituted after phase 1 dose escalation had established a recommended crizotinib dose of 250 mg twice daily in 28-day cycles.  Patients were assessed for adverse events and response to therapy.  RESULTS: Patients with ALK rearrangements tended to be younger than those without the rearrangements, and most of the patients had little or no exposure to tobacco and had adenocarcinomas.  At a mean treatment duration of 6.4 mo, the overall response rate was 57% (47 of 82 patients, with 46 confirmed partial responses and 1 confirmed complete response); 27 patients (33%) had stable disease.  A total of 63 of 82 patients (77%) were continuing to receive crizotinib at the time of data cutoff, and the estd. probability of 6-mo progression-free survival was 72%, with no median for the study reached.  The drug resulted in grade 1 or 2 (mild) gastrointestinal side effects.  CONCLUSIONS: The inhibition of ALK in lung tumors with the ALK rearrangement resulted in tumor shrinkage or stable disease in most patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWDt_eL7Lyo7Vg90H21EOLACvtfcHk0liFgv2avqZAzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKitL%252FO&md5=47440b9c944100295cca0f1859138d6b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1006448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1006448%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DSolomon%26aufirst%3DB.%26aulast%3DMaki%26aufirst%3DR.%2BG.%26aulast%3DOu%26aufirst%3DS.%2BH.%26aulast%3DDezube%26aufirst%3DB.%2BJ.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DW.%2BH.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26aulast%3DFidias%26aufirst%3DP.%26aulast%3DStubbs%26aufirst%3DH.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DSequist%26aufirst%3DL.%2BV.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DGandhi%26aufirst%3DL.%26aulast%3DMino-Kenudson%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DG.%2BC.%26aulast%3DShreeve%26aufirst%3DS.%2BM.%26aulast%3DRatain%26aufirst%3DM.%2BJ.%26aulast%3DSettleman%26aufirst%3DJ.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26aulast%3DWilner%26aufirst%3DK.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DClark%26aufirst%3DJ.%2BW.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26atitle%3DAnaplastic%2520lymphoma%2520kinase%2520inhibition%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26issue%3D18%26spage%3D1693%26epage%3D1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroshima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span> </span><span class="NLM_article-title">CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=679-690&author=H.+Sakamotoauthor=T.+Tsukaguchiauthor=S.+Hiroshimaauthor=T.+Kodamaauthor=T.+Kobayashiauthor=T.+A.+Fukamiauthor=N.+Oikawaauthor=T.+Tsukudaauthor=N.+Ishiiauthor=Y.+Aoki&title=CH5424802%2C+a+selective+ALK+inhibitor+capable+of+blocking+the+resistant+gatekeeper+mutant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DHiroshima%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DFukami%26aufirst%3DT.%2BA.%26aulast%3DOikawa%26aufirst%3DN.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DAoki%26aufirst%3DY.%26atitle%3DCH5424802%252C%2520a%2520selective%2520ALK%2520inhibitor%2520capable%2520of%2520blocking%2520the%2520resistant%2520gatekeeper%2520mutant%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26spage%3D679%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Kinoshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohwada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takanashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span> </span><span class="NLM_article-title">9-Substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazoles as highly selective and potent anaplastic lymphoma kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6286</span><span class="NLM_x">–</span> <span class="NLM_lpage">6294</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200652u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOns7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6286-6294&author=K.+Kinoshitaauthor=T.+Kobayashiauthor=K.+Asohauthor=N.+Furuichiauthor=T.+Itoauthor=H.+Kawadaauthor=S.+Haraauthor=J.+Ohwadaauthor=K.+Hattoriauthor=T.+Miyagiauthor=W.-S.+Hongauthor=M.-J.+Parkauthor=K.+Takanashiauthor=T.+Tsukaguchiauthor=H.+Sakamotoauthor=T.+Tsukudaauthor=N.+Oikawa&title=9-Substituted+6%2C6-dimethyl-11-oxo-6%2C11-dihydro-5H-benzo%5Bb%5Dcarbazoles+as+highly+selective+and+potent+anaplastic+lymphoma+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors</span></div><div class="casAuthors">Kinoshita, Kazutomo; Kobayashi, Takamitsu; Asoh, Kohsuke; Furuichi, Noriyuki; Ito, Toshiya; Kawada, Hatsuo; Hara, Sousuke; Ohwada, Jun; Hattori, Kazuo; Miyagi, Takuho; Hong, Woo-Sang; Park, Min-Jeong; Takanashi, Kenji; Tsukaguchi, Toshiyuki; Sakamoto, Hiroshi; Tsukuda, Takuo; Oikawa, Nobuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6286-6294</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">9-Substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles were discovered as highly selective and potent anaplastic lymphoma kinase (ALK) inhibitors by structure-based drug design.  The high target selectivity was achieved by introducing a substituent close to the E0 region of the ATP binding site, which has a unique amino acid sequence.  Among the identified inhibitors, compd. 13d (I) showed highly selective and potent inhibitory activity against ALK with an IC50 value of 2.9 nM and strong antiproliferative activity against KARPAS-299 with an IC50 value of 12.8 nM.  The compd. also displayed significant antitumor efficacy in an established ALK fusion gene-pos. anaplastic large-cell lymphoma (ALCL) xenograft model in mice without body wt. loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfpJsdIdDvO7Vg90H21EOLACvtfcHk0lhXhA7MkLLqIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOns7vP&md5=6293368243c840e12beefc8c8d6bb69a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm200652u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200652u%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DAsoh%26aufirst%3DK.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DKawada%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DS.%26aulast%3DOhwada%26aufirst%3DJ.%26aulast%3DHattori%26aufirst%3DK.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DHong%26aufirst%3DW.-S.%26aulast%3DPark%26aufirst%3DM.-J.%26aulast%3DTakanashi%26aufirst%3DK.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DOikawa%26aufirst%3DN.%26atitle%3D9-Substituted%25206%252C6-dimethyl-11-oxo-6%252C11-dihydro-5H-benzo%255Bb%255Dcarbazoles%2520as%2520highly%2520selective%2520and%2520potent%2520anaplastic%2520lymphoma%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6286%26epage%3D6294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kuromitsu, S.; Mori, M.; Shimada, I.; Kondoh, Y.; Shindoh, N.; Soga, T.; Furutani, T.; Konagai, S.; Sakagami, H.; Nakata, M.; Ueno, Y.; Saito, R.; Sasamata, M.; Kudou, M.</span><span> </span><span class="NLM_article-title">Anti-Tumor Activity of ASP3026. A Novel and Selective ALK Inhibitor of Anaplastic Lymphoma Kinase (ALK)</span>. Presented at the Annual Meeting of the American Association for Cancer Research (AACR), Orlando, FL,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Abstract 2821.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Kuromitsu&author=M.+Mori&author=I.+Shimada&author=Y.+Kondoh&author=N.+Shindoh&author=T.+Soga&author=T.+Furutani&author=S.+Konagai&author=H.+Sakagami&author=M.+Nakata&author=Y.+Ueno&author=R.+Saito&author=M.+Sasamata&author=M.+Kudou&title=Anti-Tumor+Activity+of+ASP3026.+A+Novel+and+Selective+ALK+Inhibitor+of+Anaplastic+Lymphoma+Kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKuromitsu%26aufirst%3DS.%26atitle%3DAnti-Tumor%2520Activity%2520of%2520ASP3026.%2520A%2520Novel%2520and%2520Selective%2520ALK%2520Inhibitor%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520%2528ALK%2529%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lovly, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuckmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Stanchina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span> </span><span class="NLM_article-title">Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4920</span><span class="NLM_x">–</span> <span class="NLM_lpage">4931</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=4920-4931&issue=14&author=C.+M.+Lovlyauthor=J.+M.+Heuckmannauthor=E.+De+Stanchinaauthor=H.+Chenauthor=R.+K.+Thomasauthor=C.+Liangauthor=W.+Pao&title=Insights+into+ALK-driven+cancers+revealed+through+development+of+novel+ALK+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLovly%26aufirst%3DC.%2BM.%26aulast%3DHeuckmann%26aufirst%3DJ.%2BM.%26aulast%3DDe%2BStanchina%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DPao%26aufirst%3DW.%26atitle%3DInsights%2520into%2520ALK-driven%2520cancers%2520revealed%2520through%2520development%2520of%2520novel%2520ALK%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D14%26spage%3D4920%26epage%3D4931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Katayama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifshits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">River, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey A. Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span> </span><span class="NLM_article-title">Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">7540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=7535-7540&issue=18&author=R.+Katayamaauthor=T.+M.+Khanauthor=C.+Benesauthor=E.+Lifshitsauthor=H.+Ebauthor=V.+M.+Riverauthor=W.+C.+Shakespeareauthor=A.+J.+Iafrateauthor=J.+A.+Jeffrey+A.+Engelmanauthor=A.+T.+Shaw&title=Therapeutic+strategies+to+overcome+crizotinib+resistance+in+non-small+cell+lung+cancers+harboring+the+fusion+oncogene+EML4-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatayama%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DT.%2BM.%26aulast%3DBenes%26aufirst%3DC.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DEb%26aufirst%3DH.%26aulast%3DRiver%26aufirst%3DV.%2BM.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DJeffrey%2BA.%2BEngelman%26aufirst%3DJ.%2BA.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DTherapeutic%2520strategies%2520to%2520overcome%2520crizotinib%2520resistance%2520in%2520non-small%2520cell%2520lung%2520cancers%2520harboring%2520the%2520fusion%2520oncogene%2520EML4-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26issue%3D18%26spage%3D7535%26epage%3D7540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Rivera, V. M.; Anjum, R.; Wang, F.; Zhang, S.; Keats, J.; Ning, Y.; Wardwell, S. D.; Moran, L.; Ye, E.; Chun, D. Y.; Mohemmad, K. Q.; Liu, S.; Huang, W.-S.; Wang, Y.; Thomas, M.; Li, F.; Qi, J.; Miret, J.; Iuliucci, J. D.; Dalgarno, D.; Narasimhan, N. I.; Clackson, T.; Shakespeare, W. C.</span><span> </span><span class="NLM_article-title">Efficacy and Pharmacodynamic Analysis of AP26113, a Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase (ALK)</span>. Presented at the Annual Meeting of the American Association for Cancer Research (AACR), Washington, D.C.,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Abstract 3623.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=V.+M.+Rivera&author=R.+Anjum&author=F.+Wang&author=S.+Zhang&author=J.+Keats&author=Y.+Ning&author=S.+D.+Wardwell&author=L.+Moran&author=E.+Ye&author=D.+Y.+Chun&author=K.+Q.+Mohemmad&author=S.+Liu&author=W.-S.+Huang&author=Y.+Wang&author=M.+Thomas&author=F.+Li&author=J.+Qi&author=J.+Miret&author=J.+D.+Iuliucci&author=D.+Dalgarno&author=N.+I.+Narasimhan&author=T.+Clackson&author=W.+C.+Shakespeare&title=Efficacy+and+Pharmacodynamic+Analysis+of+AP26113%2C+a+Potent+and+Selective+Orally+Active+Inhibitor+of+Anaplastic+Lymphoma+Kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DV.%2BM.%26atitle%3DEfficacy%2520and%2520Pharmacodynamic%2520Analysis%2520of%2520AP26113%252C%2520a%2520Potent%2520and%2520Selective%2520Orally%2520Active%2520Inhibitor%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520%2528ALK%2529%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Li, N.; Michellys, P.-Y.; Kim, S.; Pferdekamper, A. C.; Li, J.; Kasibhatla, S.; Tompkins, C. S.; Steffy, A.; Li, A.; Sun, F.; Sun, X.; Hua, S.; Tiedt, R.; Sarkisova, Y.; Marsilje, T. H.; McNamara, P.; Harris, J.</span><span> </span><span class="NLM_article-title">Activity of a Potent and Selective Phase I ALK Inhibitor LDK378 in Naive and Crizotinib-Resistant Preclinical Tumor Models</span>. Presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, San Francisco, CA,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Abstract B232.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=N.+Li&author=P.-Y.+Michellys&author=S.+Kim&author=A.+C.+Pferdekamper&author=J.+Li&author=S.+Kasibhatla&author=C.+S.+Tompkins&author=A.+Steffy&author=A.+Li&author=F.+Sun&author=X.+Sun&author=S.+Hua&author=R.+Tiedt&author=Y.+Sarkisova&author=T.+H.+Marsilje&author=P.+McNamara&author=J.+Harris&title=Activity+of+a+Potent+and+Selective+Phase+I+ALK+Inhibitor+LDK378+in+Naive+and+Crizotinib-Resistant+Preclinical+Tumor+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26atitle%3DActivity%2520of%2520a%2520Potent%2520and%2520Selective%2520Phase%2520I%2520ALK%2520Inhibitor%2520LDK378%2520in%2520Naive%2520and%2520Crizotinib-Resistant%2520Preclinical%2520Tumor%2520Models%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Galkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span> </span><span class="NLM_article-title">Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=270-275&issue=1&author=A.+V.+Galkinauthor=J.+S.+Melnickauthor=S.+Kimauthor=T.+L.+Hoodauthor=N.+Liauthor=L.+Liauthor=G.+Xiaauthor=R.+Steensmaauthor=G.+Chopiukauthor=J.+Jiangauthor=Y.+Wanauthor=P.+Dingauthor=Y.+Liuauthor=F.+Sunauthor=P.+G.+Schultzauthor=N.+S.+Grayauthor=M.+Warmuth&title=Identification+of+NVP-TAE684%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+NPM-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalkin%26aufirst%3DA.%2BV.%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWarmuth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NVP-TAE684%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520NPM-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26issue%3D1%26spage%3D270%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspnes, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klug-McLeod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawistoski, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlynn, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulford, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autry, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzzio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnette, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckbinder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffor, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span> </span><span class="NLM_article-title">Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure–activity relationships and strategies for the elimination of reactive metabolite formation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6071</span><span class="NLM_x">–</span> <span class="NLM_lpage">6077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6071-6077&author=D.+P.+Walkerauthor=F.+C.+Biauthor=A.+S.+Kalgutkarauthor=J.+N.+Baumanauthor=S.+X.+Zhaoauthor=J.+R.+Sogliaauthor=G.+A.+Aspnesauthor=D.+W.+Kungauthor=J.+Klug-McLeodauthor=M.+P.+Zawistoskiauthor=M.+A.+McGlynnauthor=R.+Oliverauthor=M.+Dunnauthor=J.-C.+Liauthor=D.+T.+Richterauthor=B.+A.+Cooperauthor=J.+C.+Kathauthor=C.+A.+Hulfordauthor=C.+L.+Autryauthor=M.+J.+Luzzioauthor=E.+J.+Ungauthor=W.+G.+Robertsauthor=P.+C.+Bonnetteauthor=L.+Buckbinderauthor=A.+Mistryauthor=M.+C.+Grifforauthor=S.+Hanauthor=A.+Guzman-Perez&title=Trifluoromethylpyrimidine-based+inhibitors+of+proline-rich+tyrosine+kinase+2+%28PYK2%29%3A+structure%E2%80%93activity+relationships+and+strategies+for+the+elimination+of+reactive+metabolite+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBi%26aufirst%3DF.%2BC.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DBauman%26aufirst%3DJ.%2BN.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DAspnes%26aufirst%3DG.%2BA.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DKlug-McLeod%26aufirst%3DJ.%26aulast%3DZawistoski%26aufirst%3DM.%2BP.%26aulast%3DMcGlynn%26aufirst%3DM.%2BA.%26aulast%3DOliver%26aufirst%3DR.%26aulast%3DDunn%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.-C.%26aulast%3DRichter%26aufirst%3DD.%2BT.%26aulast%3DCooper%26aufirst%3DB.%2BA.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DHulford%26aufirst%3DC.%2BA.%26aulast%3DAutry%26aufirst%3DC.%2BL.%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26aulast%3DUng%26aufirst%3DE.%2BJ.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DBonnette%26aufirst%3DP.%2BC.%26aulast%3DBuckbinder%26aufirst%3DL.%26aulast%3DMistry%26aufirst%3DA.%26aulast%3DGriffor%26aufirst%3DM.%2BC.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26atitle%3DTrifluoromethylpyrimidine-based%2520inhibitors%2520of%2520proline-rich%2520tyrosine%2520kinase%25202%2520%2528PYK2%2529%253A%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520strategies%2520for%2520the%2520elimination%2520of%2520reactive%2520metabolite%2520formation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6071%26epage%3D6077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span> </span><span class="NLM_article-title">Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1814</span><span class="NLM_x">–</span> <span class="NLM_lpage">1822</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800161s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Knurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1814-1822&author=R.+S.+Obachauthor=A.+S.+Kalgutkarauthor=J.+R.+Sogliaauthor=S.+X.+Zhao&title=Can+in+vitro+metabolism-dependent+covalent+binding+data+in+liver+microsomes+distinguish+hepatotoxic+from+nonhepatotoxic+drugs%3F+An+analysis+of+18+drugs+with+consideration+of+intrinsic+clearance+and+daily+dose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Can In Vitro Metabolism-Dependent Covalent Binding Data in Liver Microsomes Distinguish Hepatotoxic from Nonhepatotoxic Drugs? An Analysis of 18 Drugs with Consideration of Intrinsic Clearance and Daily Dose</span></div><div class="casAuthors">Obach, R. Scott; Kalgutkar, Amit S.; Soglia, John R.; Zhao, Sabrina X.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1814-1822</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In vitro covalent binding assessments of drugs have been useful in providing retrospective insights into the assocn. between drug metab. and a resulting toxicol. response.  On the basis of these studies, it has been advocated that in vitro covalent binding to liver microsomal proteins in the presence and the absence of NADPH be used routinely to screen drug candidates.  However, the utility of this approach in predicting toxicities of drug candidates accurately remains an unanswered question.  Importantly, the years of research that have been invested in understanding metabolic bioactivation and covalent binding and its potential role in toxicity have focused only on those compds. that demonstrate toxicity.  Investigations have not frequently queried whether in vitro covalent binding could be obsd. with drugs with good safety records.  Eighteen drugs (nine hepatotoxins and nine nonhepatotoxins in humans) were assessed for in vitro covalent binding in NADPH-supplemented human liver microsomes.  Of the two sets of nine drugs, seven in each set were shown to undergo some degree of covalent binding.  Among hepatotoxic drugs, acetaminophen, carbamazepine, diclofenac, indomethacin, nefazodone, sudoxicam, and tienilic acid demonstrated covalent binding, while benoxaprofen and felbamate did not.  Of the nonhepatotoxic drugs evaluated, buspirone, diphenhydramine, meloxicam, paroxetine, propranolol, raloxifene, and simvastatin demonstrated covalent binding, while ibuprofen and theophylline did not.  A quant. comparison of covalent binding in vitro intrinsic clearance did not sep. the two groups of compds., and in fact, paroxetine, a nonhepatotoxin, showed the greatest amt. of covalent binding in microsomes.  Including factors such as the fraction of total metab. comprised by covalent binding and the total daily dose of each drug improved the discrimination between hepatotoxic and nontoxic drugs based on in vitro covalent binding data; however, the approach still would falsely identify some agents as potentially hepatotoxic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9_hVRAC3RD7Vg90H21EOLACvtfcHk0lh8WHjCMmPpRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Knurw%253D&md5=67c82883825ef529c84d03f462b1f669</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Ftx800161s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800161s%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26atitle%3DCan%2520in%2520vitro%2520metabolism-dependent%2520covalent%2520binding%2520data%2520in%2520liver%2520microsomes%2520distinguish%2520hepatotoxic%2520from%2520nonhepatotoxic%2520drugs%253F%2520An%2520analysis%2520of%252018%2520drugs%2520with%2520consideration%2520of%2520intrinsic%2520clearance%2520and%2520daily%2520dose%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1814%26epage%3D1822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Orhan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeulen, N. P. E.</span><span> </span><span class="NLM_article-title">Conventional and novel approaches in generating and characterization of reactive intermediates from drugs/drug candidates</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.2174%2F138920011795202974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=21395525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1OjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=383-394&author=H.+Orhanauthor=N.+P.+E.+Vermeulen&title=Conventional+and+novel+approaches+in+generating+and+characterization+of+reactive+intermediates+from+drugs%2Fdrug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Conventional and novel approaches in generating and characterization of reactive intermediates from drugs/drug candidates</span></div><div class="casAuthors">Orhan, Hilmi; Vermeulen, Nico P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-394</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite several thousands of drugs are in use currently, research on new drug mols. is continuing.  Because, there are diseases still without medication, successor/better drugs make the predecessor ones obsolete, and advancement in both life sciences and anal. technologies provide identification of previously unknown mechanisms of diseases, and discovery of novel drug targets.  The two main criteria which a drug candidate should meet are high affinity for the target, and no or acceptable/tolerable toxicity in humans.  Among these two, toxicity is the limiting one; developing a drug candidate with unacceptable toxicity has to be discontinued, even if it has an extremely high pharmacol. activity.  Drug would be withdrawn, if serious toxicity arises after marketing.  Since drug development is a long (approx. 10 years), expensive, and infertile (one lead in 10.000 mols.) process, it is extremely important to detect the potential toxicity of drug candidate as early as possible.  Today, it is believed that a great majority of toxic effects are caused by reactive intermediates generated by biotransformation of the parent drug.  However, there are exptl. difficulties in identifying such metabolite(s) in vivo.  Their formation is affected by multi-factorial events; they can further be metabolized to structurally different products, and/or they may bind to a huge variety of biol. sites or macromols.  Hence, some reactive intermediates and their corresponding stable derivs. are generated in trace amts., which make their detn. more difficult.  The ability of cytochrome P450s (CYP450) and other biotransformation enzymes to function in vitro offers a great flexibility to researchers, biotransformation of any compd. can be simulated in a test tube, and metabolites/reactive intermediates are generated in an environment which has relatively much less background and less interfering multi-factorial events compared to in vivo.  To simulate biotransformation, microsomal fraction is used most frequently from human and non-human sources.  Purified or recombinant enzymes are used in detg. the individual isoenzymes responsible for certain metabolites.  Because of the chem. reactivity of intermediates, relevant, usually nucleophilic trapping agent(s) such as glutathione (GSH), N-acetylcysteine (NAC) and cyanide (CN-) are used to stabilize the metabolite.  Trapped metabolites are subjected to spectrometric and/or NMR spectroscopic analyses for structural identification.  Vertiginous advances esp. in mass spectrometric technologies offer researchers new challenges in this area.  This review is aimed at briefly summarizing the state of the art and compiling the highlighted studies in characterization of the reactive metabolites from drug mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkQwfIe6B50LVg90H21EOLACvtfcHk0lh8WHjCMmPpRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1OjsLc%253D&md5=ee04c606fbb76c5c59b1b7b5224a89f2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F138920011795202974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920011795202974%26sid%3Dliteratum%253Aachs%26aulast%3DOrhan%26aufirst%3DH.%26aulast%3DVermeulen%26aufirst%3DN.%2BP.%2BE.%26atitle%3DConventional%2520and%2520novel%2520approaches%2520in%2520generating%2520and%2520characterization%2520of%2520reactive%2520intermediates%2520from%2520drugs%252Fdrug%2520candidates%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2011%26volume%3D12%26spage%3D383%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx7002273" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlygsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=129-137&author=T.+A.+Baillie&title=Metabolism+and+toxicity+of+drugs.+Two+decades+of+progress+in+industrial+drug+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and Toxicity of Drugs. Two Decades of Progress in Industrial Drug Metabolism</span></div><div class="casAuthors">Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-137</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The science of drug metab. and pharmacokinetics (DMPK) has developed significantly over the past 20 years, and its functional role in today's pharmaceutical industry has matured to the point where DMPK has become an indispensable discipline in support of drug discovery and development.  While contributions to the lead optimization phase of discovery efforts have been particularly noteworthy in helping to select only the best drug candidates for entry into development, it should be recognized that the scope of DMPK spans the continuum of discovery through clin. evaluation and even into the post-marketing phase; as such, the breadth of DMPK's involvement is almost unique in contemporary pharmaceutical research.  This perspective summarizes notable advances in the field, many of which have been made possible by technol. developments in areas such as mol. biol., genetics, and bioanal. chem., and highlights the crit. nature of key partnerships between Drug Metab., Medicinal Chem., and Safety Assessment groups in attempting to advance drug candidates with a low potential for causing adverse events in humans.  Finally, some speculative predictions are made of the future role of DMPK in pharmaceutical research, where current advances in our mechanistic understanding of the mol. processes that control the absorption, disposition, metab., elimination, and toxicity of drugs and their biotransformation products will combine to further enhance the impact of DMPK in drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkUrTeLhTDYbVg90H21EOLACvtfcHk0li6bms21sfO1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlygsrzF&md5=e8f659251bf82cb0b1602855e725c390</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Ftx7002273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx7002273%26sid%3Dliteratum%253Aachs%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DMetabolism%2520and%2520toxicity%2520of%2520drugs.%2520Two%2520decades%2520of%2520progress%2520in%2520industrial%2520drug%2520metabolism%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D129%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40a"><span><span class="NLM_contrib-group">Garcia-Echeverria, C.; Kanazawa, T.; Kawahara, E.; Masuya, K.; Miyake, T.; Ohmori, O.; Unemura, I.; Steensma, R.; Chopiuk, G.; Jiang, J.; Wan, Y.; Ding, Q.; Zhang, Q.; Gray, N. S.; Karanewsky, D. S.</span><span> </span><span class="NLM_article-title">2,4-Pyrimidinediamines Useful in the Treatment of Neoplastic Diseases, Inflammatory and Immune System Disorders</span>. WO2005016894, 2005.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Garcia-Echeverria%2C+C.%3B+Kanazawa%2C+T.%3B+Kawahara%2C+E.%3B+Masuya%2C+K.%3B+Miyake%2C+T.%3B+Ohmori%2C+O.%3B+Unemura%2C+I.%3B+Steensma%2C+R.%3B+Chopiuk%2C+G.%3B+Jiang%2C+J.%3B+Wan%2C+Y.%3B+Ding%2C+Q.%3B+Zhang%2C+Q.%3B+Gray%2C+N.+S.%3B+Karanewsky%2C+D.+S.+2%2C4-Pyrimidinediamines+Useful+in+the+Treatment+of+Neoplastic+Diseases%2C+Inflammatory+and+Immune+System+Disorders.+WO2005016894%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3D2%252C4-Pyrimidinediamines%2520Useful%2520in%2520the%2520Treatment%2520of%2520Neoplastic%2520Diseases%252C%2520Inflammatory%2520and%2520Immune%2520System%2520Disorders" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40b"><span><span class="NLM_contrib-group">Garcia-Echeverria, C.; Kanazawa, T.; Kawahara, E.; Masuya, K.; Matsuura, N.; Miyake, T.; Ohmori, O.; Umemura, I.</span>. <span> </span><span class="NLM_article-title">2,4- Di(phenylamino)pyrimidines Useful in the Treatment of Neoplastic Diseases, Inflammatory and Immune System Disorders</span>. WO2004080980,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=C.+Garcia-Echeverria&author=T.+Kanazawa&author=E.+Kawahara&author=K.+Masuya&author=N.+Matsuura&author=T.+Miyake&author=O.+Ohmori&author=I.+Umemura&title=2%2C4-+Di%28phenylamino%29pyrimidines+Useful+in+the+Treatment+of+Neoplastic+Diseases%2C+Inflammatory+and+Immune+System+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3D2%252C4-%2520Di%2528phenylamino%2529pyrimidines%2520Useful%2520in%2520the%2520Treatment%2520of%2520Neoplastic%2520Diseases%252C%2520Inflammatory%2520and%2520Immune%2520System%2520Disorders%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Strazzolini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giumanini, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runcio, A.</span><span> </span><span class="NLM_article-title">Nitric acid in dichloromethane solution. Facile preparation from potassium nitrate and sulfuric acid</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1387</span><span class="NLM_x">–</span> <span class="NLM_lpage">1389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1387-1389&issue=7&author=P.+Strazzoliniauthor=A.+G.+Giumaniniauthor=A.+Runcio&title=Nitric+acid+in+dichloromethane+solution.+Facile+preparation+from+potassium+nitrate+and+sulfuric+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrazzolini%26aufirst%3DP.%26aulast%3DGiumanini%26aufirst%3DA.%2BG.%26aulast%3DRuncio%26aufirst%3DA.%26atitle%3DNitric%2520acid%2520in%2520dichloromethane%2520solution.%2520Facile%2520preparation%2520from%2520potassium%2520nitrate%2520and%2520sulfuric%2520acid%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26issue%3D7%26spage%3D1387%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Bossi, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccardo, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgia, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogliatto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, J. A.</span><span> </span><span class="NLM_article-title">Crystal structures of anaplastic lymphoma kinase in complex with ATP competitive inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6813</span><span class="NLM_x">–</span> <span class="NLM_lpage">6825</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi1005514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Clsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6813-6825&author=R.+T.+Bossiauthor=M.+B.+Saccardoauthor=E.+Ardiniauthor=M.+Menichincheriauthor=L.+Rusconiauthor=P.+Magnaghiauthor=P.+Orsiniauthor=N.+Avanziauthor=A.+L.+Borgiaauthor=M.+Nesiauthor=T.+Bandieraauthor=G.+Fogliattoauthor=J.+A.+Bertrand&title=Crystal+structures+of+anaplastic+lymphoma+kinase+in+complex+with+ATP+competitive+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Anaplastic Lymphoma Kinase in Complex with ATP Competitive Inhibitors</span></div><div class="casAuthors">Bossi, Roberto T.; Saccardo, M. Beatrice; Ardini, Elena; Menichincheri, Maria; Rusconi, Luisa; Magnaghi, Paola; Orsini, Paolo; Avanzi, Nilla; Borgia, Andrea Lombardi; Nesi, Marcella; Bandiera, Tiziano; Fogliatto, Gianpaolo; Bertrand, Jay A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">6813-6825</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase involved in the development of several human cancers and, as a result, is a recognized target for the development of small-mol. inhibitors for the treatment of ALK-pos. malignancies.  Here, the crystal structures of the unphosphorylated human ALK kinase domain in complex with the ATP competitive ligands PHA-E429 and NVP-TAE684 are presented.  Anal. of these structures provides valuable information concerning the specific characteristics of the ALK active site as well as giving indications about how to obtain selective ALK inhibitors.  In addn., the ALK-KD-PHA-E429 structure led to the identification of a potential regulatory mechanism involving a link made between a short helical segment immediately following the DFG motif and an N-terminal two-stranded β-sheet.  Finally, mapping of the activating mutations assocd. with neuroblastoma onto the structures may explain the roles these residues have in the activation process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2b8yuzTuAYbVg90H21EOLACvtfcHk0lgonqmEv01YAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Clsbs%253D&md5=e8e9e3fde63a196a15c874300c995342</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi1005514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1005514%26sid%3Dliteratum%253Aachs%26aulast%3DBossi%26aufirst%3DR.%2BT.%26aulast%3DSaccardo%26aufirst%3DM.%2BB.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBorgia%26aufirst%3DA.%2BL.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26atitle%3DCrystal%2520structures%2520of%2520anaplastic%2520lymphoma%2520kinase%2520in%2520complex%2520with%2520ATP%2520competitive%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D6813%26epage%3D6825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Richmond, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wogan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, W. P.</span><span> </span><span class="NLM_article-title">Interstrain differences of in vitro metabolic stability and impact on early drug discovery</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">4463</span><span class="NLM_x">–</span> <span class="NLM_lpage">4468</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=4463-4468&author=W.+Richmondauthor=M.+Woganauthor=J.+Isbellauthor=W.+P.+Gordon&title=Interstrain+differences+of+in+vitro+metabolic+stability+and+impact+on+early+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichmond%26aufirst%3DW.%26aulast%3DWogan%26aufirst%3DM.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DW.%2BP.%26atitle%3DInterstrain%2520differences%2520of%2520in%2520vitro%2520metabolic%2520stability%2520and%2520impact%2520on%2520early%2520drug%2520discovery%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26spage%3D4463%26epage%3D4468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a> (NCT01283516; NCT01634763; NCT01685060; NCT01685138; NCT01772797; NCT01742286; NCT01828099; NCT01828112).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.clinicaltrials.gov+%28NCT01283516%3B+NCT01634763%3B+NCT01685060%3B+NCT01685138%3B+NCT01772797%3B+NCT01742286%3B+NCT01828099%3B+NCT01828112%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camidge, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felip, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, D. S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vansteenkiste, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldwasser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boral, A. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehra, R.</span><span> </span><span class="NLM_article-title">Results of a first-in-human phase I study of the ALK inhibitor LDK378 in advanced solid tumors</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 9</span><span class="NLM_x">) </span> <span class="NLM_fpage">ix153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=ix153&issue=Suppl.+9&author=A.+T.+Shawauthor=D.+R.+Camidgeauthor=E.+Felipauthor=S.+Sharmaauthor=D.+S.+W.+Tanauthor=D.+Kimauthor=T.+De+Pasauthor=J.+F.+Vansteenkisteauthor=A.+Santoroauthor=G.+Liuauthor=M.+Goldwasserauthor=D.+Daiauthor=A.+L+Boralauthor=R.+Mehra&title=Results+of+a+first-in-human+phase+I+study+of+the+ALK+inhibitor+LDK378+in+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26aulast%3DFelip%26aufirst%3DE.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DD.%2BS.%2BW.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DDe%2BPas%26aufirst%3DT.%26aulast%3DVansteenkiste%26aufirst%3DJ.%2BF.%26aulast%3DSantoro%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DGoldwasser%26aufirst%3DM.%26aulast%3DDai%26aufirst%3DD.%26aulast%3DBoral%26aufirst%3DA.%2BL%26aulast%3DMehra%26aufirst%3DR.%26atitle%3DResults%2520of%2520a%2520first-in-human%2520phase%2520I%2520study%2520of%2520the%2520ALK%2520inhibitor%2520LDK378%2520in%2520advanced%2520solid%2520tumors%26jtitle%3DAnn.%2520Oncol.%26date%3D2012%26volume%3D23%26issue%3DSuppl.%25209%26spage%3Dix153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Yuan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uvarova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isbell, J.</span><span> </span><span class="NLM_article-title">Peak seeker: an algorithm for rapid determination of solubility</span> <span class="citation_source-journal">J. Lab. Autom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1016%2Fj.jala.2005.03.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=254-257&author=D.+Yuanauthor=V.+Uvarovaauthor=J.+Isbell&title=Peak+seeker%3A+an+algorithm+for+rapid+determination+of+solubility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.jala.2005.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jala.2005.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DD.%26aulast%3DUvarova%26aufirst%3DV.%26aulast%3DIsbell%26aufirst%3DJ.%26atitle%3DPeak%2520seeker%253A%2520an%2520algorithm%2520for%2520rapid%2520determination%2520of%2520solubility%26jtitle%3DJ.%2520Lab.%2520Autom.%26date%3D2005%26volume%3D10%26spage%3D254%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Bell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friche, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojanic, D.</span><span> </span><span class="NLM_article-title">Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discovery</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1177%2F1087057108317480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=18474896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlCms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=343-353&author=L.+Bellauthor=S.+Bickfordauthor=P.+H.+Nguyenauthor=J.+Wangauthor=T.+Heauthor=B.+Zhangauthor=Y.+Fricheauthor=A.+Zimmerlinauthor=L.+Urbanauthor=D.+Bojanic&title=Evaluation+of+fluorescence-+and+mass+spectrometry-based+CYP+inhibition+assays+for+use+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discovery</span></div><div class="casAuthors">Bell, Leslie; Bickford, Shari; Nguyen, Phong Hung; Wang, Jianling; He, Timothy; Zhang, Bailin; Friche, Yannick; Zimmerlin, Alfred; Urban, Laszlo; Bojanic, Dejan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">343-353</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The potential for metab.-related drug-drug interactions by new chem. entities is assessed by monitoring the impact of these compds. on cytochrome P 450 (CYP) activity using well-characterized CYP substrates.  The conventional gold std. approach for in vitro evaluation of CYP inhibitory potential uses pooled human liver microsomes (HLM) in conjunction with prototypical drug substrates, often quantified by LC-MS/MS.  However, fluorescent CYP inhibition assays, which use recombinantly expressed CYPs and fluorogenic probe substrates, have been employed in early drug discovery to provide low-cost, high-throughput assessment of new chem. entities.  Despite its greatly enhanced throughput, this approach has been met with mixed success in predicting the data obtained with the conventional gold std. approach (HLM+LC-MS).  The authors find that the predictivity of fluorogenic assays for the major CYP isoforms 3A4 and 2D6 may depend on the quality of the test compds.  Although the structurally more optimized marketed drugs yielded acceptable correlations between the fluorogenic and HLM+LC-MS/MS assays for CYPs 3A4, 2D6, and 2C9 (r2 = 0.5-0.7; p < 0.005), preoptimization, early discovery compds. yielded poorer correlations (r2 ≤ 0.2) for 2 of these major isoforms, CYPs 3A4 and 2D6.  Potential reasons for the obsd. differences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGothNUqezlyHbVg90H21EOLACvtfcHk0lhWWgq81dqydA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlCms7o%253D&md5=47a1c730535a0fd9762bf93b8ec3e5d1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1177%2F1087057108317480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057108317480%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DL.%26aulast%3DBickford%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DP.%2BH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DFriche%26aufirst%3DY.%26aulast%3DZimmerlin%26aufirst%3DA.%26aulast%3DUrban%26aufirst%3DL.%26aulast%3DBojanic%26aufirst%3DD.%26atitle%3DEvaluation%2520of%2520fluorescence-%2520and%2520mass%2520spectrometry-based%2520CYP%2520inhibition%2520assays%2520for%2520use%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2008%26volume%3D13%26spage%3D343%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Matthews, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosker, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudenski, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treacher, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. C.</span><span> </span><span class="NLM_article-title">Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=412-419&author=D.+R.+Matthewsauthor=J.+P.+Hoskerauthor=A.+S.+Rudenskiauthor=B.+A.+Naylorauthor=D.+F.+Treacherauthor=R.+C.+Turner&title=Homeostasis+model+assessment%3A+insulin+resistance+and+%CE%B2-cell+function+from+fasting+plasma+glucose+and+insulin+concentrations+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DD.%2BR.%26aulast%3DHosker%26aufirst%3DJ.%2BP.%26aulast%3DRudenski%26aufirst%3DA.%2BS.%26aulast%3DNaylor%26aufirst%3DB.%2BA.%26aulast%3DTreacher%26aufirst%3DD.%2BF.%26aulast%3DTurner%26aufirst%3DR.%2BC.%26atitle%3DHomeostasis%2520model%2520assessment%253A%2520insulin%2520resistance%2520and%2520%25CE%25B2-cell%2520function%2520from%2520fasting%2520plasma%2520glucose%2520and%2520insulin%2520concentrations%2520in%2520man%26jtitle%3DDiabetologia%26date%3D1985%26volume%3D28%26spage%3D412%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35a','cit35b'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40a','cit40b'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 249 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Shaowen Xie, Yuan Sun, Yulin Liu, Xinnan Li, Xinuo Li, Wenyi Zhong, Feiyan Zhan, Jingjie Zhu, Hong Yao, Dong-Hua Yang, Zhe-Sheng Chen, Jinyi Xu, <span class="NLM_string-name hlFld-ContribAuthor">Shengtao Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 9120-9140. <a href="https://doi.org/10.1021/acs.jmedchem.1c00270" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00270%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BAlectinib-Based%252BPROTACs%252Bas%252BNovel%252BPotent%252BDegraders%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%26aulast%3DXie%26aufirst%3DShaowen%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D11022021%26date%3D28062021%26volume%3D64%26issue%3D13%26spage%3D9120%26epage%3D9140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Beatrice Lansbergen, Paola Granatino, <span class="NLM_string-name hlFld-ContribAuthor">Tobias Ritter</span>. </span><span class="cited-content_cbyCitation_article-title">Site-Selective C–H alkylation of Complex Arenes by a Two-Step Aryl Thianthrenation-Reductive Alkylation Sequence. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (21)
                                     , 7909-7914. <a href="https://doi.org/10.1021/jacs.1c03459" title="DOI URL">https://doi.org/10.1021/jacs.1c03459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.1c03459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.1c03459%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSite-Selective%252BC%2525E2%252580%252593H%252Balkylation%252Bof%252BComplex%252BArenes%252Bby%252Ba%252BTwo-Step%252BAryl%252BThianthrenation-Reductive%252BAlkylation%252BSequence%26aulast%3DLansbergen%26aufirst%3DBeatrice%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01042021%26date%3D24052021%26volume%3D143%26issue%3D21%26spage%3D7909%26epage%3D7914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiangnan Dong, Su Li, <span class="NLM_string-name hlFld-ContribAuthor">Guangxuan Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Binimetinib Is a Potent Reversible and Time-Dependent Inhibitor of Cytochrome P450 1A2. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2021,</strong> <em>34 </em>
                                    (4)
                                     , 1169-1174. <a href="https://doi.org/10.1021/acs.chemrestox.1c00036" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.1c00036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.1c00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.1c00036%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DBinimetinib%252BIs%252Ba%252BPotent%252BReversible%252Band%252BTime-Dependent%252BInhibitor%252Bof%252BCytochrome%252BP450%252B1A2%26aulast%3DDong%26aufirst%3DJiangnan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D22012021%26date%3D17032021%26volume%3D34%26issue%3D4%26spage%3D1169%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Richard A. Ward, Stephen Fawell, Nicolas Floc’h, Vikki Flemington, Darren McKerrecher, <span class="NLM_string-name hlFld-ContribAuthor">Paul D. Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges and Opportunities in Cancer Drug Resistance. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (6)
                                     , 3297-3351. <a href="https://doi.org/10.1021/acs.chemrev.0c00383" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00383%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DChallenges%252Band%252BOpportunities%252Bin%252BCancer%252BDrug%252BResistance%26aulast%3DWard%26aufirst%3DRichard%2BA.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D29042020%26date%3D21072020%26volume%3D121%26issue%3D6%26spage%3D3297%26epage%3D3351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guoyi Yan, Xinxin Zhong, Chunlan Pu, Lin Yue, Huifang Shan, Suke Lan, Meng Zhou, Xueyan Hou, Jie Yang, Deyu Li, Shilong Fan, <span class="NLM_string-name hlFld-ContribAuthor">Rui Li</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Cysteine Located Outside the Active Site: An Effective Strategy for Covalent ALKi Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1558-1569. <a href="https://doi.org/10.1021/acs.jmedchem.0c01707" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01707</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01707%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BCysteine%252BLocated%252BOutside%252Bthe%252BActive%252BSite%25253A%252BAn%252BEffective%252BStrategy%252Bfor%252BCovalent%252BALKi%252BDesign%26aulast%3DYan%26aufirst%3DGuoyi%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29092020%26date%3D20012021%26volume%3D64%26issue%3D3%26spage%3D1558%26epage%3D1569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ikuo Fujimori, Takeshi Wakabayashi, Morio Murakami, Atsutoshi Okabe, Tsuyoshi Ishii, Aaron McGrath, Hua Zou, Kumar Singh Saikatendu, <span class="NLM_string-name hlFld-ContribAuthor">Hiroshi Imoto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (49)
                                     , 31984-32001. <a href="https://doi.org/10.1021/acsomega.0c04900" title="DOI URL">https://doi.org/10.1021/acsomega.0c04900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c04900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c04900%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DDiscovery%252Bof%252BNovel%252Band%252BHighly%252BSelective%252BCyclopropane%252BALK%252BInhibitors%252Bthrough%252Ba%252BFragment-Assisted%25252C%252BStructure-Based%252BDrug%252BDesign%26aulast%3DFujimori%26aufirst%3DIkuo%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07102020%26date%3D13112020%26date%3D30112020%26volume%3D5%26issue%3D49%26spage%3D31984%26epage%3D32001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianyong Chen, Yunlong Zhou, Xuyuan Dong, Liu Liu, Longchuan Bai, Donna McEachern, Sally Przybranowski, Chao-Yie Yang, Jeanne Stuckey, Xiaoqin Li, Bo Wen, Ting Zhao, Siwei Sun, Duxin Sun, Lingling Jiao, Yu Jing, Ming Guo, Dajun Yang, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of CJ-2360 as a Potent and Orally Active Inhibitor of Anaplastic Lymphoma Kinase Capable of Achieving Complete Tumor Regression. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13994-14016. <a href="https://doi.org/10.1021/acs.jmedchem.0c01550" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01550%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BCJ-2360%252Bas%252Ba%252BPotent%252Band%252BOrally%252BActive%252BInhibitor%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252BCapable%252Bof%252BAchieving%252BComplete%252BTumor%252BRegression%26aulast%3DChen%26aufirst%3DJianyong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D04092020%26date%3D13112020%26volume%3D63%26issue%3D22%26spage%3D13994%26epage%3D14016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaoyun Lu, Jeff B. Smaill, <span class="NLM_string-name hlFld-ContribAuthor">Ke Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry Strategies for the Development of Kinase Inhibitors Targeting Point Mutations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10726-10741. <a href="https://doi.org/10.1021/acs.jmedchem.0c00507" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00507</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00507%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252BChemistry%252BStrategies%252Bfor%252Bthe%252BDevelopment%252Bof%252BKinase%252BInhibitors%252BTargeting%252BPoint%252BMutations%26aulast%3DLu%26aufirst%3DXiaoyun%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27032020%26date%3D02062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10726%26epage%3D10741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zheng Zhao, <span class="NLM_string-name hlFld-ContribAuthor">Philip E. Bourne</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing Acquired Resistance Mechanisms of Kinase-Targeted Drugs Using an on-the-Fly, Function-Site Interaction Fingerprint Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2020,</strong> <em>16 </em>
                                    (5)
                                     , 3152-3161. <a href="https://doi.org/10.1021/acs.jctc.9b01134" title="DOI URL">https://doi.org/10.1021/acs.jctc.9b01134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.9b01134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.9b01134%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DRevealing%252BAcquired%252BResistance%252BMechanisms%252Bof%252BKinase-Targeted%252BDrugs%252BUsing%252Ban%252Bon-the-Fly%25252C%252BFunction-Site%252BInteraction%252BFingerprint%252BApproach%26aulast%3DZhao%26aufirst%3DZheng%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D13112019%26date%3D24042020%26date%3D13042020%26volume%3D16%26issue%3D5%26spage%3D3152%26epage%3D3161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaotian Kong, Peichen Pan, Huiyong Sun, Hongguang Xia, Xuwen Wang, Youyong Li, <span class="NLM_string-name hlFld-ContribAuthor">Tingjun Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery Targeting Anaplastic Lymphoma Kinase (ALK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 10927-10954. <a href="https://doi.org/10.1021/acs.jmedchem.9b00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDrug%252BDiscovery%252BTargeting%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%26aulast%3DKong%26aufirst%3DXiaotian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14032019%26date%3D26082019%26date%3D16082019%26volume%3D62%26issue%3D24%26spage%3D10927%26epage%3D10954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhixiang Chen, <span class="NLM_string-name hlFld-ContribAuthor">Dawei Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Cu/N,N′-Dibenzyloxalamide-Catalyzed N-Arylation of Heteroanilines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (17)
                                     , 6874-6878. <a href="https://doi.org/10.1021/acs.orglett.9b02509" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02509%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCu%25252FN%25252CN%2525E2%252580%2525B2-Dibenzyloxalamide-Catalyzed%252BN-Arylation%252Bof%252BHeteroanilines%26aulast%3DChen%26aufirst%3DZhixiang%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19072019%26date%3D15082019%26volume%3D21%26issue%3D17%26spage%3D6874%26epage%3D6878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Makoto Fushimi, Ikuo Fujimori, Takeshi Wakabayashi, Tomoaki Hasui, Youichi Kawakita, Keisuke Imamura, Tomoko Kato, Morio Murakami, Tsuyoshi Ishii, Yorifumi Kikko, Maki Kasahara, Atsushi Nakatani, Yuto Hiura, Maki Miyamoto, Kumar Saikatendu, Hua Zou, Scott Weston Lane, J. David Lawson, <span class="NLM_string-name hlFld-ContribAuthor">Hiroshi Imoto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent, Selective, and Brain-Penetrant 1H-Pyrazol-5-yl-1H-pyrrolo[2,3-b]pyridines as Anaplastic Lymphoma Kinase (ALK) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 4915-4935. <a href="https://doi.org/10.1021/acs.jmedchem.8b01630" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01630</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01630%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BBrain-Penetrant%252B1H-Pyrazol-5-yl-1H-pyrrolo%25255B2%25252C3-b%25255Dpyridines%252Bas%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252BInhibitors%26aulast%3DFushimi%26aufirst%3DMakoto%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21102018%26date%3D03052019%26date%3D22042019%26volume%3D62%26issue%3D10%26spage%3D4915%26epage%3D4935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ellen Watts, David Heidenreich, Elizabeth Tucker, Monika Raab, Klaus Strebhardt, Louis Chesler, Stefan Knapp, Benjamin Bellenie, <span class="NLM_string-name hlFld-ContribAuthor">Swen Hoelder</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (5)
                                     , 2618-2637. <a href="https://doi.org/10.1021/acs.jmedchem.8b01947" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01947</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01947%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252BDual%252BInhibitors%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252Band%252BBromodomain-4%252B%252528BRD4%252529%252Bby%252BTuning%252BKinase%252BSelectivity%26aulast%3DWatts%26aufirst%3DEllen%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13122018%26date%3D21022019%26volume%3D62%26issue%3D5%26spage%3D2618%26epage%3D2637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Helen L. Lightfoot, Frederick W. Goldberg, <span class="NLM_string-name hlFld-ContribAuthor">Joerg Sedelmeier</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of Small Molecule Kinase Drugs. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (2)
                                     , 153-160. <a href="https://doi.org/10.1021/acsmedchemlett.8b00445" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00445%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEvolution%252Bof%252BSmall%252BMolecule%252BKinase%252BDrugs%26aulast%3DLightfoot%26aufirst%3DHelen%2BL.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27092018%26date%3D17122018%26date%3D10012019%26date%3D18122018%26volume%3D10%26issue%3D2%26spage%3D153%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jungmin Kwon, <span class="NLM_string-name hlFld-ContribAuthor">B. Moon Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Arenesulfonyl Fluorides via Sulfuryl Fluoride Incorporation from Arynes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (2)
                                     , 428-433. <a href="https://doi.org/10.1021/acs.orglett.8b03610" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b03610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b03610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b03610%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BArenesulfonyl%252BFluorides%252Bvia%252BSulfuryl%252BFluoride%252BIncorporation%252Bfrom%252BArynes%26aulast%3DKwon%26aufirst%3DJungmin%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D12112018%26date%3D28122018%26volume%3D21%26issue%3D2%26spage%3D428%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Robert    Dugger </span><span class="hlFld-ContribAuthor "> Bryan    Li    </span><span class="hlFld-ContribAuthor "> Paul    Richardson </span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of Lorlatinib: A Macrocyclic Inhibitor of EML4-ALK for the Treatment of NSCLC. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 27-59. <a href="https://doi.org/10.1021/bk-2019-1332.ch002" title="DOI URL">https://doi.org/10.1021/bk-2019-1332.ch002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2019-1332.ch002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2019-1332.ch002%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BLorlatinib%25253A%252BA%252BMacrocyclic%252BInhibitor%252Bof%252BEML4-ALK%252Bfor%252Bthe%252BTreatment%252Bof%252BNSCLC%26aulast%3DDugger%26aufirst%3DRobert%26date%3D2019%26date%3D2019%26spage%3D27%26epage%3D59%26atitle%3DComplete%252BAccounts%252Bof%252BIntegrated%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BExamples%252Bfrom%252Bthe%252BPharmaceutical%252BIndustry%252BVolume%252B2%26aulast%3DPesti%26aufirst%3DJaan%2BA.%26date%3D2019%26date%3D2019%26volume%3D1332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ted W. Johnson, Ben Bolanos, Alexei Brooun, Rebecca A. Gallego, Dan Gehlhaar, Mehran Jalaie, Michele McTigue, <span class="NLM_string-name hlFld-ContribAuthor">Sergei Timofeevski</span>. </span><span class="cited-content_cbyCitation_article-title">Reviving B-Factors: Activating ALK Mutations Increase Protein Dynamics of the Unphosphorylated Kinase. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (9)
                                     , 872-877. <a href="https://doi.org/10.1021/acsmedchemlett.8b00348" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00348%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DReviving%252BB-Factors%25253A%252BActivating%252BALK%252BMutations%252BIncrease%252BProtein%252BDynamics%252Bof%252Bthe%252BUnphosphorylated%252BKinase%26aulast%3DJohnson%26aufirst%3DTed%2BW.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31072018%26date%3D24082018%26date%3D28082018%26date%3D24082018%26volume%3D9%26issue%3D9%26spage%3D872%26epage%3D877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinlong Zhao, Songtao Niu, Xi Jiang, Yongwen Jiang, Xiaojing Zhang, Tiemin Sun, <span class="NLM_string-name hlFld-ContribAuthor">Dawei Ma</span>. </span><span class="cited-content_cbyCitation_article-title">A Class of Amide Ligands Enable Cu-Catalyzed Coupling of (Hetero)aryl Halides with Sulfinic Acid Salts under Mild Conditions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (12)
                                     , 6589-6598. <a href="https://doi.org/10.1021/acs.joc.8b00888" title="DOI URL">https://doi.org/10.1021/acs.joc.8b00888</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b00888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b00888%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BClass%252Bof%252BAmide%252BLigands%252BEnable%252BCu-Catalyzed%252BCoupling%252Bof%252B%252528Hetero%252529aryl%252BHalides%252Bwith%252BSulfinic%252BAcid%252BSalts%252Bunder%252BMild%252BConditions%26aulast%3DZhao%26aufirst%3DJinlong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10042018%26date%3D29052018%26date%3D22052018%26volume%3D83%26issue%3D12%26spage%3D6589%26epage%3D6598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chelsea
E. Powell, Yang Gao, Li Tan, Katherine A. Donovan, Radosław
P. Nowak, Amanda Loehr, Magda Bahcall, Eric S. Fischer, Pasi A. Jänne, Rani E. George, <span class="NLM_string-name hlFld-ContribAuthor">Nathanael S. Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (9)
                                     , 4249-4255. <a href="https://doi.org/10.1021/acs.jmedchem.7b01655" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01655%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemically%252BInduced%252BDegradation%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%26aulast%3DPowell%26aufirst%3DChelsea%2BE.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D09112017%26date%3D24042018%26date%3D16042018%26volume%3D61%26issue%3D9%26spage%3D4249%26epage%3D4255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nanyi  Wang</span>, <span class="hlFld-ContribAuthor ">Lirong  Wang</span>, and <span class="hlFld-ContribAuthor ">Xiang-Qun  Xie</span>  . </span><span class="cited-content_cbyCitation_article-title">ProSelection: A Novel Algorithm to Select Proper Protein Structure Subsets for in Silico Target Identification and Drug Discovery Research. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (11)
                                     , 2686-2698. <a href="https://doi.org/10.1021/acs.jcim.7b00277" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00277%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DProSelection%25253A%252BA%252BNovel%252BAlgorithm%252Bto%252BSelect%252BProper%252BProtein%252BStructure%252BSubsets%252Bfor%252Bin%252BSilico%252BTarget%252BIdentification%252Band%252BDrug%252BDiscovery%252BResearch%26aulast%3DWang%26aufirst%3DNanyi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D17052017%26date%3D26102017%26date%3D27112017%26date%3D10102017%26volume%3D57%26issue%3D11%26spage%3D2686%26epage%3D2698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10030-10066. <a href="https://doi.org/10.1021/acs.jmedchem.6b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBrain%252BCancer%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D03082016%26date%3D23112016%26date%3D14072016%26volume%3D59%26issue%3D22%26spage%3D10030%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory R.  Ott</span>, <span class="hlFld-ContribAuthor ">Mangeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Keith S.  Learn</span>, <span class="hlFld-ContribAuthor ">Jason  Wagner</span>, <span class="hlFld-ContribAuthor ">Diane E.  Gingrich</span>, <span class="hlFld-ContribAuthor ">Joseph G.  Lisko</span>, <span class="hlFld-ContribAuthor ">Matthew  Curry</span>, <span class="hlFld-ContribAuthor ">Eugen F.  Mesaros</span>, <span class="hlFld-ContribAuthor ">Arup K.  Ghose</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Quail</span>, <span class="hlFld-ContribAuthor ">Weihua  Wan</span>, <span class="hlFld-ContribAuthor ">Lihui  Lu</span>, <span class="hlFld-ContribAuthor ">Pawel  Dobrzanski</span>, <span class="hlFld-ContribAuthor ">Mark S.  Albom</span>, <span class="hlFld-ContribAuthor ">Thelma S.  Angeles</span>, <span class="hlFld-ContribAuthor ">Kevin  Wells-Knecht</span>, <span class="hlFld-ContribAuthor ">Zeqi  Huang</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Bruckheimer</span>, <span class="hlFld-ContribAuthor ">Nathan  Anderson</span>, <span class="hlFld-ContribAuthor ">Jay  Friedman</span>, <span class="hlFld-ContribAuthor ">Sandra V.  Fernandez</span>, <span class="hlFld-ContribAuthor ">Mark A.  Ator</span>, <span class="hlFld-ContribAuthor ">Bruce A.  Ruggeri</span>, and <span class="hlFld-ContribAuthor ">Bruce D.  Dorsey</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (16)
                                     , 7478-7496. <a href="https://doi.org/10.1021/acs.jmedchem.6b00487" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00487%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BClinical%252BCandidate%252BCEP-37440%25252C%252Ba%252BSelective%252BInhibitor%252Bof%252BFocal%252BAdhesion%252BKinase%252B%252528FAK%252529%252Band%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%26aulast%3DOtt%26aufirst%3DGregory%2BR.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01042016%26date%3D15082016%26date%3D25082016%26volume%3D59%26issue%3D16%26spage%3D7478%26epage%3D7496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Sheng  Huang</span>, <span class="hlFld-ContribAuthor ">Shuangying  Liu</span>, <span class="hlFld-ContribAuthor ">Dong  Zou</span>, <span class="hlFld-ContribAuthor ">Mathew  Thomas</span>, <span class="hlFld-ContribAuthor ">Yihan  Wang</span>, <span class="hlFld-ContribAuthor ">Tianjun  Zhou</span>, <span class="hlFld-ContribAuthor ">Jan  Romero</span>, <span class="hlFld-ContribAuthor ">Anna  Kohlmann</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Jiwei  Qi</span>, <span class="hlFld-ContribAuthor ">Lisi  Cai</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Dwight</span>, <span class="hlFld-ContribAuthor ">Yongjin  Xu</span>, <span class="hlFld-ContribAuthor ">Rongsong  Xu</span>, <span class="hlFld-ContribAuthor ">Rory  Dodd</span>, <span class="hlFld-ContribAuthor ">Angela  Toms</span>, <span class="hlFld-ContribAuthor ">Lois  Parillon</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Lu</span>, <span class="hlFld-ContribAuthor ">Rana  Anjum</span>, <span class="hlFld-ContribAuthor ">Sen  Zhang</span>, <span class="hlFld-ContribAuthor ">Frank  Wang</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Keats</span>, <span class="hlFld-ContribAuthor ">Scott D.  Wardwell</span>, <span class="hlFld-ContribAuthor ">Yaoyu  Ning</span>, <span class="hlFld-ContribAuthor ">Qihong  Xu</span>, <span class="hlFld-ContribAuthor ">Lauren E.  Moran</span>, <span class="hlFld-ContribAuthor ">Qurish K.  Mohemmad</span>, <span class="hlFld-ContribAuthor ">Hyun Gyung  Jang</span>, <span class="hlFld-ContribAuthor ">Tim  Clackson</span>, <span class="hlFld-ContribAuthor ">Narayana I.  Narasimhan</span>, <span class="hlFld-ContribAuthor ">Victor M.  Rivera</span>, <span class="hlFld-ContribAuthor ">Xiaotian  Zhu</span>, <span class="hlFld-ContribAuthor ">David  Dalgarno</span>, and <span class="hlFld-ContribAuthor ">William C.  Shakespeare</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4948-4964. <a href="https://doi.org/10.1021/acs.jmedchem.6b00306" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00306%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBrigatinib%252B%252528AP26113%252529%25252C%252Ba%252BPhosphine%252BOxide-Containing%25252C%252BPotent%25252C%252BOrally%252BActive%252BInhibitor%252Bof%252BAnaplastic%252BLymphoma%252BKinase%26aulast%3DHuang%26aufirst%3DWei-Sheng%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26022016%26date%3D12052016%26date%3D26052016%26date%3D04052016%26volume%3D59%26issue%3D10%26spage%3D4948%26epage%3D4964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chih-Hsiang  Tu</span>, <span class="hlFld-ContribAuthor ">Wen-Hsing  Lin</span>, <span class="hlFld-ContribAuthor ">Yi-Hui  Peng</span>, <span class="hlFld-ContribAuthor ">Tsu  Hsu</span>, <span class="hlFld-ContribAuthor ">Jian-Sung  Wu</span>, <span class="hlFld-ContribAuthor ">Chun-Yu  Chang</span>, <span class="hlFld-ContribAuthor ">Cheng-Tai  Lu</span>, <span class="hlFld-ContribAuthor ">Ping-Chiang  Lyu</span>, <span class="hlFld-ContribAuthor ">Chuan  Shih</span>, <span class="hlFld-ContribAuthor ">Weir-Torn  Jiaang</span>, and <span class="hlFld-ContribAuthor ">Su-Ying  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrazolylamine Derivatives Reveal the Conformational Switching between Type I and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (8)
                                     , 3906-3919. <a href="https://doi.org/10.1021/acs.jmedchem.6b00106" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00106%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrazolylamine%252BDerivatives%252BReveal%252Bthe%252BConformational%252BSwitching%252Bbetween%252BType%252BI%252Band%252BType%252BII%252BBinding%252BModes%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%26aulast%3DTu%26aufirst%3DChih-Hsiang%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D22012016%26date%3D12042016%26date%3D28042016%26date%3D31032016%26volume%3D59%26issue%3D8%26spage%3D3906%26epage%3D3919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saemina  Shin</span>, <span class="hlFld-ContribAuthor ">Shinmee  Mah</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>, and <span class="hlFld-ContribAuthor ">Hwangseo  Park</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Low Micromolar Dual Inhibitors for Wild Type and L1196M Mutant of Anaplastic Lymphoma Kinase through Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (4)
                                     , 802-810. <a href="https://doi.org/10.1021/acs.jcim.6b00026" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00026%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BLow%252BMicromolar%252BDual%252BInhibitors%252Bfor%252BWild%252BType%252Band%252BL1196M%252BMutant%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252Bthrough%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DShin%26aufirst%3DSaemina%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D20012016%26date%3D04042016%26date%3D25042016%26date%3D25032016%26volume%3D56%26issue%3D4%26spage%3D802%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Menichincheri</span>, <span class="hlFld-ContribAuthor ">Elena  Ardini</span>, <span class="hlFld-ContribAuthor ">Paola  Magnaghi</span>, <span class="hlFld-ContribAuthor ">Nilla  Avanzi</span>, <span class="hlFld-ContribAuthor ">Patrizia  Banfi</span>, <span class="hlFld-ContribAuthor ">Roberto  Bossi</span>, <span class="hlFld-ContribAuthor ">Laura  Buffa</span>, <span class="hlFld-ContribAuthor ">Giulia  Canevari</span>, <span class="hlFld-ContribAuthor ">Lucio  Ceriani</span>, <span class="hlFld-ContribAuthor ">Maristella  Colombo</span>, <span class="hlFld-ContribAuthor ">Luca  Corti</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>, <span class="hlFld-ContribAuthor ">Marina  Fasolini</span>, <span class="hlFld-ContribAuthor ">Eduard  Felder</span>, <span class="hlFld-ContribAuthor ">Claudio  Fiorelli</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Andrea Lombardi  Borgia</span>, <span class="hlFld-ContribAuthor ">Chiara  Marchionni</span>, <span class="hlFld-ContribAuthor ">Marcella  Nesi</span>, <span class="hlFld-ContribAuthor ">Christian  Orrenius</span>, <span class="hlFld-ContribAuthor ">Achille  Panzeri</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Luisa  Rusconi</span>, <span class="hlFld-ContribAuthor ">Maria Beatrice  Saccardo</span>, <span class="hlFld-ContribAuthor ">Ermes  Vanotti</span>, <span class="hlFld-ContribAuthor ">Ettore  Perrone</span>, and <span class="hlFld-ContribAuthor ">Paolo  Orsini</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 3392-3408. <a href="https://doi.org/10.1021/acs.jmedchem.6b00064" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00064%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BEntrectinib%25253A%252BA%252BNew%252B3-Aminoindazole%252BAs%252Ba%252BPotent%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%25252C%252Bc-ros%252BOncogene%252B1%252BKinase%252B%252528ROS1%252529%25252C%252Band%252BPan-Tropomyosin%252BReceptor%252BKinases%252B%252528Pan-TRKs%252529%252Binhibitor%26aulast%3DMenichincheri%26aufirst%3DMaria%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14012016%26date%3D30032016%26date%3D14042016%26date%3D22032016%26volume%3D59%26issue%3D7%26spage%3D3392%26epage%3D3408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mijoon  Lee</span>, <span class="hlFld-ContribAuthor ">Tomas  Rucil</span>, <span class="hlFld-ContribAuthor ">Dusan  Hesek</span>, <span class="hlFld-ContribAuthor ">Allen G.  Oliver</span>, <span class="hlFld-ContribAuthor ">Jed F.  Fisher</span>, and <span class="hlFld-ContribAuthor ">Shahriar  Mobashery</span>  . </span><span class="cited-content_cbyCitation_article-title">Regioselective Control of the SNAr Amination of 5-Substituted-2,4-Dichloropyrimidines Using Tertiary Amine Nucleophiles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (15)
                                     , 7757-7763. <a href="https://doi.org/10.1021/acs.joc.5b01044" title="DOI URL">https://doi.org/10.1021/acs.joc.5b01044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b01044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b01044%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegioselective%252BControl%252Bof%252Bthe%252BSNAr%252BAmination%252Bof%252B5-Substituted-2%25252C4-Dichloropyrimidines%252BUsing%252BTertiary%252BAmine%252BNucleophiles%26aulast%3DLee%26aufirst%3DMijoon%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D11052015%26date%3D17072015%26date%3D07082015%26date%3D08072015%26volume%3D80%26issue%3D15%26spage%3D7757%26epage%3D7763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zilan  Song</span>, <span class="hlFld-ContribAuthor ">Yanhong  Yang</span>, <span class="hlFld-ContribAuthor ">Zhiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Junfeng  Guo</span>, <span class="hlFld-ContribAuthor ">Xinying  Yang</span>, <span class="hlFld-ContribAuthor ">Kui  Wu</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, and <span class="hlFld-ContribAuthor ">Ao  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent Inhibitory Activities against Both Wild-type and Mutant ALK Kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 197-211. <a href="https://doi.org/10.1021/jm5005144" title="DOI URL">https://doi.org/10.1021/jm5005144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5005144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5005144%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252B2%25252C4-Diarylaminopyrimidine%252BAnalogues%252B%252528DAAPalogues%252529%252BShowing%252BPotent%252BInhibitory%252BActivities%252Bagainst%252BBoth%252BWild-type%252Band%252BMutant%252BALK%252BKinases%26aulast%3DSong%26aufirst%3DZilan%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D01042014%26date%3D08052014%26date%3D08012015%26date%3D30042014%26volume%3D58%26issue%3D1%26spage%3D197%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ted W.  Johnson</span>, <span class="hlFld-ContribAuthor ">Paul F.  Richardson</span>, <span class="hlFld-ContribAuthor ">Simon  Bailey</span>, <span class="hlFld-ContribAuthor ">Alexei  Brooun</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Burke</span>, <span class="hlFld-ContribAuthor ">Michael R.  Collins</span>, <span class="hlFld-ContribAuthor ">J. Jean  Cui</span>, <span class="hlFld-ContribAuthor ">Judith G.  Deal</span>, <span class="hlFld-ContribAuthor ">Ya-Li  Deng</span>, <span class="hlFld-ContribAuthor ">Dac  Dinh</span>, <span class="hlFld-ContribAuthor ">Lars D.  Engstrom</span>, <span class="hlFld-ContribAuthor ">Mingying  He</span>, <span class="hlFld-ContribAuthor ">Jacqui  Hoffman</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hoffman</span>, <span class="hlFld-ContribAuthor ">Qinhua  Huang</span>, <span class="hlFld-ContribAuthor ">Robert S.  Kania</span>, <span class="hlFld-ContribAuthor ">John C.  Kath</span>, <span class="hlFld-ContribAuthor ">Hieu  Lam</span>, <span class="hlFld-ContribAuthor ">Justine L.  Lam</span>, <span class="hlFld-ContribAuthor ">Phuong T.  Le</span>, <span class="hlFld-ContribAuthor ">Laura  Lingardo</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Michele  McTigue</span>, <span class="hlFld-ContribAuthor ">Cynthia L.  Palmer</span>, <span class="hlFld-ContribAuthor ">Neal W.  Sach</span>, <span class="hlFld-ContribAuthor ">Tod  Smeal</span>, <span class="hlFld-ContribAuthor ">Graham L.  Smith</span>, <span class="hlFld-ContribAuthor ">Albert E.  Stewart</span>, <span class="hlFld-ContribAuthor ">Sergei  Timofeevski</span>, <span class="hlFld-ContribAuthor ">Huichun  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinjiang  Zhu</span>, <span class="hlFld-ContribAuthor ">Helen Y.  Zou</span>, and <span class="hlFld-ContribAuthor ">Martin P.  Edwards</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (11)
                                     , 4720-4744. <a href="https://doi.org/10.1021/jm500261q" title="DOI URL">https://doi.org/10.1021/jm500261q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500261q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%25252810R%252529-7-Amino-12-fluoro-2%25252C10%25252C16-trimethyl-15-oxo-10%25252C15%25252C16%25252C17-tetrahydro-2H-8%25252C4-%252528metheno%252529pyrazolo%25255B4%25252C3-h%25255D%25255B2%25252C5%25252C11%25255D-benzoxadiazacyclotetradecine-3-carbonitrile%252B%252528PF-06463922%252529%25252C%252Ba%252BMacrocyclic%252BInhibitor%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252Band%252Bc-ros%252BOncogene%252B1%252B%252528ROS1%252529%252Bwith%252BPreclinical%252BBrain%252BExposure%252Band%252BBroad-Spectrum%252BPotency%252Bagainst%252BALK-Resistant%252BMutations%26aulast%3DJohnson%26aufirst%3DTed%2BW.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17022014%26date%3D03062014%26date%3D12062014%26date%3D13052014%26volume%3D57%26issue%3D11%26spage%3D4720%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinhua  Huang</span>, <span class="hlFld-ContribAuthor ">Ted W.  Johnson</span>, <span class="hlFld-ContribAuthor ">Simon  Bailey</span>, <span class="hlFld-ContribAuthor ">Alexei  Brooun</span>, <span class="hlFld-ContribAuthor ">Kevin D.  Bunker</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Burke</span>, <span class="hlFld-ContribAuthor ">Michael R.  Collins</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Cook</span>, <span class="hlFld-ContribAuthor ">J. Jean  Cui</span>, <span class="hlFld-ContribAuthor ">Kevin N.  Dack</span>, <span class="hlFld-ContribAuthor ">Judith G.  Deal</span>, <span class="hlFld-ContribAuthor ">Ya-Li  Deng</span>, <span class="hlFld-ContribAuthor ">Dac  Dinh</span>, <span class="hlFld-ContribAuthor ">Lars D.  Engstrom</span>, <span class="hlFld-ContribAuthor ">Mingying  He</span>, <span class="hlFld-ContribAuthor ">Jacqui  Hoffman</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hoffman</span>, <span class="hlFld-ContribAuthor ">Patrick S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Robert S.  Kania</span>, <span class="hlFld-ContribAuthor ">Hieu  Lam</span>, <span class="hlFld-ContribAuthor ">Justine L.  Lam</span>, <span class="hlFld-ContribAuthor ">Phuong T.  Le</span>, <span class="hlFld-ContribAuthor ">Qiuhua  Li</span>, <span class="hlFld-ContribAuthor ">Laura  Lingardo</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Melissa West  Lu</span>, <span class="hlFld-ContribAuthor ">Michele  McTigue</span>, <span class="hlFld-ContribAuthor ">Cynthia L.  Palmer</span>, <span class="hlFld-ContribAuthor ">Paul F.  Richardson</span>, <span class="hlFld-ContribAuthor ">Neal W.  Sach</span>, <span class="hlFld-ContribAuthor ">Hong  Shen</span>, <span class="hlFld-ContribAuthor ">Tod  Smeal</span>, <span class="hlFld-ContribAuthor ">Graham L.  Smith</span>, <span class="hlFld-ContribAuthor ">Albert E.  Stewart</span>, <span class="hlFld-ContribAuthor ">Sergei  Timofeevski</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Tsaparikos</span>, <span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Huichun  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinjiang  Zhu</span>, <span class="hlFld-ContribAuthor ">Helen Y.  Zou</span>, and <span class="hlFld-ContribAuthor ">Martin P.  Edwards</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (4)
                                     , 1170-1187. <a href="https://doi.org/10.1021/jm401805h" title="DOI URL">https://doi.org/10.1021/jm401805h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401805h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401805h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BPotent%252Band%252BSelective%252BInhibitors%252Bto%252BOvercome%252BClinical%252BAnaplastic%252BLymphoma%252BKinase%252BMutations%252BResistant%252Bto%252BCrizotinib%26aulast%3DHuang%26aufirst%3DQinhua%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D22112013%26date%3D06022014%26date%3D27022014%26date%3D16012014%26volume%3D57%26issue%3D4%26spage%3D1170%26epage%3D1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianyong  Chen</span>, <span class="hlFld-ContribAuthor ">Cheng  Jiang</span>, and <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">LDK378: A Promising Anaplastic Lymphoma Kinase (ALK) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (14)
                                     , 5673-5674. <a href="https://doi.org/10.1021/jm401005u" title="DOI URL">https://doi.org/10.1021/jm401005u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401005u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401005u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLDK378%25253A%252BA%252BPromising%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252BInhibitor%26aulast%3DChen%26aufirst%3DJianyong%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03072013%26date%3D09072013%26date%3D25072013%26volume%3D56%26issue%3D14%26spage%3D5673%26epage%3D5674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steve  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Clemens  Hug</span>, <span class="hlFld-ContribAuthor ">Petar  Todorov</span>, <span class="hlFld-ContribAuthor ">Nienke  Moret</span>, <span class="hlFld-ContribAuthor ">Sarah A.  Boswell</span>, <span class="hlFld-ContribAuthor ">Kyle  Evans</span>, <span class="hlFld-ContribAuthor ">George  Zhou</span>, <span class="hlFld-ContribAuthor ">Nathan T.  Johnson</span>, <span class="hlFld-ContribAuthor ">Bradley T.  Hyman</span>, <span class="hlFld-ContribAuthor ">Peter K.  Sorger</span>, <span class="hlFld-ContribAuthor ">Mark W.  Albers</span>, <span class="hlFld-ContribAuthor ">Artem  Sokolov</span>. </span><span class="cited-content_cbyCitation_article-title">Machine learning identifies candidates for drug repurposing in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-021-21330-0" title="DOI URL">https://doi.org/10.1038/s41467-021-21330-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-021-21330-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-021-21330-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DMachine%252Blearning%252Bidentifies%252Bcandidates%252Bfor%252Bdrug%252Brepurposing%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DRodriguez%26aufirst%3DSteve%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chih-Hsi Scott  Kuo</span>, <span class="hlFld-ContribAuthor ">Pi-Hung  Tung</span>, <span class="hlFld-ContribAuthor ">Allen Chung-Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">Chin-Chou  Wang</span>, <span class="hlFld-ContribAuthor ">John Wen-Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Chien-Ying  Liu</span>, <span class="hlFld-ContribAuthor ">Fu-Tsai  Chung</span>, <span class="hlFld-ContribAuthor ">Yueh-Fu  Fang</span>, <span class="hlFld-ContribAuthor ">Yi-Ke  Guo</span>, <span class="hlFld-ContribAuthor ">Cheng-Ta  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">A retrospective study of alectinib versus ceritinib in patients with advanced non–small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2021,</strong> <em>21 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-021-08005-1" title="DOI URL">https://doi.org/10.1186/s12885-021-08005-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-021-08005-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-021-08005-1%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DA%252Bretrospective%252Bstudy%252Bof%252Balectinib%252Bversus%252Bceritinib%252Bin%252Bpatients%252Bwith%252Badvanced%252Bnon%2525E2%252580%252593small-cell%252Blung%252Bcancer%252Bof%252Banaplastic%252Blymphoma%252Bkinase%252Bfusion%252Bin%252Bwhom%252Bcrizotinib%252Btreatment%252Bfailed%26aulast%3DKuo%26aufirst%3DChih-Hsi%2BScott%26date%3D2021%26date%3D2021%26volume%3D21%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhong</span>, <span class="hlFld-ContribAuthor ">Yueshan  Li</span>, <span class="hlFld-ContribAuthor ">Liang  Xiong</span>, <span class="hlFld-ContribAuthor ">Wenjing  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Wu</span>, <span class="hlFld-ContribAuthor ">Ting  Yuan</span>, <span class="hlFld-ContribAuthor ">Wei  Yang</span>, <span class="hlFld-ContribAuthor ">Chenyu  Tian</span>, <span class="hlFld-ContribAuthor ">Zhuang  Miao</span>, <span class="hlFld-ContribAuthor ">Tianqi  Wang</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2021,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-021-00572-w" title="DOI URL">https://doi.org/10.1038/s41392-021-00572-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-021-00572-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-021-00572-w%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DSmall%252Bmolecules%252Bin%252Btargeted%252Bcancer%252Btherapy%25253A%252Badvances%25252C%252Bchallenges%25252C%252Band%252Bfuture%252Bperspectives%26aulast%3DZhong%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Pan</span>, <span class="hlFld-ContribAuthor ">Yanrong  Dan</span>, <span class="hlFld-ContribAuthor ">Dafeng  Guo</span>, <span class="hlFld-ContribAuthor ">Junhao  Jiang</span>, <span class="hlFld-ContribAuthor ">Dongzhi  Ran</span>, <span class="hlFld-ContribAuthor ">Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Binghua  Tian</span>, <span class="hlFld-ContribAuthor ">Jianyong  Yuan</span>, <span class="hlFld-ContribAuthor ">Yu  Yu</span>, <span class="hlFld-ContribAuthor ">Zongjie  Gan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2,4-pyrimidinediamine derivatives as potent dual inhibitors of ALK and HDAC. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113672. <a href="https://doi.org/10.1016/j.ejmech.2021.113672" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113672</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113672%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2%25252C4-pyrimidinediamine%252Bderivatives%252Bas%252Bpotent%252Bdual%252Binhibitors%252Bof%252BALK%252Band%252BHDAC%26aulast%3DPan%26aufirst%3DTao%26date%3D2021%26volume%3D224%26spage%3D113672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Wu</span>, <span class="hlFld-ContribAuthor ">Han  Yao</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Niuniu  Zhang</span>, <span class="hlFld-ContribAuthor ">Yangyang  Fan</span>, <span class="hlFld-ContribAuthor ">Albert S.C.  Chan</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Baijiao  An</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing a sulfoxide moiety as anaplastic lymphoma kinase (ALK) inhibition agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>48 </em>, 128253. <a href="https://doi.org/10.1016/j.bmcl.2021.128253" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128253%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252B2%25252C4-diaminopyrimidines%252Bbearing%252Ba%252Bsulfoxide%252Bmoiety%252Bas%252Banaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%252Binhibition%252Bagents%26aulast%3DWu%26aufirst%3DFeng%26date%3D2021%26volume%3D48%26spage%3D128253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Subbiah</span>, <span class="hlFld-ContribAuthor ">S.  Kuravi</span>, <span class="hlFld-ContribAuthor ">S.  Ganguly</span>, <span class="hlFld-ContribAuthor ">D.R.  Welch</span>, <span class="hlFld-ContribAuthor ">C.J.  Vivian</span>, <span class="hlFld-ContribAuthor ">M.U.  Mushtaq</span>, <span class="hlFld-ContribAuthor ">A.  Hegde</span>, <span class="hlFld-ContribAuthor ">S.  Iyer</span>, <span class="hlFld-ContribAuthor ">A.  Behrang</span>, <span class="hlFld-ContribAuthor ">S.M.  Ali</span>, <span class="hlFld-ContribAuthor ">R.W.  Madison</span>, <span class="hlFld-ContribAuthor ">J.M.  Venstrom</span>, <span class="hlFld-ContribAuthor ">R.A.  Jensen</span>, <span class="hlFld-ContribAuthor ">J.P.  McGuirk</span>, <span class="hlFld-ContribAuthor ">H.M.  Amin</span>, <span class="hlFld-ContribAuthor ">R.  Balusu</span>. </span><span class="cited-content_cbyCitation_article-title">Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma. </span><span class="cited-content_cbyCitation_journal-name">ESMO Open</span><span> <strong>2021,</strong> <em>6 </em>
                                    (4)
                                     , 100172. <a href="https://doi.org/10.1016/j.esmoop.2021.100172" title="DOI URL">https://doi.org/10.1016/j.esmoop.2021.100172</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.esmoop.2021.100172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.esmoop.2021.100172%26sid%3Dliteratum%253Aachs%26jtitle%3DESMO%2520Open%26atitle%3DPrecision%252Btherapy%252Bwith%252Banaplastic%252Blymphoma%252Bkinase%252Binhibitor%252Bceritinib%252Bin%252BALK-rearranged%252Banaplastic%252Blarge%252Bcell%252Blymphoma%26aulast%3DSubbiah%26aufirst%3DV.%26date%3D2021%26volume%3D6%26issue%3D4%26spage%3D100172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Mao</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Zhang</span>, <span class="hlFld-ContribAuthor ">Youyong  Kong</span>, <span class="hlFld-ContribAuthor ">Shanshan  Wu</span>, <span class="hlFld-ContribAuthor ">Hai-qin  Huo</span>, <span class="hlFld-ContribAuthor ">Yue  Kong</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengping  Jia</span>, <span class="hlFld-ContribAuthor ">Zikai  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Transcriptome Regulation by Oncogenic ALK Pathway in Mammalian Cortical Development Revealed by Single-Cell RNA Sequencing. </span><span class="cited-content_cbyCitation_journal-name">Cerebral Cortex</span><span> <strong>2021,</strong> <em>31 </em>
                                    (8)
                                     , 3911-3924. <a href="https://doi.org/10.1093/cercor/bhab058" title="DOI URL">https://doi.org/10.1093/cercor/bhab058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/cercor/bhab058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fcercor%2Fbhab058%26sid%3Dliteratum%253Aachs%26jtitle%3DCerebral%2520Cortex%26atitle%3DTranscriptome%252BRegulation%252Bby%252BOncogenic%252BALK%252BPathway%252Bin%252BMammalian%252BCortical%252BDevelopment%252BRevealed%252Bby%252BSingle-Cell%252BRNA%252BSequencing%26aulast%3DMao%26aufirst%3DRui%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D8%26spage%3D3911%26epage%3D3924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoki  Haratake</span>, <span class="hlFld-ContribAuthor ">Gouji  Toyokawa</span>, <span class="hlFld-ContribAuthor ">Takashi  Seto</span>, <span class="hlFld-ContribAuthor ">Tetsuzo  Tagawa</span>, <span class="hlFld-ContribAuthor ">Tasuro  Okamoto</span>, <span class="hlFld-ContribAuthor ">Koji  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Sadanori  Takeo</span>, <span class="hlFld-ContribAuthor ">Masaki  Mori</span>. </span><span class="cited-content_cbyCitation_article-title">The mechanisms of resistance to second- and third-generation ALK inhibitors and strategies to overcome such resistance. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2021,</strong> <em>26 </em>, 1-14. <a href="https://doi.org/10.1080/14737140.2021.1940964" title="DOI URL">https://doi.org/10.1080/14737140.2021.1940964</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2021.1940964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2021.1940964%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DThe%252Bmechanisms%252Bof%252Bresistance%252Bto%252Bsecond-%252Band%252Bthird-generation%252BALK%252Binhibitors%252Band%252Bstrategies%252Bto%252Bovercome%252Bsuch%252Bresistance%26aulast%3DHaratake%26aufirst%3DNaoki%26date%3D2021%26date%3D2021%26volume%3D26%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debasis  Das</span>, <span class="hlFld-ContribAuthor ">Jingbing  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Next‐Generation Kinase Inhibitors Targeting Specific Biomarkers in Non‐Small Cell Lung Cancer (NSCLC): A Recent Overview. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>71 </em><a href="https://doi.org/10.1002/cmdc.202100166" title="DOI URL">https://doi.org/10.1002/cmdc.202100166</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100166%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNext%2525E2%252580%252590Generation%252BKinase%252BInhibitors%252BTargeting%252BSpecific%252BBiomarkers%252Bin%252BNon%2525E2%252580%252590Small%252BCell%252BLung%252BCancer%252B%252528NSCLC%252529%25253A%252BA%252BRecent%252BOverview%26aulast%3DDas%26aufirst%3DDebasis%26date%3D2021%26date%3D2021%26volume%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Meng  Cao</span>, <span class="hlFld-ContribAuthor ">Tianming  Zhao</span>, <span class="hlFld-ContribAuthor ">Mingzhu  Li</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and antitumor activity of Benzo[d]imidazol-containing 2,4-diarylaminopyrimidine analogues as ALK inhibitors with mutation-combating effects. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>37 </em>, 116108. <a href="https://doi.org/10.1016/j.bmc.2021.116108" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116108%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bantitumor%252Bactivity%252Bof%252BBenzo%25255Bd%25255Dimidazol-containing%252B2%25252C4-diarylaminopyrimidine%252Banalogues%252Bas%252BALK%252Binhibitors%252Bwith%252Bmutation-combating%252Beffects%26aulast%3DLi%26aufirst%3DZheng%26date%3D2021%26volume%3D37%26spage%3D116108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanesa  Gregorc</span>, <span class="hlFld-ContribAuthor ">Chiara  Lazzari</span>, <span class="hlFld-ContribAuthor ">Mario  Mandalá</span>, <span class="hlFld-ContribAuthor ">Stefania  Ippati</span>, <span class="hlFld-ContribAuthor ">Alessandra  Bulotta</span>, <span class="hlFld-ContribAuthor ">Maria Giulia  Cangi</span>, <span class="hlFld-ContribAuthor ">Abdelrahman  Khater</span>, <span class="hlFld-ContribAuthor ">Maria Grazia  Viganò</span>, <span class="hlFld-ContribAuthor ">Aurora  Mirabile</span>, <span class="hlFld-ContribAuthor ">Lorenza  Pecciarini</span>, <span class="hlFld-ContribAuthor ">Francesca Rita  Ogliari</span>, <span class="hlFld-ContribAuthor ">Gianluigi  Arrigoni</span>, <span class="hlFld-ContribAuthor ">Greta  Grassini</span>, <span class="hlFld-ContribAuthor ">Giulia  Veronesi</span>, <span class="hlFld-ContribAuthor ">Claudio  Doglioni</span>. </span><span class="cited-content_cbyCitation_article-title">Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (9)
                                     , 2023. <a href="https://doi.org/10.3390/cancers13092023" title="DOI URL">https://doi.org/10.3390/cancers13092023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13092023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13092023%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DIntratumoral%252BCellular%252BHeterogeneity%25253A%252BImplications%252Bfor%252BDrug%252BResistance%252Bin%252BPatients%252Bwith%252BNon-Small%252BCell%252BLung%252BCancer%26aulast%3DGregorc%26aufirst%3DVanesa%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D9%26spage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daisuke  Kawauchi</span>, <span class="hlFld-ContribAuthor ">Masamichi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Kaishi  Satomi</span>, <span class="hlFld-ContribAuthor ">Shun  Yamamuro</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Eita  Uchida</span>, <span class="hlFld-ContribAuthor ">Mai  Honda‐Kitahara</span>, <span class="hlFld-ContribAuthor ">Yoshitaka  Narita</span>, <span class="hlFld-ContribAuthor ">Yasuo  Iwadate</span>, <span class="hlFld-ContribAuthor ">Koichi  Ichimura</span>, <span class="hlFld-ContribAuthor ">Arata  Tomiyama</span>. </span><span class="cited-content_cbyCitation_article-title">The ALK inhibitors, alectinib and ceritinib, induce ALK‐independent and STAT3‐dependent glioblastoma cell death. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2021,</strong> <em>4 </em><a href="https://doi.org/10.1111/cas.14885" title="DOI URL">https://doi.org/10.1111/cas.14885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.14885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.14885%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DThe%252BALK%252Binhibitors%25252C%252Balectinib%252Band%252Bceritinib%25252C%252Binduce%252BALK%2525E2%252580%252590independent%252Band%252BSTAT3%2525E2%252580%252590dependent%252Bglioblastoma%252Bcell%252Bdeath%26aulast%3DKawauchi%26aufirst%3DDaisuke%26date%3D2021%26date%3D2021%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Xinxin  Zhong</span>, <span class="hlFld-ContribAuthor ">Lin  Yue</span>, <span class="hlFld-ContribAuthor ">Chunlan  Pu</span>, <span class="hlFld-ContribAuthor ">Huifang  Shan</span>, <span class="hlFld-ContribAuthor ">Suke  Lan</span>, <span class="hlFld-ContribAuthor ">Meng  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueyan  Hou</span>, <span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Rui  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a PROTAC targeting ALK with in vivo activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113150. <a href="https://doi.org/10.1016/j.ejmech.2020.113150" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113150%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPROTAC%252Btargeting%252BALK%252Bwith%252Bin%2525C2%2525A0vivo%252Bactivity%26aulast%3DYan%26aufirst%3DGuoyi%26date%3D2021%26volume%3D212%26spage%3D113150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisabeth  Smolle</span>, <span class="hlFld-ContribAuthor ">Valentin  Taucher</span>, <span class="hlFld-ContribAuthor ">Joerg  Lindenmann</span>, <span class="hlFld-ContribAuthor ">Philipp J.  Jost</span>, <span class="hlFld-ContribAuthor ">Martin  Pichler</span>. </span><span class="cited-content_cbyCitation_article-title">Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 699. <a href="https://doi.org/10.3390/cancers13040699" title="DOI URL">https://doi.org/10.3390/cancers13040699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13040699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13040699%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DCurrent%252BKnowledge%252Babout%252BMechanisms%252Bof%252BDrug%252BResistance%252Bagainst%252BALK%252BInhibitors%252Bin%252BNon-Small%252BCell%252BLung%252BCancer%26aulast%3DSmolle%26aufirst%3DElisabeth%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gonzalo  Recondo</span>, <span class="hlFld-ContribAuthor ">Luc  Friboulet</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic strategies to overcome ALK resistance in lung cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 123-139. <a href="https://doi.org/10.1016/B978-0-12-821774-0.00004-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-821774-0.00004-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-821774-0.00004-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-821774-0.00004-8%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutic%252Bstrategies%252Bto%252Bovercome%252BALK%252Bresistance%252Bin%252Blung%252Bcancer%26aulast%3DRecondo%26aufirst%3DGonzalo%26date%3D2021%26spage%3D123%26epage%3D139%26pub%3DElsevier%26atitle%3DTherapeutic%252BStrategies%252Bto%252BOvercome%252BALK%252BResistance%252Bin%252BCancer%26date%3D2021%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Mologni</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance mechanisms to ALK TKIs in tumors other than lung cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 101-121. <a href="https://doi.org/10.1016/B978-0-12-821774-0.00005-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-821774-0.00005-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-821774-0.00005-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-821774-0.00005-X%26sid%3Dliteratum%253Aachs%26atitle%3DResistance%252Bmechanisms%252Bto%252BALK%252BTKIs%252Bin%252Btumors%252Bother%252Bthan%252Blung%252Bcancer%26aulast%3DMologni%26aufirst%3DLuca%26date%3D2021%26spage%3D101%26epage%3D121%26pub%3DElsevier%26atitle%3DTherapeutic%252BStrategies%252Bto%252BOvercome%252BALK%252BResistance%252Bin%252BCancer%26date%3D2021%26volume%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Collazo-Lorduy</span>, <span class="hlFld-ContribAuthor ">Beatriz  Jiménez</span>, <span class="hlFld-ContribAuthor ">María  Castro-Henriques</span>, <span class="hlFld-ContribAuthor ">Jordi  Remon</span>. </span><span class="cited-content_cbyCitation_article-title">ALK rearranged lung cancer: TKI treatment and outcome. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 31-53. <a href="https://doi.org/10.1016/B978-0-12-821774-0.00013-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-821774-0.00013-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-821774-0.00013-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-821774-0.00013-9%26sid%3Dliteratum%253Aachs%26atitle%3DALK%252Brearranged%252Blung%252Bcancer%25253A%252BTKI%252Btreatment%252Band%252Boutcome%26aulast%3DCollazo-Lorduy%26aufirst%3DAna%26date%3D2021%26spage%3D31%26epage%3D53%26pub%3DElsevier%26atitle%3DTherapeutic%252BStrategies%252Bto%252BOvercome%252BALK%252BResistance%252Bin%252BCancer%26date%3D2021%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryohei  Katayama</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance to anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) in patients with lung cancer: Single mutations, compound mutations, and other mechanisms of drug resistance. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 87-99. <a href="https://doi.org/10.1016/B978-0-12-821774-0.00015-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-821774-0.00015-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-821774-0.00015-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-821774-0.00015-2%26sid%3Dliteratum%253Aachs%26atitle%3DResistance%252Bto%252Banaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%252Btyrosine%252Bkinase%252Binhibitors%252B%252528TKIs%252529%252Bin%252Bpatients%252Bwith%252Blung%252Bcancer%25253A%252BSingle%252Bmutations%25252C%252Bcompound%252Bmutations%25252C%252Band%252Bother%252Bmechanisms%252Bof%252Bdrug%252Bresistance%26aulast%3DKatayama%26aufirst%3DRyohei%26date%3D2021%26spage%3D87%26epage%3D99%26pub%3DElsevier%26atitle%3DTherapeutic%252BStrategies%252Bto%252BOvercome%252BALK%252BResistance%252Bin%252BCancer%26date%3D2021%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vinayak  Palve</span>, <span class="hlFld-ContribAuthor ">Yi  Liao</span>, <span class="hlFld-ContribAuthor ">Lily L.  Remsing Rix</span>, <span class="hlFld-ContribAuthor ">Uwe  Rix</span>. </span><span class="cited-content_cbyCitation_article-title">Turning liabilities into opportunities: Off-target based drug repurposing in cancer. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2021,</strong> <em>68 </em>, 209-229. <a href="https://doi.org/10.1016/j.semcancer.2020.02.003" title="DOI URL">https://doi.org/10.1016/j.semcancer.2020.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2020.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2020.02.003%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DTurning%252Bliabilities%252Binto%252Bopportunities%25253A%252BOff-target%252Bbased%252Bdrug%252Brepurposing%252Bin%252Bcancer%26aulast%3DPalve%26aufirst%3DVinayak%26date%3D2021%26volume%3D68%26spage%3D209%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Drilon</span>, <span class="hlFld-ContribAuthor ">Chelsea  Jenkins</span>, <span class="hlFld-ContribAuthor ">Sudarshan  Iyer</span>, <span class="hlFld-ContribAuthor ">Adam  Schoenfeld</span>, <span class="hlFld-ContribAuthor ">Clare  Keddy</span>, <span class="hlFld-ContribAuthor ">Monika A.  Davare</span>. </span><span class="cited-content_cbyCitation_article-title">ROS1-dependent cancers — biology, diagnostics and therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Clinical Oncology</span><span> <strong>2021,</strong> <em>18 </em>
                                    (1)
                                     , 35-55. <a href="https://doi.org/10.1038/s41571-020-0408-9" title="DOI URL">https://doi.org/10.1038/s41571-020-0408-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41571-020-0408-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41571-020-0408-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Clinical%2520Oncology%26atitle%3DROS1-dependent%252Bcancers%252B%2525E2%252580%252594%252Bbiology%25252C%252Bdiagnostics%252Band%252Btherapeutics%26aulast%3DDrilon%26aufirst%3DAlexander%26date%3D2021%26date%3D2020%26volume%3D18%26issue%3D1%26spage%3D35%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoyuki  Naito</span>, <span class="hlFld-ContribAuthor ">Hideaki  Shiraishi</span>, <span class="hlFld-ContribAuthor ">Yutaka  Fujiwara</span>. </span><span class="cited-content_cbyCitation_article-title">Brigatinib and lorlatinib: their effect on ALK inhibitors in NSCLC focusing on resistant mutations and central nervous system metastases. </span><span class="cited-content_cbyCitation_journal-name">Japanese Journal of Clinical Oncology</span><span> <strong>2021,</strong> <em>51 </em>
                                    (1)
                                     , 37-44. <a href="https://doi.org/10.1093/jjco/hyaa192" title="DOI URL">https://doi.org/10.1093/jjco/hyaa192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jjco/hyaa192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjjco%2Fhyaa192%26sid%3Dliteratum%253Aachs%26jtitle%3DJapanese%2520Journal%2520of%2520Clinical%2520Oncology%26atitle%3DBrigatinib%252Band%252Blorlatinib%25253A%252Btheir%252Beffect%252Bon%252BALK%252Binhibitors%252Bin%252BNSCLC%252Bfocusing%252Bon%252Bresistant%252Bmutations%252Band%252Bcentral%252Bnervous%252Bsystem%252Bmetastases%26aulast%3DNaito%26aufirst%3DTomoyuki%26date%3D2021%26date%3D2020%26volume%3D51%26issue%3D1%26spage%3D37%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuka  Miyoshi</span>, <span class="hlFld-ContribAuthor ">Osamu  Ogawa</span>, <span class="hlFld-ContribAuthor ">Ai  Nishida</span>, <span class="hlFld-ContribAuthor ">Masahiro  Masuzawa</span>. </span><span class="cited-content_cbyCitation_article-title">Recurrent hyperglycemic hyperosmolar state after re-administration of dose-reduced ceritinib, an anaplastic lymphoma kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Diabetology International</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 126-129. <a href="https://doi.org/10.1007/s13340-020-00442-w" title="DOI URL">https://doi.org/10.1007/s13340-020-00442-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13340-020-00442-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13340-020-00442-w%26sid%3Dliteratum%253Aachs%26jtitle%3DDiabetology%2520International%26atitle%3DRecurrent%252Bhyperglycemic%252Bhyperosmolar%252Bstate%252Bafter%252Bre-administration%252Bof%252Bdose-reduced%252Bceritinib%25252C%252Ban%252Banaplastic%252Blymphoma%252Bkinase%252Binhibitor%26aulast%3DMiyoshi%26aufirst%3DYuka%26date%3D2021%26date%3D2020%26volume%3D12%26issue%3D1%26spage%3D126%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Firdoos Ahmad  Sofi</span>, <span class="hlFld-ContribAuthor ">Prasad V.  Bharatam</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Drugs and Biorelevant N-heterocycles Employing Recent Advances in C-N Bond Formation. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2020,</strong> <em>24 </em>
                                    (20)
                                     , 2293-2340. <a href="https://doi.org/10.2174/1385272824999200909114144" title="DOI URL">https://doi.org/10.2174/1385272824999200909114144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272824999200909114144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272824999200909114144%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BDrugs%252Band%252BBiorelevant%252BN-heterocycles%252BEmploying%252BRecent%252BAdvances%252Bin%252BC-N%252BBond%252BFormation%26aulast%3DSofi%26aufirst%3DFirdoos%2BAhmad%26date%3D2020%26volume%3D24%26issue%3D20%26spage%3D2293%26epage%3D2340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianzhong  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Haibo  Sun</span>, <span class="hlFld-ContribAuthor ">Laixue  Pang</span>, <span class="hlFld-ContribAuthor ">Baohua  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Mutation-mediated influences on binding of anaplastic lymphoma kinase to crizotinib decoded by multiple replica Gaussian accelerated molecular dynamics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2020,</strong> <em>34 </em>
                                    (12)
                                     , 1289-1305. <a href="https://doi.org/10.1007/s10822-020-00355-5" title="DOI URL">https://doi.org/10.1007/s10822-020-00355-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-020-00355-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-020-00355-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DMutation-mediated%252Binfluences%252Bon%252Bbinding%252Bof%252Banaplastic%252Blymphoma%252Bkinase%252Bto%252Bcrizotinib%252Bdecoded%252Bby%252Bmultiple%252Breplica%252BGaussian%252Baccelerated%252Bmolecular%252Bdynamics%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D12%26spage%3D1289%26epage%3D1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yukari  Ono</span>, <span class="hlFld-ContribAuthor ">Masayuki  Ninomiya</span>, <span class="hlFld-ContribAuthor ">Daiki  Kaneko</span>, <span class="hlFld-ContribAuthor ">Amol D.  Sonawane</span>, <span class="hlFld-ContribAuthor ">Taro  Udagawa</span>, <span class="hlFld-ContribAuthor ">Kaori  Tanaka</span>, <span class="hlFld-ContribAuthor ">Atsuyoshi  Nishina</span>, <span class="hlFld-ContribAuthor ">Mamoru  Koketsu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of quinoxaline-1,3,4-oxadiazole hybrid derivatives as potent inhibitors of the anti-apoptotic Bcl-2 protein. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>104 </em>, 104245. <a href="https://doi.org/10.1016/j.bioorg.2020.104245" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104245%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bquinoxaline-1%25252C3%25252C4-oxadiazole%252Bhybrid%252Bderivatives%252Bas%252Bpotent%252Binhibitors%252Bof%252Bthe%252Banti-apoptotic%252BBcl-2%252Bprotein%26aulast%3DOno%26aufirst%3DYukari%26date%3D2020%26volume%3D104%26spage%3D104245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongming  Xie</span>, <span class="hlFld-ContribAuthor ">Xinglong  Lin</span>, <span class="hlFld-ContribAuthor ">Yingjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Fuxing  Tan</span>, <span class="hlFld-ContribAuthor ">Bo  Chi</span>, <span class="hlFld-ContribAuthor ">Zhihong  Peng</span>, <span class="hlFld-ContribAuthor ">Wanrong  Dong</span>, <span class="hlFld-ContribAuthor ">Delie  An</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of ring-fused pyrazoloamino pyridine/pyrimidine derivatives as potential FAK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (21)
                                     , 127459. <a href="https://doi.org/10.1016/j.bmcl.2020.127459" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127459%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bring-fused%252Bpyrazoloamino%252Bpyridine%25252Fpyrimidine%252Bderivatives%252Bas%252Bpotential%252BFAK%252Binhibitors%26aulast%3DXie%26aufirst%3DHongming%26date%3D2020%26volume%3D30%26issue%3D21%26spage%3D127459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Cao</span>, <span class="hlFld-ContribAuthor ">Yuxiang  Chen</span>, <span class="hlFld-ContribAuthor ">Tianming  Zhao</span>, <span class="hlFld-ContribAuthor ">Shangfei  Wei</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrroformyl-containing 2,4-diaminopyrimidine derivatives as a new optimization strategy of ALK inhibitors combating mutations. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (20)
                                     , 115715. <a href="https://doi.org/10.1016/j.bmc.2020.115715" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115715</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115715%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPyrroformyl-containing%252B2%25252C4-diaminopyrimidine%252Bderivatives%252Bas%252Ba%252Bnew%252Boptimization%252Bstrategy%252Bof%252BALK%252Binhibitors%252Bcombating%252Bmutations%26aulast%3DCao%26aufirst%3DMeng%26date%3D2020%26volume%3D28%26issue%3D20%26spage%3D115715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minglin  Zhu</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Tianming  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuxiang  Chen</span>, <span class="hlFld-ContribAuthor ">Tong  Li</span>, <span class="hlFld-ContribAuthor ">Shangfei  Wei</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based modification of 2,4-diarylaminopyrimidine derivatives as ALK and ROS1 dual inhibitors to overcome secondary mutants. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (20)
                                     , 115719. <a href="https://doi.org/10.1016/j.bmc.2020.115719" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115719</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115719%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DFragment-based%252Bmodification%252Bof%252B2%25252C4-diarylaminopyrimidine%252Bderivatives%252Bas%252BALK%252Band%252BROS1%252Bdual%252Binhibitors%252Bto%252Bovercome%252Bsecondary%252Bmutants%26aulast%3DZhu%26aufirst%3DMinglin%26date%3D2020%26volume%3D28%26issue%3D20%26spage%3D115719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashleigh M.  Fordham</span>, <span class="hlFld-ContribAuthor ">Jinhan  Xie</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Gifford</span>, <span class="hlFld-ContribAuthor ">Carol  Wadham</span>, <span class="hlFld-ContribAuthor ">Lisa T.  Morgan</span>, <span class="hlFld-ContribAuthor ">Emily V. A.  Mould</span>, <span class="hlFld-ContribAuthor ">Mitali  Fadia</span>, <span class="hlFld-ContribAuthor ">Lei  Zhai</span>, <span class="hlFld-ContribAuthor ">Hassina  Massudi</span>, <span class="hlFld-ContribAuthor ">Zara S.  Ali</span>, <span class="hlFld-ContribAuthor ">Glenn M.  Marshall</span>, <span class="hlFld-ContribAuthor ">Robyn E.  Lukeis</span>, <span class="hlFld-ContribAuthor ">Jamie I.  Fletcher</span>, <span class="hlFld-ContribAuthor ">Karen L.  MacKenzie</span>, <span class="hlFld-ContribAuthor ">Toby N.  Trahair</span>. </span><span class="cited-content_cbyCitation_article-title">CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2020,</strong> <em>123 </em>
                                    (7)
                                     , 1101-1113. <a href="https://doi.org/10.1038/s41416-020-0996-2" title="DOI URL">https://doi.org/10.1038/s41416-020-0996-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-020-0996-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-020-0996-2%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DCD30%252Band%252BALK%252Bcombination%252Btherapy%252Bhas%252Bhigh%252Btherapeutic%252Bpotency%252Bin%252BRANBP2-ALK-rearranged%252Bepithelioid%252Binflammatory%252Bmyofibroblastic%252Bsarcoma%26aulast%3DFordham%26aufirst%3DAshleigh%2BM.%26date%3D2020%26date%3D2020%26volume%3D123%26issue%3D7%26spage%3D1101%26epage%3D1113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Jun  Fu</span>, <span class="hlFld-ContribAuthor ">Yun-Feng  Zhang</span>, <span class="hlFld-ContribAuthor ">An-Qi  Chang</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">β-Lactams as promising anticancer agents: Molecular hybrids, structure activity relationships and potential targets. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>201 </em>, 112510. <a href="https://doi.org/10.1016/j.ejmech.2020.112510" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112510%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B2-Lactams%252Bas%252Bpromising%252Banticancer%252Bagents%25253A%252BMolecular%252Bhybrids%25252C%252Bstructure%252Bactivity%252Brelationships%252Band%252Bpotential%252Btargets%26aulast%3DFu%26aufirst%3DDong-Jun%26date%3D2020%26volume%3D201%26spage%3D112510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juliana F.  Vilachã</span>, <span class="hlFld-ContribAuthor ">Sarah C.  Mitchel</span>, <span class="hlFld-ContribAuthor ">Muluembet Z.  Akele</span>, <span class="hlFld-ContribAuthor ">Stephen  Evans</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Groves</span>. </span><span class="cited-content_cbyCitation_article-title">Making NSCLC Crystal Clear: How Kinase Structures Revolutionized Lung Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Crystals</span><span> <strong>2020,</strong> <em>10 </em>
                                    (9)
                                     , 725. <a href="https://doi.org/10.3390/cryst10090725" title="DOI URL">https://doi.org/10.3390/cryst10090725</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cryst10090725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcryst10090725%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystals%26atitle%3DMaking%252BNSCLC%252BCrystal%252BClear%25253A%252BHow%252BKinase%252BStructures%252BRevolutionized%252BLung%252BCancer%252BTreatment%26aulast%3DVilach%25C3%25A3%26aufirst%3DJuliana%2BF.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D9%26spage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Carolin  Jaworski</span>, <span class="hlFld-ContribAuthor ">Donovan  Tung</span>, <span class="hlFld-ContribAuthor ">Carmen  Wängler</span>, <span class="hlFld-ContribAuthor ">Björn  Wängler</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>. </span><span class="cited-content_cbyCitation_article-title">Tropomyosin receptor kinase inhibitors: an updated patent review for 2016–2019. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (5)
                                     , 325-339. <a href="https://doi.org/10.1080/13543776.2020.1737011" title="DOI URL">https://doi.org/10.1080/13543776.2020.1737011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1737011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1737011%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTropomyosin%252Breceptor%252Bkinase%252Binhibitors%25253A%252Ban%252Bupdated%252Bpatent%252Breview%252Bfor%252B2016%2525E2%252580%2525932019%26aulast%3DBailey%26aufirst%3DJustin%2BJ.%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D5%26spage%3D325%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiayan  He</span>, <span class="hlFld-ContribAuthor ">Guangle  Chen</span>, <span class="hlFld-ContribAuthor ">Benxiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Li</span>, <span class="hlFld-ContribAuthor ">Jia-Rong  Chen</span>, <span class="hlFld-ContribAuthor ">Wen-Jing  Xiao</span>, <span class="hlFld-ContribAuthor ">Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Chaozhong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Decarboxylative Radical Sulfonylation. </span><span class="cited-content_cbyCitation_journal-name">Chem</span><span> <strong>2020,</strong> <em>6 </em>
                                    (5)
                                     , 1149-1159. <a href="https://doi.org/10.1016/j.chempr.2020.02.003" title="DOI URL">https://doi.org/10.1016/j.chempr.2020.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chempr.2020.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chempr.2020.02.003%26sid%3Dliteratum%253Aachs%26jtitle%3DChem%26atitle%3DCatalytic%252BDecarboxylative%252BRadical%252BSulfonylation%26aulast%3DHe%26aufirst%3DJiayan%26date%3D2020%26volume%3D6%26issue%3D5%26spage%3D1149%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Shangfei  Wei</span>, <span class="hlFld-ContribAuthor ">Tong  Li</span>, <span class="hlFld-ContribAuthor ">Lingyun  Xing</span>, <span class="hlFld-ContribAuthor ">Meng  Cao</span>, <span class="hlFld-ContribAuthor ">Nan  Jiang</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Daiying  Zuo</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of 2,4-diaminopyrimidine derivatives bearing a pyrrolyl group as ALK and ROS1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (15)
                                     , 5850-5861. <a href="https://doi.org/10.1039/C9NJ05980F" title="DOI URL">https://doi.org/10.1039/C9NJ05980F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ05980F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ05980F%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DStructure-based%252Bdesign%252Bof%252B2%25252C4-diaminopyrimidine%252Bderivatives%252Bbearing%252Ba%252Bpyrrolyl%252Bgroup%252Bas%252BALK%252Band%252BROS1%252Binhibitors%26aulast%3DWang%26aufirst%3DJie%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D15%26spage%3D5850%26epage%3D5861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olaf  Beck</span>, <span class="hlFld-ContribAuthor ">Claudia  Paret</span>, <span class="hlFld-ContribAuthor ">Alexandra  Russo</span>, <span class="hlFld-ContribAuthor ">Jürgen  Burhenne</span>, <span class="hlFld-ContribAuthor ">Margaux  Fresnais</span>, <span class="hlFld-ContribAuthor ">Kevin  Steimel</span>, <span class="hlFld-ContribAuthor ">Larissa  Seidmann</span>, <span class="hlFld-ContribAuthor ">Daniel-Christoph  Wagner</span>, <span class="hlFld-ContribAuthor ">Nadine  Vewinger</span>, <span class="hlFld-ContribAuthor ">Nadine  Lehmann</span>, <span class="hlFld-ContribAuthor ">Maximilian  Sprang</span>, <span class="hlFld-ContribAuthor ">Nora  Backes</span>, <span class="hlFld-ContribAuthor ">Lea  Roth</span>, <span class="hlFld-ContribAuthor ">Marie Astrid  Neu</span>, <span class="hlFld-ContribAuthor ">Arthur  Wingerter</span>, <span class="hlFld-ContribAuthor ">Nicole  Henninger</span>, <span class="hlFld-ContribAuthor ">Khalifa  El Malki</span>, <span class="hlFld-ContribAuthor ">Henrike  Otto</span>, <span class="hlFld-ContribAuthor ">Francesca  Alt</span>, <span class="hlFld-ContribAuthor ">Alexander  Desuki</span>, <span class="hlFld-ContribAuthor ">Thomas  Kindler</span>, <span class="hlFld-ContribAuthor ">Joerg  Faber</span>. </span><span class="cited-content_cbyCitation_article-title">Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (4)
                                     , 793. <a href="https://doi.org/10.3390/cancers12040793" title="DOI URL">https://doi.org/10.3390/cancers12040793</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12040793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12040793%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DSafety%252Band%252BActivity%252Bof%252Bthe%252BCombination%252Bof%252BCeritinib%252Band%252BDasatinib%252Bin%252BOsteosarcoma%26aulast%3DBeck%26aufirst%3DOlaf%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D4%26spage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer R.  Baker</span>, <span class="hlFld-ContribAuthor ">Cecilia C.  Russell</span>, <span class="hlFld-ContribAuthor ">Jayne  Gilbert</span>, <span class="hlFld-ContribAuthor ">Jennette A.  Sakoff</span>, <span class="hlFld-ContribAuthor ">Adam  McCluskey</span>. </span><span class="cited-content_cbyCitation_article-title">Amino Alcohol Acrylonitriles as Activators of the Aryl Hydrocarbon Receptor Pathway: An Unexpected MTT Phenotypic Screening Outcome. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (6)
                                     , 490-505. <a href="https://doi.org/10.1002/cmdc.201900643" title="DOI URL">https://doi.org/10.1002/cmdc.201900643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900643%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAmino%252BAlcohol%252BAcrylonitriles%252Bas%252BActivators%252Bof%252Bthe%252BAryl%252BHydrocarbon%252BReceptor%252BPathway%25253A%252BAn%252BUnexpected%252BMTT%252BPhenotypic%252BScreening%252BOutcome%26aulast%3DBaker%26aufirst%3DJennifer%2BR.%26date%3D2020%26volume%3D15%26issue%3D6%26spage%3D490%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian J.  Groendyke</span>, <span class="hlFld-ContribAuthor ">Chelsea E.  Powell</span>, <span class="hlFld-ContribAuthor ">Frederic  Feru</span>, <span class="hlFld-ContribAuthor ">Thomas W.  Gero</span>, <span class="hlFld-ContribAuthor ">Zhengnian  Li</span>, <span class="hlFld-ContribAuthor ">Hilary  Szabo</span>, <span class="hlFld-ContribAuthor ">Kevin  Pang</span>, <span class="hlFld-ContribAuthor ">John  Feutrill</span>, <span class="hlFld-ContribAuthor ">Bailing  Chen</span>, <span class="hlFld-ContribAuthor ">Bin  Li</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">David A.  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Benzopyrimidodiazepinone inhibitors of TNK2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126948. <a href="https://doi.org/10.1016/j.bmcl.2020.126948" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126948</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126948%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBenzopyrimidodiazepinone%252Binhibitors%252Bof%252BTNK2%26aulast%3DGroendyke%26aufirst%3DBrian%2BJ.%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mauro  Angiolini</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Structural Biology in Kinase Inhibitor Drug Discovery Success. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 363-393. <a href="https://doi.org/10.1002/9781118681121.ch16" title="DOI URL">https://doi.org/10.1002/9781118681121.ch16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118681121.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118681121.ch16%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRole%252Bof%252BStructural%252BBiology%252Bin%252BKinase%252BInhibitor%252BDrug%252BDiscovery%252BSuccess%26aulast%3DAngiolini%26aufirst%3DMauro%26date%3D2020%26date%3D2020%26spage%3D363%26epage%3D393%26pub%3DWiley%26atitle%3DStructural%252BBiology%252Bin%252BDrug%252BDiscovery%26aulast%3DRenaud%26aufirst%3DJean%25E2%2580%2590Paul%26date%3D2020%26date%3D2020%26volume%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiuqi  Miao</span>, <span class="hlFld-ContribAuthor ">Lingyun  Xing</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Sicong  Liu</span>, <span class="hlFld-ContribAuthor ">Shiliang  Yin</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Dajun  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 2-arylaminopyrimidine derivatives bearing 1,3,8-triazaspiro[4,5]decan-4-one or piperidine-3-carboxamide moiety as novel Type-I1/2 ALK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103456. <a href="https://doi.org/10.1016/j.bioorg.2019.103456" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103456%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2-arylaminopyrimidine%252Bderivatives%252Bbearing%252B1%25252C3%25252C8-triazaspiro%25255B4%25252C5%25255Ddecan-4-one%252Bor%252Bpiperidine-3-carboxamide%252Bmoiety%252Bas%252Bnovel%252BType-I1%25252F2%252BALK%252Binhibitors%26aulast%3DMiao%26aufirst%3DXiuqi%26date%3D2020%26volume%3D94%26spage%3D103456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soujanya  Vajjha</span>, <span class="hlFld-ContribAuthor ">Vijay  Bommuluri</span>, <span class="hlFld-ContribAuthor ">Chidananda Swamy  Rumalla</span>, <span class="hlFld-ContribAuthor ">Muralidharan  Kaliyaperumal</span>, <span class="hlFld-ContribAuthor ">Raghu Babu  Korupolu</span>, <span class="hlFld-ContribAuthor ">Vidyasagar  chopella</span>. </span><span class="cited-content_cbyCitation_article-title">Forced degradation of Ceritinib under stress conditions: Structural interpretation of novel degradants using HR-MS/MS and NMR. </span><span class="cited-content_cbyCitation_journal-name">Materials Today: Proceedings</span><span> <strong>2020,</strong> <em>33 </em>, 2067-2076. <a href="https://doi.org/10.1016/j.matpr.2020.01.588" title="DOI URL">https://doi.org/10.1016/j.matpr.2020.01.588</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.matpr.2020.01.588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.matpr.2020.01.588%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Today%253A%2520Proceedings%26atitle%3DForced%252Bdegradation%252Bof%252BCeritinib%252Bunder%252Bstress%252Bconditions%25253A%252BStructural%252Binterpretation%252Bof%252Bnovel%252Bdegradants%252Busing%252BHR-MS%25252FMS%252Band%252BNMR%26aulast%3DVajjha%26aufirst%3DSoujanya%26date%3D2020%26volume%3D33%26spage%3D2067%26epage%3D2076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Babar  Jamshed</span>, <span class="hlFld-ContribAuthor ">Fahad  Munir</span>, <span class="hlFld-ContribAuthor ">Numan  Shahid</span>, <span class="hlFld-ContribAuthor ">Ussama  Sadiq</span>, <span class="hlFld-ContribAuthor ">Syed Aun  Muhammad</span>, <span class="hlFld-ContribAuthor ">Noor Bader  Ghanem</span>, <span class="hlFld-ContribAuthor ">Hong  Zhong</span>, <span class="hlFld-ContribAuthor ">Xiaokun  Li</span>, <span class="hlFld-ContribAuthor ">Qiyu  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Gastrointestinal and Liver Physiology</span><span> <strong>2020,</strong> <em>318 </em>
                                    (1)
                                     , G109-G119. <a href="https://doi.org/10.1152/ajpgi.00130.2019" title="DOI URL">https://doi.org/10.1152/ajpgi.00130.2019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajpgi.00130.2019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajpgi.00130.2019%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Gastrointestinal%2520and%2520Liver%2520Physiology%26atitle%3DAntitumor%252Bactivity%252Band%252Bcombined%252Binhibitory%252Beffect%252Bof%252Bceritinib%252Bwith%252Bgemcitabine%252Bin%252Bpancreatic%252Bcancer%26aulast%3DJamshed%26aufirst%3DMuhammad%2BBabar%26date%3D2020%26volume%3D318%26issue%3D1%26spage%3DG109%26epage%3DG119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling  Li</span>, <span class="hlFld-ContribAuthor ">Xing‐Guo  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo‐Lun  Hu</span>, <span class="hlFld-ContribAuthor ">Xiao‐Hong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper‐Catalyzed Electrophilic Cyclization of
              N
              ‐Propargylamines with Sodium Sulfinate for the Synthesis of 3‐Sulfonated Quinolines. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – An Asian Journal</span><span> <strong>2019,</strong> <em>14 </em>
                                    (23)
                                     , 4358-4364. <a href="https://doi.org/10.1002/asia.201901298" title="DOI URL">https://doi.org/10.1002/asia.201901298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.201901298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.201901298%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520An%2520Asian%2520Journal%26atitle%3DCopper%2525E2%252580%252590Catalyzed%252BElectrophilic%252BCyclization%252Bof%252BN%252B%2525E2%252580%252590Propargylamines%252Bwith%252BSodium%252BSulfinate%252Bfor%252Bthe%252BSynthesis%252Bof%252B3%2525E2%252580%252590Sulfonated%252BQuinolines%26aulast%3DLi%26aufirst%3DLing%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D23%26spage%3D4358%26epage%3D4364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Collin M.  Blakely</span>, <span class="hlFld-ContribAuthor ">Jonathan W.  Riess</span>. </span><span class="cited-content_cbyCitation_article-title">Interpretation of ceritinib clinical trial results and future combination therapy strategies for ALK-rearranged NSCLC. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2019,</strong> <em>19 </em>
                                    (12)
                                     , 1061-1075. <a href="https://doi.org/10.1080/14737140.2019.1699792" title="DOI URL">https://doi.org/10.1080/14737140.2019.1699792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2019.1699792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2019.1699792%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DInterpretation%252Bof%252Bceritinib%252Bclinical%252Btrial%252Bresults%252Band%252Bfuture%252Bcombination%252Btherapy%252Bstrategies%252Bfor%252BALK-rearranged%252BNSCLC%26aulast%3DBlakely%26aufirst%3DCollin%2BM.%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D12%26spage%3D1061%26epage%3D1075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenteng  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao  Guo</span>, <span class="hlFld-ContribAuthor ">Can  Zhang</span>, <span class="hlFld-ContribAuthor ">Di  Ke</span>, <span class="hlFld-ContribAuthor ">Guolin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongping  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-aminopyridines bearing a pyridone moiety as potent ALK inhibitors to overcome the crizotinib-resistant mutants. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111734. <a href="https://doi.org/10.1016/j.ejmech.2019.111734" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111734</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111734%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-aminopyridines%252Bbearing%252Ba%252Bpyridone%252Bmoiety%252Bas%252Bpotent%252BALK%252Binhibitors%252Bto%252Bovercome%252Bthe%252Bcrizotinib-resistant%252Bmutants%26aulast%3DChen%26aufirst%3DWenteng%26date%3D2019%26volume%3D183%26spage%3D111734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niloufar  Javanmardi</span>, <span class="hlFld-ContribAuthor ">Susanne  Fransson</span>, <span class="hlFld-ContribAuthor ">Anna  Djos</span>, <span class="hlFld-ContribAuthor ">Rose-Marie  Sjöberg</span>, <span class="hlFld-ContribAuthor ">Staffan  Nilsson</span>, <span class="hlFld-ContribAuthor ">Katarina  Truvé</span>, <span class="hlFld-ContribAuthor ">Per  Kogner</span>, <span class="hlFld-ContribAuthor ">Tommy  Martinsson</span>. </span><span class="cited-content_cbyCitation_article-title">Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-37240-z" title="DOI URL">https://doi.org/10.1038/s41598-018-37240-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-37240-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-37240-z%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DLow%252BFrequency%252BALK%252BHotspots%252BMutations%252BIn%252BNeuroblastoma%252BTumours%252BDetected%252BBy%252BUltra-deep%252BSequencing%25253A%252BImplications%252BFor%252BALK%252BInhibitor%252BTreatment%26aulast%3DJavanmardi%26aufirst%3DNiloufar%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shih‐Hao  Huang</span>, <span class="hlFld-ContribAuthor ">Allen Chung‐Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">Chin‐Chou  Wang</span>, <span class="hlFld-ContribAuthor ">Wen‐Chen  Chang</span>, <span class="hlFld-ContribAuthor ">Chien‐Ying  Liu</span>, <span class="hlFld-ContribAuthor ">Stelios  Pavlidis</span>, <span class="hlFld-ContribAuthor ">Ho‐Wen  Ko</span>, <span class="hlFld-ContribAuthor ">Fu‐Tsai  Chung</span>, <span class="hlFld-ContribAuthor ">Ping‐Chih  Hsu</span>, <span class="hlFld-ContribAuthor ">Yi‐Ke  Guo</span>, <span class="hlFld-ContribAuthor ">Chih‐Hsi Scott  Kuo</span>, <span class="hlFld-ContribAuthor ">Cheng‐Ta  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Front‐line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control. </span><span class="cited-content_cbyCitation_journal-name">Thoracic Cancer</span><span> <strong>2019,</strong> <em>10 </em>
                                    (12)
                                     , 2274-2281. <a href="https://doi.org/10.1111/1759-7714.13221" title="DOI URL">https://doi.org/10.1111/1759-7714.13221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/1759-7714.13221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2F1759-7714.13221%26sid%3Dliteratum%253Aachs%26jtitle%3DThoracic%2520Cancer%26atitle%3DFront%2525E2%252580%252590line%252Btreatment%252Bof%252Bceritinib%252Bimproves%252Befficacy%252Bover%252Bcrizotinib%252Bfor%252BAsian%252Bpatients%252Bwith%252Banaplastic%252Blymphoma%252Bkinase%252Bfusion%252BNSCLC%25253A%252BThe%252Brole%252Bof%252Bsystemic%252Bprogression%252Bcontrol%26aulast%3DHuang%26aufirst%3DShih%25E2%2580%2590Hao%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D12%26spage%3D2274%26epage%3D2281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koh  Furugaki</span>, <span class="hlFld-ContribAuthor ">Marie  Mochizuki</span>, <span class="hlFld-ContribAuthor ">Mirei  Kohno</span>, <span class="hlFld-ContribAuthor ">Sei  Shu</span>, <span class="hlFld-ContribAuthor ">Naoki  Harada</span>, <span class="hlFld-ContribAuthor ">Yasushi  Yoshimura</span>. </span><span class="cited-content_cbyCitation_article-title">Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2019,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-019-5527-2" title="DOI URL">https://doi.org/10.1186/s12885-019-5527-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-019-5527-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-019-5527-2%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DExpression%252Bof%252BC-terminal%252BALK%25252C%252BRET%25252C%252Bor%252BROS1%252Bin%252Blung%252Bcancer%252Bcells%252Bwith%252Bor%252Bwithout%252Bfusion%26aulast%3DFurugaki%26aufirst%3DKoh%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Ge</span>, <span class="hlFld-ContribAuthor ">Qiaohua  Hu</span>, <span class="hlFld-ContribAuthor ">Xiangshao  Fang</span>, <span class="hlFld-ContribAuthor ">Juanhua  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Xu</span>, <span class="hlFld-ContribAuthor ">Juntao  Hu</span>, <span class="hlFld-ContribAuthor ">Xuefen  Liu</span>, <span class="hlFld-ContribAuthor ">Qin  Ling</span>, <span class="hlFld-ContribAuthor ">Yue  Wang</span>, <span class="hlFld-ContribAuthor ">He  Li</span>, <span class="hlFld-ContribAuthor ">Ming  Gao</span>, <span class="hlFld-ContribAuthor ">Longyuan  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhengfei  Yang</span>, <span class="hlFld-ContribAuthor ">Wanchun  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">LDK378 improves micro- and macro-circulation via alleviating STING-mediated inflammatory injury in a Sepsis rat model induced by Cecal ligation and puncture. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inflammation</span><span> <strong>2019,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12950-019-0208-0" title="DOI URL">https://doi.org/10.1186/s12950-019-0208-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12950-019-0208-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12950-019-0208-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inflammation%26atitle%3DLDK378%252Bimproves%252Bmicro-%252Band%252Bmacro-circulation%252Bvia%252Balleviating%252BSTING-mediated%252Binflammatory%252Binjury%252Bin%252Ba%252BSepsis%252Brat%252Bmodel%252Binduced%252Bby%252BCecal%252Bligation%252Band%252Bpuncture%26aulast%3DGe%26aufirst%3DWeiwei%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Natasha B.  Leighl</span>, <span class="hlFld-ContribAuthor ">Yi-Long  Wu</span>, <span class="hlFld-ContribAuthor ">Wen-Zhao  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging therapies for non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2019,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-019-0731-8" title="DOI URL">https://doi.org/10.1186/s13045-019-0731-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-019-0731-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-019-0731-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DEmerging%252Btherapies%252Bfor%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DZhang%26aufirst%3DChao%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhasker  Radaram</span>, <span class="hlFld-ContribAuthor ">Federica  Pisaneschi</span>, <span class="hlFld-ContribAuthor ">Yi  Rao</span>, <span class="hlFld-ContribAuthor ">Ping  Yang</span>, <span class="hlFld-ContribAuthor ">David  Piwnica-Worms</span>, <span class="hlFld-ContribAuthor ">Mian M.  Alauddin</span>. </span><span class="cited-content_cbyCitation_article-title">Novel derivatives of anaplastic lymphoma kinase inhibitors: Synthesis, radiolabeling, and preliminary biological studies of fluoroethyl analogues of crizotinib, alectinib, and ceritinib. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111571. <a href="https://doi.org/10.1016/j.ejmech.2019.111571" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111571%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bderivatives%252Bof%252Banaplastic%252Blymphoma%252Bkinase%252Binhibitors%25253A%252BSynthesis%25252C%252Bradiolabeling%25252C%252Band%252Bpreliminary%252Bbiological%252Bstudies%252Bof%252Bfluoroethyl%252Banalogues%252Bof%252Bcrizotinib%25252C%252Balectinib%25252C%252Band%252Bceritinib%26aulast%3DRadaram%26aufirst%3DBhasker%26date%3D2019%26volume%3D182%26spage%3D111571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongrui  Lei</span>, <span class="hlFld-ContribAuthor ">Fang  Jia</span>, <span class="hlFld-ContribAuthor ">Meng  Cao</span>, <span class="hlFld-ContribAuthor ">Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Minglin  Zhu</span>, <span class="hlFld-ContribAuthor ">Daiying  Zuo</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">An exploration of solvent-front region high affinity moiety leading to novel potent ALK & ROS1 dual inhibitors with mutant-combating effects. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (20)
                                     , 115051. <a href="https://doi.org/10.1016/j.bmc.2019.115051" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAn%252Bexploration%252Bof%252Bsolvent-front%252Bregion%252Bhigh%252Baffinity%252Bmoiety%252Bleading%252Bto%252Bnovel%252Bpotent%252BALK%252B%252526%252BROS1%252Bdual%252Binhibitors%252Bwith%252Bmutant-combating%252Beffects%26aulast%3DLei%26aufirst%3DHongrui%26date%3D2019%26volume%3D27%26issue%3D20%26spage%3D115051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Ridong  Li</span>, <span class="hlFld-ContribAuthor ">Xianling  Ning</span>, <span class="hlFld-ContribAuthor ">Xuyang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yan  Jin</span>, <span class="hlFld-ContribAuthor ">Yuxin  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anti-tumor efficacy of novel 2, 4-diarylaminopyrimidine derivatives bearing N-(3-pyridinylmethyl) urea moiety as anaplastic lymphoma kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 141-153. <a href="https://doi.org/10.1016/j.ejmech.2019.05.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banti-tumor%252Befficacy%252Bof%252Bnovel%252B2%25252C%252B4-diarylaminopyrimidine%252Bderivatives%252Bbearing%252BN-%2525283-pyridinylmethyl%252529%252Burea%252Bmoiety%252Bas%252Banaplastic%252Blymphoma%252Bkinase%252Binhibitors%26aulast%3DChen%26aufirst%3DHong%26date%3D2019%26volume%3D178%26spage%3D141%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Russo</span>, <span class="hlFld-ContribAuthor ">Claudia  Paret</span>, <span class="hlFld-ContribAuthor ">Francesca  Alt</span>, <span class="hlFld-ContribAuthor ">Jürgen  Burhenne</span>, <span class="hlFld-ContribAuthor ">Margaux  Fresnais</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Wagner</span>, <span class="hlFld-ContribAuthor ">Martin  Glaser</span>, <span class="hlFld-ContribAuthor ">Hannah  Bender</span>, <span class="hlFld-ContribAuthor ">Sabrina  Huprich</span>, <span class="hlFld-ContribAuthor ">Patrick N.  Harter</span>, <span class="hlFld-ContribAuthor ">Katharina  Filipski</span>, <span class="hlFld-ContribAuthor ">Nadine  Lehmann</span>, <span class="hlFld-ContribAuthor ">Nora  Backes</span>, <span class="hlFld-ContribAuthor ">Lea  Roth</span>, <span class="hlFld-ContribAuthor ">Larissa  Seidmann</span>, <span class="hlFld-ContribAuthor ">Clemens  Sommer</span>, <span class="hlFld-ContribAuthor ">Marc A.  Brockmann</span>, <span class="hlFld-ContribAuthor ">Torsten  Pietsch</span>, <span class="hlFld-ContribAuthor ">Marie A.  Neu</span>, <span class="hlFld-ContribAuthor ">Arthur  Wingerter</span>, <span class="hlFld-ContribAuthor ">Jörg  Faber</span>. </span><span class="cited-content_cbyCitation_article-title">Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (17)
                                     , 4267. <a href="https://doi.org/10.3390/ijms20174267" title="DOI URL">https://doi.org/10.3390/ijms20174267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20174267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20174267%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DCeritinib-Induced%252BRegression%252Bof%252Ban%252BInsulin-Like%252BGrowth%252BFactor-Driven%252BNeuroepithelial%252BBrain%252BTumor%26aulast%3DRusso%26aufirst%3DAlexandra%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D17%26spage%3D4267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David N.  Debruyne</span>, <span class="hlFld-ContribAuthor ">Ruben  Dries</span>, <span class="hlFld-ContribAuthor ">Satyaki  Sengupta</span>, <span class="hlFld-ContribAuthor ">Davide  Seruggia</span>, <span class="hlFld-ContribAuthor ">Yang  Gao</span>, <span class="hlFld-ContribAuthor ">Bandana  Sharma</span>, <span class="hlFld-ContribAuthor ">Hao  Huang</span>, <span class="hlFld-ContribAuthor ">Lisa  Moreau</span>, <span class="hlFld-ContribAuthor ">Michael  McLane</span>, <span class="hlFld-ContribAuthor ">Daniel S.  Day</span>, <span class="hlFld-ContribAuthor ">Eugenio  Marco</span>, <span class="hlFld-ContribAuthor ">Ting  Chen</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Kwok-Kin  Wong</span>, <span class="hlFld-ContribAuthor ">Stuart H.  Orkin</span>, <span class="hlFld-ContribAuthor ">Guo-Cheng  Yuan</span>, <span class="hlFld-ContribAuthor ">Richard A.  Young</span>, <span class="hlFld-ContribAuthor ">Rani E.  George</span>. </span><span class="cited-content_cbyCitation_article-title">BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2019,</strong> <em>572 </em>
                                    (7771)
                                     , 676-680. <a href="https://doi.org/10.1038/s41586-019-1472-0" title="DOI URL">https://doi.org/10.1038/s41586-019-1472-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41586-019-1472-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41586-019-1472-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DBORIS%252Bpromotes%252Bchromatin%252Bregulatory%252Binteractions%252Bin%252Btreatment-resistant%252Bcancer%252Bcells%26aulast%3DDebruyne%26aufirst%3DDavid%2BN.%26date%3D2019%26date%3D2019%26volume%3D572%26issue%3D7771%26spage%3D676%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debasis  Das</span>, <span class="hlFld-ContribAuthor ">Jingbing  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Li</span>, <span class="hlFld-ContribAuthor ">Jingli  Shi</span>, <span class="hlFld-ContribAuthor ">Jian  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis of orally bioavailable novel anaplastic lymphoma kinase (ALK) inhibitor diphenylaminopyrimidine analogs and efficacy study on NCI-H2228 xenografts mice model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (12)
                                     , 1514-1517. <a href="https://doi.org/10.1016/j.bmcl.2019.04.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.04.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.04.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Bof%252Borally%252Bbioavailable%252Bnovel%252Banaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%252Binhibitor%252Bdiphenylaminopyrimidine%252Banalogs%252Band%252Befficacy%252Bstudy%252Bon%252BNCI-H2228%252Bxenografts%252Bmice%252Bmodel%26aulast%3DDas%26aufirst%3DDebasis%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D1514%26epage%3D1517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongrui  Lei</span>, <span class="hlFld-ContribAuthor ">Nan  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiuqi  Miao</span>, <span class="hlFld-ContribAuthor ">Lingyun  Xing</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Haowen  Xu</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Daiying  Zuo</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel mutant-combating ALK and ROS1 dual inhibitors bearing imidazolidin-2-one moiety with reasonable PK properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>171 </em>, 297-309. <a href="https://doi.org/10.1016/j.ejmech.2019.03.038" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.038%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bmutant-combating%252BALK%252Band%252BROS1%252Bdual%252Binhibitors%252Bbearing%252Bimidazolidin-2-one%252Bmoiety%252Bwith%252Breasonable%252BPK%252Bproperties%26aulast%3DLei%26aufirst%3DHongrui%26date%3D2019%26volume%3D171%26spage%3D297%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadine  Vewinger</span>, <span class="hlFld-ContribAuthor ">Sabrina  Huprich</span>, <span class="hlFld-ContribAuthor ">Larissa  Seidmann</span>, <span class="hlFld-ContribAuthor ">Alexandra  Russo</span>, <span class="hlFld-ContribAuthor ">Francesca  Alt</span>, <span class="hlFld-ContribAuthor ">Hannah  Bender</span>, <span class="hlFld-ContribAuthor ">Clemens  Sommer</span>, <span class="hlFld-ContribAuthor ">David  Samuel</span>, <span class="hlFld-ContribAuthor ">Nadine  Lehmann</span>, <span class="hlFld-ContribAuthor ">Nora  Backes</span>, <span class="hlFld-ContribAuthor ">Lea  Roth</span>, <span class="hlFld-ContribAuthor ">Patrick N.  Harter</span>, <span class="hlFld-ContribAuthor ">Katharina  Filipski</span>, <span class="hlFld-ContribAuthor ">Jörg  Faber</span>, <span class="hlFld-ContribAuthor ">Claudia  Paret</span>. </span><span class="cited-content_cbyCitation_article-title">IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (12)
                                     , 3027. <a href="https://doi.org/10.3390/ijms20123027" title="DOI URL">https://doi.org/10.3390/ijms20123027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20123027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20123027%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DIGF1R%252BIs%252Ba%252BPotential%252BNew%252BTherapeutic%252BTarget%252Bfor%252BHGNET-BCOR%252BBrain%252BTumor%252BPatients%26aulast%3DVewinger%26aufirst%3DNadine%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D12%26spage%3D3027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeshi  Hirota</span>, <span class="hlFld-ContribAuthor ">Shota  Muraki</span>, <span class="hlFld-ContribAuthor ">Ichiro  Ieiri</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical Pharmacokinetics of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2019,</strong> <em>58 </em>
                                    (4)
                                     , 403-420. <a href="https://doi.org/10.1007/s40262-018-0689-7" title="DOI URL">https://doi.org/10.1007/s40262-018-0689-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-018-0689-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-018-0689-7%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DClinical%252BPharmacokinetics%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252BInhibitors%252Bin%252BNon-Small-Cell%252BLung%252BCancer%26aulast%3DHirota%26aufirst%3DTakeshi%26date%3D2019%26date%3D2018%26volume%3D58%26issue%3D4%26spage%3D403%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhiko  Iikubo</span>, <span class="hlFld-ContribAuthor ">Kazuo  Kurosawa</span>, <span class="hlFld-ContribAuthor ">Takahiro  Matsuya</span>, <span class="hlFld-ContribAuthor ">Yutaka  Kondoh</span>, <span class="hlFld-ContribAuthor ">Akio  Kamikawa</span>, <span class="hlFld-ContribAuthor ">Ayako  Moritomo</span>, <span class="hlFld-ContribAuthor ">Yoshinori  Iwai</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Tomiyama</span>, <span class="hlFld-ContribAuthor ">Itsuro  Shimada</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationships of pyrazine-2-carboxamide derivatives as novel echinoderm microtubule-associated protein-like 4 (EML4)–anaplastic lymphoma kinase (ALK) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (8)
                                     , 1683-1692. <a href="https://doi.org/10.1016/j.bmc.2019.03.018" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bpyrazine-2-carboxamide%252Bderivatives%252Bas%252Bnovel%252Bechinoderm%252Bmicrotubule-associated%252Bprotein-like%252B4%252B%252528EML4%252529%2525E2%252580%252593anaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%252Binhibitors%26aulast%3DIikubo%26aufirst%3DKazuhiko%26date%3D2019%26volume%3D27%26issue%3D8%26spage%3D1683%26epage%3D1692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changwei  Chen</span>, <span class="hlFld-ContribAuthor ">Peichen  Pan</span>, <span class="hlFld-ContribAuthor ">Ziyang  Deng</span>, <span class="hlFld-ContribAuthor ">Dahai  Wang</span>, <span class="hlFld-ContribAuthor ">Qifan  Wu</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>, <span class="hlFld-ContribAuthor ">Sunliang  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3,6-diaryl-1H-pyrazolo[3,4-b]pyridines as potent anaplastic lymphoma kinase (ALK) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (7)
                                     , 912-916. <a href="https://doi.org/10.1016/j.bmcl.2019.01.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.01.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.01.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3%25252C6-diaryl-1H-pyrazolo%25255B3%25252C4-b%25255Dpyridines%252Bas%252Bpotent%252Banaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%252Binhibitors%26aulast%3DChen%26aufirst%3DChangwei%26date%3D2019%26volume%3D29%26issue%3D7%26spage%3D912%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingzhu  Zhao</span>, <span class="hlFld-ContribAuthor ">Juewang  Cai</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Silver-promoted selective fluorination of 2-aminopyrimidines: synthesis of 5-fluoro-2-aminopyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (4)
                                     , 426-431. <a href="https://doi.org/10.1039/C8QO01054D" title="DOI URL">https://doi.org/10.1039/C8QO01054D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8QO01054D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8QO01054D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSilver-promoted%252Bselective%252Bfluorination%252Bof%252B2-aminopyrimidines%25253A%252Bsynthesis%252Bof%252B5-fluoro-2-aminopyrimidine%252Bderivatives%26aulast%3DZhao%26aufirst%3DMingzhu%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D4%26spage%3D426%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mu-Yang  He</span>, <span class="hlFld-ContribAuthor ">Wei-Kang  Li</span>, <span class="hlFld-ContribAuthor ">Jens  Meiler</span>, <span class="hlFld-ContribAuthor ">Qing-Chuan  Zheng</span>, <span class="hlFld-ContribAuthor ">Hong-Xing  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Insight on mutation-induced resistance to anaplastic lymphoma kinase inhibitor ceritinib from molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Biopolymers</span><span> <strong>2019,</strong> <em>110 </em>
                                    (2)
                                     , e23257. <a href="https://doi.org/10.1002/bip.23257" title="DOI URL">https://doi.org/10.1002/bip.23257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bip.23257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbip.23257%26sid%3Dliteratum%253Aachs%26jtitle%3DBiopolymers%26atitle%3DInsight%252Bon%252Bmutation-induced%252Bresistance%252Bto%252Banaplastic%252Blymphoma%252Bkinase%252Binhibitor%252Bceritinib%252Bfrom%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DHe%26aufirst%3DMu-Yang%26date%3D2019%26date%3D2019%26volume%3D110%26issue%3D2%26spage%3De23257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danilo  Rocco</span>, <span class="hlFld-ContribAuthor ">Ciro  Battiloro</span>, <span class="hlFld-ContribAuthor ">Luigi  Della Gravara</span>, <span class="hlFld-ContribAuthor ">Cesare  Gridelli</span>. </span><span class="cited-content_cbyCitation_article-title">Safety and Tolerability of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Drug Safety</span><span> <strong>2019,</strong> <em>42 </em>
                                    (2)
                                     , 199-209. <a href="https://doi.org/10.1007/s40264-018-0771-y" title="DOI URL">https://doi.org/10.1007/s40264-018-0771-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40264-018-0771-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40264-018-0771-y%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Safety%26atitle%3DSafety%252Band%252BTolerability%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252BInhibitors%252Bin%252BNon-Small-Cell%252BLung%252BCancer%26aulast%3DRocco%26aufirst%3DDanilo%26date%3D2019%26date%3D2019%26volume%3D42%26issue%3D2%26spage%3D199%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salman  Otoukesh</span>, <span class="hlFld-ContribAuthor ">Tiffany  Sanchez</span>, <span class="hlFld-ContribAuthor ">Saied  Mirshahidi</span>, <span class="hlFld-ContribAuthor ">Desiree  Wallace</span>, <span class="hlFld-ContribAuthor ">Hamid  Mirshahidi</span>. </span><span class="cited-content_cbyCitation_article-title">ASCEND-8 pharmacokinetic, safety, and efficacy data for ceritinib 450 mg with food in patients with anaplastic lymphoma kinase–positive non-small cell lung Cancer: A clinical perspective. </span><span class="cited-content_cbyCitation_journal-name">Cancer Treatment and Research Communications</span><span> <strong>2019,</strong> <em>20 </em>, 100149. <a href="https://doi.org/10.1016/j.ctarc.2019.100149" title="DOI URL">https://doi.org/10.1016/j.ctarc.2019.100149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ctarc.2019.100149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ctarc.2019.100149%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Treatment%2520and%2520Research%2520Communications%26atitle%3DASCEND-8%252Bpharmacokinetic%25252C%252Bsafety%25252C%252Band%252Befficacy%252Bdata%252Bfor%252Bceritinib%252B450%2525C2%2525A0mg%252Bwith%252Bfood%252Bin%252Bpatients%252Bwith%252Banaplastic%252Blymphoma%252Bkinase%2525E2%252580%252593positive%252Bnon-small%252Bcell%252Blung%252BCancer%25253A%252BA%252Bclinical%252Bperspective%26aulast%3DOtoukesh%26aufirst%3DSalman%26date%3D2019%26volume%3D20%26spage%3D100149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunju  Nam</span>, <span class="hlFld-ContribAuthor ">Dongkeun  Hwang</span>, <span class="hlFld-ContribAuthor ">Namdoo  Kim</span>, <span class="hlFld-ContribAuthor ">Hong-Seog  Seo</span>, <span class="hlFld-ContribAuthor ">Khalid B.  Selim</span>, <span class="hlFld-ContribAuthor ">Taebo  Sim</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 1
              H
              -pyrazolo[3,4-b]pyridine derivatives as potent ALK-L1196M inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 1426-1438. <a href="https://doi.org/10.1080/14756366.2019.1639694" title="DOI URL">https://doi.org/10.1080/14756366.2019.1639694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1639694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1639694%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252B1%252BH%252B-pyrazolo%25255B3%25252C4-b%25255Dpyridine%252Bderivatives%252Bas%252Bpotent%252BALK-L1196M%252Binhibitors%26aulast%3DNam%26aufirst%3DYunju%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D1426%26epage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Tu</span>, <span class="hlFld-ContribAuthor ">Li Ting  Song</span>, <span class="hlFld-ContribAuthor ">Rui Rui  Liu</span>, <span class="hlFld-ContribAuthor ">Hong Lin  Zhai</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao Yun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular inhibitory mechanism study on the potent inhibitor brigatinib against four crizotinib‐resistant ALK mutations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Biochemistry</span><span> <strong>2019,</strong> <em>120 </em>
                                    (1)
                                     , 562-574. <a href="https://doi.org/10.1002/jcb.27412" title="DOI URL">https://doi.org/10.1002/jcb.27412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcb.27412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcb.27412%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Biochemistry%26atitle%3DMolecular%252Binhibitory%252Bmechanism%252Bstudy%252Bon%252Bthe%252Bpotent%252Binhibitor%252Bbrigatinib%252Bagainst%252Bfour%252Bcrizotinib%2525E2%252580%252590resistant%252BALK%252Bmutations%26aulast%3DTu%26aufirst%3DJing%26date%3D2019%26date%3D2018%26volume%3D120%26issue%3D1%26spage%3D562%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christina  Athanasiou</span>, <span class="hlFld-ContribAuthor ">Zoe  Cournia</span>. </span><span class="cited-content_cbyCitation_article-title">From Computers to Bedside: Computational Chemistry Contributing to FDA Approval. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 163-203. <a href="https://doi.org/10.1002/9783527806836.ch7" title="DOI URL">https://doi.org/10.1002/9783527806836.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527806836.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527806836.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DFrom%252BComputers%252Bto%252BBedside%25253A%252BComputational%252BChemistry%252BContributing%252Bto%252BFDA%252BApproval%26aulast%3DAthanasiou%26aufirst%3DChristina%26date%3D2018%26date%3D2018%26spage%3D163%26epage%3D203%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DBiomolecular%252BSimulations%252Bin%252BStructure-Based%252BDrug%252BDiscovery%26aulast%3DGervasio%26aufirst%3DFrancesco%2BL.%26date%3D2018%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingyun  Xing</span>, <span class="hlFld-ContribAuthor ">Tongfei  Jing</span>, <span class="hlFld-ContribAuthor ">Junlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Xiuqi  Miao</span>, <span class="hlFld-ContribAuthor ">Feng  Jiang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation N2-(2-alkyoxy-6-aliphatic aminopyridin-3-yl)-2,4-diaminepyrimidine derivatives bearing acylamino or DBTD ‘head’ as potential ALK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>81 </em>, 689-699. <a href="https://doi.org/10.1016/j.bioorg.2018.09.019" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.09.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.09.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252BN2-%2525282-alkyoxy-6-aliphatic%252Baminopyridin-3-yl%252529-2%25252C4-diaminepyrimidine%252Bderivatives%252Bbearing%252Bacylamino%252Bor%252BDBTD%252B%2525E2%252580%252598head%2525E2%252580%252599%252Bas%252Bpotential%252BALK%252Binhibitors%26aulast%3DXing%26aufirst%3DLingyun%26date%3D2018%26volume%3D81%26spage%3D689%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shasha  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Liu</span>, <span class="hlFld-ContribAuthor ">Xun  Zhang</span>, <span class="hlFld-ContribAuthor ">Meiyun  Shi</span>, <span class="hlFld-ContribAuthor ">Hecheng  Wang</span>, <span class="hlFld-ContribAuthor ">Yajun  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and biological evaluation of glycol diaryl ethers as novel anti-cancer agents through structure-based optimization of crizotinib. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2018,</strong> <em>92 </em>
                                    (6)
                                     , 1972-1980. <a href="https://doi.org/10.1111/cbdd.13368" title="DOI URL">https://doi.org/10.1111/cbdd.13368</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13368%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DIdentification%252Band%252Bbiological%252Bevaluation%252Bof%252Bglycol%252Bdiaryl%252Bethers%252Bas%252Bnovel%252Banti-cancer%252Bagents%252Bthrough%252Bstructure-based%252Boptimization%252Bof%252Bcrizotinib%26aulast%3DLiu%26aufirst%3DShasha%26date%3D2018%26date%3D2018%26volume%3D92%26issue%3D6%26spage%3D1972%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm400402q&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-14%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm400402q&amp;citedByCount=249&amp;pagesCount=3&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected ALK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hypothesized mechanism of reactive adduct formation from <b>4</b> or <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure–activity relationship overview.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, DMF/DMSO, 0–20 °C ; (b) KNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 0–20 °C; (c) alcohol, Cs<sub>2</sub>CO<sub>3</sub>, 60 °C; (d) 4-pyridineboronic acid, dioxane/H<sub>2</sub>O or 1-BuOH (Pd<sub>2</sub>(dba)<sub>3</sub>, 2-dicyclohexylphosphine-2′,6′-dimethoxy biphenyl, MW, 150 °C.; (e) AcOH/TFA, PtO<sub>2</sub>, H<sub>2</sub>; (f) anhydrous CH<sub>2</sub>Cl<sub>2</sub>, TEA, Boc<sub>2</sub>O, 20 °C; (g) CH<sub>3</sub>I, THF, 40 °C, sealed tube; (h) NaBH<sub>4</sub>, CH<sub>3</sub>OH, 0–20 °C; (i) (2-methoxypyridin-4-yl)boronic acid, Pd<sub>2</sub>dba<sub>3</sub>, 2-dicyclohexylphosphine-2′,6′-dimethoxybiphenyl, K<sub>3</sub>PO<sub>4</sub>, 1-BuOH, 150 °C; (j) concentrated HCl, dioxane, reflux.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Xantphos, Pd(OAc)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, THF, MW, 150 °C; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (c) RBr (or RI), Et<sub>3</sub>N, DMF, 20 °C or <i>N</i>-methyl-4-piperidone, 1,2-dichloroethane, NaBH(OAc)<sub>3</sub>, AcOH, RT in the case of <b>17e</b>; (d) ClC(O)CH<sub>2</sub>N(Me)<sub>2</sub>·HCl, Et<sub>3</sub>N, 20 °C; (e) Pd<sub>2</sub>(dba)<sub>3</sub>, dicyclohexyl(2,4,6-triisopropylphenyl)phosphine, NaO<sup><i>t</i></sup>Bu THF, MW, 150 °C.</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking of <b>15b</b> in the ALK kinase domain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Efficacy of <b>15b</b> in a 14-day rat xenograft Karpas299 model. (b) Efficacy of <b>15b</b> in a 14-day rat xenograft H2228 model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Single-dose PK/PD relationship of <b>15b</b> (50 mg/kg) in the rat Karpas299 model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/medium/jm-2013-00402q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. HOMA-IR results of <b>15b</b> and <b>4</b> after 7 days of dosing in mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-14/jm400402q/production/images/large/jm-2013-00402q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400402q&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i66">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58460" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58460" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naeve, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, D. P.</span><span> </span><span class="NLM_article-title">ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin’s lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2175</span><span class="NLM_x">–</span> <span class="NLM_lpage">2188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=2175-2188&author=S.+W.+Morrisauthor=C.+Naeveauthor=P.+Mathewauthor=P.+L.+Jamesauthor=M.+N.+Kirsteinauthor=X.+Cuiauthor=D.+P.+Witte&title=ALK%2C+the+chromosome+2+gene+locus+altered+by+the+t%282%3B5%29+in+non-Hodgkin%E2%80%99s+lymphoma%2C+encodes+a+novel+neural+receptor+tyrosine+kinase+that+is+highly+related+to+leukocyte+tyrosine+kinase+%28LTK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DNaeve%26aufirst%3DC.%26aulast%3DMathew%26aufirst%3DP.%26aulast%3DJames%26aufirst%3DP.%2BL.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DWitte%26aufirst%3DD.%2BP.%26atitle%3DALK%252C%2520the%2520chromosome%25202%2520gene%2520locus%2520altered%2520by%2520the%2520t%25282%253B5%2529%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%252C%2520encodes%2520a%2520novel%2520neural%2520receptor%2520tyrosine%2520kinase%2520that%2520is%2520highly%2520related%2520to%2520leukocyte%2520tyrosine%2520kinase%2520%2528LTK%2529%26jtitle%3DOncogene%26date%3D1997%26volume%3D14%26spage%3D2175%26epage%3D2188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Chiarle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrogio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inghirami, G.</span><span> </span><span class="NLM_article-title">The anaplastic lymphoma kinase in the pathogenesis of cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1038%2Fnrc2291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=18097461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKku73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=11-23&issue=1&author=R.+Chiarleauthor=C.+Voenaauthor=C.+Ambrogioauthor=R.+Pivaauthor=G.+Inghirami&title=The+anaplastic+lymphoma+kinase+in+the+pathogenesis+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The anaplastic lymphoma kinase in the pathogenesis of cancer</span></div><div class="casAuthors">Chiarle, Roberto; Voena, Claudia; Ambrogio, Chiara; Piva, Roberto; Inghirami, Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-23</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The receptor tyrosine kinase anaplastic lymphoma kinase (ALK) was first identified as part of a chromosomal translocation assocd. with some anaplastic large cell lymphomas (ALCLs).  Now data are emerging that indicate that ALK might be a valid therapeutic target in ALCL and that it could also be involved in other cancers.  Tyrosine kinases are involved in the pathogenesis of most cancers.  However, few tyrosine kinases have been shown to have a well-defined pathogenetic role in lymphomas.  The anaplastic lymphoma kinase (ALK) is the oncogene of most anaplastic large cell lymphomas (ALCL), driving transformation through many mol. mechanisms.  In this review, we will analyze how translocations or deregulated expression of ALK contribute to oncogenesis and how recent genetic or pharmacol. tools, aimed at neutralizing its activity, can represent the basis for the design of powerful combination therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5HoaZPQUiUrVg90H21EOLACvtfcHk0ljom4E9eXV2Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKku73P&md5=a57d7ab61be51664ca9f5b804c3e2910</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc2291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2291%26sid%3Dliteratum%253Aachs%26aulast%3DChiarle%26aufirst%3DR.%26aulast%3DVoena%26aufirst%3DC.%26aulast%3DAmbrogio%26aufirst%3DC.%26aulast%3DPiva%26aufirst%3DR.%26aulast%3DInghirami%26aufirst%3DG.%26atitle%3DThe%2520anaplastic%2520lymphoma%2520kinase%2520in%2520the%2520pathogenesis%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer.%26date%3D2008%26volume%3D8%26issue%3D1%26spage%3D11%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Webb, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slavish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rentrop, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span> </span><span class="NLM_article-title">Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1586%2F14737140.9.3.331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=19275511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtFaltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=331-356&issue=3&author=T.+R.+Webbauthor=J.+Slavishauthor=R.+E.+Georgeauthor=A.+T.+Lookauthor=L.+Xueauthor=Q.+Jiangauthor=X.+Cuiauthor=W.+B.+Rentropauthor=S.+W.+Morris&title=Anaplastic+lymphoma+kinase%3A+role+in+cancer+pathogenesis+and+small-molecule+inhibitor+development+for+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy</span></div><div class="casAuthors">Webb, Thomas R.; Slavish, Jake; George, Rani E.; Look, A. Thomas; Xue, Liquan; Jiang, Qin; Cui, Xiaoli; Rentrop, Walter B.; Morris, Stephan W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-356</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase in the insulin receptor superfamily, was initially identified in constitutively activated oncogenic fusion forms - the most common being nucleophosmin-ALK - in anaplastic large-cell lymphomas, and subsequent studies have identified ALK fusions in diffuse large B-cell lymphomas, systemic histiocytosis, inflammatory myofibroblastic tumors, esophageal squamous cell carcinomas and non-small-cell lung carcinomas.  More recently, genomic DNA amplification and protein overexpression, as well as activating point mutations, of ALK have been described in neuroblastomas.  In addn. to those cancers for which a causative role for aberrant ALK activity is well validated, more circumstantial links implicate the full-length, normal ALK receptor in the genesis of other malignancies - including glioblastoma and breast cancer - via a mechanism of receptor activation involving autocrine and/or paracrine growth loops with the reported ALK ligands, pleiotrophin and midkine.  This review summarizes normal ALK biol., the confirmed and putative roles of ALK in the development of human cancers and efforts to target ALK using small-mol. kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoERzbvlik_c7Vg90H21EOLACvtfcHk0lh4h1czOmFA_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtFaltrc%253D&md5=a980ef18ac316bd3894b72ddd2748c17</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1586%2F14737140.9.3.331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.9.3.331%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DT.%2BR.%26aulast%3DSlavish%26aufirst%3DJ.%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26aulast%3DLook%26aufirst%3DA.%2BT.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DRentrop%26aufirst%3DW.%2BB.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26atitle%3DAnaplastic%2520lymphoma%2520kinase%253A%2520role%2520in%2520cancer%2520pathogenesis%2520and%2520small-molecule%2520inhibitor%2520development%2520for%2520therapy%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2009%26volume%3D9%26issue%3D3%26spage%3D331%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Iwahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cupples, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratzkin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span> </span><span class="NLM_article-title">Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=439-449&author=T.+Iwaharaauthor=J.+Fujimotoauthor=D.+Wenauthor=R.+Cupplesauthor=N.+Bucayauthor=T.+Arakawaauthor=S.+Moriauthor=B.+Ratzkinauthor=T.+Yamamoto&title=Molecular+characterization+of+ALK%2C+a+receptor+tyrosine+kinase+expressed+specifically+in+the+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIwahara%26aufirst%3DT.%26aulast%3DFujimoto%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DCupples%26aufirst%3DR.%26aulast%3DBucay%26aufirst%3DN.%26aulast%3DArakawa%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DRatzkin%26aufirst%3DB.%26aulast%3DYamamoto%26aufirst%3DT.%26atitle%3DMolecular%2520characterization%2520of%2520ALK%252C%2520a%2520receptor%2520tyrosine%2520kinase%2520expressed%2520specifically%2520in%2520the%2520nervous%2520system%26jtitle%3DOncogene%26date%3D1997%26volume%3D14%26spage%3D439%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bilsland, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeldon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Znamenskiy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnert, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heavens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiting, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Sanjuan, I.</span><span> </span><span class="NLM_article-title">Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=685-700&author=J.+G.+Bilslandauthor=A.+Wheeldonauthor=A.+Meadauthor=P.+Znamenskiyauthor=S.+Almondauthor=K.+A.+Watersauthor=M.+Thakurauthor=V.+Beaumontauthor=T.+P.+Bonnertauthor=R.+Heavensauthor=P.+Whitingauthor=G.+McAllisterauthor=I.+Munoz-Sanjuan&title=Behavioral+and+neurochemical+alterations+in+mice+deficient+in+anaplastic+lymphoma+kinase+suggest+therapeutic+potential+for+psychiatric+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilsland%26aufirst%3DJ.%2BG.%26aulast%3DWheeldon%26aufirst%3DA.%26aulast%3DMead%26aufirst%3DA.%26aulast%3DZnamenskiy%26aufirst%3DP.%26aulast%3DAlmond%26aufirst%3DS.%26aulast%3DWaters%26aufirst%3DK.%2BA.%26aulast%3DThakur%26aufirst%3DM.%26aulast%3DBeaumont%26aufirst%3DV.%26aulast%3DBonnert%26aufirst%3DT.%2BP.%26aulast%3DHeavens%26aufirst%3DR.%26aulast%3DWhiting%26aufirst%3DP.%26aulast%3DMcAllister%26aufirst%3DG.%26aulast%3DMunoz-Sanjuan%26aufirst%3DI.%26atitle%3DBehavioral%2520and%2520neurochemical%2520alterations%2520in%2520mice%2520deficient%2520in%2520anaplastic%2520lymphoma%2520kinase%2520suggest%2520therapeutic%2520potential%2520for%2520psychiatric%2520indications%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D685%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmer, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span> </span><span class="NLM_article-title">Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=1281-1284&author=S.+W.+Morrisauthor=M.+N.+Kirsteinauthor=M.+B.+Valentineauthor=K.+G.+Dittmerauthor=D.+N.+Shapiroauthor=D.+L.+Saltmanauthor=A.+T.+Look&title=Fusion+of+a+kinase+gene%2C+ALK%2C+to+a+nucleolar+protein+gene%2C+NPM%2C+in+non-Hodgkin%E2%80%99s+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DValentine%26aufirst%3DM.%2BB.%26aulast%3DDittmer%26aufirst%3DK.%2BG.%26aulast%3DShapiro%26aufirst%3DD.%2BN.%26aulast%3DSaltman%26aufirst%3DD.%2BL.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DFusion%2520of%2520a%2520kinase%2520gene%252C%2520ALK%252C%2520to%2520a%2520nucleolar%2520protein%2520gene%252C%2520NPM%252C%2520in%2520non-Hodgkin%25E2%2580%2599s%2520lymphoma%26jtitle%3DScience%26date%3D1994%26volume%3D263%26spage%3D1281%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Griffin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlman, E. J.</span><span> </span><span class="NLM_article-title">Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2776</span><span class="NLM_x">–</span> <span class="NLM_lpage">2780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=10383129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADyaK1MXktVOktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2776-2780&author=C.+A.+Griffinauthor=A.+L.+Hawkinsauthor=C.+Dvorakauthor=C.+Henkleauthor=T.+Ellinghamauthor=E.+J.+Perlman&title=Recurrent+involvement+of+2p23+in+inflammatory+myofibroblastic+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors</span></div><div class="casAuthors">Griffin, Constance A.; Hawkins, Anita L.; Dvorak, Cecily; Henkle, Carol; Ellingham, Tara; Perlman, Elizabeth J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2776-2780</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">Inflammatory myofibroblastic tumor (IMT) is a relatively rare soft tissue tumor.  The reactive vs. neoplastic pathogenesis of this tumor is unresolved.  We found clonal chromosome aberrations involving 2p23 upon metaphase anal. of two IMTs.  Fluorescence in situ hybridization with a probe flanking the ALK gene at 2p23 demonstrated rearrangement of the probe in both of these cases and in a third case, and immunohistochem. revealed ALK expression in all three cases.  A 2p22-24 involvement has been reported previously in four addnl. cases of IMT.  We suggest that chromosomal rearrangements involving 2p23 near or within ALK are recurrent alterations in IMT and that ALK may have a novel role outside its previously recognized realm of lymphoid neoplasms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocvXV2ukz3crVg90H21EOLACvtfcHk0lhE7ZKzAyf-Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVOktbk%253D&md5=8054eeaaf0cb85ee85afff461797c84c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DC.%2BA.%26aulast%3DHawkins%26aufirst%3DA.%2BL.%26aulast%3DDvorak%26aufirst%3DC.%26aulast%3DHenkle%26aufirst%3DC.%26aulast%3DEllingham%26aufirst%3DT.%26aulast%3DPerlman%26aufirst%3DE.%2BJ.%26atitle%3DRecurrent%2520involvement%2520of%25202p23%2520in%2520inflammatory%2520myofibroblastic%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D2776%26epage%3D2780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurashina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=561-566&author=M.+Sodaauthor=Y.+L.+Choiauthor=M.+Enomotoauthor=S.+Takadaauthor=Y.+Yamashitaauthor=S.+Ishikawaauthor=S.+Fujiwaraauthor=H.+Watanabeauthor=K.+Kurashinaauthor=H.+Hatanakaauthor=M.+Bandoauthor=S.+Ohnoauthor=Y.+Ishikawaauthor=H.+Aburataniauthor=T.+Nikiauthor=Y.+Soharaauthor=Y.+Sugiyamaauthor=H.+Mano&title=Identification+of+the+transforming+EML4%E2%80%93ALK+fusion+gene+in+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DEnomoto%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DKurashina%26aufirst%3DK.%26aulast%3DHatanaka%26aufirst%3DH.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DNiki%26aufirst%3DT.%26aulast%3DSohara%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520the%2520transforming%2520EML4%25E2%2580%2593ALK%2520fusion%2520gene%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DNature%26date%3D2007%26volume%3D448%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Non-solid oncogenes in solid tumors: EML4–ALK fusion genes in lung cancer</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2349</span><span class="NLM_x">–</span> <span class="NLM_lpage">2355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1111%2Fj.1349-7006.2008.00972.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=19032370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisF2gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=2349-2355&author=H.+Mano&title=Non-solid+oncogenes+in+solid+tumors%3A+EML4%E2%80%93ALK+fusion+genes+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer</span></div><div class="casAuthors">Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2349-2355</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  It is generally accepted that recurrent chromosome translocations play a major role in the mol. pathogenesis of hematol. malignancies but not of solid tumors.  However, chromosome translocations involving the e26 transformation-specific sequence transcription factor loci have been demonstrated recently in many prostate cancer cases.  Furthermore, through a functional screening with retroviral cDNA expression libraries, we have discovered the fusion-type protein tyrosine kinase echinoderm microtubule-assocd. protein like-4 (EML4)-anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC) specimens.  A recurrent chromosome translocation, inv(2)(p21p23), in NSCLC generates fused mRNA encoding the amino-terminal half of EML4 ligated to the intracellular region of the receptor-type protein tyrosine kinase ALK.  EML4-ALK oligomerizes constitutively in cells through the coiled coil domain within the EML4 region, and becomes activated to exert a marked oncogenicity both in vitro and in vivo.  Break and fusion points within the EML4 locus may diverge in NSCLC cells to generate various isoforms of EML4-ALK, which may constitute -5% of NSCLC cases, at least in the Asian ethnic group.  In the present review I summarize how detection of EML4-ALK cDNA may become a sensitive diagnostic means for NSCLC cases that are pos. for the fusion gene, and discuss whether suppression of ALK enzymic activity could be an effective treatment strategy against this intractable disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbxSS7U51wKbVg90H21EOLACvtfcHk0lhE7ZKzAyf-Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisF2gsw%253D%253D&md5=84386550daedbd29b3a34b11a4774684</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.00972.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.00972.x%26sid%3Dliteratum%253Aachs%26aulast%3DMano%26aufirst%3DH.%26atitle%3DNon-solid%2520oncogenes%2520in%2520solid%2520tumors%253A%2520EML4%25E2%2580%2593ALK%2520fusion%2520genes%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D2349%26epage%3D2355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B.</span><span> </span><span class="NLM_article-title">Targeting anaplastic lymphoma kinase in lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2081</span><span class="NLM_x">–</span> <span class="NLM_lpage">2086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1158%2F1078-0432.CCR-10-1591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=21288922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslCgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=2081-2086&issue=8&author=A.+T.+Shawauthor=B.+Solomon&title=Targeting+anaplastic+lymphoma+kinase+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Anaplastic Lymphoma Kinase in Lung Cancer</span></div><div class="casAuthors">Shaw, Alice T.; Solomon, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2081-2086</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Several decades of cancer research have revealed a pivotal role for tyrosine kinases as key regulators of signaling pathways, controlling cell growth and differentiation.  Deregulation of tyrosine kinase-mediated signaling occurs frequently in cancer and is believed to drive the initiation and progression of disease.  Chromosomal rearrangements involving the tyrosine kinase anaplastic lymphoma kinase (ALK) occur in a variety of human malignancies including non-small cell lung cancer (NSCLC), anaplastic large cell lymphomas, and inflammatory myofibroblastic tumors.  The aberrant activation of ALK signaling leads to "oncogene addiction" and marked sensitivity to ALK inhibitors such as crizotinib (PF-02341066).  This review focuses on ALK rearrangements in NSCLC, starting with the discovery of the EML4-ALK fusion oncogene, and culminating in the recent validation of ALK as a therapeutic target in patients with ALK-rearranged NSCLC.  Current efforts seek to expand the role of ALK kinase inhibition in lung and other cancers and to address the mol. basis for the development of resistance.  Clin Cancer Res; 17(8); 2081-6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCqEzvXv0qJrVg90H21EOLACvtfcHk0li2ixM6OYcLrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslCgs7k%253D&md5=6d0f5e1174ba934f00c10a877a3b17e1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-1591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-1591%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DSolomon%26aufirst%3DB.%26atitle%3DTargeting%2520anaplastic%2520lymphoma%2520kinase%2520in%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26issue%3D8%26spage%3D2081%26epage%3D2086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Osajima-Hakomori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, R.</span><span> </span><span class="NLM_article-title">Biological role of anaplastic lymphoma kinase in neuroblastoma</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1016%2FS0002-9440%2810%2962966-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=15972965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXms1eitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2005&pages=213-222&author=Y.+Osajima-Hakomoriauthor=I.+Miyakeauthor=M.+Ohiraauthor=A.+Nakagawaraauthor=A.+Nakagawaauthor=R.+Sakai&title=Biological+role+of+anaplastic+lymphoma+kinase+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Biological role of anaplastic lymphoma kinase in neuroblastoma</span></div><div class="casAuthors">Osajima-Hakomori, Yuko; Miyake, Izumi; Ohira, Miki; Nakagawara, Akira; Nakagawa, Atsuko; Sakai, Ryuichi</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">213-222</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor originally identified as part of the chimeric nucleophosmin-ALK protein in the t(2;5) chromosomal rearrangement assocd. with anaplastic large cell lymphoma.  We recently demonstrated that the ALK kinase is constitutively activated by gene amplification at the ALK locus in several neuroblastoma cell lines.  Forming a stable complex with hyperphosphorylated ShcC, activated ALK modifies the responsiveness of the mitogen-activated protein kinase pathway to growth factors.  In the present study, the biol. role of activated ALK was examd. by suppressing the expression of ALK kinase in neuroblastoma cell lines using an RNA interference technique.  The suppression of activated ALK in neuroblastoma cells by RNA interference significantly reduced the phosphorylation of ShcC, mitogen-activated protein kinases, and Akt, inducing rapid apoptosis in the cells.  By immunohistochem. anal., the cytoplasmic expression of ALK was detected in most of the samples of neuroblastoma tissues regardless of the stage of the tumor, whereas significant amplification of ALK was obsd. in only 1 of 85 cases of human neuroblastoma samples.  These data demonstrate the limited frequency of ALK activation in the real progression of neuroblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3yzyhgfKX4rVg90H21EOLACvtfcHk0li2ixM6OYcLrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXms1eitrc%253D&md5=591aceb254b3e707d315b6309ec5fba0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2962966-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252962966-5%26sid%3Dliteratum%253Aachs%26aulast%3DOsajima-Hakomori%26aufirst%3DY.%26aulast%3DMiyake%26aufirst%3DI.%26aulast%3DOhira%26aufirst%3DM.%26aulast%3DNakagawara%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DA.%26aulast%3DSakai%26aufirst%3DR.%26atitle%3DBiological%2520role%2520of%2520anaplastic%2520lymphoma%2520kinase%2520in%2520neuroblastoma%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2005%26volume%3D167%26spage%3D213%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Mosse, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laudenslager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attiyeh, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquaglia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laureys, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speleman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakonarson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torkamani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schork, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonini, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappaport, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span> </span><span class="NLM_article-title">Identification of ALK as a major familial neuroblastoma predisposition gene</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1038%2Fnature07261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=18724359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Ggur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=930-935&author=Y.+P.+Mosseauthor=M.+Laudenslagerauthor=L.+Longoauthor=K.+A.+Coleauthor=A.+Woodauthor=E.+F.+Attiyehauthor=M.+J.+Laquagliaauthor=R.+Sennettauthor=J.+E.+Lynchauthor=P.+Perriauthor=G.+Laureysauthor=F.+Spelemanauthor=C.+Kimauthor=C.+Houauthor=H.+Hakonarsonauthor=A.+Torkamaniauthor=N.+J.+Schorkauthor=G.+M.+Brodeurauthor=G.+P.+Toniniauthor=E.+Rappaportauthor=M.+Devotoauthor=J.+M.+Maris&title=Identification+of+ALK+as+a+major+familial+neuroblastoma+predisposition+gene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of ALK as a major familial neuroblastoma predisposition gene</span></div><div class="casAuthors">Mosse, Yael P.; Laudenslager, Marci; Longo, Luca; Cole, Kristina A.; Wood, Andrew; Attiyeh, Edward F.; Laquaglia, Michael J.; Sennett, Rachel; Lynch, Jill E.; Perri, Patrizia; Laureys, Genevieve; Speleman, Frank; Kim, Cecilia; Hou, Cuiping; Hakonarson, Hakon; Torkamani, Ali; Schork, Nicholas J.; Brodeur, Garrett M.; Tonini, Gian P.; Rappaport, Eric; Devoto, Marcella; Maris, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7215</span>),
    <span class="NLM_cas:pages">930-935</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuroblastoma is a childhood cancer that can be inherited, but the genetic etiol. is largely unknown.  Here we show that germline mutations in the anaplastic lymphoma kinase (ALK) gene explain most hereditary neuroblastomas, and that activating mutations can also be somatically acquired.  We first identified a significant linkage signal at chromosome bands 2p23-24 using a whole-genome scan in neuroblastoma pedigrees.  Re-sequencing of regional candidate genes identified three sep. germline missense mutations in the tyrosine kinase domain of ALK that segregated with the disease in eight sep. families.  Re-sequencing in 194 high-risk neuroblastoma samples showed somatically acquired mutations in the tyrosine kinase domain in 12.4% of samples.  Nine of the ten mutations map to crit. regions of the kinase domain and were predicted, with high probability, to be oncogenic drivers.  Mutations resulted in constitutive phosphorylation, and targeted knockdown of ALK mRNA resulted in profound inhibition of growth in all cell lines harboring mutant or amplified ALK, as well as in two out of six wild-type cell lines for ALK.  Our results demonstrate that heritable mutations of ALK are the main cause of familial neuroblastoma, and that germline or acquired activation of this cell-surface kinase is a tractable therapeutic target for this lethal pediatric malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMNOcIFf5xjbVg90H21EOLACvtfcHk0li2ixM6OYcLrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Ggur%252FP&md5=bb998ef8f6bfbd85f928263e13954ce4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature07261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07261%26sid%3Dliteratum%253Aachs%26aulast%3DMosse%26aufirst%3DY.%2BP.%26aulast%3DLaudenslager%26aufirst%3DM.%26aulast%3DLongo%26aufirst%3DL.%26aulast%3DCole%26aufirst%3DK.%2BA.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DAttiyeh%26aufirst%3DE.%2BF.%26aulast%3DLaquaglia%26aufirst%3DM.%2BJ.%26aulast%3DSennett%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DJ.%2BE.%26aulast%3DPerri%26aufirst%3DP.%26aulast%3DLaureys%26aufirst%3DG.%26aulast%3DSpeleman%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DHakonarson%26aufirst%3DH.%26aulast%3DTorkamani%26aufirst%3DA.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26aulast%3DTonini%26aufirst%3DG.%2BP.%26aulast%3DRappaport%26aufirst%3DE.%26aulast%3DDevoto%26aufirst%3DM.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520of%2520ALK%2520as%2520a%2520major%2520familial%2520neuroblastoma%2520predisposition%2520gene%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D930%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Azarova, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, R. E.</span><span> </span><span class="NLM_article-title">Emerging importance of ALK in neuroblastoma</span> <span class="citation_source-journal">Semin. Cancer Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1016%2Fj.semcancer.2011.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=21945349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSktLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=267-275&author=A.+M.+Azarovaauthor=G.+Gautamauthor=R.+E.+George&title=Emerging+importance+of+ALK+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging importance of ALK in neuroblastoma</span></div><div class="casAuthors">Azarova, Anna M.; Gautam, Gargi; George, Rani E.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">267-275</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Since the original descriptions of gain-of function mutations in anaplastic lymphoma kinase (ALK), interest in the role of this receptor tyrosine kinase in neuroblastoma development and as a potential therapeutic target has escalated.  As a group, the activating point mutations in full-length ALK, found in approx. 8% of all neuroblastoma tumors, are distributed evenly across different clin. stages.  However, the most frequent somatic mutation, F1174L, is assocd. with amplification of the MYCN oncogene.  This combination of features appears to confer a worse prognosis than MYCN amplification alone, suggesting a cooperative effect on neuroblastoma formation by these two proteins.  Indeed, F1174L has shown more potent transforming activity in vivo than the second most common activating mutation, R1275Q, and is responsible for innate and acquired resistance to crizotinib, a clin. relevant ALK inhibitor that will soon be com. available.  These advances cast ALK as a bona fide oncoprotein in neuroblastoma and emphasize the need to understand ALK-mediated signaling in this tumor.  This review addresses many of the current issues surrounding the role of ALK in normal development and neuroblastoma pathogenesis, and discusses the prospects for clin. effective targeted treatments based on ALK inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpqmFzh9Q3frVg90H21EOLACvtfcHk0lhy3eACdnuJtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSktLzN&md5=e07445aecd9829c465f1f4023124521f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2011.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2011.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DAzarova%26aufirst%3DA.%2BM.%26aulast%3DGautam%26aufirst%3DG.%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26atitle%3DEmerging%2520importance%2520of%2520ALK%2520in%2520neuroblastoma%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D267%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Tuma, R. S.</span><span> </span><span class="NLM_article-title">ALK gene amplified in most inflammatory breast cancers</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1093%2Fjnci%2Fdjr553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=22215853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2012&pages=87-88&issue=2&author=R.+S.+Tuma&title=ALK+gene+amplified+in+most+inflammatory+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">ALK Gene Amplified in Most Inflammatory Breast Cancers</span></div><div class="casAuthors">Tuma, Rabiya S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-88</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Inflammatory breast cancer (IBC) is a rare form of the disease that differs substantially from non-inflammatory breast cancer in presentation and response to therapy. Despite those differences, researchers have uncovered few mol. characteristics that distinguish IBC from non-inflammatory breast cancer, and IBC treatment generally relies on std. breast cancer regimens.  Recently, it has been reported that ALK gene amplification is a common feature of IBC tumors and that small-mol. ALK inhibitors are effective in mouse xenograft models.  Current developments on this recent report are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB9yX6fegRi7Vg90H21EOLACvtfcHk0lhy3eACdnuJtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWhsb0%253D&md5=46e7633055aadc3aacfc6bac9b4cb591</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjr553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjr553%26sid%3Dliteratum%253Aachs%26aulast%3DTuma%26aufirst%3DR.%2BS.%26atitle%3DALK%2520gene%2520amplified%2520in%2520most%2520inflammatory%2520breast%2520cancers%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2012%26volume%3D104%26issue%3D2%26spage%3D87%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beausoleil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innocenti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, T.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ynag, Y.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comb, M. J.</span><span> </span><span class="NLM_article-title">Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">3312</span><span class="NLM_x">–</span> <span class="NLM_lpage">3323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=3312-3323&author=H.+Renauthor=X.+Z.+Tanauthor=C.+Crosbyauthor=H.+Haackauthor=J.-M.+Renauthor=S.+Beausoleilauthor=A.+Moritzauthor=G.+Innocentiauthor=J.+Rushauthor=Y.+Zhangauthor=X.-M.+Zhouauthor=T.-L.+Guauthor=Y.-F.+Ynagauthor=M.+J.+Comb&title=Identification+of+anaplastic+lymphoma+kinase+as+a+potential+therapeutic+target+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DX.%2BZ.%26aulast%3DCrosby%26aufirst%3DC.%26aulast%3DHaack%26aufirst%3DH.%26aulast%3DRen%26aufirst%3DJ.-M.%26aulast%3DBeausoleil%26aufirst%3DS.%26aulast%3DMoritz%26aufirst%3DA.%26aulast%3DInnocenti%26aufirst%3DG.%26aulast%3DRush%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.-M.%26aulast%3DGu%26aufirst%3DT.-L.%26aulast%3DYnag%26aufirst%3DY.-F.%26aulast%3DComb%26aufirst%3DM.%2BJ.%26atitle%3DIdentification%2520of%2520anaplastic%2520lymphoma%2520kinase%2520as%2520a%2520potential%2520therapeutic%2520target%2520in%2520ovarian%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D3312%26epage%3D3323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ott, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzalone, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underiner, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quail, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100158s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=493-498&author=G.+R.+Ottauthor=R.+Tripathyauthor=M.+Chengauthor=R.+McHughauthor=A.+V.+Anzaloneauthor=T.+L.+Underinerauthor=M.+A.+Curryauthor=M.+R.+Quailauthor=L.+Luauthor=W.+Wanauthor=T.+S.+Angelesauthor=M.+S.+Albomauthor=L.+D.+Aimoneauthor=M.+A.+Atorauthor=B.+A.+Ruggeriauthor=B.+D.+Dorsey&title=Discovery+of+a+potent+inhibitor+of+anaplastic+lymphoma+kinase+with+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity</span></div><div class="casAuthors">Ott, Gregory R.; Tripathy, Rabindranath; Cheng, Mangeng; McHugh, Robert; Anzalone, Andrew V.; Underiner, Ted L.; Curry, Matthew A.; Quail, Matthew R.; Lu, Lihui; Wan, Weihua; Angeles, Thelma S.; Albom, Mark S.; Aimone, Lisa D.; Ator, Mark A.; Ruggeri, Bruce A.; Dorsey, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">493-498</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel 7-amino-1,3,4,5-tetrahydrobenzo[b]azepin-2-one derivs. within the diaminopyrimidine class of kinase inhibitors were identified that target anaplastic lymphoma kinase (ALK).  These inhibitors are potent against ALK in an isolated enzyme assay and inhibit autophosphorylation of the oncogenic fusion protein NPM-ALK in anaplastic large cell lymphoma (ALCL) cell lines.  The lead inhibitor 15 (I), which incorporates a bicyclo[2.2.1]hept-5-ene ring system in place of an aryl moiety, activates the pro-apoptotic caspases (3 and 7) and displays selective cytotoxicity against ALK-pos. ALCL cells.  Furthermore, 15 provides more than 40-fold selectivity against the structurally related insulin receptor, is orally bioavailable in multiple species, and displays in vivo antitumor efficacy when dosed orally in ALK-pos. ALCL tumor xenografts in Scid mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof0qilbcAbZ7Vg90H21EOLACvtfcHk0lj_QNJgY2-NYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtrrJ&md5=15d4f7aea64f212338d8c9cd88a36c64</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml100158s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100158s%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DTripathy%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DMcHugh%26aufirst%3DR.%26aulast%3DAnzalone%26aufirst%3DA.%2BV.%26aulast%3DUnderiner%26aufirst%3DT.%2BL.%26aulast%3DCurry%26aufirst%3DM.%2BA.%26aulast%3DQuail%26aufirst%3DM.%2BR.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520with%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D493%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Mesaros, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugan, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzalone, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quail, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B, D.</span><span> </span><span class="NLM_article-title">Novel 2,3,4,5-tetrahydro-benzo[<i>d</i>]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=463-466&author=E.+F.+Mesarosauthor=J.+P.+Burkeauthor=J.+D.+Parrishauthor=B.+J.+Duganauthor=A.+V.+Anzaloneauthor=T.+S.+Angelesauthor=M.+S.+Albomauthor=L.+D.+Aimoneauthor=M.+R.+Quailauthor=W.+Wanauthor=L.+Luauthor=Z.+Huangauthor=M.+A.+Atorauthor=B.+A.+Ruggeriauthor=M.+Chengauthor=G.+R.+Ottauthor=B%2C+D.+Dorsey&title=Novel+2%2C3%2C4%2C5-tetrahydro-benzo%5Bd%5Dazepine+derivatives+of+2%2C4-diaminopyrimidine%2C+selective+and+orally+bioavailable+ALK+inhibitors+with+antitumor+efficacy+in+ALCL+mouse+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMesaros%26aufirst%3DE.%2BF.%26aulast%3DBurke%26aufirst%3DJ.%2BP.%26aulast%3DParrish%26aufirst%3DJ.%2BD.%26aulast%3DDugan%26aufirst%3DB.%2BJ.%26aulast%3DAnzalone%26aufirst%3DA.%2BV.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DQuail%26aufirst%3DM.%2BR.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DDorsey%26aufirst%3DB%252C%2BD.%26atitle%3DNovel%25202%252C3%252C4%252C5-tetrahydro-benzo%255Bd%255Dazepine%2520derivatives%2520of%25202%252C4-diaminopyrimidine%252C%2520selective%2520and%2520orally%2520bioavailable%2520ALK%2520inhibitors%2520with%2520antitumor%2520efficacy%2520in%2520ALCL%2520mouse%2520models%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D463%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Milkiewicz, K. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of 1,2,3,4-tetrahydropyrido[2,3-<i>b</i>]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4351</span><span class="NLM_x">–</span> <span class="NLM_lpage">4362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4351-4362&author=K.+L+Milkiewiczauthor=L.+R.+Weinbergauthor=M.+S.+Albomauthor=T.+S.+Angelesauthor=M.+Cheng&title=Synthesis+and+structure%E2%80%93activity+relationships+of+1%2C2%2C3%2C4-tetrahydropyrido%5B2%2C3-b%5Dpyrazines+as+potent+and+selective+inhibitors+of+the+anaplastic+lymphoma+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL%26aulast%3DWeinberg%26aufirst%3DL.%2BR.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DCheng%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%25201%252C2%252C3%252C4-tetrahydropyrido%255B2%252C3-b%255Dpyrazines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520anaplastic%2520lymphoma%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4351%26epage%3D4362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ott, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieu, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quail, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisko, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesaros, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span> </span><span class="NLM_article-title">2,7-Disubstituted-pyrrolo[2,1-<i>f</i>][1,2,4]triazines: new variant of an old template and application to the discovery of anaplastic lymphoma kinase (ALK) inhibitors with in vivo antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6328</span><span class="NLM_x">–</span> <span class="NLM_lpage">6341</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200758k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6328-6341&issue=18&author=G.+R.+Ottauthor=G.+J.+Wellsauthor=T.+V.+Thieuauthor=M.+R.+Quailauthor=G.+J.+Liskoauthor=E.+F.+Mesarosauthor=D.+E.+Gingrichauthor=A.+K.+Ghoseauthor=W.+Wanauthor=L.+Luauthor=M.+Chengauthor=M.+S.+Albomauthor=T.+S.+Angelesauthor=Z.+Huangauthor=L.+D.+Aimoneauthor=M.+A.+Atorauthor=B.+A.+Ruggeriauthor=B.+D.+Dorsey&title=2%2C7-Disubstituted-pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazines%3A+new+variant+of+an+old+template+and+application+to+the+discovery+of+anaplastic+lymphoma+kinase+%28ALK%29+inhibitors+with+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm200758k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200758k%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DWells%26aufirst%3DG.%2BJ.%26aulast%3DThieu%26aufirst%3DT.%2BV.%26aulast%3DQuail%26aufirst%3DM.%2BR.%26aulast%3DLisko%26aufirst%3DG.%2BJ.%26aulast%3DMesaros%26aufirst%3DE.%2BF.%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3D2%252C7-Disubstituted-pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%253A%2520new%2520variant%2520of%2520an%2520old%2520template%2520and%2520application%2520to%2520the%2520discovery%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520inhibitors%2520with%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D18%26spage%3D6328%26epage%3D6341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantla, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickens, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chucholowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, T. R.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1006</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050824x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1006-1015&author=R.+Liauthor=L.+Xueauthor=T.+Zhuauthor=Q.+Jiangauthor=X.+Cuiauthor=Z.+Yanauthor=D.+McGeeauthor=J.+Wangauthor=V.+R.+Gantlaauthor=J.+C.+Pickensauthor=D.+McGrathauthor=A.+Chucholowskiauthor=S.+W.+Morrisauthor=T.+R.+Webb&title=Design+and+synthesis+of+5-aryl-pyridone-carboxamides+as+inhibitors+of+anaplastic+lymphoma+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm050824x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050824x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DMcGee%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGantla%26aufirst%3DV.%2BR.%26aulast%3DPickens%26aufirst%3DJ.%2BC.%26aulast%3DMcGrath%26aufirst%3DD.%26aulast%3DChucholowski%26aufirst%3DA.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DWebb%26aufirst%3DT.%2BR.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205-aryl-pyridone-carboxamides%2520as%2520inhibitors%2520of%2520anaplastic%2520lymphoma%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1006%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ardini, E.; Menichincheri, M.; De Ponti, C.; Amboldi, N.; Ballinari, D.; Saccardo, M. B.; Croci, V.; Stellari, F.; Texido, G.; Orsini, P.; Perrone, E.; Bandiera, T.; Borgia, A. L; Lansen, J.; Isacchi, A.; Colotta, F.; Pesenti, E.; Magnaghi, P.; Galvani, A.</span><span> </span><span class="NLM_article-title">A Highly Potent, Selective and Orally Available ALK Inhibitor with Demonstrated Antitumor Efficacy in ALK Dependent Lymphoma and Non-Small Cell Lung Cancer Models</span>. Presented at the Annual Meeting of the American Association for Cancer Research (AACR), San Diego, CA,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Abstract 3737.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=E.+Ardini&author=M.+Menichincheri&author=C.+De+Ponti&author=N.+Amboldi&author=D.+Ballinari&author=M.+B.+Saccardo&author=V.+Croci&author=F.+Stellari&author=G.+Texido&author=P.+Orsini&author=E.+Perrone&author=T.+Bandiera&author=A.+L+Borgia&author=J.+Lansen&author=A.+Isacchi&author=F.+Colotta&author=E.+Pesenti&author=P.+Magnaghi&author=A.+Galvani&title=A+Highly+Potent%2C+Selective+and+Orally+Available+ALK+Inhibitor+with+Demonstrated+Antitumor+Efficacy+in+ALK+Dependent+Lymphoma+and+Non-Small+Cell+Lung+Cancer+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DArdini%26aufirst%3DE.%26atitle%3DA%2520Highly%2520Potent%252C%2520Selective%2520and%2520Orally%2520Available%2520ALK%2520Inhibitor%2520with%2520Demonstrated%2520Antitumor%2520Efficacy%2520in%2520ALK%2520Dependent%2520Lymphoma%2520and%2520Non-Small%2520Cell%2520Lung%2520Cancer%2520Models%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sabbatini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korenchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowand, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leperi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumble, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gontarek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maksimchuk, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suravajjala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapierre, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shotwell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2811</span><span class="NLM_x">–</span> <span class="NLM_lpage">2820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1158%2F1535-7163.MCT-09-0423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=19825801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2811-2820&issue=10&author=P.+Sabbatiniauthor=S.+Korenchukauthor=J.+L.+Rowandauthor=A.+Groyauthor=Q.+Liuauthor=D.+Leperiauthor=C.+Atkinsauthor=M.+Dumbleauthor=J.+Yangauthor=K.+Andersonauthor=R.+G.+Krugerauthor=R.+R.+Gontarekauthor=K.+R.+Maksimchukauthor=S.+Suravajjalaauthor=R.+R.+Lapierreauthor=J.+B.+Shotwellauthor=J.+W.+Wilsonauthor=S.+D.+Chamberlainauthor=S.+K.+Rabindranauthor=R.+Kumar&title=GSK1838705A+inhibits+the+insulin-like+growth+factor-1+receptor+and+anaplastic+lymphoma+kinase+and+shows+antitumor+activity+in+experimental+models+of+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers</span></div><div class="casAuthors">Sabbatini, Peter; Korenchuk, Susan; Rowand, Jason L.; Groy, Arthur; Liu, Qi; Leperi, Dominic; Atkins, Charity; Dumble, Melissa; Yang, Jingsong; Anderson, Kelly; Kruger, Ryan G.; Gontarek, Richard R.; Maksimchuk, Kenneth R.; Suravajjala, Sapna; Lapierre, Russell R.; Shotwell, J. Brad; Wilson, Joseph W.; Chamberlain, Stanley D.; Rabindran, Sridhar K.; Kumar, Rakesh</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2811-2820</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The insulin-like growth factor-I receptor (IGF-IR) signaling pathway is activated in various tumors, and inhibition of IGF-IR kinase provides a therapeutic opportunity in these patients.  GSK1838705A is a small-mol. kinase inhibitor that inhibits IGF-IR and the insulin receptor with IC50s of 2.0 and 1.6 nmol/L, resp.  GSK1838705A blocks the in vitro proliferation of cell lines derived from solid and hematol. malignancies, including multiple myeloma and Ewing's sarcoma, and retards the growth of human tumor xenografts in vivo.  Despite the inhibitory effect of GSK1838705A on insulin receptor, minimal effects on glucose homeostasis were obsd. at efficacious doses.  GSK1838705A also inhibits the anaplastic lymphoma kinase (ALK), which drives the aberrant growth of anaplastic large-cell lymphomas, some neuroblastomas, and a subset of non-small cell lung cancers.  GSK1838705A inhibits ALK, with an IC50 of 0.5 nmol/L, and causes complete regression of ALK-dependent tumors in vivo at well-tolerated doses.  GSK1838705A is therefore a promising antitumor agent for therapeutic use in human cancers. [Mol Cancer Ther 2009;8(10):2811-20].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyQ0LEFOBer7Vg90H21EOLACvtfcHk0liKcNm38H7gUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Cqur7N&md5=42e56e8dd4920322b82bedd13721be5b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0423%26sid%3Dliteratum%253Aachs%26aulast%3DSabbatini%26aufirst%3DP.%26aulast%3DKorenchuk%26aufirst%3DS.%26aulast%3DRowand%26aufirst%3DJ.%2BL.%26aulast%3DGroy%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLeperi%26aufirst%3DD.%26aulast%3DAtkins%26aufirst%3DC.%26aulast%3DDumble%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26aulast%3DMaksimchuk%26aufirst%3DK.%2BR.%26aulast%3DSuravajjala%26aufirst%3DS.%26aulast%3DLapierre%26aufirst%3DR.%2BR.%26aulast%3DShotwell%26aufirst%3DJ.%2BB.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26aulast%3DChamberlain%26aufirst%3DS.%2BD.%26aulast%3DRabindran%26aufirst%3DS.%2BK.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DGSK1838705A%2520inhibits%2520the%2520insulin-like%2520growth%2520factor-1%2520receptor%2520and%2520anaplastic%2520lymphoma%2520kinase%2520and%2520shows%2520antitumor%2520activity%2520in%2520experimental%2520models%2520of%2520human%2520cancers%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D10%26spage%3D2811%26epage%3D2820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lewis, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stellwagen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saffran, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szilvassy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brake, R. L.</span><span> </span><span class="NLM_article-title">The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6540</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3005866" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6523-6540&author=R.+T.+Lewisauthor=C.+M.+Bodeauthor=D.+M.+Choquetteauthor=M.+Potashmanauthor=K.+Romeroauthor=J.+C.+Stellwagenauthor=Y.+Tefferaauthor=E.+Mooreauthor=D.+A.+Whittingtonauthor=H.+Chenauthor=L.+F.+Epsteinauthor=R.+Emkeyauthor=P.+S.+Andrewsauthor=V.+L.+Yuauthor=D.+C.+Saffranauthor=M.+Xuauthor=A.+Drewauthor=P.+Merkelauthor=S.+Szilvassyauthor=R.+L.+Brake&title=The+discovery+and+optimization+of+a+novel+class+of+potent%2C+selective%2C+and+orally+bioavailable+anaplastic+lymphoma+kinase+%28ALK%29+inhibitors+with+potential+utility+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm3005866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3005866%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DR.%2BT.%26aulast%3DBode%26aufirst%3DC.%2BM.%26aulast%3DChoquette%26aufirst%3DD.%2BM.%26aulast%3DPotashman%26aufirst%3DM.%26aulast%3DRomero%26aufirst%3DK.%26aulast%3DStellwagen%26aufirst%3DJ.%2BC.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DMoore%26aufirst%3DE.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DYu%26aufirst%3DV.%2BL.%26aulast%3DSaffran%26aufirst%3DD.%2BC.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DDrew%26aufirst%3DA.%26aulast%3DMerkel%26aufirst%3DP.%26aulast%3DSzilvassy%26aufirst%3DS.%26aulast%3DBrake%26aufirst%3DR.%2BL.%26atitle%3DThe%2520discovery%2520and%2520optimization%2520of%2520a%2520novel%2520class%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520inhibitors%2520with%2520potential%2520utility%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6523%26epage%3D6540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, W. II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jänne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of 3,5-diamino-1,2,4-triazole ureas as potent anaplastic lymphoma kinase inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200002a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=379-384&author=X.+Dengauthor=J.+Wangauthor=J.+Zhangauthor=T.+Simauthor=N.+D.+Kimauthor=T.+Sasakiauthor=W.+II+Lutherauthor=R.+E.+Georgeauthor=P.+A.+J%C3%A4nneauthor=N.+S.+Gray&title=Discovery+of+3%2C5-diamino-1%2C2%2C4-triazole+ureas+as+potent+anaplastic+lymphoma+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml200002a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200002a%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DLuther%26aufirst%3DW.%2BII%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%25203%252C5-diamino-1%252C2%252C4-triazole%2520ureas%2520as%2520potent%2520anaplastic%2520lymphoma%2520kinase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D379%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span> </span><span class="NLM_article-title">Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3314</span><span class="NLM_x">–</span> <span class="NLM_lpage">3322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1158%2F1535-7163.MCT-07-0365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=18089725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=3314-3322&issue=12&author=J.+G.+Christensenauthor=H.+Y.+Zouauthor=M.+E.+Arangoauthor=Q.+Liauthor=J.+H.+Leeauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=G.+R.+Altonauthor=B.+Mroczkowskiauthor=G.+Los&title=Cytoreductive+antitumor+activity+of+PF-2341066%2C+a+novel+inhibitor+of+anaplastic+lymphoma+kinase+and+c-Met%2C+in+experimental+models+of+anaplastic+large-cell+lymphoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma</span></div><div class="casAuthors">Christensen, James G.; Zou, Helen Y.; Arango, Maria E.; Li, Qiuhua; Lee, Joseph H.; McDonnell, Scott R.; Yamazaki, Shinji; Alton, Gordon R.; Mroczkowski, Barbara; Los, Gerrit</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">3314-3322</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A t(2;5) chromosomal translocation resulting in expression of an oncogenic kinase fusion protein known as nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) has been implicated in the pathogenesis of anaplastic large-cell lymphoma (ALCL).  PF-2341066 was recently identified as a p.o. bioavailable, small-mol. inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK fusion protein.  PF-2341066 also potently inhibited NPM-ALK phosphorylation in Karpas299 or SU-DHL-1 ALCL cells (mean IC50 value, 24 nmol/L).  In biochem. and cellular screens, PF-2341066 was shown to be selective for c-Met and ALK at pharmacol. relevant concns. across a panel of >120 diverse kinases.  PF-2341066 potently inhibited cell proliferation, which was assocd. with G1-S-phase cell cycle arrest and induction of apoptosis in ALK-pos. ALCL cells (IC50 values, ∼30 nmol/L) but not ALK-neg. lymphoma cells.  The induction of apoptosis was confirmed using terminal deoxyribonucleotide transferase-mediated nick-end labeling and Annexin V staining (IC50 values, 25-50 nmol/L).  P.o. administration of PF-2341066 to severe combined immunodeficient-Beige mice bearing Karpas299 ALCL tumor xenografts resulted in dose-dependent antitumor efficacy with complete regression of all tumors at the 100 mg/kg/d dose within 15 days of initial compd. administration.  A strong correlation was obsd. between antitumor response and inhibition of NPM-ALK phosphorylation and induction of apoptosis in tumor tissue.  In addn., inhibition of key NPM-ALK signaling mediators, including phospholipase C-γ, signal transducers and activators of transcription 3, extracellular signal-regulated kinases, and Akt by PF-2341066 were obsd. at concns. or dose levels, which correlated with inhibition of NPM-ALK phosphorylation and function.  Collectively, these data illustrate the potential clin. utility of inhibitors of NPM-ALK in treatment of patients with ALK-pos. ALCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptqY0tUwGnurVg90H21EOLACvtfcHk0liPhvlyflem3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrrL&md5=04fbbaf43ca527408bde8cabcd38e1fd</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0365%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DAlton%26aufirst%3DG.%2BR.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DLos%26aufirst%3DG.%26atitle%3DCytoreductive%2520antitumor%2520activity%2520of%2520PF-2341066%252C%2520a%2520novel%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520and%2520c-Met%252C%2520in%2520experimental%2520models%2520of%2520anaplastic%2520large-cell%2520lymphoma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26issue%3D12%26spage%3D3314%26epage%3D3322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I..</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crizotinib, A.</span><span> </span><span class="NLM_article-title">Small-molecule dual inhibitor of the c-Met and ALK receptor tyrosine kinases</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1477</span><span class="NLM_x">–</span> <span class="NLM_lpage">1490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1477-1490&author=S.+J.+Rodigauthor=G.+I..+Shapiroauthor=A.+Crizotinib&title=Small-molecule+dual+inhibitor+of+the+c-Met+and+ALK+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DShapiro%26aufirst%3DG.%2BI..%26aulast%3DCrizotinib%26aufirst%3DA.%26atitle%3DSmall-molecule%2520dual%2520inhibitor%2520of%2520the%2520c-Met%2520and%2520ALK%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D11%26spage%3D1477%26epage%3D1490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran-Dube, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botrous, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padrique, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal–epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6342</span><span class="NLM_x">–</span> <span class="NLM_lpage">6363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2007613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6342-6363&issue=18&author=J.+J.+Cuiauthor=M.+Tran-Dubeauthor=H.+Shenauthor=M.+Nambuauthor=P.-P.+Kungauthor=M.+Pairishauthor=L.+Jiaauthor=J.+Mengauthor=L.+Funkauthor=I.+Botrousauthor=M.+McTigueauthor=N.+Grodskyauthor=K.+Ryanauthor=E.+Padriqueauthor=G.+Altonauthor=S.+Timofeevskiauthor=S.+Yamazakiauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensenauthor=B.+Mroczkowskiauthor=S.+Benderauthor=R.+S.+Kaniaauthor=M.+P.+Edwards&title=Structure+based+drug+design+of+crizotinib+%28PF-02341066%29%2C+a+potent+and+selective+dual+inhibitor+of+mesenchymal%E2%80%93epithelial+transition+factor+%28c-MET%29+kinase+and+anaplastic+lymphoma+kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm2007613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2007613%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DPadrique%26aufirst%3DE.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DStructure%2520based%2520drug%2520design%2520of%2520crizotinib%2520%2528PF-02341066%2529%252C%2520a%2520potent%2520and%2520selective%2520dual%2520inhibitor%2520of%2520mesenchymal%25E2%2580%2593epithelial%2520transition%2520factor%2520%2528c-MET%2529%2520kinase%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D18%26spage%3D6342%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kwak, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camidge, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maki, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dezube, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jänne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varella-Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidias, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbs, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sequist, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino-Kenudson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shreeve, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratain, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span> </span><span class="NLM_article-title">Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1703</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1056%2FNEJMoa1006448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=20979469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKitL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1693-1703&issue=18&author=E.+L.+Kwakauthor=Y.+J.+Bangauthor=D.+R.+Camidgeauthor=A.+T.+Shawauthor=B.+Solomonauthor=R.+G.+Makiauthor=S.+H.+Ouauthor=B.+J.+Dezubeauthor=P.+A.+J%C3%A4nneauthor=D.+B.+Costaauthor=M.+Varella-Garciaauthor=W.+H.+Kimauthor=T.+J.+Lynchauthor=P.+Fidiasauthor=H.+Stubbsauthor=J.+A.+Engelmanauthor=L.+V.+Sequistauthor=W.+Tanauthor=L.+Gandhiauthor=M.+Mino-Kenudsonauthor=G.+C.+Weiauthor=S.+M.+Shreeveauthor=M.+J.+Ratainauthor=J.+Settlemanauthor=J.+G.+Christensenauthor=D.+A.+Haberauthor=K.+Wilnerauthor=R.+Salgiaauthor=G.+I.+Shapiroauthor=J.+W.+Clarkauthor=A.+J.+Iafrate&title=Anaplastic+lymphoma+kinase+inhibition+in+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer</span></div><div class="casAuthors">Kwak, Eunice L.; Bang, Yung-Jue; Camidge, Ross; Shaw, Alice T.; Solomon, Benjamin; Maki, Robert G.; Ou, Sai-Hong I.; Dezube, Bruce J.; Janne, Pasi A.; Costa, Daniel B.; Varella-Garcia, Marileila; Kim, Woo-Ho; Lynch, Thomas J.; Fidias, Panos; Stubbs, Hannah; Engelman, Jeffrey A.; Sequist, Lecia V.; Tan, WeiWei; Gandhi, Leena; Mino-Kenudson, Mari; Wei, Greg C.; Shreeve, Martin; Ratain, Mark J.; Settleman, Jeffrey; Christensen, James G.; Haber, Daniel A.; Wilner, Keith; Salgia, Ravi; Shapiro, Geoffrey I.; Clark, Jeffrey W.; Iafrate, A. John</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1693-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Oncogenic fusion genes consisting of EML4 and anaplastic lymphoma kinase (ALK) are present in a subgroup of non-small-cell lung cancers, representing 2 to 7% of such tumors.  The authors explored the therapeutic efficacy of inhibiting ALK in such tumors in an early-phase clin. trial of crizotinib (PF-02341066), an orally available small-mol. inhibitor of the ALK tyrosine kinase.  METHODS: After screening tumor samples from approx. 1500 patients with non-small-cell lung cancer for the presence of ALK rearrangements, the authors identified 82 patients with advanced ALK-pos. disease who were eligible for the clin. trial.  Most of the patients had received previous treatment.  These patients were enrolled in an expanded cohort study instituted after phase 1 dose escalation had established a recommended crizotinib dose of 250 mg twice daily in 28-day cycles.  Patients were assessed for adverse events and response to therapy.  RESULTS: Patients with ALK rearrangements tended to be younger than those without the rearrangements, and most of the patients had little or no exposure to tobacco and had adenocarcinomas.  At a mean treatment duration of 6.4 mo, the overall response rate was 57% (47 of 82 patients, with 46 confirmed partial responses and 1 confirmed complete response); 27 patients (33%) had stable disease.  A total of 63 of 82 patients (77%) were continuing to receive crizotinib at the time of data cutoff, and the estd. probability of 6-mo progression-free survival was 72%, with no median for the study reached.  The drug resulted in grade 1 or 2 (mild) gastrointestinal side effects.  CONCLUSIONS: The inhibition of ALK in lung tumors with the ALK rearrangement resulted in tumor shrinkage or stable disease in most patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWDt_eL7Lyo7Vg90H21EOLACvtfcHk0lgQoHD6JCbStA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKitL%252FO&md5=47440b9c944100295cca0f1859138d6b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1006448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1006448%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DSolomon%26aufirst%3DB.%26aulast%3DMaki%26aufirst%3DR.%2BG.%26aulast%3DOu%26aufirst%3DS.%2BH.%26aulast%3DDezube%26aufirst%3DB.%2BJ.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DW.%2BH.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26aulast%3DFidias%26aufirst%3DP.%26aulast%3DStubbs%26aufirst%3DH.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DSequist%26aufirst%3DL.%2BV.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DGandhi%26aufirst%3DL.%26aulast%3DMino-Kenudson%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DG.%2BC.%26aulast%3DShreeve%26aufirst%3DS.%2BM.%26aulast%3DRatain%26aufirst%3DM.%2BJ.%26aulast%3DSettleman%26aufirst%3DJ.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26aulast%3DWilner%26aufirst%3DK.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DClark%26aufirst%3DJ.%2BW.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26atitle%3DAnaplastic%2520lymphoma%2520kinase%2520inhibition%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26issue%3D18%26spage%3D1693%26epage%3D1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroshima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span> </span><span class="NLM_article-title">CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=679-690&author=H.+Sakamotoauthor=T.+Tsukaguchiauthor=S.+Hiroshimaauthor=T.+Kodamaauthor=T.+Kobayashiauthor=T.+A.+Fukamiauthor=N.+Oikawaauthor=T.+Tsukudaauthor=N.+Ishiiauthor=Y.+Aoki&title=CH5424802%2C+a+selective+ALK+inhibitor+capable+of+blocking+the+resistant+gatekeeper+mutant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DHiroshima%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DFukami%26aufirst%3DT.%2BA.%26aulast%3DOikawa%26aufirst%3DN.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DAoki%26aufirst%3DY.%26atitle%3DCH5424802%252C%2520a%2520selective%2520ALK%2520inhibitor%2520capable%2520of%2520blocking%2520the%2520resistant%2520gatekeeper%2520mutant%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26spage%3D679%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Kinoshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohwada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takanashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span> </span><span class="NLM_article-title">9-Substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazoles as highly selective and potent anaplastic lymphoma kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6286</span><span class="NLM_x">–</span> <span class="NLM_lpage">6294</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200652u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOns7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6286-6294&author=K.+Kinoshitaauthor=T.+Kobayashiauthor=K.+Asohauthor=N.+Furuichiauthor=T.+Itoauthor=H.+Kawadaauthor=S.+Haraauthor=J.+Ohwadaauthor=K.+Hattoriauthor=T.+Miyagiauthor=W.-S.+Hongauthor=M.-J.+Parkauthor=K.+Takanashiauthor=T.+Tsukaguchiauthor=H.+Sakamotoauthor=T.+Tsukudaauthor=N.+Oikawa&title=9-Substituted+6%2C6-dimethyl-11-oxo-6%2C11-dihydro-5H-benzo%5Bb%5Dcarbazoles+as+highly+selective+and+potent+anaplastic+lymphoma+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors</span></div><div class="casAuthors">Kinoshita, Kazutomo; Kobayashi, Takamitsu; Asoh, Kohsuke; Furuichi, Noriyuki; Ito, Toshiya; Kawada, Hatsuo; Hara, Sousuke; Ohwada, Jun; Hattori, Kazuo; Miyagi, Takuho; Hong, Woo-Sang; Park, Min-Jeong; Takanashi, Kenji; Tsukaguchi, Toshiyuki; Sakamoto, Hiroshi; Tsukuda, Takuo; Oikawa, Nobuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6286-6294</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">9-Substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles were discovered as highly selective and potent anaplastic lymphoma kinase (ALK) inhibitors by structure-based drug design.  The high target selectivity was achieved by introducing a substituent close to the E0 region of the ATP binding site, which has a unique amino acid sequence.  Among the identified inhibitors, compd. 13d (I) showed highly selective and potent inhibitory activity against ALK with an IC50 value of 2.9 nM and strong antiproliferative activity against KARPAS-299 with an IC50 value of 12.8 nM.  The compd. also displayed significant antitumor efficacy in an established ALK fusion gene-pos. anaplastic large-cell lymphoma (ALCL) xenograft model in mice without body wt. loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfpJsdIdDvO7Vg90H21EOLACvtfcHk0li1u7Lb53Witg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOns7vP&md5=6293368243c840e12beefc8c8d6bb69a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm200652u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200652u%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DAsoh%26aufirst%3DK.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DKawada%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DS.%26aulast%3DOhwada%26aufirst%3DJ.%26aulast%3DHattori%26aufirst%3DK.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DHong%26aufirst%3DW.-S.%26aulast%3DPark%26aufirst%3DM.-J.%26aulast%3DTakanashi%26aufirst%3DK.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DOikawa%26aufirst%3DN.%26atitle%3D9-Substituted%25206%252C6-dimethyl-11-oxo-6%252C11-dihydro-5H-benzo%255Bb%255Dcarbazoles%2520as%2520highly%2520selective%2520and%2520potent%2520anaplastic%2520lymphoma%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6286%26epage%3D6294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kuromitsu, S.; Mori, M.; Shimada, I.; Kondoh, Y.; Shindoh, N.; Soga, T.; Furutani, T.; Konagai, S.; Sakagami, H.; Nakata, M.; Ueno, Y.; Saito, R.; Sasamata, M.; Kudou, M.</span><span> </span><span class="NLM_article-title">Anti-Tumor Activity of ASP3026. A Novel and Selective ALK Inhibitor of Anaplastic Lymphoma Kinase (ALK)</span>. Presented at the Annual Meeting of the American Association for Cancer Research (AACR), Orlando, FL,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Abstract 2821.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Kuromitsu&author=M.+Mori&author=I.+Shimada&author=Y.+Kondoh&author=N.+Shindoh&author=T.+Soga&author=T.+Furutani&author=S.+Konagai&author=H.+Sakagami&author=M.+Nakata&author=Y.+Ueno&author=R.+Saito&author=M.+Sasamata&author=M.+Kudou&title=Anti-Tumor+Activity+of+ASP3026.+A+Novel+and+Selective+ALK+Inhibitor+of+Anaplastic+Lymphoma+Kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKuromitsu%26aufirst%3DS.%26atitle%3DAnti-Tumor%2520Activity%2520of%2520ASP3026.%2520A%2520Novel%2520and%2520Selective%2520ALK%2520Inhibitor%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520%2528ALK%2529%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lovly, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuckmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Stanchina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span> </span><span class="NLM_article-title">Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4920</span><span class="NLM_x">–</span> <span class="NLM_lpage">4931</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=4920-4931&issue=14&author=C.+M.+Lovlyauthor=J.+M.+Heuckmannauthor=E.+De+Stanchinaauthor=H.+Chenauthor=R.+K.+Thomasauthor=C.+Liangauthor=W.+Pao&title=Insights+into+ALK-driven+cancers+revealed+through+development+of+novel+ALK+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLovly%26aufirst%3DC.%2BM.%26aulast%3DHeuckmann%26aufirst%3DJ.%2BM.%26aulast%3DDe%2BStanchina%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DPao%26aufirst%3DW.%26atitle%3DInsights%2520into%2520ALK-driven%2520cancers%2520revealed%2520through%2520development%2520of%2520novel%2520ALK%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D14%26spage%3D4920%26epage%3D4931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Katayama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifshits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">River, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey A. Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span> </span><span class="NLM_article-title">Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">7540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=7535-7540&issue=18&author=R.+Katayamaauthor=T.+M.+Khanauthor=C.+Benesauthor=E.+Lifshitsauthor=H.+Ebauthor=V.+M.+Riverauthor=W.+C.+Shakespeareauthor=A.+J.+Iafrateauthor=J.+A.+Jeffrey+A.+Engelmanauthor=A.+T.+Shaw&title=Therapeutic+strategies+to+overcome+crizotinib+resistance+in+non-small+cell+lung+cancers+harboring+the+fusion+oncogene+EML4-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatayama%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DT.%2BM.%26aulast%3DBenes%26aufirst%3DC.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DEb%26aufirst%3DH.%26aulast%3DRiver%26aufirst%3DV.%2BM.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DJeffrey%2BA.%2BEngelman%26aufirst%3DJ.%2BA.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DTherapeutic%2520strategies%2520to%2520overcome%2520crizotinib%2520resistance%2520in%2520non-small%2520cell%2520lung%2520cancers%2520harboring%2520the%2520fusion%2520oncogene%2520EML4-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26issue%3D18%26spage%3D7535%26epage%3D7540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Rivera, V. M.; Anjum, R.; Wang, F.; Zhang, S.; Keats, J.; Ning, Y.; Wardwell, S. D.; Moran, L.; Ye, E.; Chun, D. Y.; Mohemmad, K. Q.; Liu, S.; Huang, W.-S.; Wang, Y.; Thomas, M.; Li, F.; Qi, J.; Miret, J.; Iuliucci, J. D.; Dalgarno, D.; Narasimhan, N. I.; Clackson, T.; Shakespeare, W. C.</span><span> </span><span class="NLM_article-title">Efficacy and Pharmacodynamic Analysis of AP26113, a Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase (ALK)</span>. Presented at the Annual Meeting of the American Association for Cancer Research (AACR), Washington, D.C.,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Abstract 3623.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=V.+M.+Rivera&author=R.+Anjum&author=F.+Wang&author=S.+Zhang&author=J.+Keats&author=Y.+Ning&author=S.+D.+Wardwell&author=L.+Moran&author=E.+Ye&author=D.+Y.+Chun&author=K.+Q.+Mohemmad&author=S.+Liu&author=W.-S.+Huang&author=Y.+Wang&author=M.+Thomas&author=F.+Li&author=J.+Qi&author=J.+Miret&author=J.+D.+Iuliucci&author=D.+Dalgarno&author=N.+I.+Narasimhan&author=T.+Clackson&author=W.+C.+Shakespeare&title=Efficacy+and+Pharmacodynamic+Analysis+of+AP26113%2C+a+Potent+and+Selective+Orally+Active+Inhibitor+of+Anaplastic+Lymphoma+Kinase+%28ALK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DV.%2BM.%26atitle%3DEfficacy%2520and%2520Pharmacodynamic%2520Analysis%2520of%2520AP26113%252C%2520a%2520Potent%2520and%2520Selective%2520Orally%2520Active%2520Inhibitor%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520%2528ALK%2529%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Li, N.; Michellys, P.-Y.; Kim, S.; Pferdekamper, A. C.; Li, J.; Kasibhatla, S.; Tompkins, C. S.; Steffy, A.; Li, A.; Sun, F.; Sun, X.; Hua, S.; Tiedt, R.; Sarkisova, Y.; Marsilje, T. H.; McNamara, P.; Harris, J.</span><span> </span><span class="NLM_article-title">Activity of a Potent and Selective Phase I ALK Inhibitor LDK378 in Naive and Crizotinib-Resistant Preclinical Tumor Models</span>. Presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, San Francisco, CA,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Abstract B232.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=N.+Li&author=P.-Y.+Michellys&author=S.+Kim&author=A.+C.+Pferdekamper&author=J.+Li&author=S.+Kasibhatla&author=C.+S.+Tompkins&author=A.+Steffy&author=A.+Li&author=F.+Sun&author=X.+Sun&author=S.+Hua&author=R.+Tiedt&author=Y.+Sarkisova&author=T.+H.+Marsilje&author=P.+McNamara&author=J.+Harris&title=Activity+of+a+Potent+and+Selective+Phase+I+ALK+Inhibitor+LDK378+in+Naive+and+Crizotinib-Resistant+Preclinical+Tumor+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26atitle%3DActivity%2520of%2520a%2520Potent%2520and%2520Selective%2520Phase%2520I%2520ALK%2520Inhibitor%2520LDK378%2520in%2520Naive%2520and%2520Crizotinib-Resistant%2520Preclinical%2520Tumor%2520Models%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Galkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span> </span><span class="NLM_article-title">Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=270-275&issue=1&author=A.+V.+Galkinauthor=J.+S.+Melnickauthor=S.+Kimauthor=T.+L.+Hoodauthor=N.+Liauthor=L.+Liauthor=G.+Xiaauthor=R.+Steensmaauthor=G.+Chopiukauthor=J.+Jiangauthor=Y.+Wanauthor=P.+Dingauthor=Y.+Liuauthor=F.+Sunauthor=P.+G.+Schultzauthor=N.+S.+Grayauthor=M.+Warmuth&title=Identification+of+NVP-TAE684%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+NPM-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalkin%26aufirst%3DA.%2BV.%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWarmuth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NVP-TAE684%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520NPM-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26issue%3D1%26spage%3D270%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspnes, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klug-McLeod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawistoski, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlynn, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulford, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autry, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzzio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnette, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckbinder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffor, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span> </span><span class="NLM_article-title">Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure–activity relationships and strategies for the elimination of reactive metabolite formation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6071</span><span class="NLM_x">–</span> <span class="NLM_lpage">6077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6071-6077&author=D.+P.+Walkerauthor=F.+C.+Biauthor=A.+S.+Kalgutkarauthor=J.+N.+Baumanauthor=S.+X.+Zhaoauthor=J.+R.+Sogliaauthor=G.+A.+Aspnesauthor=D.+W.+Kungauthor=J.+Klug-McLeodauthor=M.+P.+Zawistoskiauthor=M.+A.+McGlynnauthor=R.+Oliverauthor=M.+Dunnauthor=J.-C.+Liauthor=D.+T.+Richterauthor=B.+A.+Cooperauthor=J.+C.+Kathauthor=C.+A.+Hulfordauthor=C.+L.+Autryauthor=M.+J.+Luzzioauthor=E.+J.+Ungauthor=W.+G.+Robertsauthor=P.+C.+Bonnetteauthor=L.+Buckbinderauthor=A.+Mistryauthor=M.+C.+Grifforauthor=S.+Hanauthor=A.+Guzman-Perez&title=Trifluoromethylpyrimidine-based+inhibitors+of+proline-rich+tyrosine+kinase+2+%28PYK2%29%3A+structure%E2%80%93activity+relationships+and+strategies+for+the+elimination+of+reactive+metabolite+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBi%26aufirst%3DF.%2BC.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DBauman%26aufirst%3DJ.%2BN.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DAspnes%26aufirst%3DG.%2BA.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DKlug-McLeod%26aufirst%3DJ.%26aulast%3DZawistoski%26aufirst%3DM.%2BP.%26aulast%3DMcGlynn%26aufirst%3DM.%2BA.%26aulast%3DOliver%26aufirst%3DR.%26aulast%3DDunn%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.-C.%26aulast%3DRichter%26aufirst%3DD.%2BT.%26aulast%3DCooper%26aufirst%3DB.%2BA.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DHulford%26aufirst%3DC.%2BA.%26aulast%3DAutry%26aufirst%3DC.%2BL.%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26aulast%3DUng%26aufirst%3DE.%2BJ.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DBonnette%26aufirst%3DP.%2BC.%26aulast%3DBuckbinder%26aufirst%3DL.%26aulast%3DMistry%26aufirst%3DA.%26aulast%3DGriffor%26aufirst%3DM.%2BC.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26atitle%3DTrifluoromethylpyrimidine-based%2520inhibitors%2520of%2520proline-rich%2520tyrosine%2520kinase%25202%2520%2528PYK2%2529%253A%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520strategies%2520for%2520the%2520elimination%2520of%2520reactive%2520metabolite%2520formation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6071%26epage%3D6077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span> </span><span class="NLM_article-title">Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1814</span><span class="NLM_x">–</span> <span class="NLM_lpage">1822</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800161s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Knurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1814-1822&author=R.+S.+Obachauthor=A.+S.+Kalgutkarauthor=J.+R.+Sogliaauthor=S.+X.+Zhao&title=Can+in+vitro+metabolism-dependent+covalent+binding+data+in+liver+microsomes+distinguish+hepatotoxic+from+nonhepatotoxic+drugs%3F+An+analysis+of+18+drugs+with+consideration+of+intrinsic+clearance+and+daily+dose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Can In Vitro Metabolism-Dependent Covalent Binding Data in Liver Microsomes Distinguish Hepatotoxic from Nonhepatotoxic Drugs? An Analysis of 18 Drugs with Consideration of Intrinsic Clearance and Daily Dose</span></div><div class="casAuthors">Obach, R. Scott; Kalgutkar, Amit S.; Soglia, John R.; Zhao, Sabrina X.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1814-1822</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In vitro covalent binding assessments of drugs have been useful in providing retrospective insights into the assocn. between drug metab. and a resulting toxicol. response.  On the basis of these studies, it has been advocated that in vitro covalent binding to liver microsomal proteins in the presence and the absence of NADPH be used routinely to screen drug candidates.  However, the utility of this approach in predicting toxicities of drug candidates accurately remains an unanswered question.  Importantly, the years of research that have been invested in understanding metabolic bioactivation and covalent binding and its potential role in toxicity have focused only on those compds. that demonstrate toxicity.  Investigations have not frequently queried whether in vitro covalent binding could be obsd. with drugs with good safety records.  Eighteen drugs (nine hepatotoxins and nine nonhepatotoxins in humans) were assessed for in vitro covalent binding in NADPH-supplemented human liver microsomes.  Of the two sets of nine drugs, seven in each set were shown to undergo some degree of covalent binding.  Among hepatotoxic drugs, acetaminophen, carbamazepine, diclofenac, indomethacin, nefazodone, sudoxicam, and tienilic acid demonstrated covalent binding, while benoxaprofen and felbamate did not.  Of the nonhepatotoxic drugs evaluated, buspirone, diphenhydramine, meloxicam, paroxetine, propranolol, raloxifene, and simvastatin demonstrated covalent binding, while ibuprofen and theophylline did not.  A quant. comparison of covalent binding in vitro intrinsic clearance did not sep. the two groups of compds., and in fact, paroxetine, a nonhepatotoxin, showed the greatest amt. of covalent binding in microsomes.  Including factors such as the fraction of total metab. comprised by covalent binding and the total daily dose of each drug improved the discrimination between hepatotoxic and nontoxic drugs based on in vitro covalent binding data; however, the approach still would falsely identify some agents as potentially hepatotoxic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9_hVRAC3RD7Vg90H21EOLACvtfcHk0lj4FV-_J4vvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Knurw%253D&md5=67c82883825ef529c84d03f462b1f669</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Ftx800161s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800161s%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26atitle%3DCan%2520in%2520vitro%2520metabolism-dependent%2520covalent%2520binding%2520data%2520in%2520liver%2520microsomes%2520distinguish%2520hepatotoxic%2520from%2520nonhepatotoxic%2520drugs%253F%2520An%2520analysis%2520of%252018%2520drugs%2520with%2520consideration%2520of%2520intrinsic%2520clearance%2520and%2520daily%2520dose%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1814%26epage%3D1822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Orhan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeulen, N. P. E.</span><span> </span><span class="NLM_article-title">Conventional and novel approaches in generating and characterization of reactive intermediates from drugs/drug candidates</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.2174%2F138920011795202974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=21395525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1OjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=383-394&author=H.+Orhanauthor=N.+P.+E.+Vermeulen&title=Conventional+and+novel+approaches+in+generating+and+characterization+of+reactive+intermediates+from+drugs%2Fdrug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Conventional and novel approaches in generating and characterization of reactive intermediates from drugs/drug candidates</span></div><div class="casAuthors">Orhan, Hilmi; Vermeulen, Nico P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-394</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite several thousands of drugs are in use currently, research on new drug mols. is continuing.  Because, there are diseases still without medication, successor/better drugs make the predecessor ones obsolete, and advancement in both life sciences and anal. technologies provide identification of previously unknown mechanisms of diseases, and discovery of novel drug targets.  The two main criteria which a drug candidate should meet are high affinity for the target, and no or acceptable/tolerable toxicity in humans.  Among these two, toxicity is the limiting one; developing a drug candidate with unacceptable toxicity has to be discontinued, even if it has an extremely high pharmacol. activity.  Drug would be withdrawn, if serious toxicity arises after marketing.  Since drug development is a long (approx. 10 years), expensive, and infertile (one lead in 10.000 mols.) process, it is extremely important to detect the potential toxicity of drug candidate as early as possible.  Today, it is believed that a great majority of toxic effects are caused by reactive intermediates generated by biotransformation of the parent drug.  However, there are exptl. difficulties in identifying such metabolite(s) in vivo.  Their formation is affected by multi-factorial events; they can further be metabolized to structurally different products, and/or they may bind to a huge variety of biol. sites or macromols.  Hence, some reactive intermediates and their corresponding stable derivs. are generated in trace amts., which make their detn. more difficult.  The ability of cytochrome P450s (CYP450) and other biotransformation enzymes to function in vitro offers a great flexibility to researchers, biotransformation of any compd. can be simulated in a test tube, and metabolites/reactive intermediates are generated in an environment which has relatively much less background and less interfering multi-factorial events compared to in vivo.  To simulate biotransformation, microsomal fraction is used most frequently from human and non-human sources.  Purified or recombinant enzymes are used in detg. the individual isoenzymes responsible for certain metabolites.  Because of the chem. reactivity of intermediates, relevant, usually nucleophilic trapping agent(s) such as glutathione (GSH), N-acetylcysteine (NAC) and cyanide (CN-) are used to stabilize the metabolite.  Trapped metabolites are subjected to spectrometric and/or NMR spectroscopic analyses for structural identification.  Vertiginous advances esp. in mass spectrometric technologies offer researchers new challenges in this area.  This review is aimed at briefly summarizing the state of the art and compiling the highlighted studies in characterization of the reactive metabolites from drug mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkQwfIe6B50LVg90H21EOLACvtfcHk0lj4FV-_J4vvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1OjsLc%253D&md5=ee04c606fbb76c5c59b1b7b5224a89f2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F138920011795202974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920011795202974%26sid%3Dliteratum%253Aachs%26aulast%3DOrhan%26aufirst%3DH.%26aulast%3DVermeulen%26aufirst%3DN.%2BP.%2BE.%26atitle%3DConventional%2520and%2520novel%2520approaches%2520in%2520generating%2520and%2520characterization%2520of%2520reactive%2520intermediates%2520from%2520drugs%252Fdrug%2520candidates%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2011%26volume%3D12%26spage%3D383%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx7002273" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlygsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=129-137&author=T.+A.+Baillie&title=Metabolism+and+toxicity+of+drugs.+Two+decades+of+progress+in+industrial+drug+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and Toxicity of Drugs. Two Decades of Progress in Industrial Drug Metabolism</span></div><div class="casAuthors">Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-137</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The science of drug metab. and pharmacokinetics (DMPK) has developed significantly over the past 20 years, and its functional role in today's pharmaceutical industry has matured to the point where DMPK has become an indispensable discipline in support of drug discovery and development.  While contributions to the lead optimization phase of discovery efforts have been particularly noteworthy in helping to select only the best drug candidates for entry into development, it should be recognized that the scope of DMPK spans the continuum of discovery through clin. evaluation and even into the post-marketing phase; as such, the breadth of DMPK's involvement is almost unique in contemporary pharmaceutical research.  This perspective summarizes notable advances in the field, many of which have been made possible by technol. developments in areas such as mol. biol., genetics, and bioanal. chem., and highlights the crit. nature of key partnerships between Drug Metab., Medicinal Chem., and Safety Assessment groups in attempting to advance drug candidates with a low potential for causing adverse events in humans.  Finally, some speculative predictions are made of the future role of DMPK in pharmaceutical research, where current advances in our mechanistic understanding of the mol. processes that control the absorption, disposition, metab., elimination, and toxicity of drugs and their biotransformation products will combine to further enhance the impact of DMPK in drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkUrTeLhTDYbVg90H21EOLACvtfcHk0liDlfn7nBi0tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlygsrzF&md5=e8f659251bf82cb0b1602855e725c390</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Ftx7002273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx7002273%26sid%3Dliteratum%253Aachs%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DMetabolism%2520and%2520toxicity%2520of%2520drugs.%2520Two%2520decades%2520of%2520progress%2520in%2520industrial%2520drug%2520metabolism%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D129%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_contrib-group">Garcia-Echeverria, C.; Kanazawa, T.; Kawahara, E.; Masuya, K.; Miyake, T.; Ohmori, O.; Unemura, I.; Steensma, R.; Chopiuk, G.; Jiang, J.; Wan, Y.; Ding, Q.; Zhang, Q.; Gray, N. S.; Karanewsky, D. S.</span><span> </span><span class="NLM_article-title">2,4-Pyrimidinediamines Useful in the Treatment of Neoplastic Diseases, Inflammatory and Immune System Disorders</span>. WO2005016894, 2005.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Garcia-Echeverria%2C+C.%3B+Kanazawa%2C+T.%3B+Kawahara%2C+E.%3B+Masuya%2C+K.%3B+Miyake%2C+T.%3B+Ohmori%2C+O.%3B+Unemura%2C+I.%3B+Steensma%2C+R.%3B+Chopiuk%2C+G.%3B+Jiang%2C+J.%3B+Wan%2C+Y.%3B+Ding%2C+Q.%3B+Zhang%2C+Q.%3B+Gray%2C+N.+S.%3B+Karanewsky%2C+D.+S.+2%2C4-Pyrimidinediamines+Useful+in+the+Treatment+of+Neoplastic+Diseases%2C+Inflammatory+and+Immune+System+Disorders.+WO2005016894%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3D2%252C4-Pyrimidinediamines%2520Useful%2520in%2520the%2520Treatment%2520of%2520Neoplastic%2520Diseases%252C%2520Inflammatory%2520and%2520Immune%2520System%2520Disorders" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_contrib-group">Garcia-Echeverria, C.; Kanazawa, T.; Kawahara, E.; Masuya, K.; Matsuura, N.; Miyake, T.; Ohmori, O.; Umemura, I.</span>. <span> </span><span class="NLM_article-title">2,4- Di(phenylamino)pyrimidines Useful in the Treatment of Neoplastic Diseases, Inflammatory and Immune System Disorders</span>. WO2004080980,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=C.+Garcia-Echeverria&author=T.+Kanazawa&author=E.+Kawahara&author=K.+Masuya&author=N.+Matsuura&author=T.+Miyake&author=O.+Ohmori&author=I.+Umemura&title=2%2C4-+Di%28phenylamino%29pyrimidines+Useful+in+the+Treatment+of+Neoplastic+Diseases%2C+Inflammatory+and+Immune+System+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3D2%252C4-%2520Di%2528phenylamino%2529pyrimidines%2520Useful%2520in%2520the%2520Treatment%2520of%2520Neoplastic%2520Diseases%252C%2520Inflammatory%2520and%2520Immune%2520System%2520Disorders%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Strazzolini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giumanini, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runcio, A.</span><span> </span><span class="NLM_article-title">Nitric acid in dichloromethane solution. Facile preparation from potassium nitrate and sulfuric acid</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1387</span><span class="NLM_x">–</span> <span class="NLM_lpage">1389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1387-1389&issue=7&author=P.+Strazzoliniauthor=A.+G.+Giumaniniauthor=A.+Runcio&title=Nitric+acid+in+dichloromethane+solution.+Facile+preparation+from+potassium+nitrate+and+sulfuric+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrazzolini%26aufirst%3DP.%26aulast%3DGiumanini%26aufirst%3DA.%2BG.%26aulast%3DRuncio%26aufirst%3DA.%26atitle%3DNitric%2520acid%2520in%2520dichloromethane%2520solution.%2520Facile%2520preparation%2520from%2520potassium%2520nitrate%2520and%2520sulfuric%2520acid%26jtitle%3DTetrahedron%2520Lett.%26date%3D2001%26volume%3D42%26issue%3D7%26spage%3D1387%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Bossi, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccardo, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgia, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogliatto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, J. A.</span><span> </span><span class="NLM_article-title">Crystal structures of anaplastic lymphoma kinase in complex with ATP competitive inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6813</span><span class="NLM_x">–</span> <span class="NLM_lpage">6825</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi1005514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Clsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6813-6825&author=R.+T.+Bossiauthor=M.+B.+Saccardoauthor=E.+Ardiniauthor=M.+Menichincheriauthor=L.+Rusconiauthor=P.+Magnaghiauthor=P.+Orsiniauthor=N.+Avanziauthor=A.+L.+Borgiaauthor=M.+Nesiauthor=T.+Bandieraauthor=G.+Fogliattoauthor=J.+A.+Bertrand&title=Crystal+structures+of+anaplastic+lymphoma+kinase+in+complex+with+ATP+competitive+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Anaplastic Lymphoma Kinase in Complex with ATP Competitive Inhibitors</span></div><div class="casAuthors">Bossi, Roberto T.; Saccardo, M. Beatrice; Ardini, Elena; Menichincheri, Maria; Rusconi, Luisa; Magnaghi, Paola; Orsini, Paolo; Avanzi, Nilla; Borgia, Andrea Lombardi; Nesi, Marcella; Bandiera, Tiziano; Fogliatto, Gianpaolo; Bertrand, Jay A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">6813-6825</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase involved in the development of several human cancers and, as a result, is a recognized target for the development of small-mol. inhibitors for the treatment of ALK-pos. malignancies.  Here, the crystal structures of the unphosphorylated human ALK kinase domain in complex with the ATP competitive ligands PHA-E429 and NVP-TAE684 are presented.  Anal. of these structures provides valuable information concerning the specific characteristics of the ALK active site as well as giving indications about how to obtain selective ALK inhibitors.  In addn., the ALK-KD-PHA-E429 structure led to the identification of a potential regulatory mechanism involving a link made between a short helical segment immediately following the DFG motif and an N-terminal two-stranded β-sheet.  Finally, mapping of the activating mutations assocd. with neuroblastoma onto the structures may explain the roles these residues have in the activation process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2b8yuzTuAYbVg90H21EOLACvtfcHk0liDlfn7nBi0tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Clsbs%253D&md5=e8e9e3fde63a196a15c874300c995342</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi1005514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1005514%26sid%3Dliteratum%253Aachs%26aulast%3DBossi%26aufirst%3DR.%2BT.%26aulast%3DSaccardo%26aufirst%3DM.%2BB.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBorgia%26aufirst%3DA.%2BL.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26atitle%3DCrystal%2520structures%2520of%2520anaplastic%2520lymphoma%2520kinase%2520in%2520complex%2520with%2520ATP%2520competitive%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D6813%26epage%3D6825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Richmond, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wogan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, W. P.</span><span> </span><span class="NLM_article-title">Interstrain differences of in vitro metabolic stability and impact on early drug discovery</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">4463</span><span class="NLM_x">–</span> <span class="NLM_lpage">4468</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=4463-4468&author=W.+Richmondauthor=M.+Woganauthor=J.+Isbellauthor=W.+P.+Gordon&title=Interstrain+differences+of+in+vitro+metabolic+stability+and+impact+on+early+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichmond%26aufirst%3DW.%26aulast%3DWogan%26aufirst%3DM.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DW.%2BP.%26atitle%3DInterstrain%2520differences%2520of%2520in%2520vitro%2520metabolic%2520stability%2520and%2520impact%2520on%2520early%2520drug%2520discovery%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26spage%3D4463%26epage%3D4468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a> (NCT01283516; NCT01634763; NCT01685060; NCT01685138; NCT01772797; NCT01742286; NCT01828099; NCT01828112).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.clinicaltrials.gov+%28NCT01283516%3B+NCT01634763%3B+NCT01685060%3B+NCT01685138%3B+NCT01772797%3B+NCT01742286%3B+NCT01828099%3B+NCT01828112%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camidge, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felip, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, D. S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vansteenkiste, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldwasser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boral, A. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehra, R.</span><span> </span><span class="NLM_article-title">Results of a first-in-human phase I study of the ALK inhibitor LDK378 in advanced solid tumors</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 9</span><span class="NLM_x">) </span> <span class="NLM_fpage">ix153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=ix153&issue=Suppl.+9&author=A.+T.+Shawauthor=D.+R.+Camidgeauthor=E.+Felipauthor=S.+Sharmaauthor=D.+S.+W.+Tanauthor=D.+Kimauthor=T.+De+Pasauthor=J.+F.+Vansteenkisteauthor=A.+Santoroauthor=G.+Liuauthor=M.+Goldwasserauthor=D.+Daiauthor=A.+L+Boralauthor=R.+Mehra&title=Results+of+a+first-in-human+phase+I+study+of+the+ALK+inhibitor+LDK378+in+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DCamidge%26aufirst%3DD.%2BR.%26aulast%3DFelip%26aufirst%3DE.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DD.%2BS.%2BW.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DDe%2BPas%26aufirst%3DT.%26aulast%3DVansteenkiste%26aufirst%3DJ.%2BF.%26aulast%3DSantoro%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DGoldwasser%26aufirst%3DM.%26aulast%3DDai%26aufirst%3DD.%26aulast%3DBoral%26aufirst%3DA.%2BL%26aulast%3DMehra%26aufirst%3DR.%26atitle%3DResults%2520of%2520a%2520first-in-human%2520phase%2520I%2520study%2520of%2520the%2520ALK%2520inhibitor%2520LDK378%2520in%2520advanced%2520solid%2520tumors%26jtitle%3DAnn.%2520Oncol.%26date%3D2012%26volume%3D23%26issue%3DSuppl.%25209%26spage%3Dix153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Yuan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uvarova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isbell, J.</span><span> </span><span class="NLM_article-title">Peak seeker: an algorithm for rapid determination of solubility</span> <span class="citation_source-journal">J. Lab. Autom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1016%2Fj.jala.2005.03.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=254-257&author=D.+Yuanauthor=V.+Uvarovaauthor=J.+Isbell&title=Peak+seeker%3A+an+algorithm+for+rapid+determination+of+solubility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.jala.2005.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jala.2005.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DD.%26aulast%3DUvarova%26aufirst%3DV.%26aulast%3DIsbell%26aufirst%3DJ.%26atitle%3DPeak%2520seeker%253A%2520an%2520algorithm%2520for%2520rapid%2520determination%2520of%2520solubility%26jtitle%3DJ.%2520Lab.%2520Autom.%26date%3D2005%26volume%3D10%26spage%3D254%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Bell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friche, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bojanic, D.</span><span> </span><span class="NLM_article-title">Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discovery</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm400402q&amp;key=10.1177%2F1087057108317480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm400402q&amp;key=18474896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm400402q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlCms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=343-353&author=L.+Bellauthor=S.+Bickfordauthor=P.+H.+Nguyenauthor=J.+Wangauthor=T.+Heauthor=B.+Zhangauthor=Y.+Fricheauthor=A.+Zimmerlinauthor=L.+Urbanauthor=D.+Bojanic&title=Evaluation+of+fluorescence-+and+mass+spectrometry-based+CYP+inhibition+assays+for+use+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discovery</span></div><div class="casAuthors">Bell, Leslie; Bickford, Shari; Nguyen, Phong Hung; Wang, Jianling; He, Timothy; Zhang, Bailin; Friche, Yannick; Zimmerlin, Alfred; Urban, Laszlo; Bojanic, Dejan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">343-353</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The potential for metab.-related drug-drug interactions by new chem. entities is assessed by monitoring the impact of these compds. on cytochrome P 450 (CYP) activity using well-characterized CYP substrates.  The conventional gold std. approach for in vitro evaluation of CYP inhibitory potential uses pooled human liver microsomes (HLM) in conjunction with prototypical drug substrates, often quantified by LC-MS/MS.  However, fluorescent CYP inhibition assays, which use recombinantly expressed CYPs and fluorogenic probe substrates, have been employed in early drug discovery to provide low-cost, high-throughput assessment of new chem. entities.  Despite its greatly enhanced throughput, this approach has been met with mixed success in predicting the data obtained with the conventional gold std. approach (HLM+LC-MS).  The authors find that the predictivity of fluorogenic assays for the major CYP isoforms 3A4 and 2D6 may depend on the quality of the test compds.  Although the structurally more optimized marketed drugs yielded acceptable correlations between the fluorogenic and HLM+LC-MS/MS assays for CYPs 3A4, 2D6, and 2C9 (r2 = 0.5-0.7; p < 0.005), preoptimization, early discovery compds. yielded poorer correlations (r2 ≤ 0.2) for 2 of these major isoforms, CYPs 3A4 and 2D6.  Potential reasons for the obsd. differences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGothNUqezlyHbVg90H21EOLACvtfcHk0lhXaIiWNSF6FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlCms7o%253D&md5=47a1c730535a0fd9762bf93b8ec3e5d1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1177%2F1087057108317480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057108317480%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DL.%26aulast%3DBickford%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DP.%2BH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DFriche%26aufirst%3DY.%26aulast%3DZimmerlin%26aufirst%3DA.%26aulast%3DUrban%26aufirst%3DL.%26aulast%3DBojanic%26aufirst%3DD.%26atitle%3DEvaluation%2520of%2520fluorescence-%2520and%2520mass%2520spectrometry-based%2520CYP%2520inhibition%2520assays%2520for%2520use%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2008%26volume%3D13%26spage%3D343%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Matthews, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosker, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudenski, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treacher, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. C.</span><span> </span><span class="NLM_article-title">Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=412-419&author=D.+R.+Matthewsauthor=J.+P.+Hoskerauthor=A.+S.+Rudenskiauthor=B.+A.+Naylorauthor=D.+F.+Treacherauthor=R.+C.+Turner&title=Homeostasis+model+assessment%3A+insulin+resistance+and+%CE%B2-cell+function+from+fasting+plasma+glucose+and+insulin+concentrations+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DD.%2BR.%26aulast%3DHosker%26aufirst%3DJ.%2BP.%26aulast%3DRudenski%26aufirst%3DA.%2BS.%26aulast%3DNaylor%26aufirst%3DB.%2BA.%26aulast%3DTreacher%26aufirst%3DD.%2BF.%26aulast%3DTurner%26aufirst%3DR.%2BC.%26atitle%3DHomeostasis%2520model%2520assessment%253A%2520insulin%2520resistance%2520and%2520%25CE%25B2-cell%2520function%2520from%2520fasting%2520plasma%2520glucose%2520and%2520insulin%2520concentrations%2520in%2520man%26jtitle%3DDiabetologia%26date%3D1985%26volume%3D28%26spage%3D412%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xb7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xb7','PDB','2xb7'); return false;">PDB: 2xb7</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i62"><a href="/doi/suppl/10.1021/jm400402q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_36176"></div></div></div></div></div><hr /></hr><p class="last">GSH-trapping results (LC–UV) for <b>4</b> and <b>15b</b>, body weight of animals from Karpas299 and H2228 xenograft studies, superposition of compounds <b>15b</b> and <b>16e</b> in ALK kinase domain, and kinase selectivity comparison between <b>4</b> and <b>7</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400402q/suppl_file/jm400402q_si_001.pdf">jm400402q_si_001.pdf (913.86 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400402q&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-14%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm400402q" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400402q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b4ada3f1d1949","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
